dbgap_rnaseq_sample	dbgap_dnaseq_sample	dbgap_subject_id	cohort	used_manuscript_analyses	manuscript_dnaseq	manuscript_rnaseq	manuscript_inhibitor	consensus_sex	inferred_sex	reportedRace	reportedEthnicity	inferred_ethnicity	centerID	CEBPA_Biallelic	consensusAMLFusions	ageAtDiagnosis	age_high	isRelapse	isDenovo	isTransformed	specificDxAtAcquisition_MDSMPN	nonAML_MDSMPN_specificDxAtAcquisition	priorMalignancyNonMyeloid	priorMalignancyType	cumulativeChemo	priorMalignancyRadiationTx	priorMDS	priorMDSMoreThanTwoMths	priorMDSMPN	priorMDSMPNMoreThanTwoMths	priorMPN	priorMPNMoreThanTwoMths	dxAtInclusion	specificDxAtInclusion	ELN2017	dxAtSpecimenAcquisition	specificDxAtAcquisition	ageAtSpecimenAcquisition	timeOfSampleCollectionRelativeToInclusion	specimenGroups	diseaseStageAtSpecimenCollection	specimenType	rnaSeq	exomeSeq	totalDrug	analysisRnaSeq	analysisExomeSeq	analysisDrug	cumulativeTreatmentTypeCount	cumulativeTreatmentTypes	cumulativeTreatmentRegimenCount	cumulativeTreatmentRegimens	cumulativeTreatmentStageCount	cumulativeTreatmentStages	responseToInductionTx	typeInductionTx	responseDurationToInductionTx	mostRecentTreatmentType	currentRegimen	currentStage	mostRecentTreatmentDuration	vitalStatus	overallSurvival	causeOfDeath	X..Basophils.in.PB	X..Blasts.in.BM	X..Blasts.in.PB	X..Eosinophils.in.PB	X..Immature.Granulocytes.in.PB	X..Lymphocytes.in.PB	X..Monocytes.in.PB	X..Neutrophils.in.PB	X..Nucleated.RBCs.in.PB	ALT	AST	albumin	creatinine	fabBlastMorphology	hematocrit	hemoglobin	karyotype	LDH	MCV	otherCytogenetics	plateletCount	platelet_high	surfaceAntigensImmunohistochemicalStains	CD7.Pos.	CD33	totalProtein	wbcCount	wbccount_High	FLT3.ITD	allelic_ratio	NPM1	RUNX1	ASXL1	TP53	variantSummary	SF3B1_Mutation	SRSF2_Mutation	U2AF1_Mutation	ZRSR2_Mutation	Splicing_Mutation_either_or_SF3B1_SRSF2_U2AF1_ZRSR2	AML_MDS_wSplicingMachinery_Mutation	Found	IDH2	TET2	DNMT3A	SF3B1_Mut	platelet_high.1	Inv16_Pos	ASXL1_Mutated	TP53_Mutated	RUNX1_Mutated	FLT3_ITD_Mutated	wbccount_High.1	HighInflammation	High_AtypicalBcell	IL18R1_Expression	IL18RAP_Expression	IL1R1_Expression	IL2RB_Expression	IL4R_Expression	CXCL6_Expression	CLEC5A_Expression	IL18R1_high	IL18RAP_high	IL1R1_high	IL2RB_high	IL4R_high	CXCL6_high	CLEC5A_high	Monocyte.like	GMP.like	HSC.like	Progenitor.like	Promono.like	cDC.like	Monocyte_like	GMP_like	HSC_like	Progenitor_like	Promono_like	cDC_like	Inflammation_Scores
BA2452R	BA2452D	2157	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			34	#REF!	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	36	574	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	4	Consolidation|Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Salvage	43	Dead	595	Dead-Unknown	1	90	30	0	NA	46	30	8	NA	43	11	2.8	0.92	M4	25.5	9.1	"46,XY,add(17)(p13)[19]/46,XY[1]"	123	85	Normal	14	FALSE	"partial CD7, CD13, CD33, CD38, dim CD45, dimCD58, CD117, CD123, and HLA-DR"	TRUE	TRUE	5.8	0.6	FALSE	positive	0.960784314	positive									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	1.816067625	2.436852961	0.872750258	4.332317747	4.264750825	1.124399465	-0.229320236	no	no	no	yes	no	yes	no	NA	NA	NA	NA	NA	NA							0.279352153
BA2922R		2269	Waves1+2	yes	no	yes	yes	Male	Male	White	NON-HISPANIC	White	1		DEK-NUP214	11	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(6;9)(p23;q34); DEK-NUP214	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(6;9)(p23;q34); DEK-NUP214	14	950	Relapse|Post-Transplant|Post-Chemotherapy	Relapse	Bone Marrow Aspirate	y	n	y	y	n	y	6	DLI|Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)|Intrathecal|Targeted Therapy - Other	13	"Cyclophosphamide, TBI|HAM (Cytarabine, Mitoxantrone)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine|Cytarabine, Mitoxantrone, Sorafenib|ADE (Cytarabine, Daunorubicin & Etoposide)|Donor Lymphocyte Infusion|Cytarabine|Sorafenib|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Treo/Flu/TBI (Treosulfan, Fludarabine, Total Body Irradiation)|Methotrexate|Etoposide, Cytarabine"	8	Allogeneic - Sibling|Consolidation|Unknown|Induction|Experimental|Intensification|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	9	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	187	Dead	1655	Dead-Disease	0	80		3	NA	78	3	16	NA	42	38	4.3	0.66	M2	41.6	14.3	"48,X,-Y,+4,t(6;9)(p22;q34),+8,+10,del(15)(q11.2q15)[20]"	NA	102.9	"DEK/NUP probe set; 70/100 (70%) interphasecells scored had a 1 red/ 1 green/ 2 yellow fusion signal pattern,consistent with DEK/NUP fusion and the 6;9 translocation observed in themetaphase karyotype."	50	FALSE	"CD13, CD33, CD34, CD38, CD117,CD123, dim HLA-DR, partial MPO"	FALSE	TRUE	7.6	2.2	FALSE	positive	NA					FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	2.946448477	3.082528406	-0.902763299	5.16463166	5.821912698	-2.269707889	3.250455895	yes	no	no	yes	no	no	no	-4.058149855	-1.760976172	1.883120178	4.110471093	-4.973167482	-1.522018609	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.470393677
BA2707R	BA2707D	2313	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			68	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	y	Lung Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	72	1207	Relapse|Post-Chemotherapy	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|MiDAC|Decitabine"	3	Consolidation|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	Decitabine	Supportive/Palliative Care	9	Dead	1238	Dead-Disease	0			0	NA	14.9	0.8	2.5	0	NA	NA	NA	NA	NOS	22.7	7.6	"47,XY,del(9)(q22),+13[18]/48,idem,+mar[2]"	556	93.8	Missing ABL and ASS signal (84%)	32	TRUE	"partial CD7, CD11b, CD13, CD33, CD34, partial CD64, partial CD117, CD123, HLA-DR, and TdT-positive."	TRUE	TRUE	NA	47.2	TRUE	negative	0	negative	RUNX1 (p.A147Gfs*13; 42.3%)|RUNX1 (p.R162S; 46.5%)	ASXL1 (p.G646Wfs*12; 27.9%)		RUNX1 (p.A147fs*13 (1 bp insertion frameshift); MAF 35%)|RUNX1 (p.R162S; MAF 50%)|SRSF2 (p.P95R; MAF 44%)		yes			yes		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	4.127338634	3.65036235	2.338146061	4.126543631	6.634346624	-2.151569342	1.287690856	yes	yes	no	yes	yes	no	no	NA	NA	NA	NA	NA	NA							0.622701277
BA2409R		2418	Waves1+2	yes	no	yes	yes	Female	Female	White	NON-HISPANIC	White	1			71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|MiDAC|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	4	Allogeneic - Sibling|Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	7	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Sibling	-1	Dead	397	Dead-Disease	0	68		1	NA	30	49	3	NA	14	18	3	0.85	M5	21.9	7.6	"46,XX[20]"	313	102.9	Normal	125	TRUE	"Blast Immunphenotype: CD13, CD33, CD34, CD38, dim CD45, CD117, CD123, and HLA-DR positive; Promonocyte Immunophenotype: CD11b, CD13, CD14, CD33, CD64, and HLA-DR"	FALSE	TRUE	5.5	14.9	FALSE	negative	0	negative				BRAF (G596R)|WT1 (2400/10000 copies)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	2.618288999	3.94134755	2.767296088	4.876919069	6.782553544	-2.52260439	4.385969847	no	yes	yes	yes	yes	no	no	5.582509094	-0.257448851	-0.567137562	-3.552045511	2.011112581	6.617134536	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.735846279
BA2480R		2374	Waves1+2	yes	no	yes	no	Male	Male	Asian	NON-HISPANIC	Asian	1			56	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	60	309	Relapse|Post-Chemotherapy	Relapse	Peripheral Blood	y	n	y	y	n	y	1	Standard Chemotherapy	8	"7+3 (Cytarabine, Idarubicin)|HiDAC|Cytarabine|3+7 (Cytarabine, Daunorubicin)|Azacitidine|3+3 plus Sorafenib|Clofarabine|Clofarabine, Cytarabine"	4	Consolidation|Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Cytarabine	Consolidation	64	Dead	1735	Dead-Disease	0	77.5	75	1	NA	16	1	4	NA	NA	NA	NA	NA	NOS	26.3	9.3	"46,XY[4]"	NA	87.8	Normal	9	FALSE	"CD13, CD33, partial CD56, CD58, CD64, dim CD117, CD123and partial/dim cMPO positive"	FALSE	TRUE	NA	7.9	FALSE	positive	2.448275862	positive									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	2.338827778	3.937987222	6.654599047	5.579354969	5.041039969	-1.138252503	2.688451126	no	yes	yes	yes	no	no	no	-2.231237945	1.03979146	-0.989030828	-0.150831988	2.551645686	-3.367779148	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.62561048
BA2496R		2099	Waves1+2	yes	no	yes	yes	Male	Male	White	NON-HISPANIC	White	1			70	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	Chronic myelomonocytic leukaemia	MissingMutations	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	70	34	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	4	"Dasatinib|7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine"	4	Salvage|Experimental|Maintenance|Re-induction			NA	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Salvage	4	Dead	311	Dead-Disease	5	36	9	5	NA	21	38	22	NA	19	22	3.6	1.18	M4	28.7	9.7	"46,XY[20]"	231	99.6	Normal	47	FALSE	"CD11b, CD13, CD14, CD15, variable CD16, dim CD33, CD58, bright CD64, HLA-DR positive"	FALSE	TRUE	7.1	21	TRUE	positive	0.111111111	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	3.159853293	6.153532585	4.353157094	4.392551037	6.506492119	-0.783198133	7.202313187	yes	yes	yes	yes	yes	yes	yes	5.683529556	3.35664468	-2.213232295	-3.58542475	4.994425255	3.010298637	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.704044459
BA3037R		2391	Waves1+2	yes	no	yes	yes	Female	Female	White	NON-HISPANIC	White	1			55	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Hodgkin Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	55	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Dead	707	Dead-Disease	0	88		0	NA	6	0	1	NA	19	26	3.4	0.88	M1	28.2	9.6	"46,XX[20]"	678	99.9	Normal	19	TRUE	"partial CD7, CD13, CD25, CD33, partial CD34, dim CD45, CD117, CD123, and partial HLA-DR positive"	TRUE	TRUE	6.8	17.9	FALSE	positive	NA	positive				FLT3-ITD|NPM1|WT1 (8000/10000 copies (High))					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	2.49376655	3.772117493	1.8714754	3.225490031	6.749627317	0.716051259	-1.636140113	no	yes	no	no	yes	yes	no	-6.754582595	-6.094512677	2.533042714	1.444974266	-6.808377614	-3.876258032	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.515793481
BA2236R	BA2236D	2446	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			54	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	57	349	Relapse|Post-Chemotherapy	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	7	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|GCLAC (GCSF, Clofarabine & Cytarabine)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine"	5	Consolidation|Salvage|Induction|Re-induction|Maintenance	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	Decitabine	Re-induction	160	Dead	1378	Dead-Disease	3	71	83	2	NA	5	10	4	NA	35	31	3.9	0.81	M4	33.7	11.7	"47,XY,+21[17]/47,idem,t(10;22)(q22;q13)[cp3]/46,XY[1]"	438	100.6	80% Trisomy 21	119	TRUE	"CD13, CD33, CD38, CD58, dim CD64, CD117, and CD123"	FALSE	TRUE	7.1	33.8	TRUE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.753543555	3.620911573	0.598455727	4.574779733	5.596997549	-1.412061693	3.922874998	no	yes	no	yes	no	no	no	0.630568648	0.520923943	-1.1966538	1.13372074	2.80777444	-3.184384006	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.601911945
BA2172R		2398	Waves1+2	yes	no	yes	yes	Male	Male			AdmixedBlack	7		KMT2A_re	NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	unknown	18	0	Unknown	Unknown	Peripheral Blood	y	n	y	y	n	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	3.166388755	0.956023598	2.105891818	3.777002677	5.724803762	-0.68144834	0.763191644	yes	no	no	yes	no	yes	no	-5.143000449	2.369759986	-3.808005227	2.699183235	4.305038283	1.705862055	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.460701431
BA2865R		2271	Waves1+2	yes	no	yes	yes	Female	Female	White	NON-HISPANIC	White	1			50	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	50	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|ATRA (Tretinoin)|HiDAC|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	27	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Sibling	-1	Alive	3129	Alive	0	90	82	0	NA	1	0	2	NA	19	30	2.8	0.86	M0 	26.4	9.1	"46,XX,t(11;17)(q13;q21)[20]"	1165	97.7	"While the chromosome 17 breakpoint is clearly within band 17q21 by metaphase chromosome analysis, these results suggest that it is not within the RARA gene"	8	FALSE	"dim CD4, CD13, dim CD15, dim CD33, CD38, CD58,CD64, CD117, CD123, dim HLA-DR, and cMPO"	FALSE	TRUE	5.3	84.1	TRUE	negative	0	positive		CAS		"FLT3 (A680V)|NPM1 (W288fs*12 )|WT1 (5000/10,000 copies)"					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.854913955	1.766538076	-1.367205179	1.883679389	4.97212947	-0.670700712	1.488141969	no	no	no	no	no	yes	no	-5.988145786	-0.011238579	0.573314901	4.330595575	-1.897896762	-4.187610969	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.282228058
BA2923R		2545	Waves1+2	yes	no	yes	yes	Female	Female	White	NON-HISPANIC	White	1			81	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Anal carcinoma|Breast Cancer	y	y	n	n	y	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	81	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	n	y	y	n	y	1	Supportive/Palliative Care	1	Azacitidine	1	Supportive/Palliative Care			NA	Supportive/Palliative Care	Azacitidine	Supportive/Palliative Care	42	Dead	147	Dead-Disease	0			0	NA	12	33	7	NA	60	64	3.2	1.08	M5	26.6	8.8	"46,XX,t(8;16)(p11.2;p13.3)[8]/46,XX,del(7)(q11.2q22),del(20)(q13.1q13.3)[cp3]/46,XX[12]"	2700	92.4		46	TRUE		NA	NA	6.3	37.1	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	2.485156805	3.374907441	3.885043273	2.724323595	6.091280648	-0.703332767	4.419375859	no	no	yes	no	yes	yes	yes	4.173172522	2.015685594	-5.949381075	-5.857489378	6.714422725	3.530379477	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.710628159
BA2003R	BA2003D	2491	Both	no	no	no	no	Female	Female			AdmixedAsian	3			57	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	58	215	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Unknown	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	-1	Dead	257	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	positive	2.125	positive				FLT3-ITD|NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	TRUE	TRUE	2.301550208	4.385585013	4.521531936	0.83513308	5.90273863	0.846900161	2.913586334	no	yes	yes	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.601859182
BA2751R		2518	Waves1+2	yes	no	yes	yes	Male	Male	White	NON-HISPANIC	White	1			72	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	n	y	y	n	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	3	Dead-Other	0	95	82.5	0	NA	3	0	1	NA	47	58	2.7	0.96	M4	16.5	5.6	"46,XY[20]"	697	114	Normal	51	TRUE	"Blast phenotype: æCD13, partial CD33, CD34, CD38, CD58, CD123, HLA-DR and TdT-positive; Monocytic phenotype: æCD11b, CD14, CD33, CD38, CD58, CD64 and HLA-DR-positive"	FALSE	TRUE	4.9	97	TRUE	positive	1	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.331238766	0.419035769	1.310784323	2.279003402	5.895604023	-2.774023722	-0.049935508	no	no	no	no	no	no	no	-1.529701967	-3.697088278	2.173008069	0.560753671	-3.11702084	3.048338497	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.442938766
BA3395R		2771	Waves3+4	yes	no	yes	yes	Male	Male	White	NON-HISPANIC		1			68	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	68	132	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	n	y	y	n	y	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|Azacitidine|Azacitidine, Lenalidomide|Decitabine"	3	Unknown|Induction|Re-induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	Decitabine	Re-induction	9	Dead	344	Dead-Unknown	18	20	occasional	4	NA	39	16	4	NA	25	14	2.5	0.8	NOS	28.4	9.5	"41~46,XY,add(4)(p16),del(5)(q15q33),inv(7)(q11q34),-13,add(14)(p11.1),-16,-17,-18,add(19)(q13.1),-20,i(21)(q10),+1~4mar[cp10]/43~45,idem,-add(4)(p16),der(4)add(4)(p16)add(4)(q31)[cp10]"	215	89	5q deletion (64%) | Monosomy 16 and derivative chromosome 16 (91%)	72	TRUE	"CD13, CD33, CD34, CD56, CD117, dim CD123, HLA-DR, partial TdT positive"	FALSE	TRUE	6.5	1.2	FALSE		NA										no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	4.988973428	4.233563736	4.561451145	4.186758304	6.800524823	-1.24729776	7.577242191	yes	yes	yes	yes	yes	no	yes	2.206107467	3.847556225	-0.75209442	-2.548380542	3.983088008	-1.222745245	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.702307006
BA2286R		2340	Waves1+2	yes	no	yes	yes	Male	Male	White	NON-HISPANIC	White	1			61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	1	Standard Chemotherapy	1	"3+7 (Cytarabine, Daunorubicin)"	1	Induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	7	Alive	33	Alive	0	46		1	NA	24	5	4	NA	18	34	3.2	1.05	M2	26.4	8.8	"46,XY[20]"	551	89.1	Normal	72	TRUE	"CD13, CD33, CD34, CD117, dim CD123, HLA-DR,partial MPO (+)"	FALSE	TRUE	7	16.5	FALSE	negative	0	negative				FLT3-D835					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.17709681	3.364576432	2.127162092	4.970696446	4.520818727	-0.071873815	3.731965881	no	no	no	yes	no	yes	no	-1.125811325	1.74550153	1.836798141	3.12689545	-1.057302628	0.356730021	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.541390621
BA2488R	BA2488D	2489	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		PML-RARA	83	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	83	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	3	"Ruxolitinib|ATRA, Arsenic Trioxide|Idarubicin"	3	Induction|Maintenance|Symptom Control	Complete Response	Standard Chemotherapy	253	Standard Chemotherapy	Idarubicin	Symptom Control	0	Alive	2806	Alive	0	75	70	0	NA	17	2	23	NA	14	9	3.7	0.7	M3	23.4	8.1	"46,XX,t(15;17)(q24;q21)[12]/46,XX,idem,del(16)(q12.1q24)[3]/46,XX[5]"	367	86.2	7% 16q deletion	NA	NA	"CD13, CD33, partial CD34, CD64, CD117, CD123, and MPO-positive"	FALSE	TRUE	6.8	6	FALSE	negative	0	negative				FLT3-D835 (D835H; MAF Unlisted)|JAK2 (p.V617F; MAF 90%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	4.676015167	2.826083175	5.508704	3.986916909	6.502006447	-0.045352146	6.870253974	yes	no	yes	yes	yes	yes	yes	-3.755848879	4.073995856	-2.48745655	-0.241451484	1.175612835	-3.417204321	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.537408021
BA3379R	BA3379D	2606	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			34	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	Acute undifferentiated leukaemia	Intermediate	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	Acute undifferentiated leukaemia	34	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Cyclophosphamide, TBI|7+3 (Cytarabine, Idarubicin)|HAM-VD (Cytarabine, Mitoxantrone, Vincristine, Dexamethasone)"	4	Allogeneic - Sibling|Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Cyclophosphamide, TBI"	Allogeneic - Sibling	-1	Alive	3022	Alive	NA	88		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	231	NA	cryptic t(14;21) (54.5% of cells had three signals for AML1)	NA	NA	"CD2 , CD7 , CD13 , CD34 , dim CD45 , CD117 , HLA-DR , TdT positive"	TRUE	FALSE	NA	31.9	TRUE	positive	0.041666667	negative				FLT3-D835|FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.512021694	2.160300314	2.989419414	2.907121591	6.196469588	-1.377359964	6.156087196	no	no	yes	no	yes	no	yes	-2.16611495	-0.511113962	-0.082571484	3.328493848	-3.68876295	3.413660923	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.566532518
BA2887R		2038	Waves1+2	yes	no	yes	yes	Male	Male	White	NON-HISPANIC	White	1			24	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	24	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	4	DLI|Standard Chemotherapy|Bone Marrow Transplant|Other	8	"7+3 (Cytarabine, Idarubicin)|HiDAC|Donor Lymphocyte Infusion|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Radiation|Busulfan, Cyclophosphamide"	7	Consolidation|Salvage|Unknown|Induction|Re-induction|Maintenance|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Azacitidine	Maintenance	-1	Dead	2531	Dead-Disease	0	88		0	NA	3	40	3	NA	13	14	2.8	0.62	M4	31.7	10.9	"47,XY,+10[18]/46,XY[2]"	419	86.3	Normal	89	TRUE	"CD11b, dim CD13, dim CD14, CD33, CD34, dim CD38, partialCD56, CD58, partial CD64, CD117, CD123, dim HLA-DR, and MPO"	FALSE	TRUE	5.8	21.7	TRUE	negative	0	negative				NOTCH1 (p.V1578delV; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	6.469768497	6.722961063	0.536685131	3.162049715	4.427366397	1.240437317	5.855422004	yes	yes	no	no	no	yes	yes	-3.182351085	-2.576140344	0.536770381	2.392116605	-5.272407663	0.115814794	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.466574128
BA2712R	BA2712D	2034	Both	no	no	no	no	Female	Female	White	NON-HISPANIC	White	2			61	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Follicular lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	61	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	16	Dead-Disease	1	50	89	1	NA	0	0	0	NA	61	NA	2.5	0.84		25.3	8.4		NA	102.8		24	TRUE	"CD2(-), CD4(dim +), CD7(-), CD11b(partial +), CD13(partial +), CD14(partial +), CD15(variably and slightly bright +), CD16 (-), CD33(variably bright +), CD34(-), CD36(partial +), CD38(variably +), CD45(variably +), CD56(+), CD64(partial +), CD117(-), HLA-DR(partial dim +), MPO(+), TdT(-). (92% population of medium-sized to large cells)"	TRUE	TRUE	4.5	53	TRUE	negative	0	negative		ASXL1 (p.G646Wfs*12; 28.6%)							no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	0.53831539	0.92389842	3.110493976	2.702852354	6.264749662	-2.141896136	2.221876593	no	no	yes	no	yes	no	no	NA	NA	NA	NA	NA	NA							0.627248065
BA2858R	BA2858D	2087	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			70	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	73	93	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|Azacitidine"	2	Induction|Maintenance	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Azacitidine	Maintenance	-1	Dead	1165	Dead-Unknown	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[19]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	5.129802898	7.302256202	5.605043448	4.479731694	6.641865947	2.573099734	6.129474278	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.77722586
BA2068R	BA2068D	2469	Waves1+2	yes	yes	yes	yes	Female	Female	Black	NON-HISPANIC	Black	2			64	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	64	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Induction	5	Alive	1112	Alive	1.4	76	0	0.1	NA	94.3	1.5	2.7	NA	22	20	3.6	0.48		32.6	10.9	"46,XX[14]"	184	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x2[199],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2[200],"	32	TRUE	"CD4(few +), CD7(-), CD11b(-), CD13(-), CD14(-), CD15(partial +), CD16(-), CD34(-), CD36(-), CD38(+), CD45(+), CD56(few +), CD64(-), CD117(partial +), HLA-DR(-), MPO(+) and TdT (+)"	TRUE	FALSE	7.5	1.5	FALSE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	3.153795923	3.633583208	0.411929265	4.846678463	3.909462302	-1.436271149	-0.824696888	yes	yes	no	yes	no	no	no	-5.211062447	-1.684650554	0.382068096	0.873006495	-0.34129293	-5.88285197	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.49639547
BA2104R	BA2104D	2378	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			83	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Colon Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	83	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	9	Dead-Disease	0		90	0	NA	9	7	4	NA	242	341	1.9	2.48	M5	17.6	6.2	"47,XY,+8[6]/46,XY[13] (Specimen Source: Blood)"	2037	94.5	trisomy 8 (Specimen Source: Blood)	14	TRUE	"CD11b, CD13, dimCD14, CD15, dim CD16, CD33,     CD56,     CD58, CD64, CD123, and HLA-DR positive"	FALSE	TRUE	3.6	82	TRUE	negative	0	positive				FLT3-D835 (bone marrow)|NPM1 (An insertion mutation is present in exon 12 (near the C-terminus) of NPM.)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.500750377	3.993051187	2.754855677	2.865464441	6.958955598	-0.654487552	2.405879253	no	yes	yes	no	yes	yes	no	NA	NA	NA	NA	NA	NA							0.799098298
BA3124R	BA3124D	2832	Waves3+4	yes	yes	yes	no	Female	Female	White	NON-HISPANIC		1			62	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute erythroid leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute erythroid leukaemia	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|MiDAC|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Sibling	-1	Dead	1472	Dead-Disease	1	26		0	NA	26	1	64	NA	21	14	3.7	0.76	M6	32.5	10.4	"46,XX,del(16)(q22q23)[8]/46,XX[12]"	159	96.1	del(16q)	19	FALSE	"CD13, dim CD14, CD33, CD34, CD38, CD58, CD123, CD117, HLA-DR, partial cTdT and cMPO positive"	FALSE	TRUE	7.4	2.9	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.882506734	4.430629509	3.095454443	7.131214805	7.310398123	-1.995974726	3.317825524	yes	yes	yes	yes	yes	no	no	0.241199782	-1.769717179	-0.413087344	-0.948683902	-4.370395428	-1.176440209	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.675715583
BA2921R	BA2921D	2466	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	2			70	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	71	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	2	"7+3 (Cytarabine, Idarubicin)|Azacitidine"	2	Hypomethylating/Low Dose Cytarabine|Induction	Refractory	Standard Chemotherapy	-1	Supportive/Palliative Care	Azacitidine	Hypomethylating/Low Dose Cytarabine	-1	Dead	194	Dead-Disease	NA		78	NA	NA	12	5	3	NA	NA	NA	NA	1.12		24.7	8.2	"46,XY,del(7)(q22q36)[7]/47,idem,+22[cp12]/46,XY[1]"	NA	89.2	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1x2,D7S522x1)[187/200], (D8Z2,D20S108)x2[199],(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200], (5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	18	TRUE		NA	NA	NA	24.4	TRUE	positive	0.01010101	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	2.7826323	2.339523285	-0.213289563	3.081389854	4.726329025	-0.189052417	2.045968491	no	no	no	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.54984282
BA2449R		2081	Waves1+2	yes	no	yes	yes	Female	Female	White	NON-HISPANIC	White	1		RUNX1-RUNX1T1	7	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	7	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	1	Standard Chemotherapy	1	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	2	Induction|Re-induction	Complete Response	Standard Chemotherapy	9	Standard Chemotherapy	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	Re-induction	-1	Dead	158	Dead-Treatment	0	85	30	0	NA	42	0	27	NA	18	19	3.9	0.41	M1	27.7	9.4	"46,XX,t(8;21)(q22;q22)[19]/46,XX[1]"	747	90.5	"91.5% AML/ETO fusion, t(8;21)"	71	TRUE	"CD13, CD33, CD34, CD56, CD71, CD117, HLA-DR, MPO-positive"	TRUE	TRUE	7.3	4.8	FALSE	negative	0	negative				KIT (D816V; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.233074617	2.521438608	2.724935193	2.246470288	6.054486595	0.43652254	6.704229774	no	no	no	no	yes	yes	yes	-4.829207197	3.84705426	-1.289468637	2.444055769	-1.836987659	-0.908617509	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.340102977
BA2360R	BA2360D	2298	Waves1+2	yes	yes	yes	yes	Male	Female	White	NON-HISPANIC	White	1	bi		78	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Bladder Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	79	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	Decitabine	Induction	-1	Dead	267	Dead-Disease	0	87	72	1	NA	17	4	1	NA	19	41	3.4	0.75		32.3	10.6	"45,X,-Y[19]/46,XY[1]"	460	103.6	Normal	15	FALSE	"CD7, CD13, CD33, partial CD34, CD117, CD123, HLA-DR, MPO +"	TRUE	TRUE	6.2	8.5	FALSE	negative	0	negative				CEBPA (1031?1032 ins AAC; MAF 50%)|CEBPA (347?348 del GACCTGT; MAF 50%)|WT1 (p.R369R; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.54890583	3.452517009	0.773842173	3.207239133	3.622347941	-1.202192208	4.706267864	yes	no	no	no	no	no	yes	-3.755787065	-1.607296908	-1.188335148	3.242058389	-3.439997331	1.535237229	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.28881908
BA2802R	BA2802D	2005	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			52	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	NonInitial	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	53	234	Post-Transplant|Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	6	"7+3 (Cytarabine, Idarubicin)|Sunitinib|HAM (Cytarabine, Mitoxantrone)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Decitabine|Busulfan, Cyclophosphamide"	5	Salvage|Induction|Re-induction|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Salvage	80	Dead	404	Dead-Disease	0	50		0	NA	9	2	29	NA	32	34	3.7	0.68		34	11.1	"45~48,XY,+5,add(5)(q11.2)x2,t(7;7)(q22;q36),+11,add(13)(q13),-22[cp9]/45~47,sl,-add(5)(q11.2),der(11)t(11;12)(p11.2;q13),-12[cp6]/46,sl,t(Y;18)(p11.2;q21),der(9)t(9;17)(p13;q11.2),-17[2]/46,XY[3]"	167	102.8	Deleted 5q	152	TRUE	"partial CD7, CD13, CD33, CD34, partial CD56, CD58, HLA-DR, and partial MPO-positive CD117, CD123,"	TRUE	TRUE	6.7	14	FALSE	negative	0	negative			TP53 (p.V216M; 66.9%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	4.46988803	4.858323673	3.058336328	4.85971091	6.03404287	-0.206871603	2.911273211	yes	yes	yes	yes	no	yes	no	NA	NA	NA	NA	NA	NA							0.566460258
BA2235R	BA2235D	2407	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			60	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	MiDAC	Consolidation	104	Alive	2801	Alive	0	80		0	NA	11	13	23	NA	32	50	2.9	0.64	M2	41.1	13.4	"46,XX[20]"	660	86.1	normal	228	TRUE	"partial CD7, partial CD11b, CD13, CD33, dim CD45, CD58,     partial CD64, partial CD117, CD123, dimHLA-DR,  MPO positive"	TRUE	TRUE	7.4	53.9	TRUE	negative	0	positive				DNMT3A (p.Q696fs*9; MAF 40% )|IDH1 (p.R132H; MAF 40%)|NPM1 (p.W288fs*12; MAF ~40%)|PTPN11 (p.G503A; MAF 40%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.923101348	3.787096119	1.628561585	4.185154904	6.377832333	-1.370552466	3.488623678	no	yes	no	yes	yes	no	no	1.43470655	-0.755545892	0.65948825	1.526088659	1.908260408	2.478773948	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.606144873
BA3038R	BA3038D	2278	Waves1+2	yes	yes	yes	yes	Male	Male	Multiracial	HISPANIC	HispNative	1		CBFB-MYH11	24	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	24	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Cytarabine, Methotrexate|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Alive	3041	Alive	0	50		0	NA	19	52	16	NA	NA	NA	NA	NA	M4	26.3	9.2	"47,XY,inv(16)(p13q22),+22[20]"	NA	91.5	62.5% CBFB rearrangement|74% BCR/ABL/ASS	53	FALSE	"- 14% Myeloid blasts: CD13, CD34, CD38, CD58, partial CD64,     CD117, CD123,          HLA-DR, and MPO positive     - 30% Monoblasts/promonocytes: CD11b, CD13, CD14, CD38, CD58, bright CD64,     HLA-DR, and MPO"	FALSE	FALSE	NA	13.8	FALSE	negative	0	negative				KIT (p.D816H; MAF ~50%)|WT1 (rs16754; MAF ~50%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	1.622725335	2.207130407	-1.784790142	3.368761031	6.688677503	-1.009747239	7.917293491	no	no	no	no	yes	no	yes	4.429793118	4.146725399	-1.563144754	-4.536515395	2.798747094	4.343388544	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.734833885
BA3006R	BA3006D	2239	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			33	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	33	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC|HAM (Cytarabine, Mitoxantrone)"	4	Allogeneic - Sibling|Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	-1	Dead	439	Dead-Treatment	NA	70.8		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"46,XX[7] "	NA	NA		NA	NA	"increased CD117 positive, partial CD34 positive myeloblasts,   representing approximately 91% of the leukocytes, consistent with acute myeloid leukemia"	FALSE	FALSE	NA	NA	NA	positive	4	positive				FLT3-ITD|NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	2.761737646	1.348487816	5.920769628	0.655067771	6.019124465	-0.021355424	0.007648135	no	no	yes	no	no	yes	no	-4.983978559	-1.227370715	0.275015238	2.992319793	-1.435350656	1.042138845	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.405408148
BA2245R	BA2245D	2173	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			65	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	67	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	8	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |7+3 (Cytarabine, Idarubicin)|HiDAC|HAM (Cytarabine, Mitoxantrone)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Cladribine"	6	Hypomethylating/Low Dose Cytarabine|Salvage|Consolidation|Unknown|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Cladribine	Unknown	5	Dead	1020	Dead-Unknown	0		77	0	NA	15	1	3	NA	18	10	3.6	1.01	M2	28.1	9.3		132	93.5		22	FALSE		NA	NA	6.3	19.5	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.83348677	0.728352338	-1.587310701	3.125424095	4.299408891	-2.901989659	-0.193397474	no	no	no	no	no	no	no	-6.70108268	-2.50138264	3.642528994	2.410858724	-6.438962342	-2.389111759	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.35555396
BA2667R	BA2667D	2286	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown	UNKNOWN	White	1			74	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	74	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	126	Dead-Unknown	0	60		1	NA	26	18	24	NA	250	160	3.2	0.59	M2	22	7.1	"46,XY[20]"	399	87.4		107	TRUE	"partial CD7, CD13, CD33, CD34, CD38, CD58, CD117, CD123, TdT, and HLA-DR positive"	TRUE	TRUE	7	11.8	FALSE	negative	0	negative	RUNX1 (p.A142Gfs*4; 32.2%)			RUNX1 (p.A142Gfs*4; MAF 30% )|SRSF2 (p.P95L; MAF 48%)		yes			yes	yes	Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	3.149489649	4.798374704	0.958647032	5.938987264	5.222102663	-1.212051012	6.012542641	yes	yes	no	yes	no	no	yes	2.927893232	-0.500482824	2.923611098	1.086064173	-1.364926593	4.621719423	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.634971373
BA2239R	BA2239D	2326	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			66	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	66	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	MiDAC	Consolidation	74	Alive	2756	Alive	0	90		0	NA	14	61	1	NA	19	14	2.4	1.13	M5	23.9	7.9	"46,XY[20]"	387	103.6	normal	122	TRUE	"CD11b, dim/partial CD13, CD14, CD33, CD38, CD58, CD64,     partial CD117, dim/partial CD123, and HLA-DR positive"	FALSE	TRUE	6.3	28	TRUE	negative	0	positive				CREBBP (p.Q2208H; MAF 50%)|DNMT3A (p.R882H; MAF 50%)|NPM1 (W288fs*>9; MAF 50%)|WT1 (rs16754; MAF 50%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	0.410246244	2.123061449	1.206592604	3.341022731	6.675586551	-1.737451065	6.356703151	no	no	no	no	yes	no	yes	5.161935757	-1.771334595	-3.381362938	-3.706579309	2.439532044	3.080566825	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.694817682
BA2782R	BA2782D	2235	Waves1+2	yes	yes	yes	no	Male	Male			White	3			53	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Dead	752	Dead-Treatment	NA	73	32	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA	"atypical monocytic cells expressing weaker than   normal CD13 and CD33, with increased promonocytes/monoblasts representing approximately 44% of the leukocytes, (and increased atypical CD117 positive, CD34 negative myeloblasts showing weak expression   of aberrant CD7 and representing approximately 14% of the leukocytes)"	TRUE	TRUE	NA	22.79	TRUE	negative	0	positive				NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.016825413	2.902452582	1.841768401	2.596764032	6.680157598	-2.69590525	4.275700856	no	no	no	no	yes	no	no	6.46114278	-0.944355547	-1.608355639	-4.414232771	2.893456356	3.506590285	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.841701166
BA2649R	BA2649D	2097	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		PML-RARA	65	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"ATRA (Tretinoin)|3+7 (Cytarabine, Daunorubicin)"	1	Induction	Unknown	Standard Chemotherapy	5	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	3	Dead	7	Dead-Other	0	72	57	0	NA	36	1	8	NA	24	33	2.9	0.6	M3	20.7	6.8	"46,X,der(X)add(X)(p22.1)add(X)(q22~24),add(7)(p15),der(15)t(15;17)(q22;q21),der(17)t(15;17)(q22;q21)inv(17)(q21q21)del(17)(q21)[17]/46,XX[3] (unusual PML-RARA translocation)"	398	90.2	"76% Unusual t(15;17), with the fusion signal on the derivative chromosome 15"	10	FALSE	"partial CD2, CD13, CD33, partial CD34, CD117, CD123, MPO-positive"	FALSE	TRUE	5.6	9.8	FALSE	positive	NA	negative				FLT3-ITD (MAF 40%)|SF3B1 (p.K66N; MAF 40%)|WT1 (rs16754; MAF 50%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	3.416598963	3.427494367	5.424173312	3.483257813	6.07014346	-3.580013984	6.443747639	yes	no	yes	no	yes	no	yes	-4.516023812	3.725964844	-3.677197538	1.959146559	-0.330556788	-3.400959244	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.470929229
BA2592R	BA2592D	2070	Waves1+2	no	no	no	no	Female	Female			White	2			31	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	38	1496	Post-Chemotherapy|Post-Transplant|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	4	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other|Targeted Therapy - Kinase Inhibitor(s)	9	"Fludarabine, Melphalan|Dasatinib|7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Rituximab|Busulfan, Cyclophosphamide"	7	Allogeneic - Sibling|Hypomethylating/Low Dose Cytarabine|Consolidation|Salvage|Induction|Experimental|Re-induction	Complete Response	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Dasatinib	Experimental	24	Dead	2661	Dead-Unknown	NA	7	1	NA	NA	NA	NA	NA	NA	15	21	4.2	NA		31.9	11	"46,XX[20]"	NA	NA	nuc ish(DXZ1x2)[200]	45	TRUE		NA	NA	6.2	2.2	FALSE	negative	0	negative				BCOR (S259fs*10; MAF 15%)|CCND2 (P281R; MAF 19%)|FLT3-D835 (D835E; MAF 13%)|GATA2 (N297S; MAF 18%)|IKZF1 (Q44*; MAF 14%)|MLL2 (Y2907*; MAF 7%)|PTPN11 (E76V; MAF 17%)|PTPN11 (V45L; MAF 13%)|SETBP1 (H1100R; MAF 51%)|SF3B1 (K700E; MAF 18%)	yes				yes	yes	Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.299070264	5.215680434	2.462637097	6.452499093	4.817604546	-0.610774085	3.882506734	yes	yes	no	yes	no	yes	no	NA	NA	NA	NA	NA	NA							0.718919702
BA2861R	BA2861D	2015	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1	mono		22	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	22	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Matched Unrelated Donor	-1	Alive	2729	Alive	0	56	55	2	NA	7	33	24	NA	67	16	2.2	0.64	M4	24	8	"46,XX[24]"	373	95.2	normal	34	TRUE	"partial CD7 ,dim/partial CD10 , CD13 , CD33 , CD34 , CD38 , CD56 , CD64 , dim CD123 , HLA-DR , and MPO positive"	TRUE	TRUE	6.5	29.4	TRUE	negative	0	negative				CEBPA (p.D107fs*; MAF ~50%)|WT1 (p.Y385*; MAF 20%)|WT1 (rs16754; MAF ~50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.359287774	2.89593656	1.240437317	2.68783329	5.958911233	-1.492364345	5.694493204	no	no	no	no	no	no	yes	2.738457031	2.105551258	-2.36128976	1.457237335	-0.030320602	2.53407658	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.50151626
BA2134R		2417	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			72	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	8	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	y	y	n	y	1	Standard Chemotherapy	1	"3+7 (Cytarabine, Daunorubicin)"	1	Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	6	Dead	176	Dead-Unknown	0			1	NA	3	77	8	NA	57	27	3.5	0.61	M4	26.3	8.7	"46,XY,del(12)(p11.2p13)[15]/46,XY[5]"	324	92.8	84% 12p deletion	19	FALSE		NA	NA	7.2	56.5	TRUE	negative	0	negative		ASXL1 (p.A619fs*14; MAF 50%)		ASXL1 (p.A619fs*14; MAF 50%)|EZH2 (p.R583*; MAF 95%)|FLT3-D835|FLT3-D835 (MAF unavailable)|PTPN11 (p.D61H; MAF 15%)|RUNX1 ( p.P345?S356del; MAF 25%)|RUNX1 (p.P345?S356del; MAF 25%)|RUNX1 (p.V51; MAF 50%)|RUNX1 (p.V5I; MAF 50%)|TET2 (p.Y867H; MAF 50%)					no		Found	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	2.775216721	4.122157445	4.977352049	2.891797274	6.453001016	-2.36650898	3.800759839	no	yes	yes	no	yes	no	no	NA	NA	NA	NA	NA	NA							0.79803251
BA2909R	BA2909D	2509	Waves1+2	yes	yes	yes	yes	Male	Male	Asian	NON-HISPANIC	Asian	1		RUNX1-RUNX1T1	8	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	8	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	2	Induction|Intensification	Complete Response	Standard Chemotherapy	11	Standard Chemotherapy	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	Intensification	62	Alive	2662	Alive	0	30		0	NA	33	17	20	NA	NA	NA	NA	0.53	M2	29.3	10.3	"46,XY,t(8;21)(q22;q22)[5]/46,idem,der(7)t(7;8)(q22;q11.2)[13]/46,XY[2]"	NA	93.5	t(8;21) (34%) | t(8;21) and der(7)t(7;8) (56%) | Missing D7S486 signal (70%)	109	TRUE	"dim CD7, CD13, CD33, CD34, CD38, partial CD56,CD58, CD117, CD123, dim HLA-DR, and MPO"	TRUE	TRUE	NA	19.5	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.16243646	5.358145436	3.673523703	4.148754191	7.113624892	-0.023417433	8.32412391	yes	yes	yes	yes	yes	yes	yes	4.576512491	4.492399905	-1.858472287	-5.821752764	2.04141275	-0.379444223	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.67302201
BA2429R	BA2429D	2473	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			78	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	78	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	Azacitidine|Decitabine	2	Hypomethylating/Low Dose Cytarabine|Maintenance			NA	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	-1	Dead	356	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NOS	NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.455757934	5.917586396	-0.344579491	7.903421713	6.190778616	-2.79940292	4.559525384	yes	yes	no	yes	yes	no	yes	1.068411585	2.105781636	-0.828119342	-0.117711356	0.072564298	0.777384653	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.65249318
BA2653R	BA2653D	2191	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1	mono		42	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute megakaryoblastic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute megakaryoblastic leukaemia	42	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Re-induction	4	Dead	273	Dead-Disease	0	70		0	NA	43	6	38	NA	36	28	3.5	0.81	M7	34.8	12		762	85.2	"Extra signals were observed for BCR (22q11.2), PML (15q22), MLL (11q23),     RUNX1T1 (8q21.3) and RUNX1 (21q22) in roughly 45-60% of interphase cells.     These results suggest the presence of a hyperdiploid clone."	13	FALSE	"CD7, CD13, CD33, CD58, partial CD61, CD71, and Factor 8 positive"	TRUE	TRUE	6.8	7.9	FALSE	negative	0	negative				CEBPA (p.V119?M120insV; MAF 30% )					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.03785813	6.935583178	2.166424144	5.687960815	7.136714052	2.747269925	3.229681125	yes	yes	no	yes	yes	yes	no	3.03908681	0.09938722	-0.970373186	0.680554651	-2.460687246	-2.598284223	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.783529552
BA2947R		2506	Waves1+2	yes	no	yes	yes	Male	Male	White	NON-HISPANIC	White	1		RUNX1-RUNX1T1	14	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	14	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	y	y	n	y	1	Standard Chemotherapy	1	"COG-AAML0531 (Cytarabine, Daunorubicin, Etoposide, L-Asparaginase, Mitoxantrone +/- Gemtuzumab)"	1	Induction	Complete Response	Standard Chemotherapy	133	Standard Chemotherapy	"COG-AAML0531 (Cytarabine, Daunorubicin, Etoposide, L-Asparaginase, Mitoxantrone +/- Gemtuzumab)"	Induction	133	Alive	2487	Alive	0	62	64	0	NA	28	1	7	NA	15	9	4.1	0.58	M2	18.5	6.3	"45,X,-Y,t(8;21)(q22;q22)[4]/45,idem,del(9)(q12q22)[13]/46,XY[3]"	486	105.8	RUNX1T1/ RUNX1 fusion and t(8;21) (94%)	63	TRUE	"CD13, CD33, CD34, dim CD45, partial CD56, CD58, dim CD117, HLA-DR, MPO, and partial TdT-positive"	FALSE	TRUE	7.9	13.3	FALSE	negative	0	negative				TP53 (p.S366A; MAF 50% )					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	1.619820405	2.893539278	-2.32040487	3.112175422	6.400748588	-1.212051012	7.056474872	no	no	no	no	yes	no	yes	-3.914145461	3.118666882	-0.726031136	1.689226638	-0.40011046	-0.800111733	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.489287083
BA2032R	BA2032D	2022	Waves1+2	yes	yes	yes	yes	Female	Female			White	2			64	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	5	"Crenolanib|MEC, plexifor, GCSF|Sorafenib|7+3 (Cytarabine, Idarubicin) plus LBH|Clofarabine, Cytarabine"	4	Salvage|Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	21	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	124	Dead	455	Dead-Disease	NA	81	94	NA	NA	6	NA	NA	NA	87	47	2.8	0.53		27.2	9.7	"46,XX,t(3;11)(q21;p11.2),t(15;15)(q15;q22)[19]/46,XX,t(2;14)(q21;q11.2)[2]"	743	NA	"nuc ish(RUNX1T1,RUNX1)x2[199],(5'MLL,3'MLL)x2 (5'MLL con 3'MLLx2)[198],(PML,RARA)x2[199],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	11	FALSE	"CD7(partial +), CD15(partial +), CD33(bright +), CD34(partial +), CD45(+), and CD117(variably +). (80% population of variably-sized cells)"	TRUE	TRUE	5.2	26	TRUE	positive	15.66666667	positive									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	5.337218856	1.982276333	5.748225876	3.64476359	6.667811052	2.445112797	1.097609056	yes	no	yes	no	yes	yes	no	-8.229656229	NA	2.445134515	NA	-2.995991495	-0.678914801	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.558480086
BA2162R	BA2162D	2220	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			77	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	77	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	7	Dead	129	Dead-Disease	NA		47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,-7,+13,i(17)(q10)[20]"	NA	NA	"D7S486/ CEP 7: æ92/100 cells (92%) had a 1 red/ 1 green signal pattern, indicating monosomy 7, consistent with the metaphase karyotype. | RARA: æ79/100 cells (79%) had three signals, consistent with the isochromosome 17q observed in the metaphase karyotype and the presence of three copies of the long arm. æThere was no evidence for PML/RARA fusion. | TP53: æ89/100 cells (89%) had a single signal, reflecting deletion and consistent with the isochromosome 17q observed in the metaphase karyotype."	NA	NA	"CD13, CD33, CD34, CD117, dim CD123, and HLA-DR-positive"	FALSE	TRUE	NA	25.3	TRUE	negative	0	negative		ASXL1 (p.W583*; 47.9%)		ASXL1 (p.W583*; MAF 50%)|ETV6 (p.N384*; MAF 40%)|FBXW7 (p.T196A; MAF 50%)|SRSF2 (p.P95H; MAF 70%)		yes			yes	yes	Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	2.751194071	4.98230143	0.824641148	4.463019399	6.269279939	-0.610774085	5.761816992	no	yes	no	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.703426192
BA2564R	BA2564D	2339	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	18	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	18	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	Re-induction	-1	Alive	540	Alive	0	50	22	0	NA	24	49	20	NA	13	15	3.6	0.77	M4	21	7.4	"46,XX,inv(16)p13.1q22)[4]/47,idem,+22[15]/46,XX[1]"	415	97.8	CBFB rearrangement and inv(16) (64%) | +22 (71%)	23	TRUE	"Blast phenotype:  CD13, CD33, CD34, CD38, CD58, dim CD123,     HLA-DR-positive               - Monocytic phenotype:  CD11b, CD13, CD14, CD33, CD58, CD64, HLA-DR-positive"	FALSE	TRUE	7.6	8.8	FALSE	negative	0	negative				KRAS (p.G13D; MAF 10%)|NRAS (p.G13D; MAF 30%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.873823879	3.617128726	0.168253562	3.587426621	6.799311741	0.433070764	7.813859144	yes	yes	no	no	yes	yes	yes	4.312507743	4.902823851	-2.168965087	-1.503548934	4.350533771	2.553294845	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.719749747
BA2597R	BA2597D	2290	Waves1+2	yes	yes	yes	yes	Female	Female			White	4			79	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	79	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Azacitidine, Lenalidomide"	1	Induction	Refractory	Standard Chemotherapy	137	Standard Chemotherapy	"Azacitidine, Lenalidomide"	Induction	137	Dead	189	Dead-Disease	NA	73	56	NA	NA	NA	1	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,del(16)(p11.2)[3]/46,XX[2]"	NA	NA		NA	NA	"CD34, CD4(dim), CD7, CD11c(dim), CD13, CD33(dim),CD38, CD117, and HLA-DR"	TRUE	TRUE	NA	8.7	FALSE	negative	0	negative		ASXL1 (p.G645Vfs*58; 12.5%)		IDH2 (R140Q)					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.760644005	4.757988911	-0.010879244	4.702770403	5.957652786	-0.997814662	0.706893141	yes	yes	no	yes	no	no	no	-2.738169101	-2.163284316	0.251346763	1.464557115	-2.563642955	-5.635201284	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.653540977
BA3243R		2683	Waves3+4	yes	no	yes	yes	Male	Male	Unknown			2		PML-RARA	51	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	y	y	n	y	1	Targeted Therapy - Other	1	"ATRA, Arsenic Trioxide"	1	Experimental			NA	Targeted Therapy - Other	"ATRA, Arsenic Trioxide"	Experimental	193	Alive	1051	Alive	NA	47	48	NA	NA	NA	NA	NA	NA	16	15	3.6	NA	M3	22.9	8.3	"46,XY,t(15;17)(q24;q21.1)/46,XY"	NA	NA	"nuc ish(PML,RARA)x3(PML con RARAx2)[164/200] (Labs conducted twice on day of specimen collection. This is result 1 of 2 on 8/6/2013.) | nuc ish(PML,RARA)x3(PML con RARAx2)[190/200] (Labs conducted twice on day of specimen collection. This is result 2 of 2 on 8/6/2013.)"	23	FALSE	"CD2(partial +), CD4(-), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(-), CD16(-), CD33(bright +), CD34(-), CD36(-), CD38(variable +), CD45(moderately +), CD56(-), CD64(+), CD117(+), HLA-DR(-), MPO(+), TdT(-) (Labs conducted twice on day of specimen collection. This is result 1 of 2 on 8/6/2013.) | CD2(partial +), CD4(-), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(partial +), CD16(-), CD33(bright +), CD34(-), CD36(-), CD38(variably +), CD45 (variably +), CD56(-), CD64(+), CD117(+), HLA-DR(-) (Labs conducted twice on day of specimen collection. This is result 2 of 2 on 8/6/2013.)"	TRUE	TRUE	6.4	2.8	FALSE	positive	0.020408163	negative				FLT3-D835|FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	1.944245803	1.258055477	1.869762619	2.671289769	5.546582594	-0.730775878	1.20914253	no	no	no	no	no	yes	no	1.22570073	-1.987018277	1.820164117	-0.076416291	-0.624130574	4.143432881	Monocyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.587891854
BA2106R	BA2106D	2055	Waves1+2	yes	yes	yes	yes	Female	Female			White	4			35	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	37	1	Post-Chemotherapy|Relapse	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Cyclophosphamide, Etoposide, TBI"	5	Allogeneic - Sibling|Consolidation|Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Re-induction	53	Dead	761	Dead-Disease	NA	92	97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XX[5]"	NA	NA		NA	NA	"CD45, DIM CD64, DIM CD13, DIM CD33, CD15, CD38, MPO, CD11C, DIM CD4, DIM PARTIAL CD19, CD117, AND HLA-DR"	FALSE	TRUE	NA	140	TRUE	negative	0	positive				FLT3-D835|IDH1|NPM1					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	1.368503796	0.741906919	-1.303085909	2.128709626	3.333194398	1.054184415	-0.821921733	no	no	no	no	no	yes	no	-8.600407511	NA	3.247068394	NA	-5.119715226	-0.422024045	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.251968687
BA2939R		2055	Waves1+2	no	no	no	no	Female	Female			White	4			35	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	37	160	Residual Disease|Post-Chemotherapy|Post-Transplant	Residual	Peripheral Blood	y	n	y	y	n	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Cyclophosphamide, Etoposide, TBI"	5	Allogeneic - Sibling|Consolidation|Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Re-induction	53	Dead	761	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XX[5]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	2.141679992	2.080985544	-0.492659737	3.596142745	3.347740082	0.725196498	-0.249756304	no	no	no	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.282270342
BA2427R	BA2427D	2559	Waves1+2	yes	yes	yes	no	Female	Female			White	4		CBFB-MYH11	53	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	60	0	Post-Chemotherapy|Relapse	Relapse	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	5	"7+3 (Cytarabine, Idarubicin)|3+7 (Cytarabine, Daunorubicin)|Azacitidine, Gemtuzumab|MEC (Cytarabine, Etoposide, Mitoxantrone)|Etoposide, Cytarabine"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"Azacitidine, Gemtuzumab"	Re-induction	-1	Alive	2522	Alive	NA	82	25	NA	NA	NA	19	NA	NA	NA	NA	NA	NA	M4eo	NA	NA	"47,XX,t(16;16)(p13;q22),+22[20]"	NA	NA	CBFB inv(16)	NA	NA	"Positive (ABNORMAL CD34+ BLAST POPULATION, 11%, EXPRESSING CD117, CD15,CD13, CD33 (DIM), AND HLA-DR, WITH ABERRANT EXPRESSION OF CD19(DIM-PARTIAL) AND CD22 (DIM-PARTIAL)ABNORMAL MONOCYTIC POPULATION EXPRESSING CD64, CD14, CD34(DIM), CD2 (DIM), CD7 (DIM), AND CD8 (DIM-PARTIAL))"	TRUE	TRUE	NA	4.3	FALSE	negative	0	negative				FLT3-D835					no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.537760101	3.607338896	-0.322754389	5.640114849	6.732801149	-2.607754004	6.594680877	yes	yes	no	yes	yes	no	yes	2.426970696	-0.431739269	0.902254911	0.904831704	-1.465112799	4.036811685	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.821168606
BA2841R	BA2841D	2274	Waves1+2	yes	yes	yes	no	Male	Male	Asian	NON-HISPANIC	Asian	4	bi		31	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	32	0	Relapse|Post-Chemotherapy	Relapse	Bone Marrow Aspirate	y	y	n	y	y	n	4	DLI|Standard Chemotherapy|Bone Marrow Transplant|Supportive/Palliative Care	7	"7+3 (Cytarabine, Idarubicin)|HiDAC|Donor Lymphocyte Infusion|GCLAC (GCSF, Clofarabine & Cytarabine)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine|Fludarabine, Cyclophosphamide, TBI "	6	Allogeneic - Sibling|Consolidation|Salvage|Unknown|Induction|Re-induction	Complete Response	Standard Chemotherapy	8	Supportive/Palliative Care	Decitabine	Salvage	-1	Alive	1377	Alive	NA	28	23	NA	NA	NA	6	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA		NA	NA	"CD34, CD117, CD38, MPO, CD11c (dim),CD13, CD33, CD15, and HLA-DR,CD7 and CD56 (partial)"	TRUE	TRUE	NA	4	FALSE	negative	0	negative				CEBPA (Double mutation)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	4.530889065	5.489154828	3.275863051	4.307272677	5.178401552	-0.43050765	3.128286852	yes	yes	yes	yes	no	yes	no	-0.80964421	-0.812147853	-1.199944097	3.08134263	-3.073314829	0.021312084	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.525471628
BA2446R	BA2446D	2429	Waves1+2	yes	yes	yes	yes	Female	Female	Pacific Islander	NON-HISPANIC	Asian	1		MLLT3-KMT2A	30	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Acute Promyelocytic Leukemia	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	30	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	4	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |7+3 (Cytarabine, Idarubicin)|HiDAC|Decitabine"	4	Consolidation|Salvage|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	6	Supportive/Palliative Care	Decitabine	Supportive/Palliative Care	31	Dead	270	Dead-Disease	0	64	65	0	NA	28.9	25.4	19.3	1.7	48	33	3.6	0.64	M1	21.8	7.5	"46,XX,t(9;11)(p11;q34)[19]/46,XX[1]"	NA	111.8	Disruption of MLL signal and t(9;11) (65%)	29	TRUE	"CD11b, CD13, CD14,  CD33, CD64, CD56, CD123 and HLA-DR positive"	FALSE	TRUE	6.1	29.25	TRUE	negative	0	negative				CREBBP (p.A254T; MAF 50%)|CREBBP (p.T910S; MAF 40%)|FLT3-D835 (p.D835; MAF 35%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.182386113	3.230736327	1.729446892	3.782287302	5.767986768	-1.303085909	2.946448477	no	no	no	yes	no	no	no	1.691308114	-1.647408519	-2.033999761	-2.306580339	2.461101771	4.560761218	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.651390041
BA2025R	BA2025D	2429	Waves1+2	no	no	no	no	Female	Female	Pacific Islander	NON-HISPANIC	Asian	1		MLLT3-KMT2A	30	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	y	Acute Promyelocytic Leukemia	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	31	147	Relapse|Post-Chemotherapy	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	4	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |7+3 (Cytarabine, Idarubicin)|HiDAC|Decitabine"	4	Consolidation|Salvage|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	6	Supportive/Palliative Care	Decitabine	Supportive/Palliative Care	31	Dead	270	Dead-Disease	0	75	35	0	NA	9.9	9.9	37.2	0.8	37	39	3.1	0.56	M1	22.1	7.7	"46,XX,t(9;11)(p22;q23)[20]/46,XX[1]"	NA	89.8	MLL disruption and t(9;11) (70%)	39	TRUE	"dim/partial CD13, CD33, CD38, CD56, CD58, CD64, partialCD117, CD123 and HLA-DR positive"	FALSE	TRUE	6	43.72	TRUE	negative	0	negative				FLT3-D835 (MAF 70%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.132742106	1.003177255	0.995038776	3.796356461	5.168197031	-3.742027569	2.079500717	no	no	no	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.513797913
BA2645R	BA2645D	2230	Waves1+2	yes	yes	yes	yes	Male	Male			Asian	4			73	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	73	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|Decitabine|Stanford Protocol 9153 (TLI, ATG)"	4	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Stanford Protocol 9153 (TLI, ATG)"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	330	Dead-Disease	NA	84	71	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XY[20]"	NA	NA		NA	NA	"\ CD4(subset), CD11c(partial), CD13(partial), CD14(partial), CD15(partial), CD33(subset), CD34(subset), CD38, CD64(subset), CD117(subset), HLA-DR and MPO\\\"""""	FALSE	TRUE	NA	16.2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.043497687	4.290007951	4.584426689	6.044847679	5.629804244	1.65628111	1.602315747	yes	yes	yes	yes	no	yes	no	0.659344996	-3.938152807	0.960708522	0.594414889	-2.336365677	2.591661005	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.747446927
BA2525R	BA2525D	2543	Waves1+2	yes	yes	yes	yes	Female	Female			White	4			72	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"Azacitidine, Lenalidomide|Temozolomide, Vorinostat"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"Temozolomide, Vorinostat"	Re-induction	-1	Dead	420	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,del(5)(q31q35),inv(7)(p15q32),del(12)(q?15)[2]/45~46,idem,add(3)(q27),-9,-del(12)(q?15),+add(12)(q13),-16,-17,+mar1,+mar2x2[cp16]/46,XX[2]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	0.538461538	positive			TP53	TP53					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	TRUE	NA	FALSE	TRUE	6.870847832	7.072510297	0.340080739	7.378746611	7.106932866	-2.850011737	2.501327532	yes	yes	no	yes	yes	no	no	-3.470840366	-2.587374441	-1.096711134	-3.635599387	-4.371486661	-2.147937094	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.593000289
BA2876R	BA2876D	2198	Waves1+2	yes	yes	yes	no	Female	Female			White	4			71	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Supportive/Palliative Care	3	"Cytarabine|Azacitidine|Stanford Protocol 9153 (TLI, ATG)"	3	Hypomethylating/Low Dose Cytarabine|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor			NA	Standard Chemotherapy	Cytarabine	Supportive/Palliative Care	9	Dead	719	Dead-Disease	NA	34	8	NA	NA	NA	15	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,t(8;19)(q24;q13),del(11)?(q14q23)[19]/46,XX[1]"	NA	NA		NA	NA	"CD34, CD117, CD38, DIM CD13, CD33, HLA-DR, AND PARTIAL CD7"	TRUE	TRUE	NA	4.2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.087933111	6.07014346	4.730520584	7.322178749	7.122667752	1.66286831	4.968965188	yes	yes	yes	yes	yes	yes	yes	4.636471586	-2.624166929	-1.091423405	-1.02087546	-1.541625182	2.277083487	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.919927811
BA2357R	BA2357D	2245	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown		HispNative	2			52	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	52	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|AG-221|HAM (Mitoxantrone, Cytarabine) plus Crenolanib|Fludarabine, Melphalan, ATG"	5	Consolidation|Salvage|Induction|Experimental|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	15	Bone Marrow Transplant	"Fludarabine, Melphalan, ATG"	Allogeneic - Matched Unrelated Donor	-1	Dead	1237	Dead-Disease	NA	21	5	NA	NA	68	4	23	NA	17	23	3.6	0.89		28.3	8.5	"89<4n>,XXY,-Y,-7,-12,+13,+13,-17,-21[2]/46,XY[18]"	183	NA	"nuc ish(RUNX1T1x4,RUNX1x3)[33/200],(5'MLL,3'MLL)x4(5'MLL con 3'MLLx4)[41/200],(PMLx4,RARAx3~4)[31/200],(5'CBFB,3'CBFB)x4(5'CBFB con 3'CBFBx4)[27/200]"	22	TRUE	"partialCD4, partialCD15, dimCD33, CD34, CD38, dimCD45, CD117, HLA-DR, TdT, MPO"	FALSE	TRUE	7.5	3.42	FALSE	negative	0	negative	RUNX1 (p.R201Q; 33.9%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	2.581782402	6.568400336	4.609372286	4.830238718	6.893799069	-0.351437901	6.303723145	no	yes	yes	yes	yes	yes	yes	3.04530339	2.067172298	1.616698604	-0.450235701	0.415403602	0.105022418	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.737966683
BA2546R	BA2546D	2259	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|Decitabine|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Consolidation	-1	Dead	228	Dead-Treatment	1.8	51		0.9	NA	41.2	37.7	11.4	0	20	20	3.2	1.37	M4	33.7	11	"42~45,XY,del(4)(q31q35),del(5)(q13q35),add(9)(q21),add(13)(p11.2),-16,-21[cp15]/40~46,sl,+9,-add(9)(q21),-15,+der(16)t(15;16)(q11.1;p13.3),-18,+mar[cp5]"	NA	92.6	Extra MLL signal (5%) | 5q deletion (95%) | Abnormal 9q (33%) | Partial deletion of RUNX1 (34%)	24	TRUE	"CD13, CD33, CD34, CD56, CD58, dim CD64, CD117 and partial HLA-DR."	FALSE	TRUE	7.1	5.23	FALSE	negative	0	negative			TP53 (p.X307_splice; 46.6%)|TP53 (p.R273S; 40.4%)	"TP53 (Intron 7, 5' splice site mutation; MAF 40%)|TP53 (p.R273S; MAF 40%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	4.074385753	4.637752326	4.091937332	4.841081905	5.843920428	-0.173595676	6.662326941	yes	yes	yes	yes	no	yes	yes	5.969202395	1.105526309	-0.37840492	-4.276256134	1.376944365	1.751971822	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.735491748
BA2742R	BA2742D	2403	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			62	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	2	Dead-Disease	0	95	95	0	NA	9.5	1.9	4.8	0.2	93	104	3.2	1.85	M5	26.2	8.5	"46,XY[20]"	2941	104.8	Normal	92	TRUE	"CD4, CD11b, CD13, CD14, partial CD16, CD33, CD38,      partial CD56, CD58, CD64, CD123, and HLA-DR positive"	FALSE	TRUE	6.5	250.23	TRUE	positive	15.66666667	negative	RUNX1 (p.X205_splice; 56.7%)			"DNMT3A (p. R882C; MAF 50%)|DNMT3A (p.R882C; MAF 50%)|FLT3-ITD (MAF 90%)|RUNX1 (Intron 5, 3' splice site mutation; MAF 50%)"					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	FALSE	-0.327714125	-0.084538785	5.794877004	1.791228288	6.185071588	-1.496394605	5.589899853	no	no	yes	no	yes	no	yes	3.268907422	0.273090507	-2.688358147	-3.814470043	2.74445343	6.200199886	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.65984891
BA2316R	BA2316D	2403	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			62	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	62	1	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Dead	2	Dead-Disease	0	95	95	0	NA	9.5	1.9	4.8	0.2	93	104	3.2	1.85	M5	26.2	8.5	"46,XY[20]"	2941	104.8	Normal	92	TRUE	"CD4, CD11b, CD13, CD14, partial CD16, CD33, CD38, partial CD56, CD58, CD64, CD123, and HLA-DR positive"	FALSE	TRUE	6.5	250.23	TRUE	positive	NA	negative	RUNX1 (p.X205_splice; 44.3%)			"DNMT3A (p. R882C; MAF 50%)|DNMT3A (p.R882C; MAF 50%)|FLT3-ITD (MAF 90%)|RUNX1 (Intron 5, 3' splice site mutation; MAF 50%)"					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	FALSE	-0.342203265	1.051640088	5.69915969	1.726597896	6.237084376	-3.262674237	5.839177706	no	no	yes	no	yes	no	yes	NA	NA	NA	NA	NA	NA							0.679645521
BA2421R	BA2421D	2195	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown		White	2			75	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	75	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine"	4	Consolidation|Induction|Re-induction|Maintenance	Refractory	Standard Chemotherapy	56	Standard Chemotherapy	Azacitidine	Maintenance	34	Dead	383	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,+8,inv(9)(p11q12)c[1]/48,idem,+3[5]/49,idem,+3,+15[1]/50,idem,+3,+8,+mar(8]/46,XY,inv(9}(p11q12)c[5]"	NA	NA	"nuc ish (D8Z2x3~4)[134/200],(D15Z4x3)[114/200]"	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.542541271	4.72738279	2.292743766	5.883277015	6.292251183	-0.967118058	3.54890583	yes	yes	no	yes	yes	yes	no	1.900282121	1.0294408	-2.052780234	-2.809644816	2.247075874	-2.715259036	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.772794902
BA2087R	BA2087D	2221	Waves1+2	yes	yes	yes	yes	Female	Female	Unknown		White	2		MLLT3-KMT2A	40	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	40	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Alive	1435	Alive	NA	84	29	NA	NA	63	3	5	NA	21	23	3.7	0.65		35	12	"46,XX,t(9;11)(p22;q23)[20]"	613	NA	"nuc ish(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL sep 3'MLLx1) [179/200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	34	FALSE	"brightCD4, partialCD11b, brightCD15, brightCD33, partialCD36, partialCD38, CD45, brightCD64, partialCD117, HLA-DR (86% population of cells)"	FALSE	TRUE	6.5	9.1	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	2.938249606	4.020027987	0.108803166	5.623836383	5.931636687	-3.047881897	0.900465292	yes	yes	no	yes	no	no	no	-1.888600396	NA	-4.799097077	NA	3.037726523	1.399748659	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.582611004
BA2910R	BA2910D	2261	Waves1+2	yes	yes	yes	yes	Female	Female			White	2			79	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	79	0	Post-Chemotherapy|Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	2	"7+3 (Cytarabine, Idarubicin)|Crenolanib"	2	Induction|Experimental	Complete Response	Standard Chemotherapy	4	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	14	Dead	124	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	0.470588235	positive				FLT3-ITD (High level (>50%))|NPM1 (Positive for insertion mutation in exon 12)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	4.194089346	2.333922722	2.391874654	3.428475056	6.160031709	2.239092599	-0.827405877	yes	no	no	no	yes	yes	no	-6.259656652	-4.438480451	1.844131463	4.324349016	-5.110759776	-0.358713133	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.50329059
BA2148R	BA2148D	2128	Waves1+2	yes	yes	yes	yes	Female	Female			HispNative	2		CBFB-MYH11	31	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	31	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response i	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	95	Alive	143	Alive	NA	57	45	3	NA	25	20	7	NA	NA	NA	NA	1.04		22	7.4	"46,XX,inv(16)(p13.1q22)[11]/47,idem,+22[4]/46,XX[5]"	229	NA	"nuc ish(D4Z1,D10Z1)x2[199],(SCFD2,LNX,PDGFRA/KIT)x2[200],(5'PDGFRB,3'PDGFRB)x2(5'PDGFRB con 3'PDGFRBx2)[200],(5'FGFR1,3'FGFR1)x2([200],(RUNX1T1,RUNX1)x2[200](ABL1x2,BCRx3)[63/200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[197],(ETV6,RUNX1)x2[198],(PML,RARA)x2[200],(CBFBx2)(5ÍCBFB sep 3ÍCBFBx1)[147/200]"	30	FALSE	"CD2(-), CD4(-), CD7(-), CD11b(-), CD13(variably +), CD14(-), CD15(partial+), CD16(-), CD22(few +), CD33(dim + to -), CD34(+), CD36(-), CD38(variably +), CD41(-), CD45(variably +), CD56(-), CD61(-), CD64(-), CD117(variably +), HLA-DR(partial +), Gly-A(-), MPO(+), TdT(partial +)"	TRUE	TRUE	NA	13.63	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	6.137679039	4.763896529	8.698245009	5.390206819	8.280973356	4.185154904	7.735953237	yes	yes	yes	yes	yes	yes	yes	2.400612425	NA	1.329801992	NA	-0.931502812	1.164235563	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	1.04427999
BA2329R	BA2329D	2186	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			61	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	61	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Salvage	126	Dead	370	Dead-Disease	NA	19	10	NA	NA	27.7	NA	39.2	NA	47	22	3.8	0.5	M5	25.8	8.5	"47~49,XY,-21,+1~4mar[cp21]/46,XY[2]"	NA	86.6	Monosomy 21 (30%)	40	TRUE	"Blasts (15-20%): CD11b, CD13, CD33, CD34, CD38, CD58, partial CD64, CD117, and HLA-DR, and partial TdT positive - Aberrant monocytic population (20%): CD11b, CD13, CD14, bright CD33, dim CD56, CD64, and HLA-DR positive"	FALSE	TRUE	7.6	5.5	FALSE	negative	0	negative				CSF3R (p. T618I; MAF: 50%)|WT1 (benign SNP rs16754 (R369R: no amino acid change); MAF: 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	4.122974584	5.111860155	4.877625484	4.452819975	7.170295959	-1.525164703	6.456996666	yes	yes	yes	yes	yes	no	yes	4.635577441	2.862450342	-2.84997604	-3.009269809	4.020169333	3.153592255	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.773611432
BA2677R	BA2677D	2186	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			61	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	62	43	Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Salvage	126	Dead	370	Dead-Disease	NA	17	2	NA	NA	32.2	NA	34.2	NA	34	15	3.7	0.3	M5	32.4	10.4	"46~49,XY,-21,+1~4mar[cp20]"	NA	87.2	Monosomy 21 (45%)	21	FALSE	"Myeloid blasts:CD13, CD33, CD34, CD38, CD58, dimCD64, CD117, and HLA-DR+ ææ Promonocytes/immature monocytes:CD11b, CD13, CD14, CD33, CD64, and HLA-DR+"	FALSE	TRUE	7	7.2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.296780527	4.499929638	4.369417953	4.063630547	6.416033467	-3.817489535	6.362275141	yes	yes	yes	yes	yes	no	yes	NA	NA	NA	NA	NA	NA							0.744612385
BA3178R		2789	Waves3+4	yes	no	yes	no	Male	Male				3		MLLT3-KMT2A	71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	71	7	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	n	y	n	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	3	Consolidation|Induction|Re-induction	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	"CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	Re-induction	-1	Dead	179	Dead-Disease	NA	84.2	93	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5a	NA	NA	"49,XY,+8,+8,t(9;11)(p22;q23),+der(9)t(9;11)"	NA	NA	"8q22 (RUNX1T1): gain of two copies present  11q23 (MLL): rearrangement present (95% RUNX, 91% MLL)"	NA	NA	"CD4+, CD33+, CD117+, HLA-DR+ myeloblasts"	FALSE	TRUE	NA	93.46	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.370450274	0.827628838	-0.392107614	2.324649572	4.711215377	-2.063108614	-1.463854919	no	no	no	no	no	no	no	-7.274112435	-1.77813417	-4.702243697	-1.628432416	3.192420864	5.789579501	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.359656043
BA2072R	BA2072D	2115	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	35	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	35	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	HiDAC	Consolidation	94	Alive	1848	Alive	0	70	27	1.8	NA	19.6	37.5	7.1	0	20	17	3.1	0.88	M4	14.3	4.8	"46,XX,t(16;16)(p13.1;q22)[16]/47,idem,+22[4]"	505	100.7	Trisomy 22 (16%) | t(16;16) (90%)	36	TRUE	"Myeloid blasts (21%): CD13, CD33, CD34, CD38, CD58, CD117, CD123, HLA-DR, and MPO positive. Promonocytic/monocytic cells (55%): CD11b, CD13, CD14, CD33, dim/partial CD34, CD38, CD58, CD64, variable CD123, HLA-DR, and MPO-positive. (Included both populations of cells)"	FALSE	TRUE	7.8	49.4	TRUE	negative	0	negative				CREBBP (P552S; MAF 50%)|KDM6A (K395N; MAF 50%)|KIT (D816V; MAF 1%)|NRAS (G13D; MAF 6%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.266545006	2.568576507	0.148322439	4.328218317	6.194796125	-1.408818349	6.343220953	no	no	no	yes	yes	no	yes	4.212679673	NA	-0.485339144	NA	-0.430203159	6.00156906	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.720664777
BA3029R	BA3029D	2079	Waves1+2	yes	yes	yes	no	Male	Male			White	2			62	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	6	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Crenolanib|Clofarabine, Cytarabine|Busulfan, Cyclophosphamide"	5	Consolidation|Induction|Experimental|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	24	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	141	Dead	568	Dead-Unknown	0	81	59	0	NA	0	0	10	NA	34	15	4	NA		30.2	10.7	"46,XY"	NA	NA		17	TRUE	"CD2(-), CD4(dim +), CD10(-), CD11b(-), CD13(+), CD14(-), CD15(variably +), CD16(-), CD33(bright +), CD34(-), CD36(-), CD38(+), CD45(moderately +), CD56(-), CD64 (partial +), CD117(variably +), HLA-DR(-), MPO(+), TdT(-)."	FALSE	TRUE	6	1.8	FALSE	positive	10.11111111	positive				"CCND3 (Foundation, P203S; MAF 8%)|CHEK2 (Foundation; T367fs*15; MAF 9%)|DNMT3A (Foundation, R882H; MAF 9%)|FLT3 (Foundation, Y591_V592INSVDFREYEYDLKWEFPRENLEFD; MAF 13%)|NPM1 (Foundation; W288fs*10+;MAF 8%)"					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	3.847392747	3.294414242	4.526233338	5.156329382	5.997243165	0.95732621	-0.540513338	yes	no	yes	yes	no	yes	no	-3.684456588	-0.657874236	0.684303673	2.589971882	-1.458627881	-4.447178628	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.483484389
BA2735R	BA2735D	2079	Waves1+2	no	no	no	no	Male	Male			White	2			62	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	64	254	Post-Chemotherapy|Post-Transplant|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	6	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Crenolanib|Clofarabine, Cytarabine|Busulfan, Cyclophosphamide"	5	Consolidation|Induction|Experimental|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	24	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	141	Dead	568	Dead-Unknown	NA			NA	NA	NA	NA	NA	NA	23	26	2.9	NA		27.9	9.6	"45,XY,der(12;16)(q10;p10)[2]/46,XY[18]"	NA	NA	"nuc ish(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2) [200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x1(5'CBFB con 3'CBFBx1)[31/200]"	30	FALSE		NA	NA	5	27.4	TRUE	positive	5.666666667	positive				CCND3 (P203S; MAF unlisted)|CHEK2 (T367fs*15; MAF unlisted)|DNMT3A (R882H; MAF unlisted)|FLT3-ITD|NPM1 (W288fs*10+; MAF unlisted)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	6.815699908	6.385505936	5.096709014	2.632459474	6.677802347	1.929655182	1.471277842	yes	yes	yes	no	yes	yes	no	NA	NA	NA	NA	NA	NA							0.593742526
BA2733R	BA2733D	2408	Waves1+2	yes	no	yes	no	Female	Female			White	2		CBFB-MYH11	33	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	33	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	103	Alive	920	Alive	0	72	18	0	NA	38	26	3	NA	85	30	3.4	NA		25.9	9	"47,XX,inv(16)(p13.1q22),+22"	NA	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2x3, D20S108x2)[7/200],(RUNX1T1,RUNX1)x2[197],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[198], (CBFBx2)(5ÍCBFB sep 3ÍCBFBx1)[140/200]"	18	TRUE	"CD2(-), CD7(-), CD11b(-), CD13(variably +), CD14(-), CD15(variably +), CD16(-), CD33(+), CD34(variably +), CD36(-), CD38(+), CD45(+), CD56(-), CD64(partial +), CD117(+), HLA-DR(+)"	TRUE	TRUE	6.1	26.3	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.483958923	3.041317535	-1.862588421	4.133976047	5.749015817	-2.305703239	6.053619738	no	no	no	yes	no	no	yes	1.318467559	3.014475378	-0.042705442	-0.072465691	1.108321603	3.231905572	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.656905846
BA2995R	BA2995D	2281	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	2			71	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	55	Dead	156	Dead-Unknown	0	76	58	2	NA	38	6	14	NA	27	25	3.1	NA		25	8.5	"46,XY"	NA	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1x2,D7S522x1)[29/200],(D8Z2,D20S108)x2[199],(RUNX1T1,RUNX1)x2 [200],(5'MLL,3'MLL)x3(5'MLL con 3'MLLx3)[11/200],(PML,RARA)x2[199],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	93	TRUE	"CD2(-), CD4(partial dim +), CD7(partial +), CD11b(partial +), CD13(partial +), CD15(-), CD19(-), CD22(partial +), CD33(partial and variably +), CD34(variably +), CD36(partial +), CD38(variably +), CD45(partial +), CD56(-), CD64(partial +), CD117 (partial +), HLA-DR(+), TdT(partial +), MPO(-)"	TRUE	TRUE	5.8	7.5	FALSE	negative	0	negative	RUNX1 (p.P333Rfs*261; 48.9%)|RUNX1 (p.D332G; 51.1%)|RUNX1 (p.R162G; 47.3%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	5.073726057	6.80845562	3.501370809	4.243160748	5.711759699	-3.628235815	1.770057057	yes	yes	yes	yes	no	no	no	-1.100005813	-4.908521081	4.769734736	-2.054791561	-5.030451502	2.725529454	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.613573722
BA2069R	BA2069D	2179	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1		MLLT3-KMT2A	55	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	4	Dead	246	Dead-Disease	1.4	75	23	8.5	NA	11.4	8.5	34	0.2	62	31	3.8	1.44	M5	38.1	12.2	"46,XY,t(9;11)(p22;q23)[20]"	497	87.6	MLL rearrangement and t(9;11) (86%)	32	TRUE	"CD11b, partial CD13, CD33, CD38, CD56, CD58, CD64, partial CD117, CD123, and HLA-DR+ "	FALSE	TRUE	7.9	10.21	FALSE	positive	1.083333333	positive				No gene mutations found in the 43 genes tested					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	0.020492332	1.582482866	0.884640282	2.897727105	5.660519196	-4.162213222	1.706922136	no	no	no	no	no	no	no	-2.047024432	NA	-5.418608728	NA	5.192972356	4.231131766	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.49858318
BA2100R	BA2100D	2485	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown		White	2			73	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Prostate Cancer	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	74	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	7	"Cytarabine, Fludarabine, Sorafenib|Crenolanib|Azacitidine|Sorafenib|Decitabine, Sorafenib |Clofarabine, Cytarabine|Sapacitabine (CYC682-06)"	6	Hypomethylating/Low Dose Cytarabine|Salvage|Unknown|Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	39	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	33	Dead	658	Dead-Unknown	1	32	67	2	NA	8	3	14	NA	15	30	4.1	NA		32.8	11	"46,XY,+1,dic(1;15)(q12;p11.2)[2]/46,XY[18] "	NA	NA	"18].nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2 [200],(RUNX1T1,RUNX1)x2[198],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	90	FALSE	"CD4(partial dim +), CD7(-), CD10(-), CD11b(-), CD13(+), CD14(-), CD15(-), CD16(-), CD19(-), CD20(-), CD22(-), CD33(variably +), CD34(+), CD36(-), CD38(variably +), CD45 (variably +), CD56(-), CD64(-), CD79a(-) | CD117(variably +), HLA-DR (variably +), MPO(predominantly -), TdT(-)"	TRUE	TRUE	5.8	24.2	TRUE	positive	1.222222222	negative	RUNX1 (p.R201Q; 47.2%)			FLT3-ITD (NOT FOUNDATION NO MAF AVAILABLE)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	TRUE	5.122054313	4.572293286	4.753808985	3.150065299	5.973614304	-0.387302959	4.486581334	yes	yes	yes	no	no	yes	yes	2.296252962	NA	2.81949916	NA	-0.809535461	1.724483345	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.765994177
BA2953R	BA2953D	2485	Waves1+2	no	no	no	no	Male	Male	Unknown		White	2			73	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Prostate Cancer	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	74	37	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	7	"Cytarabine, Fludarabine, Sorafenib|Crenolanib|Azacitidine|Sorafenib|Decitabine, Sorafenib |Clofarabine, Cytarabine|Sapacitabine (CYC682-06)"	6	Hypomethylating/Low Dose Cytarabine|Salvage|Unknown|Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	39	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	33	Dead	658	Dead-Unknown	6	66	40	2	NA	19	20	8	NA	22	36	4.3	NA		34.7	11.6	"46,XY"	NA	NA	"nuc ish(D5S721,D5S23,EGR1)x2[198],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[199],(RUNX1T1, RUNX1)x2[198],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[199]"	67	TRUE	"CD2(-), CD4(-), CD7(-), CD8(-), CD10(-), CD11b(partial +), CD13(+), CD14(-), CD15(-), CD16(-), CD19(-), CD20(-), CD22(-), CD33(variable and bright +), CD34(variably +) (Within this population, there is a small subset of cells (1.7% of total events) that is CD10(partial +), CD13(partial +), CD19(+), CD20(partial +), CD22(partial +), CD33(+), CD34(variably +), CD38(+), CD45(+), CD79a(+), CD117(partial +), HLA-DR(+) and TdT(partial +).) | CD36(-), CD38(variably +), CD45(moderately +), CD56(-), CD64(partial +), CD117(variably +), HLA-DR(variably +)."	TRUE	TRUE	6.2	13.9	FALSE	positive	3	negative	RUNX1 (p.R201Q; 51.8%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	TRUE	3.939270525	2.852206063	2.514712869	2.273772977	5.038566273	-2.104319609	5.081518239	yes	no	no	no	no	no	yes	NA	NA	NA	NA	NA	NA							0.60830279
BA2681R	BA2681D	2288	Waves1+2	yes	yes	yes	no	Female	Female			White	3			68	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Not specified	y	n	n	n	n	n	y	y	MYELOPROLIFERATIVE NEOPLASMS	Secondary myelofibrosis	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	68	49	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Cyclophosphamide, Fludarabine, TBI|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine"	3	Allogeneic - Sibling|Hypomethylating/Low Dose Cytarabine|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	-1	Dead	339	Dead-Disease	NA	29	40	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,der(9)t(9;12)(p13;q13),del(11)(q21q25),der(12)add(12)(p11.2)add(12)(q13),del(13)(q14q22)[9]/46,idem,add(12)(q24.3),+13,-del(13)[9]/46,idem,add(17)(p13)[2]"	NA	NA		NA	NA		NA	NA	NA	11.36	FALSE	negative	0	negative		ASXL1 (p.G645Vfs*58; 8.3%)|ASXL1 (p.C789Wfs*2; 30.5%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	4.550221992	5.966665131	3.815692991	4.829884315	5.279352426	-0.032401808	5.273936282	yes	yes	yes	yes	no	yes	yes	4.366092364	0.455721807	1.814471201	1.894205923	-0.814038317	0.874187294	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.669481889
BA2248R	BA2248D	2105	Waves1+2	yes	yes	yes	no	Male	Male			HispNative	2			21	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	22	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	13	"HiDAC|Crenolanib|Etoposide|Topotecan|Decitabine|Clofarabine|Thioguanine|7+3 (Cytarabine, Idarubicin)|Cyclophosphamide|Thiotepa|Sorafenib|Mitoxantrone|Vinorelbine"	4	Induction|Experimental|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	5	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	15	Dead	551	Dead-Disease	0	88	92	0	NA	8	0	0	NA	22	20	3.3	0.51		25.8	9.1		208	NA		NA	NA		NA	NA	6.4	3.2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	4.762160527	3.068070311	3.773862403	1.785590031	5.367982112	-1.160989408	1.480737862	yes	no	yes	no	no	no	no	-4.892133365	0.882919947	1.96469577	4.786482504	-0.663554897	-3.33150584	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.350038789
BA2832R		2108	Waves1+2	yes	no	yes	yes	Male	Male			White	2			68	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	y	y	n	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	5	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	5	Dead	29	Dead-Disease	NA		41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	9.5	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	3.857297584	4.490554223	3.504351008	5.576013105	6.34007878	-2.039805595	6.308412575	yes	yes	yes	yes	yes	no	yes	-0.507187786	5.291847962	1.288430267	0.830156291	3.433624453	-3.156116241	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.643243835
BA2308R	BA2308D	2248	Waves1+2	yes	yes	yes	yes	Male	Male			White	4		GATA2-MECOM	71	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	72	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	4	"Dasatinib|7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine"	4	Hypomethylating/Low Dose Cytarabine|Induction|Experimental|Maintenance	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	-1	Dead	555	Dead-Disease	NA	82		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"45,XY,-7,t(3;3)[20]"	NA	NA		NA	NA	"CD34+ CD38, CD13,CD33, CD117, HLA-DR, DIM CD7, PARTIAL CD11C, CD2(SUBSET), CD15(MINOR SUBSET), DIM cCD79a(MINOR SUBSET), AND PARTIAL CD4"	TRUE	TRUE	NA	NA	NA	positive	5.25	negative				FLT3-D835					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	3.331149311	2.947012969	0.855575139	5.089050932	4.003299605	-1.154393194	3.238076097	yes	no	no	yes	no	no	no	-1.875563108	-0.706066079	4.182772428	3.228350344	-2.014574181	-1.564992037	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.591101187
BA2413R		2248	Waves1+2	no	no	no	no	Male	Male			White	4		GATA2-MECOM	71	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	72	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	n	y	y	n	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	4	"Dasatinib|7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine"	4	Hypomethylating/Low Dose Cytarabine|Induction|Experimental|Maintenance	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	-1	Dead	555	Dead-Disease	NA	82		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"45,XY,-7,t(3;3)[20]"	NA	NA		NA	NA	"CD34+ CD38, CD13,CD33, CD117, HLA-DR, DIM CD7, PARTIAL CD11C, CD2(SUBSET), CD15(MINOR SUBSET), DIM cCD79a(MINOR SUBSET), AND PARTIAL CD4"	TRUE	TRUE	NA	NA	NA	negative	0	negative				FLT3-D835					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	2.508634271	2.625530291	0.585076283	5.199058743	3.00083017	-1.006443181	1.358502446	no	no	no	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.571270698
BA2701R	BA2701D	2419	Waves1+2	yes	yes	yes	yes	Male	Male			Black	2			51	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	51	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Alive	1487	Alive	NA	82	1	NA	NA	17	35	23	NA	16	14	3.7	0.8		25	8.7	"46,XY[20]"	NA	83.8		16	TRUE	"CD1a(-), CD2(-), surface CD3(-), cytoplasmic CD3(partial dim +), CD4(partial dim +), CD5(dim +), CD7(+), CD8(-), CD10(-), CD11b(partial +), CD13(+), CD14(-), CD15(-), CD16 (-), CD22(partial dim +), CD33(variably +), CD34(+), CD36(-), CD38(partial +), CD45(variably +), CD56(variably +), CD64(-), | CD117(variably +), HLA-DR(partial +), MPO(-), and TdT(+)"	TRUE	TRUE	6.8	3.2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	7.171167869	7.34547705	4.50750808	4.03785813	6.948815899	-1.350350461	4.912645484	yes	yes	yes	yes	yes	no	yes	5.439606969	-0.756784939	0.841674142	-0.839508417	0.659265011	0.851002779	Monocyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.803010796
BA2634R	BA2634D	2047	Waves1+2	yes	yes	yes	yes	Male	Male			White	3			74	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	75	0	Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|Etoposide, Mitoxantrone"	3	Hypomethylating/Low Dose Cytarabine|Salvage|Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Salvage	-1	Dead	415	Dead-Disease	NA	60.1		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"46,XY,add(1)(p34),del(7)(q22),del(20)(q11.2)[20]"	NA	NA	"normal, no evidence of RUNX1T1/RUNX1 transloc or 11q23 or 16q22"	NA	NA	"Increased CD34 positive myeloblasts, representing approximately 55% of the leukocytes"	FALSE	FALSE	NA	NA	NA	positive	1.941176471	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	TRUE	TRUE	6.383067824	6.534480568	3.062997067	5.715903043	6.301423724	-1.367205179	4.554520229	yes	yes	yes	yes	yes	no	yes	4.010217336	-2.271676056	3.045624072	-0.385858516	-2.047203287	1.127361152	Monocyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.667183732
BA2937R	BA2937D	2212	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			61	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	61	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|HAM (Cytarabine, Mitoxantrone)|Hydroxyurea|Busulfan, Cyclophosphamide"	5	Allogeneic - Sibling|Salvage|Induction|Re-induction|Symptom Control	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Dead	213	Dead-Treatment	0	25	20	13	NA	6	12	55	0.9	45	34	3.1	0.8		31.1	9.8	"42~44,XY,t(1;10)(q12;q21),-5,-7,-11,add(13)(p11.1),der(18)t(11;18)(q14;q21.1),add(20)(q12),+1~3mar[cp4]/41~44,sl,add(4)(q23)[cp9]/41~44,sl,del(4)(q21q?27)[cp5]/41~42,"	NA	88.9	Monosomy 5 (52%) | 5p deletion (39%) | Monosomy 7 (48%) | Abnormal 7q arm (48%)	243	TRUE	"CD13, CD33,CD34, CD38, dimCD56, CD58, CD117, and HLA-DR+"	FALSE	TRUE	6.4	96.64	TRUE	negative	0	negative			TP53 (p.R248Q; 96.4%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	5.765687009	6.385991643	3.921638856	3.922044406	6.468245227	0.635764115	6.649159646	yes	yes	yes	yes	yes	yes	yes	4.241630957	3.062410482	0.077213375	-1.219871626	3.433556732	1.608929972	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.76612443
BA2600R	BA2600D	2254	Waves1+2	yes	yes	yes	no	Female	Female			White	4			64	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	64	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Fludarabine, BCNU, Melphalan|Decitabine, Midostaurin"	2	Allogeneic - Sibling|Induction	Complete Response	Standard Chemotherapy	249	Bone Marrow Transplant	"Fludarabine, BCNU, Melphalan"	Allogeneic - Sibling	-1	Alive	1021	Alive	NA	79		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XX,t(2;3)(p13;q25~26)[2]/46,idem,i(14)(q10)[18]"	NA	NA		NA	NA	"CD34, partial CD117, CD38, CD33, partial CD13,partial CD11C, CD4, partial CD14, partial CD64, partial CD2, and HLA-DR"	FALSE	TRUE	NA	NA	NA	positive	1	negative	RUNX1 (p.P430S; 60.0%)|RUNX1 (p.R166*; 41.2%)			FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	TRUE	NA	TRUE	TRUE	5.026906786	6.198749954	4.338658989	4.896263954	6.095575465	-0.452652967	5.442103413	yes	yes	yes	yes	yes	yes	yes	3.346062278	-0.935677443	3.569692498	1.326721472	0.8162458	4.151696999	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.758429043
BA2019R	BA2019D	2365	Waves1+2	yes	yes	yes	no	Male	Male			HispNative	3			39	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	T lymphoblastic leukaemia/lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	39	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	7	"Nelarabine|POMP (Prednisone, Methotrexate, 6-MP, Vincristine)|3+7 (Cytarabine, Daunorubicin)|HyperCVAD|Azacitidine|GCLAC (GCSF, Clofarabine & Cytarabine)|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	5	Hypomethylating/Low Dose Cytarabine|Salvage|Induction|Maintenance|Re-induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"GCLAC (GCSF, Clofarabine & Cytarabine)"	Re-induction	-1	Dead	169	Dead-Disease	NA	59.3	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,t(10;11)(p13;q14)[11]/45,sl,-Y[7]/46,sdl1,t(1;8)(q12;p21)[2]"	NA	NA	Normal	NA	NA	"Increased atypical myeloblasts (partial CD34+, weak CD7+, partial CD61+), representing approximately 91% of the leukocytes, consistent with persistent acute myeloid leukemia."	TRUE	FALSE	NA	1.7	FALSE	negative	0	negative			TP53 (p.R282W; 72.5%)						no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	3.911949968	2.623482227	1.990437336	3.137136059	5.337919529	-3.286356894	1.382955476	yes	no	no	no	no	no	no	-1.435833308	NA	-2.431712108	NA	-4.517108897	-5.131331993	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.515085149
BA2412R	BA2412D	2260	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			85	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	86	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Decitabine	Supportive/Palliative Care	169	Dead	333	Dead-Disease	0			0	NA	17	44	39	0	15	9	3.5	0.9	M5	25.7	8.2		175	88		18	TRUE		NA	NA	6.9	13.22	FALSE	negative	0	negative			TP53 (p.R248W; 72.2%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	4.451365321	5.972010448	3.448025032	5.716694706	6.879120863	1.539016813	6.065967418	yes	yes	yes	yes	yes	yes	yes	6.27702643	-1.039947185	-1.33904023	-6.742707064	0.070281074	5.466644881	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.879809304
BA2334R	BA2334D	2270	Waves1+2	yes	yes	yes	yes	Female	Female			White	2		DEK-NUP214	30	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(6;9)(p23;q34); DEK-NUP214	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(6;9)(p23;q34); DEK-NUP214	31	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	6	"7+3 (Cytarabine, Idarubicin)|Crenolanib|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine, Sorafenib |Quizartinib"	3	Salvage|Induction|Experimental	Refractory	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	52	Dead	568	Dead-Disease	NA	65	47	NA	NA	NA	NA	NA	NA	49	31	4.2	0.85		NA	NA	"47~49,XX,t(6;9)(p23;q24),+8,+13,+15[cp8]/47~49,idem,+del(13)(q12q22)[cp12]"	329	NA		10	TRUE	"CD34(partial +), CD13(+), CD14(-), CD15(few +), CD30(-), CD33(+), CD38(variably +), CD45 (moderately +), CD64(variably +), CD4(partial +), CD117(+), CD123(variably +), HLA-DR(+), CD79a(-), CD22(-), intracellular CD3(-), TdT(-), MPO(partial +), other myeloid and lymphoid antigens(-)."	TRUE	TRUE	6.3	20.2	FALSE	positive	2.125	negative				FLT3-D835|FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	3.819493057	4.751327373	5.578204761	3.969281028	5.845089876	-0.957759019	4.213671421	yes	yes	yes	yes	no	yes	no	0.554849396	-0.871070761	1.677640712	2.958738755	-0.512241861	-1.997111587	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.500346113
BA2050R		2270	Waves1+2	no	no	no	no	Female	Female			White	2		DEK-NUP214	30	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(6;9)(p23;q34); DEK-NUP214	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(6;9)(p23;q34); DEK-NUP214	31	3	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	n	y	y	n	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	6	"7+3 (Cytarabine, Idarubicin)|Crenolanib|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine, Sorafenib |Quizartinib"	3	Salvage|Induction|Experimental	Refractory	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Crenolanib	Experimental	52	Dead	568	Dead-Disease	NA	65	52	0	NA	10	0	28	NA	NA	26	3.9	0.87		22.4	7.9	"47~49,XX,t(6;9)(p23;q24),+8,+13,+15[cp8]/47~49,idem,+del(13)(q12q22)[cp12]"	NA	90.9		20	TRUE	"CD34(partial +), CD13(+), CD14(-), CD15(few +), CD30(-), CD33(+), CD38(variably +), CD45 (moderately +), CD64(variably +), CD4(partial +), CD117(+), CD123(variably +), HLA-DR(+), CD79a(-), CD22(-), intracellular CD3(-), TdT(-), MPO(partial +), other myeloid and lymphoid antigens(-)."	TRUE	TRUE	NA	43.3	TRUE	positive	3.761904762					FLT3-D835|FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	2.589522834	2.983647066	5.660519196	2.318844673	5.142288444	-0.783198133	4.756557293	no	no	yes	no	no	yes	yes	NA	NA	NA	NA	NA	NA							0.45483948
BA3230R	BA3230D	2777	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Induction	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	Decitabine	Induction	-1	Dead	329	Dead-Disease	0.8	25	40	0	NA	4.7	1.6	38.9	1.3	13	49	2.4	0.68	M2	19.6	6.8	"46,XX,del(12)(p12p13)[23]"	NA	94.2	Normal	9	FALSE	"dim CD5, CD13, dim CD33, CD34, variable CD38, CD58, CD117, dim CD123 and HLA-DR positive"	FALSE	TRUE	4.5	68.85	TRUE	positive	0.694915254	negative		ASXL1 (p.E635Rfs*15; 22.0%)		CREBBP (W1745*; MAF ~50%)|FLT3-ITD (MAF ~50%)|SF3B1 (p.K666M; MAF ~50%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	5.816486103	6.170779131	6.347373671	0.919835107	5.938573569	-0.988728384	7.06807721	yes	yes	yes	no	no	no	yes	3.363807024	4.315475789	-1.997332753	-0.622957564	4.594175378	-3.470748986	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.572930229
BA2481R	BA2481D	2159	Waves1+2	no	no	no	no	Male	Male			White	2			NA	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	n		y	n	y	n	n	n	n	n	MYELODYSPLASTIC SYNDROMES	Refractory anaemia with excess blasts	NonAML	MYELODYSPLASTIC SYNDROMES	Refractory anaemia with excess blasts	NA	4	Unknown		Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Induction	Unknown	Standard Chemotherapy	60	Standard Chemotherapy	Decitabine	Induction	60	Dead	116	Dead-Unknown	NA	3		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	NA	NA	The findings reveal a slightly expanded population of myeloblasts with an essentially unremarkable immunophenotype. There is no definitive immunophenotypic evidence of a hematolymphoid malignancy.	FALSE	FALSE	NA	NA	NA	negative	NA	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	4.581190546	6.961566555	5.218130479	3.455047072	6.685371663	0.471360863	8.342320805	yes	yes	yes	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.493599842
BA2731R	BA2731D	2036	Waves1+2	yes	yes	yes	yes	Male	Male			White	2	bi		63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	1346	Alive	NA	86	85	0	NA	9	3	3	NA	16	27	2.9	0.75		NA	NA	"46,XY,del(11)(q14q23)[13]/46,XY[7].ishdel(11)(5'MLL-,3'MLL+)[2]."	682	NA	"nuc ish(D5S721,D5S23,EGR1)x2[198],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(5'MLLx1,3'MLLx2)(5'MLL con 3'MLLx1)[118/200]"	NA	NA	"CD7(+), CD11b(-), CD13(dim +), CD14(-), CD15(partial +), CD16(-), CD33(variably +/subset bright +), CD34(+), CD36(-), CD38(+), CD45(+), CD56(partial +), CD64(partial +), CD117(+), HLA-DR(+), MPO(+), TdT(-)."	TRUE	TRUE	6.6	33	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.364101076	2.501989048	1.972594566	3.607338896	6.534480568	-0.482855916	5.272144758	yes	no	no	no	yes	yes	yes	5.335541772	-0.150021608	-2.352515699	-1.638570173	-0.095723471	4.616170785	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.739850202
BA2418R	BA2418D	2405	Waves1+2	yes	yes	yes	no	Female	Female			White	2			47	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	2	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	2	"Crenolanib|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Salvage|Experimental			NA	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	4	Dead	934	Dead-Unknown	0	84	72	0	NA	28	0	0	NA	10	17	2.8	0.56		14.5	5.3		291	NA		10	TRUE		NA	NA	5.1	1.2	FALSE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.440981737	2.888840019	1.964440872	5.193067466	5.499811476	0.061899566	-2.713314441	yes	no	no	yes	no	yes	no	-6.253264603	-2.861501913	1.393448091	4.16452697	-3.856529834	-1.018167111	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.372084619
BA2294R	BA2294D	2499	Waves1+2	yes	yes	yes	yes	Female	Male			HispNative	4		RUNX1-RUNX1T1	62	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Induction	-1	Alive	239	Alive	NA	52	57	NA	NA	NA	6	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,t(8;21)(q22;q22)[14]"	NA	NA		NA	NA	"CD34, PARTIAL CD38, CD33, CD13, CD64, PARTIAL CD11C, PARTIAL CD19, HLA-DR, PARTIAL CD15, CD117, AND MPO"	FALSE	TRUE	NA	12.9	FALSE	negative	0	negative				NRAS					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.168114613	4.187944625	-0.973688092	5.015316954	6.272022849	0.068042127	7.265037787	yes	yes	no	yes	yes	yes	yes	-0.122397605	2.453001312	-0.371553266	0.868553852	-0.354540745	-0.245636438	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.629133063
BA2816R	BA2816D	2016	Waves1+2	yes	yes	yes	no	Male	Male			White	4			21	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	21	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	2	"SWOG S1203 (7+3 +/- Vorinostat)|Fludarabine, Cyclophosphamide, TBI "	2	Allogeneic - Sibling|Induction	Complete Response	Standard Chemotherapy	177	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Allogeneic - Sibling	-1	Alive	605	Alive	NA	66	1	NA	NA	NA	17	NA	NA	NA	NA	NA	NA	M1	NA	NA	"45,XY,-7[6]/47,XY,+13[cp5]/46,XY[12]"	NA	NA		NA	NA	"CD34, CD4, CD13, CD15, partial CD33, CD38, partial CD117, partial CD11c, HLA-DR, MPO and TdT"	FALSE	TRUE	NA	2.1	FALSE	negative	0	negative	RUNX1 (p.R201*; 33.3%)			NRAS					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	3.813860416	4.606483871	0.039160142	5.475040559	5.217076666	-3.422944933	2.916071003	yes	yes	no	yes	no	no	no	-0.798020807	-1.836806516	2.048343423	-0.215069154	-2.045874763	4.493173566	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.775538092
BA2814R	BA2814D	2539	Waves1+2	yes	yes	yes	yes	Male	Male			White	3		MLLT3-KMT2A	62	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"7+3 (Cytarabine, Idarubicin)|Fludarabine, TBI|MiDAC|FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) |ODSH (2 O, 3-O Desulfated Heparin) "	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, TBI"	Allogeneic - Matched Unrelated Donor	-1	Dead	979	Dead-Disease	NA	93	58	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5a	NA	NA	"47,XY,+8,t(9;11)(p21;q23)[9]/46,XY[11]"	NA	NA	"8q22 (RUNX1T1): gain present  11q23 (MLL): rearrangement present (83.5% 11q23, 84.5% 8q22)"	NA	NA	"Large population of promonocytes/monoblasts that represent approximately 88% of the leukocytes, consider acute monoblastic leukemia."	FALSE	FALSE	NA	14.66	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.348487816	1.139679676	3.23020313	1.949289437	6.369828867	-2.671580925	2.228584264	no	no	yes	no	yes	no	no	0.802135727	2.302226122	-6.493292361	-3.644471967	6.042142165	3.263403913	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.547471103
BA2631R	BA2631D	2369	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			60	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	MiDAC	Consolidation	114	Alive	2769	Alive	0.8	30	55	4.5	NA	19.7	8.3	15.9	0.3	49	23	3.5	1.22	M2	30.6	10.6	"46,XY[21]"	536	95.6	Normal	141	TRUE	"CD7, CD13, CD33, partial CD34, CD38, CD58, CD117, CD123,HLA-DR, and MPO positive"	TRUE	TRUE	7.2	11.93	FALSE	negative	0	positive				CEBPA (p. Q83fs*27 (c.245?246insTGTTCCA); MAF 50%)|FLT3 ( p.N841I; MAF 12%)|FLT3 (p.I836delI; MAF 25%)|NPM1 (p.W288fs*>9; MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.054788152	2.739328747	-0.261236045	3.964635524	5.3404797	-0.625770429	6.179899465	no	no	no	yes	no	yes	yes	0.374746321	0.746491876	0.107483406	3.265121806	1.023312697	-0.416637768	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.467968197
BA2023R	BA2023D	2075	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			55	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide"	4	Allogeneic - Sibling|Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	5	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Dead	386	Dead-Treatment	0	54	40	0	NA	14	59.6	5.3	0	463	477	2.7	1.14	M4	19.3	6.6	"47,XY,+8[16]/46,XY[4]"	NA	93.7	Trisomy 8 (82%)	47	TRUE	"partial CD13, CD15,  CD33, CD56, CD38, CD58, CD64, dimCD123, HLA-DR and MPO positive"	FALSE	TRUE	5.7	16.66	FALSE	negative	0	negative		ASXL1 (p.G646Wfs*12; 27.3%)		"NRAS (p.G12R, MAF 50%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	1.05539234	2.688451126	2.916656154	3.240646494	6.646840272	-1.485040412	4.840048947	no	no	yes	no	yes	no	yes	5.338421106	NA	-6.058193363	NA	3.800252159	3.270073138	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.800577492
BA2375R	BA2375D	2330	Waves1+2	yes	yes	yes	no	Male	Male	Black	NON-HISPANIC	Black	1			72	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	Decitabine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	-1	Dead	107	Dead-Disease	2.6		41	0	NA	15.3	9.3	28.8	0.6	36	31	3.8	1.66	M0	23.3	7.2	"46,XY,-7,+mar.ishder(7)del(7)(p11.2)del(7)(q11.2)(D7Z1+)[20]/45,XY,-7[2]/46,XY[3]"	398	82	"Two of twenty-five metaphase cells examined were monosomy 7, shown by  fluorescent in situ hybridization (FISH) in  a companion study  (GLC-13-06587) to be a true clone.  Twenty cells appeared to be missing a  chromosome 7 with an additional small marker."	42	FALSE	"CD13, dimCD19, partial CD33, partial CD34, CD38, CD58, dim cCD79a, CD117, and TdT positive."	TRUE	TRUE	6.6	12.44	FALSE	negative	0	negative	RUNX1 (p.R166G; MAF 22%)			CBL (p.L370del; MAF 63%)|JAK2 (p.V617F; MAF 43%)|RUNX1 (p.R166G; MAF 22%)|U2AF1 (p.Q157R; MAF 40%)			yes		yes	yes	Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	6.020771653	7.137564015	2.234588564	7.577242191	6.960916228	-1.837546925	3.843473655	yes	yes	no	yes	yes	no	no	4.332554214	-0.86250731	2.898892526	-1.109632768	-1.566325086	3.214139134	Monocyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.849795382
BA2485R		2540	Waves1+2	yes	no	yes	no	Male	Male	Multiracial	HISPANIC	HispNative	1			56	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	56	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	n	y	n	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	HiDAC	Consolidation	111	Alive	1389	Alive	0.8	95		0	NA	25.6	0	0	0.7	27	16	3.4	0.97	M1	11.1	3.7	"46,XY[20]"	314	95.7	Normal	20	FALSE	"CD13, CD33, CD38, partial CD56 (7%), CD58, CD117, CD123, and partial MPO positive"	FALSE	TRUE	7.1	13.26	FALSE	positive	NA	positive				FLT3-ITD (Internal tandem duplication; MAF: 40%)|IDH2 (p.R140Q; MAF: 50%)|NPM1 (p.W288fs*9; MAF: 40%)					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	3.768072434	0.478564734	0.965478501	1.452270628	4.575134679	-1.813378709	-0.883218417	yes	no	no	no	no	no	no	-7.453051353	-1.637648804	-0.469356694	2.977543684	0.048152406	-8.611949259	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.264187353
BA2455R	BA2455D	2373	Waves1+2	yes	yes	yes	no	Male	Male			White	4			72	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Supportive/Palliative Care	1	Hydroxyurea	1	Supportive/Palliative Care			NA	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	-1	Dead	33	Dead-Disease	NA	94	71	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	M5	NA	NA	"48,XYY,+8[21]"	NA	NA		NA	NA	"CD38, CD56, CD13(dim), CD64, CD11c, CD4, CD56, HLA-DR, and CD15"	FALSE	FALSE	NA	24.2	TRUE	negative	0	positive				FLT3-D835|NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	0.764705649	2.134894412	2.13094475	3.687560228	5.863798374	-1.471201234	0.95732621	no	no	no	no	no	no	no	0.22824194	-1.256095727	-4.980419921	-3.936173789	6.007819789	3.505368105	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.605926081
BA2636R	BA2636D	2576	Waves1+2	yes	yes	yes	yes	Male	Male			White	4			74	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	74	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	4	"Hydroxyurea|Decitabine|Temozolomide, Vorinostat|Azacitidine, MLN4924"	4	Salvage|Induction|Re-induction|Symptom Control	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	Decitabine	Salvage	-1	Dead	357	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative		ASXL1 (p.G645Vfs*58; 43.8%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	2.419637195	4.520106979	2.836965422	5.967846347	6.13289458	0.130813833	6.485600187	no	yes	yes	yes	yes	yes	yes	1.208411696	1.565247659	1.193866048	0.867397458	1.929481454	-0.658998415	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.67953805
BA2325R	BA2325D	2492	Both	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			74	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	74	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"3+7 (Cytarabine, Daunorubicin)"	1	Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	6	Alive	29	Alive	0.9	60	9	0	NA	11.4	44.7	35.1	7.1	17	28	2.6	0.79	M4	28.1	9.4	"46, XX,t(2;16)(p23;p13.3)(13) "	645	98.3		71	TRUE	"CD13, CD14, CD16, CD33, CD64 and HLA-DR"	FALSE	TRUE	6.2	35.91	TRUE	negative	0	positive				NPM1 (p.W288fs*>9 (C-terminal frame-shift); MAF 44%)|PTPN11 (p.E76Q; MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.728098026	4.852632498	3.5765847	4.271957484	6.67173083	-0.093173525	6.021607404	no	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.859723913
BA2169R	BA2169D	2399	Waves1+2	yes	yes	yes	no	Male	Male	White	HISPANIC	HispNative	2			38	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	39	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Supportive/Palliative Care	4	"7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)"	4	Salvage|Unknown|Induction|Maintenance		Standard Chemotherapy	5	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Unknown	6	Alive	416	Alive	NA	N/A	16	NA	NA	20	10	54	NA	152	49	4.3	0.77		30.5	10.6		340	NA		215	TRUE		NA	NA	7	4.01	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.140579648	5.250746734	1.782959625	5.991126785	5.665885045	-0.813495335	3.004264998	yes	yes	no	yes	no	yes	no	-0.056710174	NA	3.597178387	NA	-3.90612466	0.858020051	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.692586744
BA2156R	BA2156D	2017	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	bi		55	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Other malignant neoplasm without specification of site	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	2733	Alive	0	50	25	0	NA	45.3	19.6	9.3	6	27	20	3.7	1.01	M2	30.6	10.1	"46,XY[20]"	NA	98.4	Normal	15	FALSE	"CD7, CD13, CD33, CD34, CD38, CD64, CD123, HLA-DR, and MPO"	TRUE	TRUE	6.3	3.85	FALSE	negative	0	negative				CEBPA (c.242?243insCTTGGTT (7bp out-of-frame insertion); MAF 50%)|CEBPA (c.912?913insTTG (3 bp in-frame insertion); MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.393553061	3.797231154	0.172276062	4.733327968	3.997503433	-1.033493909	4.692226159	yes	yes	no	yes	no	no	yes	-4.846738283	NA	-0.078162661	NA	-4.272494016	-0.954524431	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.343875304
BA2511R	BA2511D	2567	Waves1+2	yes	yes	yes	yes	Female	Female			White	4		GATA2-MECOM	71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	AG-221	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	AG-221	Hypomethylating/Low Dose Cytarabine	-1	Alive	1008	Alive	NA	22	8	NA	NA	NA	10	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XX,inv(3)?(q21q25)[21]"	NA	NA		NA	NA	"CD34, CD117, CD38, CD56 (minor subset), partial CD13, partial CD33, CD11c, and HLA-DR"	FALSE	TRUE	NA	2.6	FALSE	negative	0	negative				IDH2					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.243521333	6.005137682	4.1566116	6.72582978	7.158765707	1.093888501	4.592242188	yes	yes	yes	yes	yes	yes	yes	4.688727088	0.278458125	-0.401775568	-1.532462752	0.109258261	1.029321327	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.987995911
BA2168R	BA2168D	2297	Waves1+2	yes	yes	yes	yes	Female	Female	Unknown		HispNative	2			47	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	48	0	Post-Chemotherapy|Post-Transplant|Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)|Busulfan, Cyclophosphamide"	4	Allogeneic - Sibling|Consolidation|Salvage|Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	-1	Dead	582	Dead-Unknown	0	62	66	0	NA	7	0	13	NA	24	40	3.4	NA		35.5	12.1	"46,XX"	NA	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[198],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	29	TRUE	"CD2(-), CD4(partial +), CD7(-), CD11b(partial +), CD13(+), CD14(-), CD15(partial +), CD16(-), CD33(bright +), CD34(partial +), CD36(-), CD38(variably +), CD45(variably +), CD56(partial +), CD64(-), CD117(partial +), HLA-DR(partial dim +)"	TRUE	TRUE	5.8	58.5	TRUE	positive	3.166666667	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	4.400323485	2.213099709	6.073057105	2.798042346	5.444974816	1.693449976	1.475379471	yes	no	yes	no	no	yes	no	-4.618383881	NA	1.535810303	NA	-0.335959464	-3.966554007	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.409992115
BA2505R		2023	Waves1+2	yes	no	yes	no	Male	Male			White	4		GATA2-MECOM	71	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	n	y	n	n	1	Standard Chemotherapy	3	"CPX-351 (Liposomal Cytarabine + Daunorubicin)|Lenalidomide|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	23	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Re-induction	4	Dead	262	Dead-Unknown	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"45,XY,inv(3)(q21q26),-7[20]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.455757934	4.208734346	0.177883691	6.559145862	5.598152486	-2.026911798	4.690472571	yes	yes	no	yes	no	no	yes	1.599061267	-1.890326816	2.085581514	1.532386587	-1.932226103	4.857195148	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.758860706
BA2860R	BA2860D	2413	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			68	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	n		y	n	y	n	n	n	n	n	MYELODYSPLASTIC SYNDROMES	"Myelodysplastic syndrome, unclassifiable"	NonAML	MYELODYSPLASTIC SYNDROMES	"Myelodysplastic syndrome, unclassifiable"	68	0	Unknown		Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	Azacitidine	1	Induction	Unknown	Standard Chemotherapy	6	Standard Chemotherapy	Azacitidine	Induction	6	Dead	299	Dead-Unknown	0	N/A	15	1.7	NA	38.7	3.4	30.3	0	27	23	3	1.18		21	7	"45~48,XY,del(5)(q22q35),+8,del(13)(q12q14),- 20,der(21)t(20;21)(p11.2;p11.1),+der(22)t(?;22)(?;q11.2)[cp15]/46,XY[4]"	1138	88.6		26	FALSE	"CD13, CD33, CD34, CD38, CD58, CD117, CD123 and HLA-DR positive"	FALSE	TRUE	5.7	2.42	FALSE	negative	NA	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.313273136	6.738011341	4.208734346	6.71780036	7.549707292	1.157245805	6.121388413	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.83794128
BA2871R	BA2871D	2273	Waves1+2	yes	yes	yes	no	Female	Female			White	3			80	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	80	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Unknown	1	Bevacizumab	1	Unknown			NA	Unknown	Bevacizumab	Unknown	-1	Dead	10	Dead-Disease	NA	84		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"44-47,XX,del(5)(q13q33),der(14;18)(q10;q10),-20,-21,+1-4mar[cp15]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative			TP53 (p.R306*; 28.8%)|TP53 (p.X187_splice; 21.9%)						no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	NA	TRUE	TRUE	5.555868047	6.16270218	2.747269925	8.416089831	6.311620981	-3.363664044	3.885891201	yes	yes	yes	yes	yes	no	no	1.782372385	-1.405103396	1.252581432	0.072710396	-1.224993964	3.329236172	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.754419174
BA2655R	BA2655D	2458	Waves1+2	yes	yes	yes	no	Male	Male			White	2			58	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	59	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	8	"E7070, Idarubicin, Cytarabine|5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|HiDAC|GCLAC (GCSF, Clofarabine & Cytarabine)|MEC (Cytarabine, Etoposide, Mitoxantrone)|BL-8040|IGN523"	4	Salvage|Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	-1	Dead	357	Dead-Disease	1	10	6	0	NA	32.7	12.6	53.7	NA	45	19	3.7	0.69		26.8	9.4	"46,XY[20]"	88	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x1[47/200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[199],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	75	TRUE	"CD2 (-), CD4(+), CD7(+), CD11b(-), CD13(+), CD14(-), CD15(-), CD16(-), CD33(+), CD34(bright +), CD36(-), CD38(variable +), CD45(moderately +), CD56(-), CD64(-), CD117(+), HLA-DR(+)."	TRUE	TRUE	5.8	1.6	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.611972101	5.921162914	4.083594502	6.28328279	6.150174091	1.201853861	5.291578156	yes	yes	yes	yes	yes	yes	yes	2.350212721	0.223016878	0.777041612	-0.838587091	0.120302799	-0.866159662	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.734032803
BA2227R	BA2227D	2345	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			17	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	17	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	3	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)|Clofarabine, Cyclophosphamide, Etoposide|HAM (Cytarabine, Mitoxantrone)"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	74	Standard Chemotherapy	"Clofarabine, Cyclophosphamide, Etoposide"	Re-induction	5	Dead	713	Dead-Disease	0	90		0	NA	48.5	0.6	1.2	1.6	18	11	3.5	0.7	M1	25.6	9.1	"46,XY[20]"	NA	87.4	Normal	25	TRUE	"CD13, partial CD33, CD34, CD38, moderate CD45, CD58, CD117, CD123, TdT, and partial MPO positive."	FALSE	TRUE	6.9	4.34	FALSE	negative	0	negative				MLL (PTD)|WT1 (MAF A382fs*6; 40%)|WT1 (MAF p.R462G; 40%)|WT1 (p.R462G ; MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	0.04543104	2.355073983	-0.006757303	3.120495315	3.958477395	1.095167045	3.811641575	no	no	no	no	no	yes	no	-5.837386024	NA	2.644575713	NA	-1.069915378	-3.402267023	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.299759111
BA2812R	BA2812D	2563	Waves1+2	yes	yes	yes	yes	Male	Male			White	3			46	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	MissingKaryo	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	46	14	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	2.843610145	6.061685775	4.396640906	3.714700688	6.026159553	-0.132932488	7.755101358	no	yes	yes	no	no	yes	yes	2.352552585	5.117922681	-4.147846455	-1.752518181	4.852790265	0.986962969	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.533359395
BA2125R	BA2125D	2562	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			71	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Basal Cell Carcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|Azacitidine, Lenalidomide|Decitabine"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"Azacitidine, Lenalidomide"	Re-induction	28	Dead	295	Dead-Disease	0	46	49.1	0	NA	20.5	8	17	0.9	32	39	3.3	0.73	M2	20.7	6.4	"42~45,XX,add(5)(q13),der(17)add(17)(p11.2)add(17)(q11.2),-18,-22[cp6]/43~44,sl,add(13)(q32),add(14)(q11.2),+mar[cp12]/43~44,sl,add(14)(q11.2),-21, "	685	79	5q deletion (85%) | Loss of RARA on 17q21 (46%)	11	FALSE	"partial CD7, CD13, partial CD33, CD34, partial CD38, CD58, CD117, dim/partial CD123, partial TdT, HLA-DR positive."	TRUE	TRUE	6.6	12.87	FALSE	negative	0	negative			TP53 (p.V173M; 77.4%)	SUZ12 (V186D)|TP53 (V173M; MAF 80%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	4.235093564	4.113058746	3.615338297	4.788201595	6.115037183	-4.318740899	4.52552363	yes	yes	yes	yes	yes	no	yes	1.051293373	NA	0.64149626	NA	1.890443631	1.103259136	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.608785627
BA2603R	BA2603D	2314	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			63	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	2438	Alive	1.7	29	14	0.8	NA	9.4	28.2	49.6	1.6	18	26	2.8	0.74	M4	21.2	7.3	"46,XX[20]"	514	101.4	Normal	57	TRUE	"CD13, CD33, CD38, CD58, CD117, CD123, HLA-DR, and MPO positive (Myeloid blast phenotype) | CD11b, variable CD13, CD14, CD33, dimCD56, CD64, HLA-DR-positive (Monocytic phenotype)"	FALSE	TRUE	6.1	63.75	TRUE	negative	0	positive				CREBBP (p.V319I; MAF 50%)|DNMT3A (p.R882H; MAF 50%)|DNMT3A (p.T138I; MAF 50%)|NPM1 (p.W288fs*12; MAF 50%)|NRAS (p.Q61H; MAF 40%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.777728307	4.800439135	2.616268835	2.55995121	6.889932081	-1.276942076	6.933559364	no	yes	no	no	yes	no	yes	4.337925243	1.417832145	-2.196558101	-0.008988068	3.144668007	-1.289328658	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.563621081
BA2808R	BA2808D	2300	Waves1+2	yes	yes	yes	no	Male	Male			White	4			56	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	56	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|GCLAC (GCSF, Clofarabine & Cytarabine)|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Induction|Re-induction	Complete Response	Standard Chemotherapy	27	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Dead	198	Dead-Unknown	NA	72	88	NA	NA	NA	1	NA	NA	NA	NA	NA	NA		NA	NA	"40~43,XY,add(1)(p36),-2,-4,-5,-8,-12,-14,-15,-16,-17,?add(17)(p13),der(19)?t(8;19)(q11.2;p13),-20,-22,+7mar[cp18]"	NA	NA		NA	NA	"CD34, CD38 (dim), CD13, CD33 (dim),CD64 (partial), CD11c, CD4 (partial), CD15, CD117, HLA-DR, and MPO(partial)."	FALSE	TRUE	NA	12.9	FALSE	positive	0.388888889	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	4.190217873	1.923986914	1.561191974	3.333737476	5.581951198	-0.985898598	-0.79940311	yes	no	no	no	no	no	no	-1.847523578	-4.365066998	3.16596239	1.042892084	-4.211041191	0.198368206	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.508020438
BA2282R	BA2282D	2574	Waves1+2	no	no	no	no	Male	Male			White	3		PML-RARA	41	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	44	0	Post-Chemotherapy|Post-Transplant	Remission	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	7	"Busulfan, Fludarabine|Etoposide, TBI|PETHEMA Trial LPA05 (ATRA (Tretinoin), Idarubicin, Mitoxantrone, Cytarabine)|Idarubicin, Mitoxantrone|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|ATRA, Arsenic Trioxide|ATRA, 6-MP, Methotrexate"	5	Allogeneic - Sibling|Consolidation|Induction|Maintenance|Re-induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Etoposide, TBI"	Allogeneic - Sibling	-1	Alive	2350	Alive	NA	1.2		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	48% PML/RARA translocation	NA	NA	"CD117+, HLA-DR negative, partial CD34+ (Right inguinal biopsy)"	FALSE	FALSE	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.118618509	5.913602206	3.321449604	7.439314136	7.238947297	-0.618039918	5.158488325	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.896540972
BA2482R	BA2482D	2067	Both	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	10	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	10	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	3	Induction|Intensification|Re-induction	Refractory	Standard Chemotherapy	10	Standard Chemotherapy	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)"	Intensification	29	Alive	2453	Alive	0.8	50		0	NA	10.5	21	7.3	0.5	NA	NA	2.1	0.41	M2	24.7	8.3	"46,XX,inv(16)(p13q22)[17]/46,XX[3]"	702	88.5	CBFB rearrangement and inverted 16 (85%)	31	TRUE	"CD13, dim CD33, CD34, CD38, CD58, CD117, CD123, dim/partial HLA-DR, and MPO positive"	FALSE	TRUE	NA	55.35	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	3.474494846	2.38904504	-1.221749414	1.693449976	6.468245227	-1.370552466	7.377710384	yes	no	no	no	yes	no	yes	NA	NA	NA	NA	NA	NA							0.64253313
BA2822R	BA2822D	2227	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			37	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	38	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	2	"7+3 (Cytarabine, Idarubicin)|Azacitidine"	2	Induction|Maintenance	Refractory	Standard Chemotherapy	6	Supportive/Palliative Care	Azacitidine	Maintenance	-1	Dead	207	Dead-Disease	0		95	0	NA	0.9	0	0	0.1	17	56	1.8	0.6		23	7.9	"48~54,XY,add(2)(p13),+5,add(5)(q13),del(5)(q13),+10,+11,+13,+13,del(13)(q32),+14,-15,-16,del(17)(p12),-20,+21,+21,+22,+mar[cp9]/49~52,sl,-del(17)(p12)[cp8]/51~54,sl"	NA	86.8	Extra chromosome 5 (98%) | 5q deletion (98%) | Monosomy 16 (93%) | Extra copies of chromosome 21 (63%) | Monosomy 17 (99%) | Extra chromosome 11 (99%)	20	TRUE	"CD10, CD13, CD33, CD34, CD56 and HLA-DR positive"	FALSE	TRUE	5.3	38.47	TRUE	negative	0	negative			TP53 (p.R273H; 90.9%)	"NRAS (p.G13D, MAF 46%)|TP53 (p.R273H, MAF 96%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	3.678111865	1.78647363	1.567397786	1.695502181	4.817948795	-0.358388936	4.500292914	yes	no	no	no	no	yes	yes	-6.504674232	1.226281633	3.284663889	0.7699441	-0.928158524	-6.62449223	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.366045378
BA2594R	BA2594D	2554	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			72	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Other malignant neoplasm without specification of site	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	Azacitidine|Decitabine	3	Consolidation|Induction|Maintenance	Unknown	Standard Chemotherapy	38	Standard Chemotherapy	Azacitidine	Maintenance	36	Dead	252	Dead-Disease	0	55	46	0	NA	27.8	27	20.6	0	32	31	2.2	1.37	M4	20.6	6.6	"43~44,X,-Y,t(3;11)(p21.3;p11.2),del(5)(q11.1;q31.1),add(12)(p11.2),-21[cp17]/44~45,idem,-t(3;11),+9[cp4]"	435	85.8	Previous FISH results were consistent with the deleted 5q and trisomy 9	33	TRUE	"CD13, CD33, CD34, partial CD56,variable CD117, dim CD123, and dim HLA-DR+"	FALSE	TRUE	5.9	20.82	FALSE	negative	0	negative			TP53 (p.H193R; 90.7%)	TP53 (p.H193R; MAF 92%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	5.208309749	5.790454551	4.566214579	4.400700402	6.884920678	1.273501254	6.550271563	yes	yes	yes	yes	yes	yes	yes	5.219882331	1.096933908	3.12111549	-1.547547753	0.779534911	1.649116113	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.682889244
BA2747R	BA2747D	2205	Waves1+2	yes	yes	yes	yes	Male	Male			Asian	4			85	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	85	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Decitabine, Midostaurin"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Decitabine, Midostaurin"	Induction	-1	Dead	357	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY[14]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	0.485478165	0.91026955	3.955998025	2.692844599	5.138732416	-1.183186756	-1.60211287	no	no	yes	no	no	no	no	-9.8893118	-0.458923	0.861197774	3.367179281	-2.937389649	-0.253607739	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.293477064
BA2561R	BA2561D	2231	Waves1+2	yes	yes	yes	no	Male	Male			White	3			75	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	5	"7+3 (Cytarabine, Idarubicin)|CLAG (Cladribine, Cytarabine, Filgrastim)|MiDAC|ODSH (2 O, 3-O Desulfated Heparin) |SGN-CD33A"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	21	Standard Chemotherapy	"CLAG (Cladribine, Cytarabine, Filgrastim)"	Consolidation	-1	Dead	335	Dead-Disease	NA	64	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY,add(8)(p21),t(8;19)(p11.2;q13.3)[18]/46,XY[2]"	NA	NA	Normal	NA	NA	"Large population of atypical myelomonocytic cells (CD4+, bright CD64+, MPO positive, partial CD14), representing 85% of the total leukocytes"	FALSE	FALSE	NA	4.67	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.543509631	1.426744801	1.940033158	2.034823448	4.861131167	-0.130727984	6.533478446	no	no	no	no	no	yes	yes	-1.162928747	0.313497582	-5.989542576	-3.965892519	7.291724428	0.846981554	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.455666323
BA2094R		2231	Waves1+2	no	no	no	no	Male	Male			White	3			75	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	75	265	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	n	n	y	n	n	1	Standard Chemotherapy	5	"7+3 (Cytarabine, Idarubicin)|CLAG (Cladribine, Cytarabine, Filgrastim)|MiDAC|ODSH (2 O, 3-O Desulfated Heparin) |SGN-CD33A"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	21	Standard Chemotherapy	"CLAG (Cladribine, Cytarabine, Filgrastim)"	Consolidation	-1	Dead	335	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	9.7	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.451995392	4.085996266	0.928175924	5.923925984	5.668164125	-2.550433881	5.46037171	no	yes	no	yes	no	no	yes	NA	NA	NA	NA	NA	NA							0.58087951
BA2567R	BA2567D	2162	Waves1+2	yes	yes	yes	no	Male	Male			White	3			46	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	MissingKaryo	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	46	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	3	DLI|Standard Chemotherapy|Bone Marrow Transplant	8	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC|Donor Lymphocyte Infusion|Azacitidine|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)|Clofarabine|ODSH (2 O, 3-O Desulfated Heparin) "	6	Allogeneic - Sibling|Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Re-induction|Post-Transplant Relapse	Complete Response	Standard Chemotherapy	-1	DLI	Donor Lymphocyte Infusion	Post-Transplant Relapse	-1	Dead	1005	Dead-Disease	NA	25.9	0.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA		NA	NA	Normal	NA	NA	"Increased atypical CD56 positive, weak CD117 positive myelomonocytic cells representing approximately 23% of the leukocytes"	FALSE	FALSE	NA	3.6	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.629093932	7.377710384	5.546939725	7.071808265	7.43426787	1.389607154	2.579056469	yes	yes	yes	yes	yes	yes	no	6.291082799	-3.192172245	-2.868682395	-6.818532584	-1.863739718	-0.28272012	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.97429725
BA2906R	BA2906D	2561	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1		KMT2A_re	5	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	5	0	Initial Acute Leukemia Diagnosis|Post-Transplant|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"ADE (Cytarabine, Daunorubicin & Etoposide)|Cyclophosphamide, TBI|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Allogeneic - Sibling|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	9	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Sibling	-1	Dead	2241	Dead-Other	0		80	0	NA	33	0	0	0	12	32	3	0.44	M5	17.1	5.7	"46,XY[25]"	1072	98.8	MLL rearrangement (76%)	34	TRUE	"CD4, CD11b, CD15, CD33, bright CD34, CD38, CD58, CD64,CD71, CD117, CD123, HLA-DR and dim/partial MPO positive"	TRUE	TRUE	7.4	95.2	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.164060104	0.28485128	-1.076614523	1.636402799	5.011833437	-2.280127137	1.584533275	no	no	no	no	no	no	no	-7.246691095	-1.969685318	-2.875094427	0.650686546	0.145668294	2.620379545	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.456427587
BA2956R	BA2956D	2123	Waves1+2	yes	yes	yes	yes	Male	Male			White	2		CBFB-MYH11	56	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	57	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	3	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	3	Dead	421	Dead-Disease	0	N/A	54	0	NA	38	8	0	NA	15	23	3	1.3		NA	NA	"46,XY,del(5)(q15q35),inv(16)(p13.1q22)[20]"	409	NA	"nuc ish(D5S721x2,D5S23x2,EGR1x1)[182/200],(D7Z1,D7S522)x2[199], (RUNX1T1,RUNX1)x2[199],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[192],(PML,RARA)x2[198],(5'CBFB,3'CBFB)x2(5'CBFB sep 3'CBFBx1)[176/200]"	NA	NA	"CD2(-), CD4(partial dim +), CD7(partial dim +), CD11b(-), CD13(+), CD14(-), CD15(+), CD16(-), CD19(-), CD20(-), CD22(few dim +), CD25(-), CD33(+), CD34(+), CD36 (-), CD38(variably +), CD45(moderately +), CD56(-), CD64(few dim +), CD79a(-), CD117(+), CD123(+) (PB) | HLA-DR(variably +), MPO(+), TdT(+). (PB)"	TRUE	TRUE	6.6	8.2	FALSE	negative	0	negative				NRAS (G12D; MAF 16%)|NRAS (G13D; MAF 13%)|NRAS (Q61H; MAF 5%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.094890592	4.018799325	4.810253601	3.208805012	6.117606628	-0.976484324	5.146470241	yes	yes	yes	no	yes	no	yes	3.489802935	0.113905939	1.072544582	-1.100388598	-1.507241024	0.732096832	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.681012824
BA2474R	BA2474D	2029	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			46	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	46	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	5	"7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|MiDAC"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Re-induction	4	Dead	1373	Dead-Disease	0	80		1.6	NA	9.9	14.9	10.7	0	52	28	2.5	0.77	M4	25.2	8.4	"46,XX[20]"	550	88.1	Normal	107	TRUE	"dim CD11b, CD13, CD33, partial CD34, dim CD45, dim CD64, CD117, CD123, and dim HLA-DR+"	FALSE	TRUE	6.3	57.23	TRUE	negative	0	positive				DNMT3A (p.R882C; MAF 46%)|NPM1 (p.W288fs*12; MAF 43%)|PTPN11 (p.E76Q; MAF 40%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	2.261333777	3.322963546	0.349158084	3.673523703	5.93252196	-1.565142279	4.931220233	no	no	no	no	no	no	yes	3.720488842	-1.610449408	0.740592608	1.877627328	0.137569813	2.246871786	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.614384507
BA2065R	BA2065D	2029	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			46	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	424	Relapse	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	5	"7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|MiDAC"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Re-induction	4	Dead	1373	Dead-Disease	0	70	59	3.5	0.9	17.7	0	13.3	0	184	77	2.8	0.72	M4	37	12.6	"46,XX[20]"	NA	94.4	Normal	138	TRUE	"CD13, CD33, partial CD34, partial CD38, dim partial  CD64, CD117 and CD123 positive"	FALSE	TRUE	5.7	16.95	FALSE	negative	0	positive				DNMT3A (p.R882C; MAF 39%)|NPM1 (p.W288fs*>9 ; MAF 39%)|PTPN11 (p.E76Q; MAF 41%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.742431412	1.295814481	-0.404193883	3.212667677	5.603072247	-0.871720723	2.331714407	no	no	no	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.55872906
BA2737R		2241	Waves1+2	yes	no	yes	yes	Female	Female			White	2		RUNX1-RUNX1T1	57	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Ovarian cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	57	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	n	y	y	n	y	2	Standard Chemotherapy|Supportive/Palliative Care	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Cytarabine|Decitabine, Hydroxyurea"	4	Consolidation|Induction|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	5	Supportive/Palliative Care	"Decitabine, Hydroxyurea"	Supportive/Palliative Care	-1	Dead	138	Dead-Unknown	0	76	79	0	NA	9	5	4	NA	45	41	3.2	NA		28.6	9.6	"46~47,XX,t(1;11)(p34;p15),der(8)del(8)(p11.2p23)t(1;8)(q21;q24.3),add(9)(q34),del(9)(q13q22),add(16)(p13.3),+1~2mar[cp11] /47~48,idem,+13[cp2]/47~48,idem,-13,der(21)t(8;21)(q13;p12),+2~3mar[cp6]/46,XX[1] "	NA	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200], (5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[199],(RUNX1T1x3,RUNX1x2)[69/200]/(RUNX1T1x2,RUNX1x3)[7/200],(PML,RARA)x2 [200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	64	FALSE	"CD2(-), CD4(+), CD5(equivocal), CD7(-), CD11b(+), CD13(-), CD14(partial +), CD15(+), CD16(-), CD33 (bright +), CD34(-), CD36(+), CD38(variably +), CD45(variably +), CD56(+), CD64(+), CD117(partial +), HLA-DR(+)"	TRUE	TRUE	6.3	19.5	FALSE	negative	0	negative	RUNX1 (Y414*; MAF 16%)			CREBBP (MYST3-CREBBP fusion; MAF unlisted)|RUNX1 (Y414*; MAF 16%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	2.356536176	2.586312112	-0.863064	4.069641909	5.659007204	-1.539633623	4.273087929	no	no	no	yes	no	no	no	-2.280596564	-1.167595503	-3.830845542	-2.803129024	5.411240294	5.121541105	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.567942866
BA2463R		2241	Waves1+2	no	no	no	no	Female	Female			White	2		RUNX1-RUNX1T1	57	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	y	Ovarian cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	58	111	Relapse|Post-Chemotherapy	Relapse	Peripheral Blood	y	n	y	y	n	y	2	Standard Chemotherapy|Supportive/Palliative Care	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Cytarabine|Decitabine, Hydroxyurea"	4	Consolidation|Induction|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	5	Supportive/Palliative Care	"Decitabine, Hydroxyurea"	Supportive/Palliative Care	-1	Dead	138	Dead-Unknown	0	N/A	58	0	NA	14	3	19	NA	24	116	3.7	NA		21.4	7.7	"46~47,XX,t(1;11)(p34;p15),der(8)del(8)(p11.2p23)t(1;8)(q21;q24.3),add(9)(q34),del(9)(q13q22),add(16)(p13.3),+1~2mar[cp11] /47~48,idem,+13[cp2]/47~48,idem,-13,der(21)t(8;21)(q13;p12),+2~3mar[cp6]/46,XX[1]"	NA	NA	"nuc ish(D5S721,D5S23,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200], (5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[199],(RUNX1T1x3,RUNX1x2)[69/200]/(RUNX1T1x2,RUNX1x3)[7/200],(PML,RARA)x2 [200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	10	FALSE	"CD2(-), CD4(+), CD7(-), CD11b(partial +), CD13(partial +), CD14(partial +),CD15(variably +), CD16(-), CD33(variably +), CD34(-), CD36(+), CD38(variably +), CD45(variably +), CD56 (variable +), CD64(partial +), CD117(-), HLA-DR(+)."	TRUE	TRUE	6	11.2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	0.23878428	2.293575033	0.417200903	2.996165962	4.458296907	-2.539470233	3.238076097	no	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.604764593
BA2110R	BA2110D	2305	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|Fludarabine|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|MiDAC"	4	Consolidation|Salvage|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Fludarabine	Consolidation	4	Dead	439	Dead-Disease	0.1	70		0.1	1.7	8.3	85.2	4.6	0.2	16	13	2.7	0.87	M4	30.4	9.6	"46,XX[20]"	506	101.7	Normal	112	TRUE	"CD11b, partial CD13, partial CD14, dim CD15, partial      CD16, CD33, CD38, CD58, CD64, partial CD123 and HLA-DR positive"	FALSE	TRUE	7.4	58.86	TRUE	positive	NA	positive				DNMT3A ( p.R882H; MAF 50%)|FLT3-ITD (MAF 10%)|FLT3-N676K (MAF 12%)|NPM1 (p.W288fs*12; MAF 50%)|PTPN11 (p.F71L; MAF 14%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	2.321125304	2.984199528	1.332427638	3.309577828	6.644646271	-0.437848975	5.236379786	no	no	no	no	yes	yes	yes	7.058671063	NA	-2.73380008	NA	1.957511272	3.018442485	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.796803233
BA2992R	BA2992D	2348	Waves1+2	yes	yes	yes	yes	Female	Female			HispNative	4		CBFB-MYH11	52	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	52	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	SWOG S1203 (7+3 +/- Vorinostat)	1	Induction	Complete Response	Standard Chemotherapy	8	Standard Chemotherapy	SWOG S1203 (7+3 +/- Vorinostat)	Induction	8	Alive	36	Alive	NA	91	79	NA	NA	NA	0	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,inv(16)(p13.1q22)[cp20]"	NA	NA		NA	NA	"CD34, PARTIAL CD117, CD15, CD38, PARTIAL CD13, CD33, CD64, PARTIAL CD14(SUBSET), PARTIAL CD11c, DIM CD4, HLA-DR AND BRIGHT MPO"	FALSE	TRUE	NA	28.1	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.872369612	2.425970736	0.854132266	3.344106222	5.810445579	-3.422944933	5.899601259	no	no	no	no	no	no	yes	3.511316132	0.813459999	-0.250435779	-0.94891577	0.061311228	4.868670176	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.667159387
BA2220R	BA2220D	2394	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			23	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Mediastinum mass	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	23	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	2	"Trametinib|HAEP (Cytarabine, Etoposide, Cisplatin) "	3	Consolidation|Induction|Experimental	Complete Response	Standard Chemotherapy	8	Targeted Therapy - Kinase Inhibitor(s)	Trametinib	Experimental	197	Dead	318	Dead-Disease	3.2	3	30	2.1	NA	25.8	1.1	36.6	43.4	32	131	3	0.91	M6b	17.9	5.7	"48,XY,add(6)(p22),der(7)t(7;19)(p11.1;p12),i(13)(q10)x2,add(14)(q24),+mar1,+mar2[cp20]"	16499	95.2	Low-level tetraploidy or near-tetraploidy (5%)	24	FALSE		NA	NA	5.6	40.76	TRUE	negative	0	negative			TP53 (p.G245S; 83.1%)	NRAS (p.G12C; MAF 86%)|TP53 (p.G245S; MAF 87%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	3.694815097	2.989978183	2.263488224	4.178644794	5.088705654	0.282808392	3.706178281	yes	no	no	yes	no	yes	no	0.239124578	NA	1.548246567	NA	-4.08493721	-2.156867107	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.510560757
BA2720R	BA2720D	2394	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			23	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Mediastinum mass	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	24	163	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	2	"Trametinib|HAEP (Cytarabine, Etoposide, Cisplatin) "	3	Consolidation|Induction|Experimental	Complete Response	Standard Chemotherapy	8	Targeted Therapy - Kinase Inhibitor(s)	Trametinib	Experimental	197	Dead	318	Dead-Disease	0	5	10	0	2.9	36.2	1.5	47.8	NA	30	146	3.4	0.82	M6b	25.5	7.9	"48,XY,add(6)(p22),der(7)t(7;19)(p11.2;p12),del(9)(p13p22),i(13)(q10)x2,add(14)(q24),+mar1,+mar2[cp2]/46~48,sl,add(17)(p1?3),add(22)(q13)[cp9]/46~48,sl,add(21)(p11.2)[cp6]/47~48,sl,add(1)(p36.1)[cp2]/48,sl,t(2;17)(p21;p11.2)[1]"	NA	98.5	Low-level tetraploidy or near-tetraploidy	48	TRUE	"A CD34 positive blasts population comprises approximately 4% of cellular gated events. Approximately 3% of cells are lymphocytes composed of 28% B cells, 45% T cells and 27% NK cells. | T cells are present in a CD4:CD8 ratio of about 1.1:1 and do not demonstrate aberrant antigen expression. A monoclonal B cell population is not identified."	FALSE	FALSE	6.1	11.28	FALSE	negative	0	negative			TP53 (p.G245S; 89.1%)	NRAS (p.G12C; MAF 97%)|TP53 (p.G245S; MAF 96%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	2.993923877	4.603307764	3.185942568	5.45014856	5.897651351	0.144506183	2.746048812	yes	yes	yes	yes	no	yes	no	NA	NA	NA	NA	NA	NA							0.624151388
BA2063R	BA2063D	2165	Waves1+2	yes	yes	yes	no	Male	Male			White	2			71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	MissingKaryo	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Cytarabine|BL-8040"	4	Consolidation|Salvage|Induction|Experimental	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Cytarabine	Salvage	-1	Dead	973	Dead-Disease	0.5	N/A	0	2.5	NA	56.8	2.6	37.6	NA	21	27	3.9	0.93		33.4	11.2		195	NA		89	TRUE		NA	NA	6.9	2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.112917374	6.497515924	5.658282478	7.68529643	7.729413981	0.878502133	5.642030677	yes	yes	yes	yes	yes	yes	yes	3.498475478	NA	-0.494247958	NA	-4.213260727	-1.668239496	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.94353592
BA2772R	BA2772D	2397	Waves1+2	yes	yes	yes	no	Male	Male			HispNative	2			61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	5	Alive	71	Alive	1	81	68	NA	NA	5	2	2	NA	85	52	3.1	0.85		28.8	10.1	"46,XY[20]"	1205	NA	"nuc ish(D4Z1,D10Z1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(ETV6,RUNX1)x2[200]"	20	FALSE	"CD2(-),CD4(partial dim +), CD7(-), CD11b(few +), CD13(+), CD14(-), CD15(partialCD22(-), CD25(appears partial dim +), CD33(bright +), CD34(few +), CD36(-), CD38(variable +), CD45(moderately +), CD56(-), CD64(partial +), CD79a(-), CD117(+), CD123(partial +), HLA-DR(partial +), MPO(+), TdT(-)."	TRUE	TRUE	6.2	152.75	TRUE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.814322082	1.825951595	1.564264587	1.934965274	5.36365752	-0.157247813	6.77834046	no	no	no	no	no	yes	yes	-1.355791242	2.517134253	-1.50534913	4.248077511	3.003537906	-4.191816676	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.459999623
BA2935R	BA2935D	2130	Waves1+2	yes	yes	yes	no	Male	Male			White	4			78	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	78	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	3	"Azacitidine|Sorafenib|Decitabine, Midostaurin"	3	Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	317	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	8	Dead	705	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XY[25]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	0.886792453	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	TRUE	TRUE	1.588500487	2.426640259	3.425512866	2.81142912	6.022458868	-0.023417433	2.846785231	no	no	yes	no	no	yes	no	3.587334776	-0.209892206	-0.611043095	-0.524178137	2.883479467	4.234064006	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.655818558
BA2260R	BA2260D	2447	Waves1+2	yes	yes	yes	yes	Male	Male			White	3		CBFB-MYH11	58	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	58	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|ODSH (2 O, 3-O Desulfated Heparin) "	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	210	Alive	1250	Alive	NA	50.8		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"48,XY,+8,inv(16)(p13.1q22),+22[18]/49,sl,+21[2]"	NA	NA	"8q22 (RUNX1T1): gain present  16q22 (CBFB): rearrangement present  21q22 (RUNX1): gain or rearrangement present (96%, 71.5%, 11% respectively)"	NA	NA	Relative increase of CD34 positive myeloblasts representing approximately 20% of the leukocytes and increased promonocytes/monoblasts consistent with acute myeloid leukemia with   myelomonocytic differentiation	FALSE	FALSE	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	1.293512368	1.166223357	1.779380179	2.317363609	6.272453015	-1.326670666	6.108293317	no	no	no	no	yes	no	yes	3.027493614	NA	-1.980458172	NA	2.011556568	5.420184343	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.700153573
BA2787R	BA2787D	2447	Waves1+2	no	no	no	no	Male	Male			White	3			58	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	58	100	Post-Chemotherapy	Remission	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|ODSH (2 O, 3-O Desulfated Heparin) "	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	210	Alive	1250	Alive	NA	0.4		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	29.18	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	8.342320805	8.689629605	6.434375	3.484727976	8.218326993	2.403770051	6.743264683	yes	yes	yes	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.859980809
BA2676R	BA2676D	2008	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			48	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	n		y	n	y	n	n	n	n	n	MYELODYSPLASTIC SYNDROMES	Refractory anaemia with excess blasts	NonAML	MYELODYSPLASTIC SYNDROMES	Refractory anaemia with excess blasts	48	0	Unknown		Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Decitabine|Busulfan, Cyclophosphamide"	2	Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	116	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	2114	Alive	0	17	5.3	0	NA	67.3	22.1	5.3	0	36	20	3.5	0.82		32.5	10.2	"47,XY,+8[18]/46,XY[2]"	155	83.5	Trisomy 8 (84%)	105	TRUE	"CD13, CD33, CD34, CD38, CD58, CD117, CD123, MPO+"	FALSE	TRUE	7.9	0.94	FALSE	negative	NA	negative				DNMT3A (p.R882C; MAF 45%)|IDH1 (p.R132C; MAF 44%)|TET2 (p.P455R; MAF 45%)					no		Found	TRUE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.495979988	5.418675896	3.374907441	4.042705178	7.106932866	2.780169213	6.080690639	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.592548165
BA2948R	BA2948D	2279	Waves1+2	yes	yes	yes	no	Male	Male			White	3			67	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	67	0	Post-Chemotherapy|Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	3	Azacitidine|Decitabine|Clofarabine	2	Hypomethylating/Low Dose Cytarabine|Induction	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	-1	Dead	30	Dead-Disease	NA	33		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"42,X,add(Y)(p11.1),add(3)(q12),add(4)(q25),del(5)(q12q33),-7,add(8)(p11.2),-11,add(13)(p11.2),del(16)(q22),-17,add(19)(q12.3),-20,add(21)(p11.2),-22,+mar[20]"	NA	NA	"43% del 5q31, 56% del 7q31, 58% del20q"	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.774193771	6.924328874	4.914065789	6.798135307	7.383617601	1.611280218	7.688957095	yes	yes	yes	yes	yes	yes	yes	3.29023312	2.94270764	-0.533637677	-3.470871511	2.718167381	-2.446109936	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.837988153
BA3296R	BA3296D	2684	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			18	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	B lymphoblastic leukaemia/lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	18	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy|Post-Transplant	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Other	3	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)|Radiation"	2	Re-induction|Allogeneic - Matched Unrelated Donor			NA	Bone Marrow Transplant	"Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)"	Allogeneic - Matched Unrelated Donor	-1	Dead	336	Dead-Treatment	0.6	0.5	0	0.4	NA	15.6	6.3	75.6	0	32	27	4.6	0.78		44	15.5	"46,XY[20] "	NA	89.4	"MLL (11q23): æ 88% of cells had a 0r1g1f split signal pattern consistent with rearrangement|9p21: 76% of cells were missing both signals for 9p21, consistent with homozygous deletion of 9p21|ETV6 (12p13): 68% of cells had an extra signal for ETV6 (Solid Tissue/Skin)"	291	TRUE	"CD43, CD68, CD163 (weak) and lysozyme positive (Solid Tissue/Skin)"	FALSE	FALSE	7.5	13.67	FALSE	negative	0	negative				EP300 (p.P318A (possible germline polymorphism); MAF 41%)|FAM5C (p.R353C (possible germline polymorphism); MAF 44%)|NOTCH2 (p.E366V; MAF 65%)|PHF6 (p.T12fs*23 (5 bp insertion with frame-shift); MAF 40%)|PTPN11 (p.D61V (confirmed somatic); MAF 39%) (Solid Tissue/Skin)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	5.441385132	8.056263834	5.857723741	5.251094901	8.302553922	2.671289769	7.390433207	yes	yes	yes	yes	yes	yes	yes	6.400213158	3.602481732	-3.692449671	-8.43778129	3.269915405	-0.743774118	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.750469031
BA2524R	BA2524D	2134	Waves1+2	yes	yes	yes	yes	Female	Female			White	4		CBFB-MYH11	51	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Stanford Protocol 9022 (BU/CY)"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	Stanford Protocol 9022 (BU/CY)	Allogeneic - Matched Unrelated Donor	-1	Alive	839	Alive	NA	74	61	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	M4eo	NA	NA	"46,XX,inv(16)(p13q22)[20]"	NA	NA		NA	NA	"CD34+ EXPRESSING CD38, CD13, CD33, PARTIAL DIM CD2, PARTIAL CD64; DIM PARTIAL CD11C, PARTIAL DIM CD4, COEXPRESSION OF CD117 AND CD15, HLA-DR, MPO, AND PARTIAL DIM TDT"	FALSE	TRUE	NA	34.4	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.385501194	1.978180802	2.215353766	4.027293906	6.42233933	-0.318202985	6.765387875	no	no	no	yes	yes	yes	yes	3.926895455	1.752308147	1.069726409	1.468730315	-0.290400648	2.475500646	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.765130601
BA2811R	BA2811D	2448	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1		PML-RARA	47	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"ATRA, Arsenic Trioxide|APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	26	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Consolidation	31	Alive	2197	Alive	0	85	75	0	NA	14.8	13.1	13.9	0.9	19	37	3.3	0.6	M3	19.5	6.5	"46,XX,t(15;17)(q24;q21)[4]/45,idem,-22[15]/46,XX[1]"	819	70.8		9	FALSE	"CD2, CD13, CD33, CD34, CD56, CD58, CD64, CD117, CD123, dim/partial HLA-DR, dim/partial TdT and MPO positive"	FALSE	TRUE	7.1	25.11	TRUE	positive	NA	negative				FLT3-ITD (MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	4.579059055	1.770057057	6.53249966	3.397647648	6.498464294	-2.79940292	4.111856758	yes	no	yes	no	yes	no	no	-6.813656662	3.075555047	-3.077098229	1.314730761	-0.127314164	-3.187863402	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.470126924
BA2540R	BA2540D	2176	Waves1+2	yes	yes	yes	yes	Female	Female			White	4		MLLT3-KMT2A	69	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Hydroxyurea	1	Induction	Unknown	Standard Chemotherapy	365	Standard Chemotherapy	Hydroxyurea	Induction	NA	Unknown	0		NA	94	83	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	M5a	NA	NA	"46,XX[1]"	NA	NA		NA	NA	"CD38, CD56, slightly dim CD4, CD33, dim CD13, CD64, CD11c, CD15 and partial CD117"	FALSE	TRUE	NA	137.6	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	-1.257273156	0.57211605	-0.091124956	2.387702282	4.497773126	-2.012862382	5.471382439	no	no	no	no	no	no	yes	-4.925904598	-3.984135924	-2.925817359	0.389733145	3.353278727	-3.104466845	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.380097487
BA2928R	BA2928D	2490	Both	no	no	no	no	Female	Female	White	NON-HISPANIC	HispNative	1		MLLT3-KMT2A	48	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	48	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Fludarabine, Melphalan|Idarubicin and Cytarabine"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Dead	1705	Dead-Treatment	0			0	NA	9.5	0	6	0	51	152	3.1	0.85	M5	30.4	9.7	"47,XX,+8,t(9;11)(p22;q23)[20]"	4484	80.4	MLL rearrangement (80%) | Trisomy 8 (78%)	87	TRUE	"CD4, partial CD11b, CD15, CD33, CD56, CD58, CD64, CD117, CD123, HLA-DR, and butyrate esterase positive"	FALSE	TRUE	6	49.29	TRUE	negative	0	negative				FLT3-D835 (MAF 10%)|JAK1 (p.I878V; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.738891992	1.350736081	-1.138252503	3.356972191	5.314673653	-2.707305721	-0.452652967	no	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.384052043
BA2302R	BA2302D	2336	Waves1+2	yes	yes	yes	yes	Female	Female			White	4			78	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Uterine Sarcoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	78	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Azacitidine, MLN4924"	1	Induction	Refractory	Standard Chemotherapy	111	Standard Chemotherapy	"Azacitidine, MLN4924"	Induction	111	Dead	161	Dead-Disease	NA	78	77	NA	NA	NA	1	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		NA	NA	"CD34 and MPO, with partial CD38, CD33, CD13, CD11c, CD117 and HLADR"	FALSE	TRUE	NA	5.6	FALSE	negative	0	negative				IDH1					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	1.823271903	3.34723699	-0.339812182	5.150010982	4.746053145	-0.157247813	1.577334173	no	no	no	yes	no	yes	no	-4.005250352	NA	2.915565537	NA	-2.543978622	-2.960384757	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.523447335
BA2792R	BA2792D	2166	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			51	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	n		y	n	y	n	n	n	n	n	MYELODYSPLASTIC SYNDROMES	Refractory anaemia with excess blasts	NonAML	MYELODYSPLASTIC SYNDROMES	Refractory anaemia with excess blasts	51	0	Unknown		Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Fludarabine, Melphalan|Azacitidine, Lenalidomide"	2	Induction|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	117	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	286	Dead-Treatment	0	4	6	0	NA	38.9	1.1	56.7	NA	58	51	3.5	0.87		22.4	7.5	"47,XY,+8[2]/46,XY[18]"	438	93.7	Trisomy 8	20	FALSE	CD34/CD117 positive myeloid blasts comprise about 4% of total CD45+ cells with possible partial TdT expression	FALSE	FALSE	5.9	2.23	FALSE	negative	NA	negative				WT1 (p.A382fs*4; MAF 44%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.812145536	5.452344246	2.799233832	5.539035092	6.715012451	0.216969424	5.72556302	no	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.570794008
BA2651R	BA2651D	2160	Waves1+2	yes	yes	yes	yes	Female	Female			White	4		MLLT3-KMT2A	22	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	22	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	4	"ATRA (Tretinoin)|Cyclophosphamide, TBI|3+7 (Cytarabine, Daunorubicin)|GCLAC (GCSF, Clofarabine & Cytarabine)"	4	Induction|Experimental|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	7	Bone Marrow Transplant	"Cyclophosphamide, TBI"	Allogeneic - Matched Unrelated Donor	-1	Alive	826	Alive	NA	65	90	NA	NA	NA	0.1	NA	NA	NA	NA	NA	NA	M1	NA	NA	"46,XX,t(9;11)(p22;q23)[22]"	NA	NA		NA	NA	"CD34, CD38 (dim partial), CD13, CD33 (dim partial), CD11c, CD4 (dim partial), HLA-DR, CD117 and MPO"	FALSE	TRUE	NA	40.2	TRUE	negative	0	negative				FLT3-D835					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	1.575369363	1.722045083	0.30501147	3.467514401	5.055783561	0.120930374	1.794023127	no	no	no	no	no	yes	no	-3.856044936	-1.372046931	0.789946964	4.010168942	-1.169822007	0.770285986	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.477522986
BA2595R	BA2595D	2148	Waves1+2	yes	yes	yes	no	Male	Male			White	4			65	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	66	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	3	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)|Targeted Therapy - Other	8	"HiDAC|AG-221|Gilteritinib (ASP2215)|3+7 (Cytarabine, Daunorubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine|MEC, Lenalidomide|Clofarabine, Cytarabine"	5	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Experimental|Re-induction	Complete Response	Standard Chemotherapy	-1	Targeted Therapy - Other	AG-221	Experimental	-1	Dead	395	Dead-Disease	NA	96	85	NA	NA	NA	5	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,t(4;15)(q31;q22),add(12)(p11~12)[cp7]/46~51,XY,del(7)(q11.2q36),add(12)(p11~12),add(20)(q11.2)[cp5]/46,XY,?inv(8)(p21q22)[cp7]/46,XY[cp2]"	NA	NA		NA	NA	"CD38, CD33; WITH PARTIAL CD34, CD56, CD13, CD11C, CD2 AND CD15/CD117"	FALSE	TRUE	NA	0.1	FALSE	negative	0	negative				IDH2					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	2.474996833	3.999561505	3.418072141	3.524703782	5.832192805	0.880316656	1.794023127	no	yes	yes	no	no	yes	no	-0.747210543	-0.037079548	-2.111841686	0.771994111	1.219749029	0.188279026	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.551363947
BA2619R	BA2619D	2184	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			62	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HAM (Cytarabine, Mitoxantrone)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Salvage|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"HAM (Cytarabine, Mitoxantrone)"	Salvage	7	Dead	167	Dead-Other	6.1	22	17.4	5.2	16.5	31.3	1.7	21.8	0.2	13	11	3.2	0.78	M2	29.5	9.5	"59~62,XX,+X,+1,+2,del(5)(q13q34),+6,+8,+8,+9,+11,+11,i(11)(q10),+12,+14,+16,+19,+22,+mar[cp19]/46,XX[1]"	444	101.4	"Trisomy 9 (88%) | Missing ERG1 signal (75%) | 2 small red/2 \normal\\ red pattern with the PML probe (79%) | Trisomy 11 and i(11q) (92%) | Tetrasomy 8 (87%) | Trisomy 16 (81%)\"""""	34	TRUE	"CD13, CD34, CD58 and CD117"	FALSE	FALSE	7	10.75	FALSE	negative	0	negative			TP53 (p.R280T; 41.1%)|TP53 (p.X33_splice; 37.9%)	"GATA1 (p.N160S; MAF:40%)|NRAS (p.G12D; MAF 11%)|TP53 (Intron 4, 3' Splice site (C.97-1G>A); MAF 26%)|TP53 (p.R280T;  MAF 36%"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	3.926178741	5.335031781	4.200237724	4.930522504	6.704229774	-0.054271382	5.276160194	yes	yes	yes	yes	yes	yes	yes	1.203140188	1.969937764	3.114610833	-0.377628809	2.523439336	-2.349216886	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.586831322
BA3013R	BA3013D	2457	Waves1+2	yes	no	yes	no	Male	Male			HispNative	4		KMT2A_re	47	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	3	Standard Chemotherapy|Supportive/Palliative Care|Intrathecal	5	"HiDAC|Cytarabine|SWOG S1203 (7+3 +/- Vorinostat)|Hydroxyurea|MEC, Lenalidomide"	5	Consolidation|Induction|CNS|Re-induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	7	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	9	Dead	228	Dead-Disease	NA	70	79	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XY,t(11;19)(q23;p13.1)[20]"	NA	NA		NA	NA	"CD34+ BLAST POPULATION, 40%, EXPRESSING CD117, CD15 (DIM PARTIAL), CD13 (DIM PARTIAL), CD33 (DIM PARTIAL), CD38, CD4 (DIM PARTIAL), CD11C (DIM PARTIAL), CD64 (DIM PARTIAL), MPO (BRIGHT), AND ABERRANT CD7 (MINOR SUBSET DIM), WITH POSSIBLE CD19"	TRUE	TRUE	NA	261.2	TRUE	positive	0.075268817	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	3.202417589	3.060581114	3.228085833	1.198283915	5.462998018	-0.497690291	5.23565647	yes	no	yes	no	no	yes	yes	1.018166214	1.363370487	-1.716597871	2.203832447	2.345442697	1.208467346	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.458430743
BA2405R	BA2405D	2354	Waves1+2	yes	yes	yes	no	Female	Female			White	3			44	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	44	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	6	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)|7+3 (Cytarabine, Idarubicin) plus Sorafenib|Ponatinib"	5	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Experimental|Re-induction	Unknown	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Ponatinib	Experimental	-1	Dead	342	Dead-Disease	NA	86.1	65	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"Large population of atypical CD34 positive myeloblasts (weak CD4+, weak CD33+), representing approximately 78% of the leukocytes suggestive of acute myeloid leukemia"	FALSE	TRUE	NA	11.38	FALSE	positive	0.449275362	negative	RUNX1 (p.Q262*; 72.4%)			FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	TRUE	2.38904504	3.988974495	0.590127224	5.878514159	6.454019489	-0.874344283	-0.382770172	no	yes	no	yes	yes	yes	no	-8.465034986	NA	3.586571723	NA	-7.634637559	-0.066424235	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.436188185
BA2856R	BA2856D	2376	Waves1+2	yes	yes	yes	no	Male	Male			White	3			55	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|ODSH (2 O, 3-O Desulfated Heparin) "	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	129	Alive	1022	Alive	NA	37	20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	283	TRUE	"Increased atypical CD117 positive myeloid blasts (weak CD7  positive, HLA-DR negative), representing 18% of the total  leukocytes, consistent with a myeloid neoplasm"	TRUE	FALSE	NA	16.11	FALSE	negative	0	positive				NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.579059055	5.814821246	5.23139219	4.582631802	6.695805771	1.132098452	1.469167148	yes	yes	yes	yes	yes	yes	no	0.966426924	-2.282857399	0.332662943	-2.440104641	-2.225380621	-5.632588384	Monocyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	Not_cDC_Like	1.010542149
BA2377R	BA2377D	2385	Waves1+2	yes	yes	yes	yes	Male	Male			White	2		MLLT3-KMT2A	35	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	35	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide, Thymoglobulin"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide, Thymoglobulin"	Allogeneic - Matched Unrelated Donor	-1	Alive	1156	Alive	NA	86		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,der(4)t(4;9;11)(p14;p22;q23),der(9)del(9)(p13p22)t(4;9;11),der(11)t(4;9;11)[19]/46,XY[1].isht(4;9;11)(5'MLL-,3'MLL+;5'MLL-,3'MLL-;5'MLL+,3'MLL-)[1] "	NA	NA	"nuc ish(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL sep 3'MLLx1)[189/200],(PML,RARA)x2 [200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[198]"	NA	NA	"CD2(-), CD4(+), CD7(-), CD11b(+), CD13(partial +), CD14(-), CD15(+), CD16(-), CD33(+), CD34(-), CD36(partial +), CD45(+), CD56(variably +), CD64(+), CD117(partial +), CD79a(-), HLA-DR(+), MPO(-), Tdt(-)"	TRUE	TRUE	NA	NA	NA	positive	2.448275862	positive		ASXL1 (p.D943Qfs*6; 38.5%)		ASXL1 (D943fs*6; MAF 25%)|FLT3-D835 (BMA)|KMT2A (MLL-AF9 fusion)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	-0.305832616	1.54697322	5.630561549	2.683474124	6.481205729	-3.4062923	-1.21830795	no	no	yes	no	yes	no	no	-3.889223992	NA	-3.089732984	NA	-0.913009393	2.781909716	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.566377116
BA2499R	BA2499D	2003	Waves1+2	yes	yes	yes	yes	Male	Male			White	2			71	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	71	0	Post-Chemotherapy|Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	107	Dead	53	Dead-Disease	0	N/A	50	1	NA	17	1	13	NA	19	42	3.2	1.83		23.7	7.7		766	92.2		11	FALSE		NA	NA	7.1	45.6	TRUE	negative	0	negative	RUNX1 (p.R320*; 46.2%)								no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	1.574324473	5.871790358	4.501744354	4.316644349	5.341183037	-0.979592395	7.06807721	no	yes	yes	yes	no	no	yes	0.398752943	4.619563539	1.716997901	1.761940231	3.3174095	-2.436198307	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.618355146
BA3023R	BA3023D	2149	Waves1+2	yes	yes	yes	no	Female	Female			HispNative	4			27	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	27	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	HiDAC|SWOG S1203 (7+3 +/- Vorinostat)	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	8	Standard Chemotherapy	HiDAC	Consolidation	137	Alive	791	Alive	NA	69	68	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	M2	NA	NA	"48,XX,+3,+10[2]/46,XX[18]"	NA	NA		NA	NA	"CD34, CD38, CD13, CD33, CD11C, CD19, PARTIAL CD4, HLA-DR, PARTIAL CD15, CD117, PARTIAL CD61, AND PARTIAL CD7"	TRUE	TRUE	NA	5.1	FALSE	negative	0	positive				NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.59279126	2.619556586	3.34723699	4.93436696	5.825802632	0.357962098	2.711168133	no	no	yes	yes	no	yes	no	-4.275314282	0.823385012	0.705800231	3.900312699	0.959965806	-3.416686828	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.637166625
BA2095R		2054	Waves1+2	yes	no	yes	yes	Female	Female	White	NON-HISPANIC	White	1		PML-RARA	69	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	y	y	n	y	1	Standard Chemotherapy	1	"APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)"	Induction	-1	Alive	33	Alive	0	83	77	0	0	16.1	5.3	4.5	1.2	31	51	3.2	1.05	M3	22.7	8.1	"45,XX,dic(12;18)(p11.2;p11.2),t(15;17)(q22;q21)[19]/46,XX[1]"	1816	92.3	PML/RARA fusion (91%)	33	TRUE	"dim CD2, CD13, CD33, CD34 (variable), CD56, CD58, CD64, CD117, CD123 and cytoplasmic MPO positive; HLA-DR negative"	FALSE	TRUE	5.7	16.03	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.521232143	2.566589507	3.67854705	5.03748168	5.734798621	-2.73735737	8.079711656	yes	no	yes	yes	no	no	yes	-8.073510949	NA	-3.520785321	NA	3.140598014	-3.380283022	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.399303563
BA2275R	BA2275D	2199	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			57	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Brain Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	57	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	Decitabine	1	Induction	Unknown	Standard Chemotherapy	10	Standard Chemotherapy	Decitabine	Induction	10	Dead	35	Dead-Unknown	0	45		0.9	27.8	18.2	12.2	40.9	0	32	19	2	0.83	M2	26.9	9.1	"44~48,XY,-5,del(7)(q22),+11,idic(11)(p11.2)x2,-12,der(13)t(1;13)(p13;p12),add(17)(q25),der(18)t(12;18)(q13;q11.2),-22,+2mar[cp14]/44~47,sl,-9,+16[cp3]/46~47,sl,der(1)t(1;3)(q21;q21),der(3)t(1;3)(q21;q21)ins(3)(3;?)(p21;?),-idic(11)(p11.2)[cp4]/46,XY[1]"	NA	97.1	"EGR1/5p; 88% , consistent with monosomy 5  | D7S486; 96% , consistent with deletion 7q  | BCR; 84% of cells had three signals for BCR (22q11.2)| MLL; 28% of cells had three intact signals for MLL, while another 76% of cells had four intact signals. "	77	TRUE	"CD13, CD33, CD34, CD71, CD117, dim CD123 and HLA-DR+"	TRUE	TRUE	6.7	5.92	FALSE	negative	0	negative			TP53 (p.R248Q; 95.8%)	TP53 (p.R248Q; MAF 80%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	4.876587899	6.527793851	5.069165817	3.037956318	7.237197009	2.417576281	7.043446336	yes	yes	yes	no	yes	yes	yes	2.81328578	NA	0.534894828	NA	3.957435409	-3.774576195	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.588919879
BA2901R	BA2901D	2529	Waves1+2	yes	yes	yes	yes	Male	Male			White	2			68	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Melanoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)"	4	Consolidation|Induction|Re-induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Maintenance	-1	Alive	1203	Alive	0	79	54	NA	NA	10	42	30	NA	8	26	4	NA		20.8	6.8	"46,XY "	NA	NA	IGH-MYEOV and IGH-CCND1 rearrangement; MAF unlisted	61	TRUE	"CD2(-), CD4(equivocal), CD7(partial +), CD11b (equivocal), CD13(+), CD14(-), CD15(-), CD16(equivocal), CD33(-), CD34(bright +), CD36(-), CD38(dim +), CD45(+), CD56(equivocal), CD64(-), CD117(+), CD123(equivocal), HLA-DR(dim +), MPO(partial +), TdT(-) (Population 1 of 4 (0.02% of total events), consists of small myeloblasts) | CD2(-), CD4(equivocal), CD7(-), CD11b (-), CD13(partial +), CD14(-), CD15(partial +), CD16(-), CD25(-), CD33(variably +), CD34(-), CD36(-), CD38(moderately bright +), CD45(dim +), CD56(-), CD64(-), CD117(+), CD123(+), HLA-DR(partial +), MPO(partial +), TdT(-) (Population 2 of 4 (3.8% of total events), consists of immature myeloid cells) | CD13(partial +), CD14(partial +), CD36(variably +), CD45(variably +), CD56(partial +), HLA-DR(partial +), MPO(partial +) (Population 3 of 4 (61% of total events), consists of monocytes) | CD19(-), CD20(-), CD38(bright +), CD45(-), CD56(+), surface Ig(-), intracellular kappa(+), intracellular lambda(-) (Population 4 of 4 (0.34% of total events), consists of plasma cells)"	TRUE	TRUE	7.1	41.4	TRUE	negative	0	positive				DNMT3A (R882C; MAF 50%)|NPM1 (W288fs*10+; MAF 34%)|NRAS (G13D; MAF 44%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.611627168	4.801796871	4.836545994	4.208327586	6.730506765	-0.56909391	6.507482447	no	yes	yes	yes	yes	yes	yes	5.398559919	-1.191322526	-2.174766767	-2.434073357	3.154157664	1.44556038	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.871672419
BA2221R	BA2221D	2529	Waves1+2	no	no	no	no	Male	Male			White	2			68	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Melanoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	68	184	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)"	4	Consolidation|Induction|Re-induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Maintenance	-1	Alive	1203	Alive	NA	1	0	0	NA	42.6	0	57.4	NA	23	24	4.6	NA		35.4	12	"46,XY "	NA	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	61	FALSE	"CD38(bright +), CD45(-), CD56(+), intracellular kappa(+), intracellular lambda(-)"	FALSE	FALSE	7.5	2.6	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.373077598	7.271107115	4.769220742	7.856333678	6.646840272	2.078728662	6.631705986	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.80593121
BA2387R	BA2387D	2454	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			71	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Thyroid Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|MiDAC|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	462	Dead-Treatment	0	95	88	0	0	6.7	5.1	0	0.1	20	20	2.6	0.62	M5	21.4	7	"46,XX,idic(7)(q11.2)[20]"	373	93.9		19	FALSE	"CD11b, CD13, CD33, partial CD34,      CD38, CD58, CD64, CD117, CD123, partial HLA-DR and cMPO positive"	FALSE	TRUE	5.8	78.71	TRUE	negative	0	negative				BCOR (p.T870fs*46 (2 bp deletion); MAF 50%)|IDH1 (p.R132C; MAF 50%)|MLL (PTD)|PTPN11 (p.S502L; MAF 50% )					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.156429311	-0.043192785	-1.170291732	1.979028308	4.939975224	-1.57285324	-3.638332397	no	no	no	no	no	no	no	-10.54997012	NA	0.023612711	NA	-6.003324933	-0.202192185	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.311650749
BA2657R	BA2657D	2104	Waves1+2	no	no	no	no	Male	Male	White	HISPANIC	HispNative	1			45	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	46	196	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Supportive/Palliative Care	5	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |7+3 (Cytarabine, Idarubicin)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine"	4	Hypomethylating/Low Dose Cytarabine|Salvage|Induction|Maintenance	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) "	Salvage	4	Dead	259	Dead-Disease	0			0	1.7	7.8	51.3	18.3	0	29	19	3	0.52	M2	20.6	7	"47,XY,der(7)t(1;7)(q10;p10)+8[20]"	NA	87.3		5	FALSE		NA	NA	5.8	11.13	FALSE	negative	0	negative	RUNX1 (p.S308Qfs*292; 42.4%)								no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	2.984807312	1.928060593	2.373440498	2.899447561	6.746700423	-2.922698139	4.596524794	yes	no	no	no	yes	no	yes	NA	NA	NA	NA	NA	NA							0.769572041
BA2962R	BA2962D	2558	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			75	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	IntermediateOrAdverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|Cytarabine|Fludarabine, TBI|Decitabine"	4	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, TBI"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	327	Dead-Disease	0	90		0	0	6	2.6	0	0.1	18	49	2.6	0.94	M5	26.8	9.1	"46,XY[20]"	1173	105.5	Normal	45	TRUE	"dim partial CD11b, dim variable CD13, CD33, CD34, CD38, CD58, partial CD64, CD117, CD123, HLA-DR, partial TdT, dim MPO positive"	FALSE	TRUE	6.8	98.9	TRUE	positive	NA	negative				DNMT3A (intron 7 splice site (at invariant AG splice donor); MAF 50% )|DNMT3A (p.P777L; MAF 50%)|FLT3-ITD (MAF 40%)|IDH2 (p.R140Q; MAF 45%)|MLL (PTD; no MAF available)|WT1 (Intron 1 splice site (at invariant AG splice donor); MAF 90% )					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.645555631	-0.657151313	0.120930374	1.938354819	5.004479882	-2.493836153	1.339102202	no	no	no	no	no	no	no	-4.845841349	-0.979674239	-0.402570096	3.601578257	-0.603913507	3.76869376	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.310285846
BA2195R	BA2195D	2013	Waves1+2	yes	yes	yes	yes	Female	Female			Black	4	N/A		68	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	CPX-351 (Liposomal Cytarabine + Daunorubicin)	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	CPX-351 (Liposomal Cytarabine + Daunorubicin)	Induction	-1	Dead	70	Dead-Disease	NA	33	37	NA	NA	NA	8	NA	NA	NA	NA	NA	NA		NA	NA	"42~45,XX,-18[cp14]/43~45,idem,+2~3mar[cp3]/47,XX,+8[cp2]/45,X,-X[1]"	NA	NA		NA	NA	"CD34+ BLAST POPULATION, 33%, EXPRESSING PARTIAL CD38, PARTIAL CD4, PARTIAL CD11C, HLA-DR, CD117, PARTIAL CD13, PARTIAL CD33, PARTIAL CD15, AND MPO"	FALSE	TRUE	NA	29.1	TRUE	negative	0	negative	RUNX1 (p.S322Nfs*277; 9.7%)		TP53 (p.I195T; 22.2%)|TP53 (p.P151R; 54.8%)	CEBPA (Triple positive)|IDH2					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	TRUE	TRUE	3.454564138	6.646311693	5.319763325	4.657598538	6.45847747	-0.883218417	6.091280648	yes	yes	yes	yes	yes	yes	yes	4.235141584	NA	1.816408555	NA	3.092716953	0.421259398	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.856118635
BA2688R	BA2688D	2289	Waves1+2	yes	yes	yes	no	Female	Female			White	2			53	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute erythroid leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute erythroid leukaemia	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide, Thymoglobulin|Fludarabine, Cyclophosphamide, TBI "	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Allogeneic - Matched Unrelated Donor	-1	Dead	137	Dead-Treatment	0	9	4	0	NA	61	10	22	NA	14	40	3.3	0.65	M6	22.1	7.4	"46,XX,del(9)(q22q34)[20]."	NA	93.4	"nuc ish(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200], (5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	38	FALSE	"CD34 (partial +), CD2(partial dim +), CD13(dim +), CD33(variably to bright +), CD25(-), CD38(+), CD45(moderately +), CD15 (partial +), CD117(+), CD123(dim +), HLA-DR(partial +), MPO(+), TdT(-), other myeloid and lymphoid antigens (-)"	FALSE	TRUE	5.8	2.1	FALSE	negative	0	negative				DNMT3A (R882C; MAF 43%)|IDH2 (R140Q; MAF 3%)|WT1 (splice site 1099-6_1104delCTGCAGGATGTG; MAF 28%)					no		Found	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.743933047	4.650152755	3.993433527	6.724081412	6.720058598	3.920420033	4.501023602	yes	yes	yes	yes	yes	yes	yes	1.644507847	-2.089561192	-0.098254771	-1.307855587	-0.110113834	-0.951651954	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.945986582
BA2420R	BA2420D	2106	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			69	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	3	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|MiDAC"	3	Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	MiDAC	Consolidation	63	Dead	470	Dead-Disease	0	80		0	0	78.5	15.1	6.4	2.9	21	15	3.1	1.01	M0	23.5	7.5	"47,XY,+8[2]/46,XY[18]"	NA	101.7	Consistent with karyotype	47	TRUE	"dim CD13, dimCD33, CD34, dim CD38, CD58, dimCD64, CD117, CD123, dim HLA-DR, TdT positive"	FALSE	TRUE	6.7	2.05	FALSE	negative	0	negative	RUNX1 (p.H242Afs*14; 24.5%)			MLL (PTD)|RUNX1 (p.H242fs*14; MAF 42% )|RUNX1 (p.N136K; MAF 30%)|U2AF1 (p.S34F; MAF 40%)			yes		yes		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	2.156453828	3.178374621	2.524098871	5.643896541	5.769945422	-2.914937222	3.502344577	no	no	no	yes	no	no	no	-1.670450502	NA	2.403012334	NA	-0.833638682	3.605700887	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.5460892
BA2727R	BA2727D	2510	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		GATA2-MECOM	36	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	38	494	Residual Disease|Post-Chemotherapy|Post-DLI|Post-Transplant	Residual	Peripheral Blood	y	y	y	y	y	y	3	DLI|Standard Chemotherapy|Bone Marrow Transplant	7	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |7+3 (Cytarabine, Idarubicin)|Donor Lymphocyte Infusion|Azacitidine|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Decitabine|Busulfan, Cyclophosphamide"	6	Hypomethylating/Low Dose Cytarabine|Salvage|Unknown|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	4	Standard Chemotherapy	Decitabine	Salvage	4	Dead	533	Dead-Disease	0			0.9	0	13.9	0	0.9	0.4	59	28	2.8	NA		32.6	10.3	"46,XX,inv(3)(q21q26)[5]"	NA	99.4	FISH) was performed with a MECOM/RPN1 probe set. 125/200 (62.5%) interphase cells scored had a 1 red/ 1 green/ 2 yellow double fusion signal pattern reflecting MECOM/RPN1 fusion and the paracentric inversion of the long arm of a chromosome 3 observed in the metaphase karyotype.  FISH was also perfor	38	FALSE		NA	NA	6.7	7.08	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.29498986	1.438366504	-1.934277071	4.711215377	3.325515708	-1.033493909	0.711453578	no	no	no	yes	no	no	no	-8.185169229	-3.977545277	3.898596243	3.566263552	-6.011975669	-3.047467113	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.393833738
BA2756R	BA2756D	2169	Waves1+2	yes	yes	yes	no	Male	Male			White	4			69	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	69	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	4	"CPX-351 (Liposomal Cytarabine + Daunorubicin)|Decitabine, Midostaurin|FLAG-IDA, Gemtuzumab|MEC, Lenalidomide"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	79	Standard Chemotherapy	"MEC, Lenalidomide"	Salvage	5	Dead	304	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[22]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	NA	negative				FLT3-ITD|IDH1					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	0.545208456	1.993749612	0.128934221	4.520106979	5.298043939	-1.160989408	4.705237917	no	no	no	yes	no	no	yes	-6.179567731	2.896246784	-0.151449836	3.462998968	2.08903318	-4.506365828	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.373036459
BA2122R	BA2122D	2026	Waves1+2	no	no	no	no	Female	Female			White	4			75	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	77	716	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	1131	Dead	1134	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"46,XX[8]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.R162K; 95.1%)	ASXL1 (p.Q512*; 56.3%)|ASXL1 (p.G645Vfs*58; 9.1%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	6.031110101	6.789809223	6.665643923	4.363858513	7.128890623	1.022224828	6.271580315	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.782444121
BA2053R	BA2053D	2370	Waves1+2	yes	yes	yes	yes	Male	Male			White	2		CBFB-MYH11	31	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	31	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	5	Alive	595	Alive	NA	80	56	2	NA	17	21	3	NA	63	39	3.9	0.91		28.8	10.2	"46,XY,inv(16)(p13.1q22)[7]/46,idem,add(17)(p11.2)[13]"	434	NA	"nuc ish(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[198],(PML,RARA)x2[198],(CBFBx2)(5ÍCBFB sep 3ÍCBFBx1)[164/200]"	34	TRUE	"CD2(partial +), CD4(partial +), CD5(partial dim +), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(partial +), CD16(-), CDCD33(variably +), CD34(variably +), CD36(few +), CD38(variably +), CD45(moderate to dim +), CD56(-), CD64(partial +),CD117(+), CD123(variably +), HLA-DR(partial +), MPO(+), TdT(few +)."	TRUE	TRUE	8.2	41.35	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.022012835	3.289060137	4.347585191	4.917578728	6.493008534	1.238096702	7.053626848	yes	no	yes	yes	yes	yes	yes	1.60313249	NA	1.615150545	NA	-0.988287502	3.454241045	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.902516471
BA2080R	BA2080D	2135	Waves1+2	yes	yes	yes	yes	Male	Male			White	2	mono		77	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Lung Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	78	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"7+3 (Cytarabine, Idarubicin)|Cytarabine|Bortezomib|Decitabine|Fludarabine, Cytarabine"	5	Hypomethylating/Low Dose Cytarabine|Salvage|Unknown|Induction|Experimental	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	-1	Alive	344	Alive	NA	73	84	NA	NA	10	NA	6	NA	9	13	4.2	0.82		NA	NA	"46,XY[20]"	165	NA		NA	NA	"CD2(-), CD4(- to partial dim +), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(few +), CD16(-), CD19(few +), CD33(variably +), CD34(variably +), CD36(-), CD38(variably +), CD45(variably +), CD56(-), CD64(-), CD117(+), HLA-DR (+), MPO(partial +), TdT(partial +)."	TRUE	TRUE	6.5	13.8	FALSE	negative	0	negative				ATM (S1993fs*23; MAF 44%)|CEBPA (L81fs*72; MAF 92%)|MUTYH (G382D; MAF 49%)|STAG2 (R1205*; MAF 92%)|TET2 (C1273S; MAF 46%)|TET2 (M823fs*1; MAF 47%)					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	5.285747578	5.93293802	4.167156836	2.627466439	4.881845714	-1.697539521	4.689765802	yes	yes	yes	no	no	no	yes	-0.747824059	NA	1.197911024	NA	-1.021897058	-0.53091884	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.501062162
BA2415R	BA2415D	2200	Waves1+2	no	no	no	no	Male	Male			White	3			48	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	49	152	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	6	"Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)|7+3 (Cytarabine, Idarubicin)|HiDAC|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)|FLAG-IDA, Gemtuzumab|Cytarabine, Methotrexate"	5	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor|CNS|Re-induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	443	Dead-Disease	NA	1.6		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA	"Relative increase of phenotypically normal, slightly left shifted myeloid cells without flow cytometric evidence of monoclonality, acute leukemia, plasma cell dyscrasia, or   lymphoproliferative disorder."	FALSE	FALSE	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	5.785010096	7.809563946	5.111518533	4.411677437	7.766140738	2.505270189	7.339785745	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.682308113
BA2081R	BA2081D	2358	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			64	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	64	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	6	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|R-CEOP (Cyclophosphamide, Etoposide, Prednisolone, Rituximab, Vincristine)|MiDAC|FATE Trial RIC (Fludarabine, Melphalan, Rabbit ATG) |R-CHOP (Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine)"	4	Consolidation|Induction|Re-induction|Double Umbilical Cord Blood Transplant (DUCBT)	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"R-CEOP (Cyclophosphamide, Etoposide, Prednisolone, Rituximab, Vincristine)"	Induction	3	Alive	2485	Alive	0	90	30	0	0	37.5	27.7	0	2.6	37	31	1.8	0.52	M4	23.5	7.7	"46,XX,del(17)(q25)[3]/46,sl,del(3)(q12q21)[cp17]"	452	94.4		56	TRUE	"dim CD4, partial variable CD7, CD13, CD33, partial CD34, CD38, partial CD58, CD117, CD123, HLA-DR, TDT and partial MPO positive."	TRUE	TRUE	6.2	6.44	FALSE	negative	0	negative	RUNX1 (p.R162K; 82.0%)			KRAS (p.G12V; MAF 30%)|NRAS (p.G12D; MAF 7%)|RUNX1 (p.R162K; MAF 85% )					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	1.816932462	1.869762619	0.070115652	4.289276162	6.153111683	-3.560100812	4.89378287	no	no	no	yes	yes	no	yes	-0.374540512	NA	0.958789857	NA	0.26775802	4.150753424	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.620898951
BA2354R	BA2354D	2050	Waves1+2	yes	yes	yes	yes	Male	Male	Asian	NON-HISPANIC	Asian	1		RUNX1-RUNX1T1	37	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	37	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"3+7 (Cytarabine, Daunorubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Etoposide, Mitoxantrone|Busulfan, Cyclophosphamide"	4	Salvage|Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	0	Alive	1348	Alive	0.8			0	7.5	17.5	0	37.5	0.4	22	13	3	0.89	M2	15.8	5.5	"45,X,-Y,t(8;21)(q22;q22)[20]"	411	100.6	"RUNX1T1/RUNX1: æ 94% of cells had the dual fusion signal pattern consistent with RUNX1T1/RUNX1 fusion and t(8;21), as seen on metaphase analysis."	42	TRUE	"dim CD7, CD13, dim CD33, CD34, CD38, CD56, dim partial      CD64, CD117, dim CD123, HLA-DR, MPO, dim TdT positive"	TRUE	TRUE	7	8.15	FALSE	negative	0	negative				EZH2 (p.F445fs*3; MAF 30% )|KIT (p.N822K (exon 17); MAF 5% )|KIT (p.Y418_D419insFL (exon 8); MAF 29%)|TET2 (p.G1160E; MAF 49% )					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	4.805356331	5.253852829	3.956413745	3.204027111	6.208728417	-1.231423649	7.777132138	yes	yes	yes	no	yes	no	yes	-0.212900291	NA	-1.783073662	NA	0.691275406	-1.397461333	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.422869383
BA3273R	BA3273D	2729	Waves3+4	yes	yes	yes	yes	Male	Male				2			NA	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	NA	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Cyclophoshamide, TBI, ATG|CALGB 10403"	2	Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Cyclophoshamide, TBI, ATG"	Allogeneic - Matched Unrelated Donor	-1	Alive	560	Alive	NA	96		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"47,XY,der(7)t(1;7)(q21;q36),+14[4]/46,XY[16]"	NA	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[199],(D8Z2, D20S108)x2[200],(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2 [198],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	NA	NA	"CD2(-), CD4(+), CD7(-), CD11b(few dim +), CD13(-), CD14(-), CD15(partial +), CD16(-), CD19(partial +), CD20(-), CD22(partial +), CD25(partial +), CD33(partial +), CD34(+), CD36(-), CD38(+), CD45(partial +) | CD64(-), CD79a(partial +), CD117 (-), HLA-DR(partial +), CD123(variably +), MPO(+), TdT(+)"	TRUE	TRUE	NA	NA	NA	negative	0	negative				IKZF1 (Foundation; S63fs*2)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	5.010074523	5.596997549	3.587426621	4.248092398	6.195218968	-0.482855916	1.615159124	yes	yes	yes	yes	yes	yes	no	-0.484053278	-2.325161907	0.420167869	-3.067349314	-2.554893451	-1.133118464	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.582227562
BA2893R	BA2893D	2455	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			59	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	59	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Azacitidine, Sorafenib|Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)|7+3 (Cytarabine, Idarubicin)|HiDAC"	4	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Azacitidine, Sorafenib"	Hypomethylating/Low Dose Cytarabine	-1	Dead	254	Dead-Disease	NA	51.5	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"Large population of CD117 positive myeloblasts (predominantly CD34 negative, HLA-DR negative), representing approximately 71% of the leukocytes consistent with acute myeloid leukemia."	FALSE	FALSE	NA	89.17	TRUE	positive	1	positive				NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.233852064	1.560156281	4.79382003	2.241208066	5.563644509	1.512424753	3.678111865	no	no	yes	no	no	yes	no	-4.366022989	0.446756016	0.76385537	3.395516477	1.234081924	-5.673491567	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.382094824
BA2044R	BA2044D	2267	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			57	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	57	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Fludarabine, Melphalan, TBI"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	371	Bone Marrow Transplant	"Fludarabine, Melphalan, TBI"	Allogeneic - Sibling	-1	Dead	245	Dead-Treatment	0.3	50		0	0.6	32.6	14.7	51.8	0	82	52	3.4	0.78	M2	29.6	10.1	"46,XY,hsr(6)(p21p23)[17]/46,XY[5]"	160	93.7	Normal	91	TRUE	"CD13, CD33, CD34, CD38, CD58, CD117, CD123, and HLA-DR+"	FALSE	TRUE	7.5	3.53	FALSE	negative	0	negative	RUNX1 (p.Y377*; 11.5%)|RUNX1 (p.I114Afs*25; 33.0%)			RUNX1 (p.I114fs*25; MAF ~50% )|U2AF1 (p.S34F; MAF 43%)			yes		yes	yes	Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	3.963805754	4.120206457	3.969281028	5.016314662	6.739225147	-0.802256476	3.083662214	yes	yes	yes	yes	yes	yes	no	2.906986877	NA	0.182016278	NA	0.871116894	5.012127679	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.621304757
BA2309R	BA2309D	2335	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	7			64	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	n		y	n	n	n	n	n	y	n	MYELOPROLIFERATIVE NEOPLASMS	Essential thrombocythaemia	NonAML	MYELOPROLIFERATIVE NEOPLASMS	Essential thrombocythaemia	77	0	Post-Chemotherapy|Residual Disease		Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	Ruxolitinib|Imatinib|Hydroxyurea	2	Induction|Re-induction		Standard Chemotherapy	4626	Standard Chemotherapy	Ruxolitinib	Re-induction	-1	Alive	5397	Alive	NA	15		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,+der(1;9)(q10;p10)[17]/94,idemx2[2]/46,XY[1]"	NA	NA	"Fluorescent in situ hybridization (FISH) was performed with a 9p/CEP 9 probe set. Both probes hybridized to the derivative chromosome. 90/100 (90%) interphase cells scored had a 3 red/ 3 green signal pattern, reflecting the extra derivative. "	NA	NA	"dimCD7, CD13, dim CD33, CD34, CD71, and CD117 positive"	TRUE	TRUE	NA	NA	NA	negative	NA	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.849953399	5.296283456	2.913586334	6.910045469	6.645188941	-1.208905032	4.746053145	yes	yes	yes	yes	yes	no	yes	NA	NA	NA	NA	NA	NA							0.663686965
BA2489R	BA2489D	2480	Waves1+2	yes	yes	yes	yes	Male	Male			Black	2			63	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	3	"AG-221|Azacitidine|Fludarabine, Melphalan, TBI, ATG"	3	Hypomethylating/Low Dose Cytarabine|Experimental|Allogeneic - Child			NA	Bone Marrow Transplant	"Fludarabine, Melphalan, TBI, ATG"	Allogeneic - Child	-1	Alive	1156	Alive	0	20	0	0	NA	76	0	24	NA	18	16	4.1	1.24		24.9	8.3	"46,XY[20]"	148	100.4		72	FALSE		NA	NA	7.4	1.8	FALSE	negative	0	negative		ASXL1 (p.G646Wfs*12; 31.2%)		ASXL1 (G646fs*12; MAF 30%)|CIITA (Q320fs*41; MAF 51%)|CUX1 (P442fs*16; MAF 38%)|IDH2 (R140Q; MAF 46%)|SRSF2 (P95H; MAF 40%)|STAG2 (R614*; MAF 90%)		yes			yes	yes	Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	1.332427638	7.796635603	5.608414257	4.430629509	7.474165456	-1.995974726	5.606173771	no	yes	yes	yes	yes	no	yes	2.114787776	NA	0.235973788	NA	1.899876632	-2.956821384	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.705378003
BA2908R	BA2908D	2516	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine|Decitabine"	4	Consolidation|Induction|Maintenance|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Supportive/Palliative Care	58	Alive	666	Alive	0	90	60	0	0	31.2	0.9	0	0	19	25	3.3	0.78	M1	21.4	7.4	"46,XY,del(13)(q12q2?1)[14]"	509	103.4	"all 100 interphase cells scored (100%) were missing one set of 13S319 and RB1 probe signals, consistent with deleted 13q and the metaphase karyotype"	17	TRUE	"CD13, partial/dim CD33, CD38, CD58, CD117 and MPO"	FALSE	TRUE	6.6	5.39	FALSE	negative	0	negative				DNMT3A (p.R882H; MAF 44% )|IDH2 (p.R172K; MAF 43%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.81871141	2.336033537	-0.342203265	4.43749634	3.615795147	0.604875403	-2.269707889	no	no	no	yes	no	yes	no	-9.688697241	-5.332455416	3.596310001	5.285717882	-9.860425627	-2.615867175	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.300215118
BA2054R	BA2054D	2058	Waves1+2	yes	yes	yes	no	Female	Female			White	3			49	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	49	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Matched Unrelated Donor	-1	Alive	1168	Alive	NA	54	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XX,del(17)(p11.2)[15]/46,XX[5]"	NA	NA	consistent with karyotype (68% del 17p13)	NA	NA	"Most of the atypical cells (data not shown) are myeloid blasts that express CD117, partial CD7 (about 30% positive), CD13, CD33, HLA-DR, weak CD4, and partial CD15 (about 50% positive), but do not express CD34, CD14(MO2), or CD64. (The monocytic cells (percentages shown) are atypical in that they express weaker than normal CD13, with brighter than normal and more uniform than normal CD15, with phenotypically normal expression of bright CD33, bright CD64, CD4, and HLA-DR, and include approximately 80% that are phenotypically consistent with promonocytes/monoblasts, based on the lack of CD14(MO2).)"	TRUE	TRUE	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	3.213182977	5.416466741	3.536801956	2.200430448	6.801788717	-0.3326533	5.773314205	yes	yes	yes	no	yes	yes	yes	4.057651189	NA	-2.671368299	NA	5.343709975	1.476319428	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.604482896
BA2872R	BA2872D	2415	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			65	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Pancreatic adenocarcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	65	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"3+7 (Cytarabine, Daunorubicin)|Decitabine|5+2 (Ara-C, Daunorubicin)"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Salvage	9	Dead	158	Dead-Disease	0	18	12	0.9	32	7.4	35.2	18.5	4.8	44	165	2.9	1.65	M2	20.1	6.7	"46,XY,i(17)(q10)[20]"	3923	81	"TP53/CEP17: 85% of cells were missing a signal for TP53, consistent with deletion due to the i(17) seen on metaphase analysis.  PML/RARA: 69% of cells had three signals for RARA (17q21), consistent with three copies of 17q due to the i(17) seen on metaphase analysis."	40	TRUE	"CD13, CD33, CD34, CD117, and HLA-DR positive"	FALSE	TRUE	5.7	161.89	TRUE	negative	0	negative				ASXL1 (p.R693fs*10; MAF 49% )|CREBBP (p.S893L; MAF 52% )|NRAS (p.G12D; MAF 46% )					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	3.827308739	6.048565377	3.76546798	2.400959234	6.734673352	1.842642149	7.237197009	yes	yes	yes	no	yes	yes	yes	5.290915706	2.777583497	-1.986331442	-3.430837923	3.202903345	1.888190108	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.675710494
BA2526R		2308	Waves1+2	yes	no	yes	no	Female	Female			White	4			50	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	55	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	n	n	y	n	n	2	Standard Chemotherapy|Supportive/Palliative Care	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine|Decitabine|MEC, Lenalidomide"	4	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Supportive/Palliative Care	Decitabine	Hypomethylating/Low Dose Cytarabine	-1	Dead	1938	Dead-Disease	NA	72	81	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"50,XX,del(1)(q32),+8,+9,t(15;16)(q15~21;q12~22),+19,+21[cp20]"	NA	NA		NA	NA	"ABNORMAL CD34+ BLAST POPULATION, 72%, EXPRESSING DIM PARTIAL CD4, DIM PARTIAL CD7, DIM PARTIAL CD8, CD33, CD38, PARTIAL CD64, CD117, PARTIAL HLA-DR, AND DIM PARTIAL TdT"	TRUE	TRUE	NA	3.8	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	2.029967851	3.154333545	-1.234441799	5.421981955	5.307094214	-2.03573425	2.369121808	no	no	no	yes	no	no	no	-10.47995002	-1.952128556	0.719768418	1.823070807	-4.595161784	-4.214682224	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.430541897
BA3145R	BA3145D	2523	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		2		DEK-NUP214	74	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	77	979	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	3	"Crenolanib|HAM (Mitoxantrone, Cytarabine) plus Crenolanib|Azacitidine, Pracinostat"	2	Induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Targeted Therapy - Other	Crenolanib	Maintenance	433	Dead	1003	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,t(6;9)(p23;q34),+8[13]/48,idem,+13[4]/46,XY[3]"	NA	NA	"DEK-NUP214 fusion; MAF unavailable (DEK-NUP214 fusion; MAF unavailable) | nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[198], (RUNX1T1,RUNX1)x2[199],(5'MLL,3'MLL)x3(5'MLL con 3'MLLx3)[17/200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	NA	NA		NA	NA	NA	NA	NA	positive	NA	negative		ASXL1 (p.G645Vfs*58; 10.5%)		DNMT3A (F827fs*4)|FLT3-ITD					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	4.130497691	3.437568197	3.181648409	3.172411119	5.578957561	0.635764115	3.00018755	yes	no	yes	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.435922305
BA2041R	BA2041D	2121	Waves1+2	yes	yes	yes	no	Female	Female	White		White	2			32	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	32	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Bu/Cy/ATG|7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	Bu/Cy/ATG	Allogeneic - Matched Unrelated Donor	-1	Alive	1101	Alive	0	24	2	2	NA	54	0	44	NA	10	22	4.4	0.49		25.9	9	"47,XX,+8[13]/46,XX[7]"	125	97.1	"nuc ish(D5S2064,D5S630,EGR1)x2[199],(D7Z1,D7S522)x2[197],(D8Z2x3,D20S108x2)[101/200], (RUNX1T1x3,RUNX1x2)[91/200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[188], (5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[199]"	67	TRUE	"CD2(-), CD4(dim +), CD7(partial +), CD11b(-), CD13(variably +), CD14(-), CD15(partial dim +), CD16(-), CD25(-), CD33(bright +), CD34(-), CD36(-), CD38(+), CD41(-), CD45(+), CD56(-), CD64(-), CD71(+), CD117(+), CD123(+), GLy-A(-), HLA-DR(partial + and variable), TdT(-), MPO(+)."	TRUE	TRUE	7.1	1.4	FALSE	negative	0	negative				PTPN11 (G60A; MAF 18%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.588218891	5.092527267	3.31524316	4.524430027	5.737384113	0.570510286	4.126543631	no	yes	yes	yes	no	yes	no	-1.085265193	NA	0.69528475	NA	0.285454366	-4.157493557	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.651956431
BA2096R		2121	Waves1+2	no	no	no	no	Female	Female	White		White	2			32	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	32	46	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	n	y	y	n	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Bu/Cy/ATG|7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	Bu/Cy/ATG	Allogeneic - Matched Unrelated Donor	-1	Alive	1101	Alive	0	2	0	0	NA	NA	44	56	NA	NA	NA	NA	NA		23.2	7.7	"47,XX,+8[3]/46,XX[17]"	130	89.9	"nuc ish(D8Z2x3,D20S108x2)[27/200]"	113	TRUE	"CD2(-), CD4(dim +), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(partial dim +), CD16(-), CD33(+ to bright +), CD34(-), CD38(+), CD45(+), CD56(-), CD64(-), CD117(+), HLA-DR(dim +)."	TRUE	TRUE	NA	0.9	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.34027558	4.104688262	2.983647066	6.254911359	5.109750056	-0.923451509	5.535340401	no	yes	yes	yes	no	yes	yes	NA	NA	NA	NA	NA	NA							0.715872793
BA2464R	BA2464D	2575	Waves1+2	yes	yes	yes	no	Female	Female	White	HISPANIC	HispNative	1		PML-RARA	40	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	40	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"ATRA, Arsenic Trioxide"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	33	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Consolidation	193	Alive	2505	Alive	0	90	20	0	0.8	75.9	0	2.6	2.6	24	15	3.2	0.68	M3	20.3	7.1	"46,XX,t(15;17)(q22;q21)[17]/46,XX[3]"	259	85.3	58% PML-RARA  (c/w karyotype)	53	FALSE	"CD13, CD33, CD58, CD64, CD117, CD123 and MPO positive"	FALSE	TRUE	7.3	1.9	FALSE	negative	0	negative				IKZF1 (p.E80X; MAF 37%)|WT1 (p.E340X; MAF 32%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.720608478	1.636402799	4.682030332	3.94891193	6.27872786	-1.244346533	4.903610565	no	no	yes	yes	yes	no	yes	-6.157097994	NA	-3.017182745	NA	2.00055648	-6.000933561	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.45446159
BA2902R	BA2902D	2144	Waves1+2	yes	yes	yes	no	Male	Male			Asian	4			83	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	83	1	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"Azacitidine|Decitabine, Midostaurin"	2	Hypomethylating/Low Dose Cytarabine|Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"Decitabine, Midostaurin"	Induction	-1	Dead	47	Dead-Disease	NA	78		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[13]"	NA	NA		NA	NA	"ABNORMAL CD34-NEGATIVE BLAST POPULATION, 65%, EXPRESSING MYELOPEROXIDASE, CD117, CD13, CD33, AND CD56, AND SHOWING PARTIAL EXPRESSION OF CD38, CD64(DIM), CD11c(DIM), CD4(DIM) AND HLA-DR"	FALSE	TRUE	NA	NA	NA	positive	1.083333333	positive				FLT3-ITD|NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	TRUE	TRUE	2.98881255	3.233922826	3.031621114	5.0328937	5.185832737	1.846329256	0.843813627	yes	no	yes	yes	no	yes	no	-1.239890913	-3.07343753	-0.052974603	1.206523604	-1.183917873	-3.615870279	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.655437583
BA2541R	BA2541D	2484	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1		KMT2A_re	39	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	39	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Methotrexate"	3	Induction|CNS|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Re-induction	4	Dead	216	Dead-Disease	0	>90		0	0	28.3	17.7	3.5	0	19	14	3	0.97	M5	31.1	10.7	"46,XY,t(6;11)(q27;q23)[20]"	NA	98.4	MLL: 80% of cells had a split signal pattern consistent with the disruption of MLL due to the t(6;11).	31	FALSE	"dim CD4, partial CD11b, CD13, CD33, CD34, partial      CD38, partial CD64, CD117, CD123, HLA-DR and dim MPO positive."	FALSE	TRUE	6.2	21.12	TRUE	negative	0	negative				MLL (PTD)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.257995289	1.940888905	0.764705649	2.882795628	5.23139219	0.357962098	3.794651912	no	no	no	no	no	yes	no	0.00687744	-0.51024026	0.542359783	3.117057121	0.329704149	0.678300735	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.434880623
BA2143R	BA2143D	2127	Waves1+2	no	no	no	no	Female	Female			White	2		PML-RARA	51	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	y	Breast Cancer	y	n	y	n	n	n	n	n	MYELODYSPLASTIC SYNDROMES	"Myelodysplastic syndrome, unclassifiable"	NonAML	MYELODYSPLASTIC SYNDROMES	"Myelodysplastic syndrome, unclassifiable"	51	0	Unknown		Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	Decitabine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	4	Alive	507	Alive	0	9	11	0.8	NA	28.2	13.7	43.6	NA	19	28	2.6	0.7		27.2	9.1	"44,XX,der(5)t(5;9)(p15;q22)del(5)(q11.2q15),-7,-9,-18,del(20)(q11.2q13.1),+mar[cp8]/43~44,XX,-der(5),del(7)(q11.2q32),add(11)(p15),del(12)(p11.2p13),der(15)t(15;17)(p12;q11.2),-16,-18,+mar[cp9]/43,XX,del(5)(q13q33),del(7),add(11),del(12),der(15),-16,-18,+mar[cp3].ishder(15)(PML+,RARA+)[1]."	517	92.4	"nuc ish(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200], (PML,RARA)x2[200],(5'CBFB,3'CBFB)x1(5'CBFB con 3'CBFBx1)[108/200]"	74	TRUE	"CD2 (-), CD4(- to dim +), CD7(-), CD11b(-), CD13(bright +), CD14(-), CD15(-), CD16(-), CD25(dim +), CD33(+), CD34(+), CD36(-), CD38(partial +), CD45(moderate to slightly dim +), CD56(-), CD64(-), CD117(+), CD123(dim +), HLA-DR(variably+), MPO(-), TdT(-)"	TRUE	TRUE	6.2	NA	NA	negative	NA	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.949113314	7.08974259	5.236739668	4.445552992	7.187316632	1.341422887	6.486060874	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.831632781
BA2769R	BA2769D	2482	Waves1+2	yes	yes	yes	no	Female	Female			White	4			72	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	0	Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine, Midostaurin"	3	Induction|Maintenance|Re-induction	Complete Response	Standard Chemotherapy	186	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Re-induction	62	Alive	417	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.R320*; 24.2%)|RUNX1 (p.R207W; 20.0%)								no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	4.619654589	6.519178195	3.240646494	6.540424989	6.218877406	-0.465140761	7.29431703	yes	yes	yes	yes	yes	yes	yes	4.13205399	2.77355137	0.580315009	0.056889474	3.129169514	1.418631799	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.75267915
BA2843R	BA2843D	2178	Waves1+2	yes	yes	yes	yes	Male	Male			White	4			84	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	84	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Decitabine, Midostaurin"	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"Decitabine, Midostaurin"	Induction	-1	Dead	67	Dead-Disease	NA	85	88	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M0	NA	NA	"46,XY[20]"	NA	NA		NA	NA	"CD34, CD38, CD117, CD13, CD4, HLA-DR, AND TDT"	FALSE	FALSE	NA	30	TRUE	positive	0.851851852	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	3.105464065	2.257645142	1.038589712	3.33543703	5.74356819	-1.453400325	1.239301512	yes	no	no	no	no	no	no	-3.902176571	-5.331928803	6.820045523	2.306056256	-7.183340483	-1.408284783	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.39733232
BA2497R	BA2497D	2517	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1		KMT2A_re	71	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	MiDAC	Consolidation	5	Dead	162	Dead-Disease	0	80	80	0	2	21	4	1	0.8	29	282	3.2	1.61	M5	31.8	10	"47,XY,t(1;11)(p32;q23),+8[cp20]"	7759	102.3	"CEP 8:  56% had three signals, consistent with the trisomy 8 in the metaphase karyotype|RUNX1T1: 70% had three signals, consistent with the trisomy 8 in the metaphase karyotype|MLL: 72% reflected MLL rearrangement and its involvement in the 1;11 translocation."	59	TRUE	"CD11b, CD13, partial CD14, CD15, CD33,CD38, CD45, CD56, CD58, CD64, HLA-DR and MPO-positive"	FALSE	TRUE	6.1	71.19	TRUE	negative	0	negative				CREBBP (p.Q1765*; MAF 4% )|KRAS (p.G13D; MAF 27%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	0.953128031	2.166424144	2.910634753	2.876171125	6.429076022	-0.857140024	5.295931882	no	no	yes	no	yes	yes	yes	4.174433422	NA	-5.380147129	NA	5.527534425	1.233533751	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.683553372
BA2718R	BA2718D	2119	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	bi		61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|MiDAC"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Sibling	-1	Alive	2423	Alive	0	90	90.5	0	0	8.2	2.2	0.9	0.8	22	43	3.1	1.21	M1	17.3	5.2	"46,XY[20]"	1873	96.1	Normal	34	TRUE	"CD7, CD13, CD33, CD34, CD117, HLA-DR, cMPO (+)"	TRUE	TRUE	6.9	427.46	TRUE	negative	0	negative				CEBPA (p.A30fs*130; MAF 40%)|CEBPA (p.N307_V308ins; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.888840019	2.131669073	-0.123773304	1.035973365	2.665472463	-1.471201234	3.351243669	yes	no	no	no	no	no	no	-4.824170757	-2.428254367	-0.567322267	2.827759333	-5.388689852	0.471134637	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.223517017
BA2575R	BA2575D	2043	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	36	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	36	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	15	Dead-Treatment	0	74	82	1.7	1.7	6.7	82.3	3.4	0	45	36	2.7	0.68	M4	20.4	7.1	"46,XX,inv(16)(p13.1q22)[20]"	NA	87.6	"CBFB; 76/100 cells (76%) had the abnormal 1 red/ 1 green/1 yellow signal pattern, reflecting CBFB rearrangement. "	12	FALSE	"Immunophenotyping done on the peripheral blood on 12/1/2014      identified a myeloid blast population with the following immunophenotype:      CD13, partial CD15, CD33, CD34, CD38, CD58, variable CD64, CD117, HLA-DR      and cMPO. And, it identified a promonocyte/monoblast population expressing:"	FALSE	TRUE	5.8	117.53	TRUE	negative	0	negative				KRAS (p.G12D; MAF 9% )|NRAS (p.G12D; MAF 10%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.839125001	1.21396754	1.001803682	2.843610145	6.302355846	-2.596511197	7.439314136	no	no	no	no	yes	no	yes	6.355850288	0.52810211	-1.059590027	-5.300897819	-1.138117686	6.300477338	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.798916407
BA2593R		2461	Waves1+2	yes	no	yes	yes	Male	Male			White	3			53	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	n	y	y	n	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Alive	21	Alive	NA	66	56	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY[20]"	NA	NA	Normal	123	TRUE	"large population of atypical CD117 positive myeloblasts (partial CD34+, weak CD4+, weak partial CD7+, partial CD64+), representing approximately 57% of the leukocytes and increased   promonocytes/monoblasts representing approximately 13% of the total leukocytes"	TRUE	FALSE	NA	180	TRUE	positive	1.083333333	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.929655182	2.654167603	2.891181262	0.763191644	6.108293317	-1.57285324	2.233852064	no	no	yes	no	yes	no	no	-0.638998307	0.535230282	0.388403672	-0.137358419	0.481138141	4.131526192	Not_Monoctyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.457661788
BA2791R	BA2791D	2573	Waves1+2	yes	yes	yes	yes	Male	Male			HispNative	2		PML-RARA	26	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	26	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"ATRA, Arsenic Trioxide"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Consolidation	5	Alive	211	Alive	NA	81	37	3	NA	33	1	15	NA	47	44	4.4	0.8	M3	18.6	6.3	"46,XY,t(15;17)(q24;q21.1)[10]/46,XY[10]"	484	NA	"nuc ish(PML,RARA)x3(PML con RARAx2)[173/200]"	105	TRUE	"CD2(-), CD4(-), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(partial dim +), CD16(-), CD25(-), CD33(bright +), CD34(-/small subset +), CD36(-), CD38(variably +), CD45(+), CD56(-), CD64(equivocal/appears partial dim +), CD117(+), CD123(-), HLA-DR(-), MPO(appears partial +), TdT(few +)."	TRUE	TRUE	6.7	4.95	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	3.440001747	2.659912571	5.191610414	4.443717515	6.316324471	-1.749367227	7.918959154	yes	no	yes	yes	yes	no	yes	-5.369070283	3.293551778	-1.974461414	1.713800497	0.465453434	-6.41140018	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.557258173
BA2620R	BA2620D	2150	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|MiDAC"	3	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Mismatched Unrelated Donor	0	Alive	2426	Alive	0.8		30	0	12.5	24.2	28.3	18.4	0	23	29	3	0.78		22.4	7.4		561	107.2		60	FALSE	"CD7, minor subset CD11b, CD13, minor subset CD14,      dim CD33, CD34, CD38, CD58, minor subset CD64, CD117, CD123, HLA-DR, subset      myeloperoxidase positive"	TRUE	TRUE	6.6	31.66	TRUE	positive	NA	negative		ASXL1 (p.R549Pfs*2; 42.0%)		FLT3-ITD (MAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	3.424053486	5.198381336	3.957633888	3.780013852	6.353994761	-1.10133902	6.291373866	yes	yes	yes	yes	yes	no	yes	5.075321471	1.589574899	1.242396605	-0.851339061	2.315175271	4.63295618	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.833239364
BA2629R	BA2629D	2486	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|MiDAC"	3	Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	MiDAC	Consolidation	44	Dead	104	Dead-Treatment	0	80		0	0	45.5	0.8	0	0.3	14	18	2.4	0.73	M0	21.3	6.9	"46,XY,t(1;4)(q21;p14)[20]"	178	103.4	Normal	57	FALSE	"partial CD7, partial CD13, CD34, partial CD38,      partial CD117, dim CD123, HLA-DR and TDT positive"	TRUE	FALSE	7	13.68	FALSE	negative	0	negative	RUNX1 (p.R250Lfs*13; 50.0%)			BCOR (p.S571*; MAF 90% )|MLL (PTD)|ZRSR2 (p.C181F; MAF 88%)				yes	yes		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	2.041106692	1.371851629	-0.231575701	4.17562397	6.148462792	-2.969312096	-4.190401735	no	no	no	yes	yes	no	no	-8.457254661	-8.113028311	5.153655144	1.302560157	-9.566038143	2.092481232	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.34918862
BA2870R	BA2870D	2364	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			77	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	77	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	Azacitidine|Decitabine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	6	Dead	16	Dead-Disease	0	95	9	0	0.9	53	0	28.7	0.8	10	16	4	1.02	M5	25.8	8.6	"47,XX,+1,add(1)(p22)[15]/47,XX,+1,i(1)(q10)[5]"	601	97	"1p36/1q25: 81% of cells had three signals for 1q25 and two for 1p36, consistent with the larger clone above (ie. the clone with add(1)(p22). Another 13% of cells had four signals for 1q25 and two signals for 1p36, consistent with the smaller clone above (ie. the clone with the i(1)(q10))."	8	FALSE	"CD4, CD11b, CD15, CD33, CD38, CD58, CD64, CD123 and partial HLA-DR positive"	FALSE	TRUE	8.2	3.65	FALSE	negative	0	positive				FLT3-V491L (p.V491L; MAF 9%)|NPM1 (p.W288fs*12; MAF ~50% )|PTPN11 (p.S502L; MAF 44%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.845322357	1.216274304	-0.470048586	3.309577828	4.377846905	-3.077199316	0.608034603	no	no	no	no	no	no	no	-6.222457031	-2.955233247	-4.710254931	0.727860683	0.933734439	-2.661138955	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.338106563
BA2423R	BA2423D	2151	Waves1+2	yes	yes	yes	no	Male	Male			White	4			57	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	58	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Binimetinib (MEK162)"	3	Consolidation|Induction|Experimental	Refractory	Standard Chemotherapy	-1	Targeted Therapy - Other	Binimetinib (MEK162)	Experimental	-1	Dead	111	Dead-Disease	NA	70	8	NA	NA	NA	10	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[14]"	NA	NA		NA	NA		NA	NA	NA	7.1	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.792407904	4.253385425	4.170979826	7.200735632	6.175136203	-2.067474047	1.38411904	yes	yes	yes	yes	yes	no	no	6.181594653	NA	-1.449193798	NA	-0.431762389	5.414966953	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.907979329
BA2682R	BA2682D	2103	Waves1+2	yes	yes	yes	no	Female	Female			White	4			75	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	"Decitabine, Midostaurin"	1	Induction	Refractory	Standard Chemotherapy	206	Standard Chemotherapy	"Decitabine, Midostaurin"	Induction	206	Dead	320	Dead-Unknown	NA	90		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XX,t(5;16)(q31;p13)[3]/46,XX[14]"	NA	NA		NA	NA	"Partial CD34, cd38, cd117, cd15, cd33, partial cd13, partial cd64, cd11c, dim partial cd4, hla-dr and mpo"	FALSE	FALSE	NA	NA	NA	negative	0	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	2.964675357	3.359015729	2.701051548	5.486497885	6.272453015	-0.320515318	4.069250368	yes	no	no	yes	yes	yes	no	1.582430914	0.723998788	-1.091429027	2.677704864	4.025772311	2.000373056	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.678529239
BA2276R	BA2276D	2294	Waves1+2	yes	yes	yes	no	Male	Male	Unknown	NON-HISPANIC	White	2			80	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	80	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"Decitabine, ABT-199|Hydroxyurea"	2	Unknown|Supportive/Palliative Care			NA	Standard Chemotherapy	"Decitabine, ABT-199"	Unknown	-1	Dead	364	Dead-Disease	0	21	47	0	NA	5	10	41	NA	25	52	4.1	1.26		35	11.1	"46,XY[20]"	639	90.4	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2 [200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	110	TRUE	"CD2(-), CD4(-), CD7(-), CD11b(-), CD13(bright +), CD14(-), CD15(few +), CD16 (-), CD33(variably +), CD34(+), CD36(-), CD38(partial + with an unusual pattern of expression vs. CD34), CD45(moderate to slightly dim +), CD56(-), CD64(-), CD117(+), HLA-DR(dim +). (21% population of medium-sized to large cells)"	TRUE	TRUE	7.5	64.6	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.942573538	6.673398106	5.33434096	3.379465735	6.582016751	-1.076614523	6.566337574	no	yes	yes	no	yes	no	yes	1.169296709	NA	1.87E-05	NA	2.812716444	-2.769491873	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.522747082
BA2348R	BA2348D	2032	Waves1+2	no	no	no	no	Female	Female			White	5			43	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	44	0	Post-Chemotherapy	Remission	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|GCLAC (GCSF, Clofarabine & Cytarabine)|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Induction|Re-induction	Refractory	Standard Chemotherapy	12	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Alive	1105	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,add(3)(q21)[12]/52,sl,+6,+8,+10,+13,+20,+21[8]"	NA	NA	"Positive for an EVI1 rearrangement: < 0.9% |ABNORMAL - Low level gain of chromosome 8 and 20q12 sequences, trisomy:  < 0.3%)"	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.85443565	6.617532226	4.984444534	3.876088039	7.210533576	2.307289857	7.57365574	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.923226353
BA2709R	BA2709D	2346	Waves1+2	yes	yes	yes	yes	Female	Female	Unknown		White	2		CBFB-MYH11	30	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	30	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	40	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Re-induction	-1	Alive	1024	Alive	0	36	22	0	NA	12	44	5	NA	61	44	4.2	0.59		31.8	11	"46,XX,inv(16)(p13q22)[20]"	441	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[199],(D8Z2,D20S108)x2 [199],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(RUNX1T1,RUNX1)x2[200],(PML,RARA)x2[200], (5'CBFBx2,3'CBFBx1)(5ÍCBFB sep 3'CBFBx1)[195/200],(ABL1,BCR)x2[200]"	33	FALSE	"CD34, CD13, partialCD15, CD38, CD45, CD117, CD123, HLA-DR, dimMPO (15% population of variably-sized blasts)"	FALSE	FALSE	7	55	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.254510812	2.476413292	1.3401803	3.343077242	5.813217606	0.140622878	6.858323158	no	no	no	no	no	yes	yes	4.426867398	2.12824087	-0.388503379	-1.532838903	1.24416806	5.915321944	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.742995512
BA2789R	BA2789D	2141	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			66	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	66	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|MiDAC|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Matched Unrelated Donor	2	Dead	1715	Dead-Other	0	95	90.2	0	2.5	4.9	0.8	1.6	0.6	19	23	3	0.5	M1	18.9	6.1		501	100.5	Normal	10	TRUE	"CD13, CD33, dim CD71, CD117, CD123, and MPO"	TRUE	TRUE	6.4	66.67	TRUE	negative	0	positive				IDH2 (p.R140Q; MAF 46%)|NPM1 (p.W288fs*9; MAF 42%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.010052081	1.34249067	-0.891707138	2.624190487	3.657744187	-1.955393393	1.564264587	no	no	no	no	no	no	no	-5.550388992	-1.36141504	0.630764843	3.967003572	-0.077963937	-2.627467717	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.253400297
BA2694R	BA2694D	2552	Waves1+2	yes	yes	yes	yes	Male	Male			White	5			76	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Basal Cell Carcinoma	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	76	0	Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	2	AG-221|Decitabine	2	Hypomethylating/Low Dose Cytarabine|Experimental			NA	Targeted Therapy - Other	AG-221	Experimental	-1	Dead	680	Dead-Disease	NA	70	55	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	46	TRUE	"positive for CD13, CD34, CD38, CD117, and HLA-DR; negative for MPO, and B-cell and T-cell markers"	FALSE	FALSE	NA	4.5	FALSE	negative	0	negative	RUNX1 (p.E422Afs*173; 58.1%)	ASXL1 (p.E657*; 50.0%)							no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	3.006070829	4.826719544	-0.130727984	5.867413642	5.859771533	0.5247837	4.938917227	yes	yes	no	yes	no	yes	yes	3.117159753	-0.610822017	1.346473827	2.149925137	-1.140920933	1.499801068	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.763959558
BA2722R	BA2722D	2244	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			82	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	82	0	Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	122	Dead	35	Dead-Disease	7.6			4.2	8.5	28	6.8	12.7	0.1	24	22	3.1	0.96		31.5	11	"43~46,XX,add(2)(q11.2),-4,del(5)(q23),add(7)(q32),+8,add(11)(q23),-16,del(17)(p12),-18,+22[cp19]/46,XX[1]"	1304	86.8		21	TRUE		NA	NA	7.3	17.63	FALSE	negative	0	negative			TP53 (p.P151S; 96.9%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	4.179020839	5.980544427	4.277230765	2.492492077	7.078454149	-0.015069307	6.680708328	yes	yes	yes	no	yes	yes	yes	0.766235335	4.245244409	1.898241825	-1.228720271	3.71472905	-1.883369938	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.608153001
BA2538R	BA2538D	2283	Waves1+2	yes	yes	yes	no	Male	Male			White	2			81	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Colon Cancer	n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	81	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Supportive/Palliative Care|Targeted Therapy - Other	2	AG-221|Hydroxyurea	2	Experimental|Supportive/Palliative Care			NA	Targeted Therapy - Other	AG-221	Experimental	14	Dead	72	Dead-Disease	0		12	0	NA	69	5	12	NA	30	41	3.3	0.76		30.3	10.5	"46,XY[20]"	227	85.6	"nuc ish(RUNX1T1,RUNX1)x2[199],(ABL1,BCR)x2[200],(CCND1,IGH)x2[199]"	117	TRUE		NA	NA	8.8	33.1	TRUE	negative	0	negative	RUNX1 (p.Q213Rfs*24; 85.5%)	ASXL1 (p.G646Wfs*12; 25.0%)		"ASXL1 (Foundation, G646fs*12; MAF 33%)|FLT3 (Foundation, E596_Y597INSYEYDLPYDPRS; MAF 27%)|IDH2 (Foundation, R140Q; MAF 45%)|RUNX1 (Foundation, Q213fs24; MAF 82%)|SRSF2 (FOUNDATION, P95R; MAF 48%)"		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	2.39740781	3.902619235	2.548037457	4.599018015	6.836012105	0.336529519	2.514712869	no	yes	no	yes	yes	yes	no	-1.009436862	NA	4.666167	NA	-2.163979186	0.781370571	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.576566213
BA2583R	BA2583D	2175	Waves1+2	yes	yes	yes	yes	Male	Male			White	5			80	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	80	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Targeted Therapy - Other	1	AG-221	1	Experimental			NA	Targeted Therapy - Other	AG-221	Experimental	-1	Dead	34	Dead-Disease	NA	90	48	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,del(20)(q11.2q13.1)[12]/45,sl,-7[3]/45,XY,-7[5]/46,XY[2]"	NA	NA	Tetrasomy 5p/q; Monosomy 7; Loss 20q12 (15.5%); Tetrasomy 8cen and 20q12 (7	65	TRUE	"positive for CD13, dim CD33, CD34, CD38, dim CD45, CD117, HLA-DR and TdT"	FALSE	TRUE	NA	6.6	FALSE	negative	0	negative	RUNX1 (p.R162G; 80.6%)			IDH1 (C.G395A; p.R132H; MAF unknown)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	1.111947663	2.110674448	2.888840019	4.600086036	5.052200759	-2.888864664	2.74304172	no	no	yes	yes	no	no	no	-3.273400828	NA	5.438380201	NA	-3.339012629	1.817547856	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.526694461
BA2292R	BA2292D	2056	Waves1+2	no	no	no	no	Male	Male			White	5			69	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Squamous cell carcinoma	y	y	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	70	55	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	3	"7+3 (Cytarabine, Idarubicin)|Azacitidine, Lenalidomide|Rituximab"	2	Induction|Experimental	Unknown	Standard Chemotherapy	-1	Targeted Therapy - Other	Rituximab	Experimental	-1	Alive	454	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M6a	NA	NA	"46,XY[18]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	positive	1.222222222	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	4.210627019	4.311020574	4.31926619	4.498497481	4.821176987	0.958647032	3.365073358	yes	yes	yes	yes	no	yes	no	NA	NA	NA	NA	NA	NA							0.577881604
BA2806R	BA2806D	2285	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown		White	2			42	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	42	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Bu/Cy/ATG|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	Bu/Cy/ATG	Allogeneic - Matched Unrelated Donor	-1	Alive	1016	Alive	NA	81	85	NA	NA	4	7	4	NA	89	50	3	0.94		27.8	9.5		945	95.5		39	FALSE	"partialCD4, partial/dimCD7, partialCDllb, CD13, partialCD15, partialCD22, partialCD25, brightCD33, partialCD34, CD38, CD45, CD117, partialCD123, HLA-DR, partialMPO, partialTdT"	TRUE	TRUE	5.7	48.03	TRUE	positive	0.960784314	positive		ASXL1 (p.G645Vfs*58; 8.0%)		FLT3-ITD|NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.94605022	1.612255669	2.079500717	3.241245784	5.258927463	-1.228223179	3.656354228	no	no	no	no	no	no	no	-2.507195902	0.676958105	0.801376192	4.614671158	1.186639079	-0.389847579	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.410767061
BA2153R	BA2153D	2301	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			70	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	70	15	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Supportive/Palliative Care	4	"7+3 (Cytarabine, Idarubicin)|Azacitidine, Itacitinib|Azacitidine|Decitabine"	2	Salvage|Induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"Azacitidine, Itacitinib"	Salvage	449	Dead	1389	Dead-Disease	0	90	91	0	0	78.1	0.9	1.7	0	46	27	2	0.74	M0	24.4	8.1	"47,XY,+4[9]/46,XY[11] "	NA	103.8		23	TRUE	"CD7, CD13, CD33, CD34, CD38, CD56, CD117, CD123, HLA-DR and MPO+ (see Note) (Expression of the following antigens is dim and/or partial: æCD7, CD33, CD34, CD38, CD56, CD123, HLA-DR and MPO.) | Small clonal B cell population (<1% of total cells); CD19, CD20, and kappa+"	TRUE	TRUE	4.7	4.85	FALSE	negative	0	negative		ASXL1 (p.Q588*; MAF 43% )		ASXL1 (p.Q588*; MAF 43% )					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	4.046331176	2.020939054	-0.334928321	3.856461801	4.983367855	-2.671580925	1.014003384	yes	no	no	yes	no	no	no	-5.464816403	NA	5.909701794	NA	-8.184114471	-4.039362694	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.412927808
BA2674R	BA2674D	2301	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			70	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	71	281	Post-Chemotherapy|Relapse	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	4	"7+3 (Cytarabine, Idarubicin)|Azacitidine, Itacitinib|Azacitidine|Decitabine"	2	Salvage|Induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"Azacitidine, Itacitinib"	Salvage	449	Dead	1389	Dead-Disease	0	90		0	0	27.8	2.9	8.6	0.4	81	43	3.3	NA	M0	31.9	10.2	"47,XY,+4[2]/46,XY[18]"	235	94.7	"Two of twenty metaphase cells examined were abnormal, with trisomy 4, as seen previously."	91	TRUE	"partial CD7 (~35%), CD13, partial dim CD33, CD34, CD38, variable CD56, and CD117"	TRUE	TRUE	6.6	73.42	TRUE	negative	0	negative		ASXL1 (p.Q588*; MAF 49%)		ASXL1 (p.Q588*; MAF 49%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.527421199	2.085728775	0.632666941	2.798042346	5.008304145	-0.988728384	2.141679992	no	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.499168959
BA2809R	BA2809D	2301	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			70	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	72	423	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	4	"7+3 (Cytarabine, Idarubicin)|Azacitidine, Itacitinib|Azacitidine|Decitabine"	2	Salvage|Induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"Azacitidine, Itacitinib"	Salvage	449	Dead	1389	Dead-Disease	0			0	0	15.5	6.9	5.2	0	79	38	3.1	0.8	M0	27.9	9.1	"47,XY,+4[2]/46,XY[18]"	NA	87.7	"Two of twenty metaphase cells examined were abnormal, with trisomy 4, as seen previously."	44	TRUE		NA	NA	6.3	50.58	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.886436035	1.787325474	0.013944418	2.942453125	4.791365812	-3.025992957	1.157245805	yes	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.443191216
BA3025R	BA3025D	2262	Waves1+2	yes	yes	yes	yes	Female	Female	White	HISPANIC	HispNative	1	bi		28	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	30	2	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	6	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine|Fludarabine, Cyclophosphamide, TBI "	6	Hypomethylating/Low Dose Cytarabine|Consolidation|Salvage|Induction|Re-induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Dead	843	Dead-Disease	0			0	0	4.1	0	2.1	32.3	54	37	3.7	0.3	NOS	27.3	9.2	"46,XX,t(2;9)(q31;p21)[17]/46,X,t(X;9)(q22;p21)[3]"	NA	91.3		8	FALSE	"CD7, CD13, CD33, CD34, CD38, CD58, dim CD71, CD117, HLA-DR, MPO and partial TDT positive."	TRUE	TRUE	6.3	20.18	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.677600918	1.97096633	1.183738061	3.022563692	2.193045694	-2.039805595	1.467051365	no	no	no	no	no	no	no	-7.942162171	-1.648632951	-0.83494242	4.030693222	-4.54687905	-2.054366647	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.24848526
BA2523R	BA2523D	2225	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	4			46	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	46	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	5	"HiDAC|GCLAC (GCSF, Clofarabine & Cytarabine)|SWOG S1203 (7+3 +/- Vorinostat)|MEC, Lenalidomide|Etoposide, Cytarabine"	4	Consolidation|Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"GCLAC (GCSF, Clofarabine & Cytarabine)"	Salvage	-1	Alive	874	Alive	NA	90		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY[20]"	NA	NA		NA	NA	"MPO, HLA-DR, CD11c,CD13, CD33, DIM CD7, PARTIAL CD64, PARTIAL CD4, AND LACKING CD34"	TRUE	TRUE	NA	NA	NA	negative	0	positive				DNMT3A|IDH1|NPM1|NRAS					no		Found	TRUE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	1.070285281	-0.204556344	0.962688765	2.121525013	5.45304162	-2.067474047	0.521473783	no	no	no	no	no	no	no	-6.321211039	NA	-0.68784991	NA	-0.579118666	-4.734168895	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.252489154
BA3027R	BA3027D	2324	Waves1+2	yes	yes	yes	yes	Female	Female			White	5			53	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Ovarian cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	53	33	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|GCLAC (GCSF, Clofarabine & Cytarabine)"	2	Induction|Re-induction	Complete Response	Standard Chemotherapy	29	Standard Chemotherapy	"GCLAC (GCSF, Clofarabine & Cytarabine)"	Re-induction	17	Dead	72	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"53~55,XX,+1,+2,der(5)t(5;13)(q13;q12),+6,add(7)(q32),+8,+11,-13,+14,i(17)(q10),+19,+19,+21,+mar[cp7]/46,XX[7]"	NA	NA	Gain of 8 (4/301 cells); Gain of 8q22/21q22 (7.7/301 cells); Gain 11q23 (5/200 cells)	NA	NA		NA	NA	NA	NA	NA	negative	0	negative			TP53 (p.S215R; 15.2%)						no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	NA	TRUE	TRUE	4.931563456	6.397384984	5.033235873	6.786833539	7.074051678	1.875020429	5.904762398	yes	yes	yes	yes	yes	yes	yes	6.305261703	1.214037053	-1.590221162	-4.569494634	1.869430594	1.442885382	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	1.099556977
BA2441R	BA2441D	2250	Waves1+2	yes	yes	yes	yes	Male	Male	White	HISPANIC	HispNative	1			50	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	50	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Salvage|Induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	4	Dead	99	Dead-Disease	0	76	93	0	0	6.1	1.7	1.8	0	7	10	2.2	0.44	M0	18.8	6.3	"43~47,XY,del(1)(q42),r(2)(p2?3q37),t(3;5)(q27;q31),del(4)(q31),+del(5)(q31),add(5)(q11.2),-7,del(11)(q23),add(12)(p13),-22,+mar[cp11]/43~46,idem,add(14)(q24)[cp8]"	NA	85.8	deleted 5q and three short arm signals; monosomy 7 and the metaphase karyotype; no evidence for MLL deletion or rearrangement	14	TRUE	"CD7, CD11b, CD13, dim CD33, CD34, CD38, CD58, ææCD117 and HLA-DR+"	TRUE	TRUE	5.9	50.74	TRUE	negative	0	negative			TP53 (p.R273H; 53.6%)|TP53 (p.G105D; 52.9%)	"NRAS ( p.Q61K; MAF 37%)|TP53 (p.G105D, MAF 60%)|TP53 (p.R273H; MAF 44%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	3.347740082	1.063462797	0.686505344	2.721241501	3.615338297	-3.709646114	2.028375843	yes	no	no	no	no	no	no	-4.346555286	NA	3.634751192	NA	-2.81420418	0.757468006	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.448196229
BA2514R	BA2514D	2409	Waves1+2	yes	yes	yes	yes	Female	Female			Black	2			67	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Acute Myeloid Leukemia	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	67	0	Post-Chemotherapy|Post-Transplant|Post-DLI|Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	4	Standard Chemotherapy|Supportive/Palliative Care|Targeted Therapy - Kinase Inhibitor(s)|Targeted Therapy - Other|Bone Marrow Transplant	4	"AG-120|MEC (Cytarabine, Etoposide, Mitoxantrone)|Sorafenib|Hydroxyurea"	3	Salvage|Experimental|Supportive/Palliative Care			NA	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	-1	Dead	449	Dead-Disease	0	24	6	0	NA	77	10	7	NA	29	37	4.1	0.89		30.1	9.9	"46,XX[20]"	511	NA	"nuc ish(DXZ1x2)[182]//(DXZ1,DYZ3)x1[18]. nuc ish(D5S2064,D5S630,EGR1)x2[197],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2 [200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2) [200]"	288	TRUE	"CD2(-), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(partial +), CD33(variably +), CD34(+), CD36 (-), CD38(+), CD45(+), CD56(-), CD64(partial dim +), CD117(+), HLA-DR(+)"	TRUE	TRUE	8	3.3	FALSE	negative	0	negative			TP53 (p.R283C; 47.5%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	3.516455317	5.7056619	4.22250535	3.057668158	6.314924756	2.425270274	6.718374775	yes	yes	yes	no	yes	yes	yes	2.357948593	NA	1.261213632	NA	1.909893991	-1.361809882	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.614293192
BA2695R	BA2695D	2409	Waves1+2	no	no	no	no	Female	Male			Black	2			67	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Acute Myeloid Leukemia	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	68	254	Post-Chemotherapy|Post-DLI|Post-Transplant|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	4	Standard Chemotherapy|Supportive/Palliative Care|Targeted Therapy - Kinase Inhibitor(s)|Targeted Therapy - Other|Bone Marrow Transplant	4	"AG-120|MEC (Cytarabine, Etoposide, Mitoxantrone)|Sorafenib|Hydroxyurea"	3	Salvage|Experimental|Supportive/Palliative Care			NA	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	-1	Dead	449	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	18	25	4.1	NA		20.4	6.8	"47,XX,+11[5]/48,idem,+19[15] "	NA	NA	"nuc ish(DXZ1x2)[181]//(DXZ1,DYZ3)x1[19] nuc ish(RUNX1T1,RUNX1)x2[199],(5'MLL,3'MLL)x3(5'MLL con 3'MLLx3)[176/200],(PML,RARA)x2[196], (5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[199]"	24	TRUE		NA	NA	7.4	27.5	TRUE	positive	1.325581395	negative			TP53 (p.R283C; 45.1%)	FLT3-ITD|IDH1 (R132G)|IDH1 (p.R132G; MAF 51%)|KMT2A (MLL-PTD (exons 2-10))|TP53 (p.R283C; MAF 49%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	TRUE	3.040172106	3.63913648	5.000667997	4.873422525	6.209205633	-1.942942469	6.57456923	yes	yes	yes	yes	yes	no	yes	NA	NA	NA	NA	NA	NA							0.78152644
BA2520R	BA2520D	2400	Waves1+2	yes	yes	yes	yes	Male	Male			White	5			80	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Mature B-Cell Neoplasm	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	80	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Targeted Therapy - Other|Targeted Therapy - Kinase Inhibitor(s)	3	"Cytarabine|Decitabine|PF-04449913 (Hedgehog Inhibitor), LDAC"	3	Consolidation|Salvage|Experimental			NA	Targeted Therapy - Kinase Inhibitor(s)	Decitabine	Salvage	-1	Dead	309	Dead-Disease	NA	80	86	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M0	NA	NA	"46,XY,del(20)(q11.2q13.1)[15]/46,XY[5]"	NA	NA	Positive for deletion of 20q12 in 11.5% of 200 cells	4	FALSE	"positive for dim CD7, dim CD10, CD34, CD38, dim CD45, cCD79a, CD99, HLA-DR, TdT, dim PAX5"	TRUE	FALSE	NA	NA	NA	negative	0	negative	RUNX1 (p.R204*; 45.5%)|RUNX1 (p.S141*; 45.1%)	ASXL1 (p.D720Rfs*18; 14.1%)		ASXL1 (p.718_724del; MAF 50.3%)|RUNX1 (p.R177X; MAF 47%)|RUNX1 (p.S114X; MAF 44.8%)|SRSF2 (p.P95H; MAF 45.1%)		yes			yes		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	NA	FALSE	TRUE	3.732809492	4.074801989	1.124399465	6.747855302	4.956449885	-2.760852267	1.34489747	yes	yes	no	yes	no	no	no	-3.638676448	NA	2.218407419	NA	-3.26448447	-0.62311606	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.49230989
BA2479R		2362	Waves1+2	yes	no	yes	no	Female	Female			White	5			71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	n	y	n	n	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Complete Response	Standard Chemotherapy	115	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	115	Alive	1044	Alive	NA	65		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		96	TRUE	"positive for CD33, CD13, CD117, and myeloperoxidase; negative for CD34 and HLA-DR"	FALSE	TRUE	NA	1.6	FALSE	negative	0	positive				ASXL1 (p.A1312V; MAF 33.6%)|IDH1 (p.A1312V; MAF 32.1%)|NPM1 (p.L258fs; MAF 31.1%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.133332979	6.44756726	2.277454383	8.643556921	7.605103304	0.030874783	-0.268163697	yes	yes	no	yes	yes	yes	no	0.465982215	NA	-1.021947992	NA	-4.753271917	-2.038572926	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.732410104
BA2281R		2303	Waves1+2	yes	no	yes	no	Male	Male	White	NON-HISPANIC	White	1		PML-RARA	25	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	25	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	n	y	n	n	1	Standard Chemotherapy	1	"APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	28	Standard Chemotherapy	"APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)"	Induction	28	Alive	35	Alive	0	90		0	0	22.3	0	0.9	0.7	25	50	3.2	0.9	M3	21.3	7.7	"46,XY,t(4;15;17)(q21;q22;q21),add(12)(p12)[1]/46,idem,t(5;22)(q11.2;q11.2)[18]/46,XY[1]"	921	92.2	FISH c/w PML/RARA fusion	16	TRUE	"CD13, dim CD15, CD34, bright CD33, variable CD56, CD64, CD117, CD123, variable HLA-DR, and bright MPO"	FALSE	TRUE	6.8	18.25	FALSE	positive	NA	negative				FLT3-ITD (MAF 44%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	3.767242081	1.434107002	4.567287032	2.626189726	6.115931107	-3.122130162	6.081089332	yes	no	yes	no	yes	no	yes	-7.978407349	NA	-2.050241045	NA	0.949690916	-1.826690178	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.481779539
BA2932R	BA2932D	2069	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			29	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	IntermediateOrAdverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	29	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	24	Standard Chemotherapy	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	2383	Alive	0	95	78	0.9	0	11.7	0	13.5	1.8	20	25	3	0.54	M1	23	7.9	"46,XX[20]"	1119	95.8	Normal	12	FALSE	"dim CD2, dim CD7, CD13, dim CD19, dim CD20,      CD33, partial CD34, variable CD38, dim CD64, CD117, CD123, and HLA-DR      positive."	TRUE	TRUE	6.1	68.79	TRUE	positive	NA	negative				FLT3-ITD (MAF 50%)|MLL (PTD)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	-0.780448523	1.299583003	2.113133927	2.329580031	3.54397006	-1.167234051	3.931658649	no	no	no	no	no	no	no	-5.891010798	-0.337718518	3.703983168	3.819865084	-1.657340599	-0.222980431	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.289882242
BA2123R	BA2123D	2000	Waves1+2	yes	yes	yes	no	Male	Male			White	2			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	Decitabine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	214	Dead	269	Dead-Treatment	NA	10	1	0	NA	80	2	17	NA	24	27	4.3	1.48		20.4	7.2	"46,XY[20]"	275	93.3	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[199](RUNX1T1, RUNX1)x2[199],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	23	TRUE	"CD2(-), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(partial dim +), CD16(-), CD33 (bright +), CD34(partial +), CD36(-), CD38(variably +), CD45(+), CD56(-), CD64(-), CD117(+), HLA-DR (+), GLy-A(-), MPO(partial +), TdT(-)."	TRUE	TRUE	6.9	1.6	FALSE	negative	0	positive				DNMT3A (W297*; MAF 44%)|FLT3-D835 (D835Y; MAF 6%)|GATA2 (P161A; MAF 51%)|NPM1 (W288fs*10+; MAF 26%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	0.388417745	2.702257125	3.332681415	4.022859936	4.866048033	-2.053730838	2.326749366	no	no	yes	yes	no	no	no	-2.753054983	NA	-1.486620346	NA	-1.804547698	-4.042908801	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.471111662
BA2844R	BA2844D	2275	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown		HispNative	2	N/A		61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine"	3	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	-1	Alive	195	Alive	0	64	47.4	1.7	NA	23.3	27.6	0	NA	29	26	3.7	1.01		32.9	10.3	"46,XY[20]"	578	99.7	"nuc ish(D5S2064,D5S630,EGR1)x2[199],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	20	TRUE	"CD2(-), CD7(partial +), CD11b(partial +), CD13(+), CD14(-), CD15(partial +), CD16(-), CD19(few appear very dim +), CD25(-), CD33(variably +), CD34(variably +), CD36(subset +), CD38(+), CD45 (variably +), CD56(+), CD64(partial +), CD117(+), CD123(-), HLA-DR(+), MPO(+), TdT(-). (73% population of medium to large sized cells)"	TRUE	TRUE	7.2	20.8	FALSE	negative	0	negative				ASXL1 (G967DEL; MAF 45%)|CEBPA (A111FS*56; MAF 48%)|GATA2 (A318V; MAf 37%)|GATA2 (L321F; MAF 7%)|NRAS (G13V; MAF 37%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	2.862515491	2.221876593	1.028884744	3.413989372	4.333803972	-1.363856605	5.702197684	yes	no	no	no	no	no	yes	-1.849083461	-3.328144621	-0.807585088	2.179705274	-2.318805787	3.501846367	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.530002494
BA2660R	BA2660D	2170	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			43	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	43	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	3	"7+3 (Cytarabine, Idarubicin)|Cytarabine|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Induction|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	6	Supportive/Palliative Care	Cytarabine	Supportive/Palliative Care	125	Dead	245	Dead-Disease	0			0	0	31.9	12.4	2.6	0.1	26	16	3	0.77	M4	22.1	7.5	"46,XX[20]"	297	95.7	Normal	59	TRUE	"Myeloid blast (52%) immunophenotype: CD13, variable CD33, CD34, variable CD38, variable CD117, HLA-DR, and TdT positive | Monocytic blast/promonocyte (28%) immunophenotype: dim CD2, CD11b,æCD13, variable CD14, bright CD33, dim CD34, CD38, CD58, CD64, andæHLA-DR positive"	FALSE	TRUE	6.5	22.95	TRUE	positive	NA	negative	RUNX1 (p.R250Lfs*13; 46.7%)			FLT3-ITD (MAF 47%)|RUNX1 (p.K110Q; MAF 38%)|SUZ12 (p.E261fs*2; MAF 52%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	FALSE	2.174859837	0.865715541	3.459594729	3.094890592	6.031110101	-0.692658874	5.191610414	no	no	yes	no	no	yes	yes	0.881483927	-3.678080463	2.136217874	1.469256495	-2.405298489	5.246212619	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.571142016
BA2836R	BA2836D	2242	Waves1+2	yes	yes	yes	yes	Male	Male			White	2			59	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	59	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	HiDAC	Consolidation	107	Dead	430	Dead-Unknown	0	35	27.4	0	NA	36.8	6.6	29.2	NA	13	25	2.9	1.4		23.6	7.6	"46,XY[20]"	383	NA	"nuc ish(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200], (5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	35	TRUE	"CD2(-), CD7(-), CD11b(-), CD13(+), CD14(-), CD15(- to partial dim +), CD16(-), CD25(-), CD33(+ to slightly bright +), CD34(partial +), CD36(equivocal), CD38(slightly dim and variable), CD45(dim +), CD56(-), CD64(-), CD117(+), CD123(+), HLA-DR(+), MPO(+), TdT(-)."	TRUE	TRUE	6	3.6	FALSE	negative	0	positive				CEBPA (H224fs*97; MAF 7%)|CEBPA (Y181*; MAF 15%)|IDH2 (R140Q; MAF 35%)|NPM1 (W288fs*10+; MAF 26%)|POT1 (splice site 1164-1G>A; MAF 48%)|SRSF2 (P95R; MAF 37%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.84794513	3.988974495	1.408184558	4.704530812	5.351555208	0.170321229	3.596599359	no	yes	no	yes	no	yes	no	1.315337836	1.215618392	-0.21233053	2.046358397	2.583644708	0.733728085	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.64528824
BA2714R	BA2714D	2366	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			60	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|SWOG S1203 (7+3 +/- Vorinostat)"	3	Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	167	Standard Chemotherapy	Azacitidine	Salvage	6	Dead	870	Dead-Disease	0	90	61	1	4	47	10	1	0.1	30	26	2.4	1.17	M4	14	4.6	"46,XY[20]"	612	104.5	Normal	80	TRUE	"dim CD4, dim CD7, dim CD11b, CD13, CD33, variable CD34, CD38, CD58, variable CD64, CD117, CD123, dim HLA-DR, MPO, and dim TdT"	TRUE	TRUE	5.8	70.84	TRUE	negative	0	positive				FLT3-V491L (p.V491L; MAF 51%)|NPM1 (p.W288fs*12; MAF 50%)|SF3B1 (p.K666Q; MAF 47%)|WT1 (p.Y395fs*51; MAF 49%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.488141969	1.018229942	-0.155093445	3.117239626	6.229043006	-1.982860036	1.532974469	no	no	no	no	yes	no	no	0.447887559	0.26739871	-2.813343188	1.141385413	1.800042232	2.222674867	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.628516903
BA3317R	BA3317D	2366	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1			60	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	62	769	Post-Chemotherapy|Relapse	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|SWOG S1203 (7+3 +/- Vorinostat)"	3	Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	167	Standard Chemotherapy	Azacitidine	Salvage	6	Dead	870	Dead-Disease	0	80	45	1.8	0	49.6	0	3.5	0.9	31	20	3	0.85	M4	26.2	9.3	"46,XY,t(3;4)(p21;q21)[20]"	261	99.6	Normal	44	TRUE	"CD13, CD34, dim CD33, CD38, CD58, CD71, CD117, CD123, partial TdT, and partial MPO+ "	TRUE	TRUE	6.1	3.42	FALSE	negative	0	positive				FLT3 (p.N841T; MAF 43%)|NPM1 (p.W288fs*12; MAF 41%)|SF3B1 (p.K666Q; MAF 48%)|WT1 (p.Y395fs*51; MAF 44%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.130716438	1.087265128	-0.416155586	3.594713283	3.842193862	-0.638748848	0.364990869	no	no	no	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.336926047
BA2440R	BA2440D	2263	Waves1+2	yes	yes	yes	yes	Male	Male			White	5			76	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	76	1	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Alive	31	Alive	NA	20		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"41~42,XY,del(3)(p13p21),add(4)(q21),add(5)(q11.2),-7,-10,add(12)(p11.2),-15,add(15)(q21),add(17)(p11.2),-19,-20,-22,+2mar[cp6]/42~43,sl,+21[cp5]/42,sl,i(21)(q10)[cp2]/43~44,sl,+add(7)(p11)[cp2]/43~46,sl,+add(7)(p11),+21[cp4]/81~87<4n>,slx2[cp2]"	NA	NA	"Loss of chromosome 5q31 sequences (73.5%)|Loss of chromosome 7 sequences (monosomy 7) (61.5%)|Gain of 21q22 (AML1) sequences (11.5%)|Polysomy for 8, 20q (7.5%), 11q, 15q, 16q and 17q sequences"	91	TRUE		NA	NA	NA	5.6	FALSE	negative	0	negative				ASXL1 (p.E1102D; MAF 31.1%)|DNMT3A (p.F543C; MAF 35.7%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.747269925	4.767096327	3.716097572	4.551297836	6.345033334	2.057901585	4.889545346	no	yes	yes	yes	yes	yes	yes	3.74519297	NA	0.021730864	NA	1.815346418	1.639388125	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.80755386
BA2036R	BA2036D	2445	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Dead	21	Dead-Treatment	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA	"Large population of atypical myeloblasts (CD56 positive,  weak CD117 positive, CD34 negative, HLA-DR negative),  representing approximately 87% of the leukocytes,  consistent with acute myeloid leukemia"	FALSE	FALSE	NA	NA	NA	negative	0	positive				KMT2A (p.Ile3572Ser (NM_001197104.1); MAF 44.1%)|NPM1 (p.Trp288fs (NM_002520.6); MAF 27.4%)|TET2 (p.His724fs; MAF 43.5%)					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	6.24227196	3.999561505	2.718149952	4.777689554	6.610065685	-0.940696846	1.074138718	yes	yes	no	yes	yes	yes	no	-2.175864303	NA	-3.845762102	NA	3.496842306	-5.406060163	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.522214484
BA2828R	BA2828D	2306	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1		CBFB-MYH11	64	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Mature B-Cell Neoplasm	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	64	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Re-induction	5	Alive	2175	Alive	0			0	0.9	48.7	30.1	5.3	0	10	7	2.6	1.33	M4	23.2	7.7	"46,XY,inv(16)(p13q22)[17]/46,XY[3]"	NA	87.2	c/w karyotype	53	FALSE		NA	NA	5.9	8.69	FALSE	negative	0	negative				KRAS (p.G12D; MAF 27%)|NOTCH1 (p.G2299S; MAF 47%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.89233682	5.127393461	0.962688765	6.645188941	6.324985105	-1.405271122	6.837801883	yes	yes	no	yes	yes	no	yes	5.535460918	0.134572951	-0.256472451	-1.986104617	-1.017598761	2.582840913	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.83918892
BA2251R	BA2251D	2334	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	bi		85	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	85	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	105	Dead	167	Dead-Disease	0			2.5	0	14.6	2.4	0	0.5	14	15	3.5	0.98		33.2	10.7	"46,XY[20]"	289	89.5	Normal	8	TRUE		NA	NA	7.4	25.63	TRUE	negative	0	negative				CEBPA (p.F77*83; MAF 50%)|CEBPA (p.K313_V314insK; MAF 50%)|TET2 (p.I1025L; MAF 50%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.926645975	3.345682135	-0.382770172	5.258580999	3.869766307	-1.290112818	2.577729403	yes	no	no	yes	no	no	no	-2.868048364	NA	-1.280835487	NA	-4.896544291	0.580788702	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.356625778
BA2952R	BA2952D	2114	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		MLLT3-KMT2A	16	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	16	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)|Cytarabine, Mitoxantrone|Etoposide, Cytarabine"	2	Induction|Intensification	Complete Response	Standard Chemotherapy	10	Standard Chemotherapy	"Cytarabine, Mitoxantrone"	Intensification	-1	Alive	2272	Alive	0	93		0	0	33	67	0	0	NA	NA	NA	0.72	M5	18.2	6.1	"46,XX,t(9;11)(p22;q23)[3]/50,sl,+6,+8,+der(9)t(9;11),+19[14]/51,sdl1,+5[3]"	934	100	"MLL: æ 14% of cells had a pattern consistent with the t(9;11) seen on metaphase analysis. æAn addition 65% of cells had a signal pattern, consistent with the clone with the +der(9). | BCR/ABL+ASS: æ 62% of cells had three signals for both ABL and ASS (9q34), consistent with the clone with +9. | RUNX1T1 (8q22): æ 69% of cells had three signals for RUNX1T1, consistent with the clone with +8. | EGR1: æ 7% of cells had three signals for EGR1 (5q31), consistent with the clone with +5."	39	FALSE	"CD11b, dim CD13, dim CD15, CD33, CD38, dim CD45, CD56,      CD58, bright CD64, dim CD117, CD123, HLA-DR, and variable MPO positive"	FALSE	TRUE	NA	24.72	TRUE	negative	0	negative				KRAS (p.G13D; MAF 6%)|NRAS (p.Q61H; MAF 19%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.756017274	0.028593421	1.747013702	2.523417057	5.832936649	-4.148282172	7.154055161	no	no	no	no	no	no	yes	-1.470083086	0.18465311	-4.273358462	-1.734505515	5.091020062	2.344687345	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.568847335
BA2410R	BA2410D	2495	Waves1+2	yes	yes	yes	no	Female	Female			White	2			57	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	57	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin) plus Crenolanib"	1	Induction	Complete Response i	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin) plus Crenolanib"	Induction	-1	Dead	81	Dead-Treatment	NA	55	47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"It reveals 0.23% CD34 (+) myeloid blasts with the following immunophenotype: CD2(-), CD7(-), CD13(+), CD15(-/few +), CD33 (bright +), CD36(few +), CD38(partial +), CD45(+), CD64(-), CD117(+), HLA-DR(-), MPO (partial +). (A limited/targeted immunophenotypic analysis could be performed on this paucicellular specimen.) | CD2(-), CD4(partial dim +), CD7(-), CD11b(-), CD13(variably +), CD15(-/few +), CD33(bright +), CD34(-), CD36(- /few +), CD38(+), CD45(+), CD56(-), CD64(few +), CD117(+), and HLA-DR(-) (There is also a 16% population of medium-sized cells with the following immunophenotype)"	TRUE	TRUE	NA	26.5	TRUE	positive	NA	positive				ASXL1 (E981G; MAF 49%)|DNMT3A (F290fs*24; MAF 40%)|FLT3-ITD (MAF 18%)|JAK2 (N322I; MAF 51%)|NPM1 (W288fs*10+; MAF 38%)					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	1.67574341	3.09979908	2.38904504	4.106337586	5.216385714	2.061119916	4.464478356	no	no	no	yes	no	yes	yes	-2.464338724	NA	1.191245008	NA	0.114689211	-4.071457732	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.501041864
BA2139R	BA2139D	2342	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			48	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	48	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Cytarabine|TBI, VP-16"	4	Consolidation|Induction|CNS|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"TBI, VP-16"	Allogeneic - Matched Unrelated Donor	-1	Alive	939	Alive	NA	86	77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5b	NA	NA	"46,XX "	NA	NA		NA	NA	"Large population of atypical monocytic cells (weaker than  normal CD33, partial loss of CD13) including  promonocytes/monoblasts representing approximately 50% of  the leukocytes suggestive of acute monoblastic or monocytic  leukemia. | Large population of atypical monocytic cells (weaker than normal CD33, partial loss of CD13) including promonocytes/monoblasts representing approximately 50% of the leukocytes"	FALSE	TRUE	NA	81	TRUE	positive	0.785714286	positive				DNMT3A (p.Arg882Cys; MAF 47.1%)|FLT3-ITD|NPM1 (p.Trp288fs (NM_002520.6); MAF 27.9%)					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	2.628089617	3.820360948	3.514045267	2.746048812	6.928331113	-1.598667209	3.255227085	no	yes	yes	no	yes	no	no	6.722796014	NA	-5.68060793	NA	2.806575943	3.831225355	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.752192043
BA2051R	BA2051D	2464	Waves1+2	yes	yes	yes	no	Male	Male			White	5		CBFB-MYH11	60	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"HiDAC|7+3 (Cytarabine, Idarubicin) plus Sorafenib|Fludarabine, Cyclophosphamide, Thiotepa, TBI"	3	Consolidation|Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, Thiotepa, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Dead	581	Dead-Disease	NA	33	23	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,inv(16)(p13.1q22)[18]/47,sl,+22[2]"	NA	NA	FISH positive for CBFB rearrangement in 49% of cells	42	TRUE	"Flow cytometry shows the large majority of analyzed cells fall within the monocyte gate, which are predominantly mature as evidenced by coexpression of CD14 and CD64. A smaller subset of cells within the monocyte gate consists of immature monocytes with decreased expression of CD14 and/or CD64. (A discrete population of myeloblasts is also present.)"	FALSE	FALSE	NA	29	TRUE	negative	0	negative				NRAS (p.Q61K; MAF 24.1%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.845655809	1.895537678	3.145024555	4.100328819	6.42044454	0.624724661	6.585715882	yes	no	yes	yes	yes	yes	yes	5.426644839	NA	-0.255004223	NA	-0.857163081	5.94213911	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.875943239
BA2532R	BA2532D	2323	Waves1+2	yes	yes	yes	yes	Female	Female	Unknown		White	2		PML-RARA	42	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Cervical Cancer|Pituitary Tumor	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	42	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Targeted Therapy - Other|Intrathecal	3	"ATRA, Arsenic Trioxide|ATRA, 6-MP, Methotrexate|Methotrexate"	3	Induction|Experimental|Maintenance	Complete Response	Standard Chemotherapy	22	Standard Chemotherapy	"ATRA, 6-MP, Methotrexate"	Maintenance	-1	Alive	952	Alive	0	92	83	0	NA	11	4	0	NA	35	35	3.9	0.66	M3	22.2	7.6	"46,XX,t(15;17)(q24;q21.1)[1]"	475	88.4	"nuc ish(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML, RARA)x3(PML con RARAx2)[154/200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	35	TRUE	"CD2(-), CD4(partial +), CD11b(few dim +), CD13(+), CD14(-), CD15(-), CD16 (-), CD25(-), CD33(bright +), CD34(-), CD36(-), CD38(variably +), CD45(variably +), CD56(-), CD64(+), CD117(variably +), CD123(+), HLA-DR(-), myeloperoxidase(+), and TdT(-)."	FALSE	TRUE	5.8	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	1.868079095	2.910057525	4.155450936	4.138243199	6.326356137	-0.833484064	4.29117725	no	no	yes	yes	yes	yes	no	-2.775756603	NA	-0.832664331	NA	-1.772965974	-4.469458217	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.6407912
BA2986R	BA2986D	2110	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			48	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	56	0	Residual Disease|Post-Chemotherapy|Post-DLI|Post-Transplant	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	3	DLI|Standard Chemotherapy|Bone Marrow Transplant	7	"7+3 (Cytarabine, Idarubicin)|HiDAC|Donor Lymphocyte Infusion|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|Cytarabine, Mitoxantrone|Busulfan, Cyclophosphamide"	5	Allogeneic - Sibling|Consolidation|Unknown|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Re-induction	5	Dead	3069	Dead-Disease	0	62	5	0	0	83.2	1.8	0	0	28	21	2.5	0.8		24.1	8.3	"46,XX,t(1;11)(q44;q13),del(6)(p23)[9]/46,idem,t(17;20)(q25;q11.2)[11]"	290	94.5	"All probe results were within normal laboratory limits.      *Note: while it was not disrupted, MLL (11q23) was observed on the end of      the derivative chromosome 1 on available metaphase cells, reflecting the      t(1;11)."	53	TRUE	"dim CD2, CD13, CD33, CD34, CD38, CD117, dim CD123, dim      HLA-DR, and TdT positive"	FALSE	TRUE	6.5	1.46	FALSE	negative	0	negative				BCOR (p.A1262S; MAF 45% )|DNMT3A (p.R882H; MAF 15% )|GATA1 (c.-12C>T; MAF 35%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	4.791024581	6.6047618	0.450991498	8.270316657	4.964400321	-3.144296937	0.78292856	yes	yes	no	yes	no	no	no	-5.401552958	-3.626517453	3.244814577	1.710711601	-3.722822785	1.934230382	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.572024108
BA2494R	BA2494D	2246	Waves1+2	yes	yes	yes	no	Male	Male			White	5			60	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute megakaryoblastic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute megakaryoblastic leukaemia	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	Azacitidine	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Induction	-1	Dead	204	Dead-Disease	NA	13	rare	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M7	NA	NA	"46,XY,del(13)(q12q14)[3]/46,XY[17]"	NA	NA	Normal	136	TRUE	"CD3  - Scattered cells positive, 5-10% of marrow cells CD20  - Scattered cells positive, 5-10% of marrow cells CD34  - Rare cells positive, <1% of marrow cells CD30  - Negative CD43  - Positive in >60% of marrow cells, including the clusters of immature cells (CD117  - Scattered and small loose clusters of cells positive, 10-15% of marrow cells CD138  - Occasional cells positive, 2% of marrow cells Glycophorin A - Occasional cells positive, 3-5% of marrow cells MPO  - Scattered and clusters of cells positive, 20% of marrow cells)"	FALSE	FALSE	NA	3.1	FALSE	negative	0	negative	RUNX1 (p.A338Rfs*262; 22.2%)			JAK2 (p.V617F; MAF 3.8%)|TET2 (p.R1261L; MAF 27.7%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	3.988571934	5.120634987	3.46118181	6.276035046	6.637582014	1.286409274	3.32094023	yes	yes	yes	yes	yes	yes	no	3.112721558	NA	0.455694137	NA	-1.240423216	-2.381103786	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.822657532
BA2515R	BA2515D	2533	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown		White	2	mono		74	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	75	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Decitabine"	3	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	48	Dead	324	Dead-Unknown	0	32	5	0	NA	69	8	18	NA	23	22	4.3	1.21		32.9	11.1	"46,XY[18]"	199	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[198],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	178	TRUE	"CD2(-), CD4(partial dim +), CD7(partial +), CD11b(partial dim +), CD13(+), CD14(-), CD15(-), CD16(-), CD19(-), CD22 (-), CD25(-), CD33(variably +), CD34(bright +), CD36(-), CD38(bright +), CD45(moderate/dim +), CD56(-), CD64(-), CD79a (-), CD117(+), CD123(-), HLA-DR(+), MPO(+), TdT(partial +) (34% population of variably-sized cells)"	TRUE	TRUE	7.1	2.3	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.615795147	6.386940213	4.344961184	5.558140161	6.344121059	-0.330243421	5.601562106	yes	yes	yes	yes	yes	yes	yes	2.107744816	NA	-1.021927489	NA	2.401579417	0.632922978	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.681263338
BA2748R	BA2748D	2566	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1	bi		10	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	10	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)|ADE (Cytarabine, Daunorubicin & Etoposide)|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Busulfan, Cyclophosphamide"	3	Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	33	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	2143	Alive	0	80	75	1.7	6.1	17.4	7.8	11.3	0.7	24	22	3.7	0.51	M2	30.3	9.1	"46,XX[20]"	688	83.7	Normal	74	FALSE	"variable CD7, variable CD13, CD33, partial CD34, bright CD38, partial CD56, CD58, variable CD71, CD117, CD123, HLA-DR, and MPO positive"	TRUE	TRUE	7.3	39.69	TRUE	negative	0	negative				"CEBPA (p.G96fs*12; MAF ~50% )|CEBPA (p.G96fs*12; MAF ~50%)|CEBPA (p.R306_N307insPPT; MAF ~50%)|MLL (PTD (low level mutation))|NRAS (p.G12A, MAF 6%)|NRAS (p.G12A; MAF 6% )|NRAS (p.G12D; MAF 5% )|NRAS (p.G12D; MAF 5%)|NRAS (p.G13D; MAF 8%)|NRAS (p.G13R; MAF 5%)|NRAS (p.Q61H; MAF 10%)"					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.782959625	3.346723399	1.171341152	2.855841088	4.525166108	-0.475055563	5.90273863	no	no	no	no	no	yes	yes	-1.588352035	0.181795107	0.043118157	3.103892993	-1.141278123	0.138788938	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.397712068
BA2577R	BA2577D	2566	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1	bi		10	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	12	568	Post-Chemotherapy|Relapse	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)|ADE (Cytarabine, Daunorubicin & Etoposide)|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Busulfan, Cyclophosphamide"	3	Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	33	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	2143	Alive	0	46		0	0	81.3	8.3	10.4	18.1	31	27	3.8	0.53	M2	30.5	10.2	"47,XX,+10[19]/46,XX[1]"	NA	96.8	Normal	11	FALSE	"variable CD7, ædim CD13, CD33, CD34 bright CD38,CD56, CD58, CD117, HLA-DR positive"	TRUE	TRUE	7	1.93	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.646281853	2.073819033	1.200682277	3.468042098	4.591882571	-2.208091383	5.523551412	no	no	no	no	no	no	yes	NA	NA	NA	NA	NA	NA							0.328117846
BA2622R	BA2622D	2453	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			76	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Basal Cell Carcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	76	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	3	CPX-351 (Liposomal Cytarabine + Daunorubicin)|Decitabine|Incyte trial (azacitidine and JAK 1 inhibitor)	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	35	Standard Chemotherapy	Incyte trial (azacitidine and JAK 1 inhibitor)	Induction	77	Dead	520	Dead-Unknown	0	50	5	2	0.2	52.2	37.1	8.5	0	18	16	3.7	1.45	M0	22.3	7.6	"47,XY,+8[3]/46,XY[17]"	NA	118.6	5% trisomy 8	104	TRUE	"#1 Immunophenotype: CD13, CD34, CD38, dim CD45, CD58, CD117, HLA-DR and TdT positive | #2 Immunophenotype: dim CD4, partial CD13, dim CD34, CD38, CD58, CD123, HLA-DR, and partial TdT positive"	FALSE	FALSE	7.7	4.48	FALSE	negative	0	negative	RUNX1 (p.A338Rfs*256; 73.3%)	ASXL1 (p.G646Wfs*12; 20.0%)		CBL (p.Y371H; MAF 43%)|EZH2 (p.K30fs*8; MAF 48%)|RUNX1 (p.A338fs*; MAF 41%)|SF3B1 (p.H662Q; MAF 28%)	yes				yes	yes	Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	4.074385753	4.27835541	3.877403932	7.240537792	6.312990183	-3.689319128	1.957630753	yes	yes	yes	yes	yes	no	no	4.251939824	NA	1.507359138	NA	-5.550416732	4.905517059	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.755388239
BA2758R	BA2758D	2453	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			76	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	y	Basal Cell Carcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	77	417	Post-Chemotherapy|Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	CPX-351 (Liposomal Cytarabine + Daunorubicin)|Decitabine|Incyte trial (azacitidine and JAK 1 inhibitor)	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	35	Standard Chemotherapy	Incyte trial (azacitidine and JAK 1 inhibitor)	Induction	77	Dead	520	Dead-Unknown	0	50	10	0.9	NA	60.3	38.5	0.3	NA	19	19	3.2	1	M0	24.2	8.6	"47,XY,+8[cp14]/47,sl,der(21)t(1;21)(q11;p11.1)[2]/46~47,sl,der(22)t(1;22)(q11;p11.2)[cp2]/46,XY[1]"	261	102.5	50/100 (50%) interphase cells scored had a signal pattern reflecting trisomy 8.	7	FALSE	"dim CD4, CD13, bright CD34, dim CD45, CD117, HLA-DR, and dim TdT positive"	FALSE	FALSE	7.2	3.4	FALSE	negative	0	negative	RUNX1 (p.A338Rfs*256; 71.0%)	ASXL1 (p.G646Wfs*12; 21.1%)							no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	2.989978183	3.431432838	2.884615103	6.044016657	6.141074966	-3.885142957	2.303002517	yes	no	yes	yes	yes	no	no	NA	NA	NA	NA	NA	NA							0.824161219
BA2930R	BA2930D	2453	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			76	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Basal Cell Carcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	77	472	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	CPX-351 (Liposomal Cytarabine + Daunorubicin)|Decitabine|Incyte trial (azacitidine and JAK 1 inhibitor)	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	35	Standard Chemotherapy	Incyte trial (azacitidine and JAK 1 inhibitor)	Induction	77	Dead	520	Dead-Unknown	0	54	occasional	6.9	NA	51.6	39.6	1.9	NA	20	23	3.2	1	M0	25.4	8.6	"47,XY,+8[cp15]/47,sl,der(22)t(1;22)(q11;p11.2)[2]/46,XY,dup(1)(q21q42)[cp2]"	NA	92	60/100 (60%) interphase cells scored had a signal pattern reflecting trisomy 8. 	22	FALSE	"Positive (The myeloid blasts are CD13, CD34, CD38, CD117, and HLA-DR;Atypical monocytic cells comprise approximately 41% of analyzed events and are CD11b, CD13, CD14, CD64, and dim HLA-DR positive. T cells show a CD4:CD8 ratio of 6.9:1 without aberrant antigen expression. B cells are polytypic by surface light chain expression)"	FALSE	FALSE	7.2	4.5	FALSE	negative	0	negative	RUNX1 (p.A338Rfs*256; 76.9%)								no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	3.998334968	3.504839741	3.905525244	5.754917397	6.21716449	-3.774925246	4.157010369	yes	yes	yes	yes	yes	no	no	NA	NA	NA	NA	NA	NA							0.787145886
BA2970R	BA2970D	2327	Waves1+2	yes	yes	yes	yes	Male	Male	Black	NON-HISPANIC	Black	2			63	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Supportive/Palliative Care	2	Ruxolitinib|Hydroxyurea	1	Supportive/Palliative Care			NA	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	103	Dead	8	Dead-Disease	1	9	15.4	2.9	NA	20.2	16.3	42.3	NA	NA	NA	NA	0.6		22.7	7	"46,XY[20]"	1086	NA	"nuc ish(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[199], (5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	126	TRUE	"CD34(+), CD7(partial +), CD13(+), CD33(+), CD38(partial +), CD45(moderately +), CD56 (+), CD117(+), HLA-DR(variably +), other myeloid and lymphoid antigens(-)."	TRUE	TRUE	NA	73.4	TRUE	positive	9	positive		ASXL1 (p.W898*; 42.1%)		ASXL1 (Foundation; W898*; MAF 47%)|KRAS (Foundation; A59T mutation; MAF 47%)|KRAS (Foundation; G13C; MAF 3%)|SUZ12 (Foundation; W617*; MAF 49%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	2.536142514	7.455713454	5.079761292	3.176785506	5.268147981	1.476380914	7.100069657	no	yes	yes	no	no	yes	yes	2.865967048	1.372650662	2.386205252	-0.710466774	2.682477866	-0.483279886	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.780282338
BA2839R	BA2839D	2107	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	2			44	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	44	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	6	Dead-Disease	0	62	19	1	NA	18	35	25	NA	24	90	1.8	0.73		22.4	7.2	"47,XY,+21[19]/46,XY[1]"	NA	NA	"nuc ish(RUNX1T1x2,RUNX1x3)[140/200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML, RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	18	FALSE	"CD2(-_), CD7(dim + to -_), CD11b(-_), CD13(+), CD14(-_), CD15 (partial +), CD33(bright +), CD34(partial +), CD36(-_), CD38(variably +), CD45(+), CD56(-_), CD64(partial +), CD117(+), HLA-_DR(variably +)"	TRUE	TRUE	7.1	8	FALSE	positive	0.960784314	negative	RUNX1 (p.E223*; 64.8%)								no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	TRUE	2.738714433	3.03679972	4.158187291	3.816959788	5.633227131	-1.296592903	0.81729515	no	no	yes	yes	no	no	no	-0.715077077	-0.430574928	0.185992121	0.45728624	0.537698649	1.845882809	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.610897555
BA2868R	BA2868D	2442	Waves1+2	yes	yes	yes	yes	Male	Male			White	3	bi		69	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Induction	-1	Dead	250	Dead-Disease	NA	60		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA	"weak  CD7, CD13, partial CD15, weak CD33, CD34, weak CD64, CD117,  myeloperoxidase, and HLA-DR, but do not express CD14(MO2),  CD42b, or CD61."	TRUE	TRUE	NA	33	TRUE	negative	0	negative				CEBPA (c.117delC; MAF 27.2%)|CEBPA (c.938_939insATC; MAF 18.1%)|TET2 (c.3454G>T; MAF 40.9%)|WT1 (c.1137_1138insA; MAF 43.7%)|WT1 (c.872+1G>A; MAF 40%)					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	4.062012542	2.308021862	0.253940584	3.960513623	4.175248373	-1.488532145	4.337528963	yes	no	no	yes	no	no	no	-1.373468114	0.098134077	-2.366035493	3.335312559	-0.962354249	0.367161773	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.437537895
BA3011R	BA3011D	2236	Waves1+2	yes	yes	yes	yes	Male	Male	Multiracial	HISPANIC	HispNative	1		PML-RARA	32	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	32	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	1	"ATRA, Arsenic Trioxide"	2	Consolidation|Experimental			NA	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Consolidation	232	Alive	2104	Alive	0	80		0	19.6	56.3	0.9	3.6	0.1	31	20	3	0.84	M3	19.1	6.3	"46,XY,t(15;17)(q22;q21)[20]"	NA	96.5	70% PML/RARA	49	TRUE	"CD13, CD33, CD64, CD117, CD123 and  MPO-positive"	FALSE	TRUE	6.9	7.19	FALSE	positive	NA	negative				"FLT3-ITD (MAF 7%)|MPL (p.E484G, MAF 3%)|WT1 (p.F451C; MAF 51% )"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	3.456022198	4.146816948	6.223783503	3.194121341	6.846574344	1.039925439	6.44469447	yes	yes	yes	no	yes	yes	yes	-2.898947869	3.73445143	-0.007391821	-2.131520928	0.667533376	-6.793659696	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.690551557
BA2052R	BA2052D	2412	Waves1+2	yes	yes	yes	yes	Male	Male	Unknown		White	2			71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Supportive/Palliative Care	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Supportive/Palliative Care	Azacitidine	Hypomethylating/Low Dose Cytarabine	-1	Dead	288	Dead-Unknown	0.9	34		2.8	NA	NA	NA	NA	NA	28	27	4.2	1.18		29.3	9.8	"46,XY,inv(4)(p14p16.1)[3]/46,XY[16]"	194	NA	"nuc ish(D5S2064,D5S630,EGR1)x4[32/200],(D7Z1,D7S522)x4[17/200],(D8Z2, D20S108)x4[27/200],(RUNX1T1,RUNX1)x4[32/200],(5'MLL,3'MLL)x4(5'MLL con 3'MLLx4)[21/200],(PML,RARA)x4 [34/200],(5'CBFB,3'CBFB)x4(5'CBFB con 3'CBFBx4)[35/200]"	73	TRUE	"CD2 (-), CD7(few +), CD11b(-), CD13(partial dim +), CD14(-), CD15(partial dim +), CD16(-), CD22(partial dim +), CD33(-), CD34(bright +), CD36(-), CD38(moderately bright +), CD45(partial +), CD56(-), CD64(-), CD117(partial +), HLADR(+) (32% population of medium to large cells)"	TRUE	TRUE	7.1	NA	NA	negative	0	negative				"BCOR (Foundation; Q1337*; MAF 56%)|CTCF (Foundation; R49H; MAF 19%)|RUNX1 (Foundation; loss, splice site 477_508+22>GGG; MAF 50%)|SRSF2 (Foundation; R94_S101del;MAF 39%)|TET2 (Foundation; splice site 3409+2T>G; MAF 51%)"		yes			yes		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	3.12161169	4.845625219	4.035420656	4.943441779	6.563268979	-1.93006375	4.045158301	yes	yes	yes	yes	yes	no	no	1.904790124	NA	5.472320485	NA	0.273665948	-0.711394412	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.736746152
BA2510R	BA2510D	2073	Waves1+2	yes	yes	yes	no	Male	Male			White	5		KMT2A_re	65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	3	"7+3 (Cytarabine, Idarubicin)|Venetoclax (ABT-199), Azacitidine|Fludarabine, Cyclophosphamide, TBI "	3	Experimental|Re-induction|Double Umbilical Cord Blood Transplant (DUCBT)			NA	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Dead	210	Dead-Disease	NA	95	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"48,XY,+8,der(11)t(11;?)(q23;?),+21[19]/46,XY[1]"	NA	NA	Gain of 8q22 and 21q22 (88%)	33	FALSE	"positive for CD11b, CD13, CD33, CD38, dim CD45, dim CD56, CD64, and HLA-DR"	FALSE	TRUE	NA	19.8	FALSE	negative	0	negative		ASXL1 (p.W960*; 48.8%)		ASXL1 (p.W960X; MAF 29.4%)|PTPN11 (p.E76V; MAF 29.5%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	0.880316656	1.895537678	0.041398241	3.22332801	4.819388543	-2.528601933	-0.233793723	no	no	no	no	no	no	no	-6.966782449	NA	-3.814968627	NA	2.228697939	5.459682193	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.428577289
BA2691R	BA2691D	2521	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			83	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	MissingKaryo	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	83	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Dead	50	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.577539671	4.499563156	4.842123184	7.248181873	6.996533871	-1.741340014	2.177847751	yes	yes	yes	yes	yes	no	no	5.389875	NA	-0.711088717	NA	-2.424246438	3.069148	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.861940435
BA2374R	BA2374D	2487	Waves1+2	yes	yes	yes	no	Female	Female	Black	NON-HISPANIC	Black	1		PML-RARA	36	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	36	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	2	"ATRA, Arsenic Trioxide|APML4 Protocol (ATRA, Arsenic Trioxide, Idarubicin)"	2	Induction|Experimental	Complete Response	Standard Chemotherapy	27	Targeted Therapy - Other	"ATRA, Arsenic Trioxide"	Experimental	-1	Alive	2180	Alive	0	90	90	0	28.8	1.8	1.8	0.9	0.4	37	27	3.9	0.76	M3	26.3	8.2	"46,XX,der(15)t(15;17)(q22;q21),der(17)t(15;17)del(17)(q21)[15]/46,XX[1]"	605	89.2	95% of cells had a variant abnormal signal pattern with PML/RARA fusion.  PML (15q22) (SO) / RARA (17q21) (SG) t(15;17)	25	FALSE	"Immunophenotype: CD13, CD33, partial CD34, CD64, CD117, CD123 and MPO positive"	FALSE	TRUE	7.5	103.66	TRUE	positive	NA	negative				FLT3-ITD (MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.432779555	1.733150935	4.301648273	1.613155801	6.195633156	-1.764774393	6.94819582	no	no	yes	no	yes	no	yes	-4.777671267	NA	-4.100426903	NA	3.032997876	-4.677623374	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.452369894
BA2804R	BA2804D	2101	Waves1+2	yes	yes	yes	yes	Male	Male			White	5	mono		87	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	87	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	2	AG-120|Decitabine	2	Hypomethylating/Low Dose Cytarabine|Experimental			NA	Targeted Therapy - Other	AG-120	Experimental	-1	Dead	249	Dead-Disease	NA	60	39	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	M5	NA	NA	"47,XY,+21[3]/46,XY[9]"	NA	NA	9.5% gain 21q22	43	TRUE	"A distinct blastic population, expressing CD7, CD13, CD15, CD33, CD34, CD38, dim CD45, CD64, MPO, and HLA-DR | A large monocytic population, positive for CD11b, CD13, CD14, CD15, CD33, CD38, CD45, CD64, HLA-DR and MPO"	TRUE	TRUE	NA	139.9	TRUE	negative	0	negative				ASXL1 (p.G642fs; MAF 31.6%)|CEBPA (p.A66fs; MAF 37.3%)|CEBPA (p.Q162fs; MAF 50.3%)|IDH1 (p.R132C; MAF 48.7%)|TP53 (p.N107D; MAF 97.6%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	4.076001538	5.97482137	3.378445713	2.180034982	5.836403806	0.695918604	7.839857484	yes	yes	yes	no	no	yes	yes	3.672505397	4.400358271	-2.741373353	-0.409431786	3.867694445	-1.567267097	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.541634488
BA2670R	BA2670D	2456	Waves1+2	yes	yes	yes	yes	Female	Female	White		White	2			72	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	73	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Other	4	"Lenalidomide|Azacitidine|Decitabine|Clofarabine, Cytarabine"	2	Hypomethylating/Low Dose Cytarabine|Maintenance			NA	Other	"Clofarabine, Cytarabine"	Hypomethylating/Low Dose Cytarabine	-1	Dead	465	Dead-Disease	0		25	0	NA	2	54	18	NA	41	34	3.6	0.58		27.5	8.8	"46,XX,+1,der(1;21)(q10;q10)[6]/46,XX[14]"	NA	NA	"nuc ish(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200]"	NA	NA		NA	NA	6.2	58.2	TRUE	negative	0	negative				RUNX1 (PB)|SF3B1 (PB)	yes				yes	yes	Found	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	4.558465291	4.905695821	6.006804942	5.245407749	6.879120863	1.602315747	5.529127847	yes	yes	yes	yes	yes	yes	yes	6.285917315	NA	3.409450736	NA	-0.30465415	2.974557998	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	1.066673618
BA2675R	BA2675D	2133	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	mono		10	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	IntermediateOrAdverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	10	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	4	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal|Other	4	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)|Cytarabine|Unknown|MiDAC"	3	Unknown|Induction|Re-induction	Refractory	Standard Chemotherapy	10	Bone Marrow Transplant	Unknown	Unknown	-1	Alive	2095	Alive	0	75	86	0	0	7.5	1.8	4.7	0.1	13	23	3.6	0.47	M2	21.6	6.9	"46,XY[20] "	970	96		42	FALSE	"variable CD7, dim CD11b, CD13, CD33, partial CD34, dim CD64, CD117, CD123, HLA-DR, and dim MPO positive"	TRUE	TRUE	7.8	133.63	TRUE	positive	NA	negative				CEBPA (p.R142fs*19; MAF 52%)|FLT3-ITD (MAF 48%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.192150153	0.536685131	0.357962098	1.701306886	4.324878488	1.450150612	1.823271903	no	no	no	no	no	yes	no	-4.789643469	NA	1.110583023	NA	-1.635403321	-0.725599721	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.397595653
BA2031R	BA2031D	2387	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		KMT2A_re	2	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	2	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	4	"COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)|Cytarabine|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Busulfan, Cyclophosphamide"	3	Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	136	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	1937	Alive	0	80	70	0	1.8	46	0	0	0.2	22	53	NA	0.24	M5	22	6.9	"46,XX,t(6;11)(q27;q23)[19]/46,XX[1]"	NA	92.8		40	TRUE	"CD4, CD11b, variable CD13, CD15, CD33, variable CD56, CD58, CD64, lysozyme, and dim HLA-DR positive"	FALSE	TRUE	NA	57.08	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	-0.827405877	0.468137149	-0.56663882	2.446510688	6.185493482	-3.345232203	3.683079805	no	no	no	no	yes	no	no	-2.811963307	NA	-4.963539793	NA	1.390033185	1.958905177	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.502653066
BA2589R	BA2589D	2064	Waves1+2	yes	yes	yes	yes	Female	Female			HispNative	5			42	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	42	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	3	"7+3 (Cytarabine, Idarubicin)|AG-221|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	3	Salvage|Induction|Experimental	Refractory	Standard Chemotherapy	-1	Targeted Therapy - Other	AG-221	Experimental	-1	Dead	448	Dead-Disease	NA	50	51	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	256	TRUE	"positive for CD13, CD34, CD38, dim CD45, CD117, HLA-DR, and MPO"	FALSE	FALSE	NA	10.7	FALSE	negative	0	negative				ASXL1 (p.G652S; MAF 41.3%)|ASXL1 (p.S1231F; MAF 50.4%)|DNMT3A (p.S307fs; MAF 45.6%)|IDH1 (c.C315T; p.G105G; MAF 46.6%)|IDH2 (p.R140Q; MAF 43.8%)|SRSF2 (p.P95H; MAF 42.2%)		yes			yes		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.068863171	5.346914821	5.469904883	6.332354356	7.030483189	2.360639815	6.346913297	yes	yes	yes	yes	yes	yes	yes	1.135472369	NA	3.052932188	NA	1.198889109	2.271073158	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.983780749
BA2198R	BA2198D	2338	Waves1+2	yes	no	yes	no	Male	Male			White	3			61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Dead	42	Dead-Disease	NA	84	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA	"partial  weak CD4 (20% positive), CD13, partial weak CD11b (60%  positive), partial weak CD15 (20% positive), CD34, CD117,  myeloperoxidase, and partial HLA-DR (60% positive)"	FALSE	FALSE	NA	25	TRUE	negative	0	negative	RUNX1 (p.R166Q; 46.0%)|RUNX1 (p.R162K; 44.5%)	ASXL1 (p.E635Rfs*15; 10.5%)		ASXL1 (p.Glu635Argfs*15; MAF 9%)|CSF3R (p.Tyr779*; MAF 5.4%)|IDH2 (p.Arg140Gln; 37.7%)|PHF6 (p.Arg319*; MAF 88.6%)|RUNX1 (p.Arg162Lys; MAF 43%)|RUNX1 (p.Arg166Gln; MAF 35.3%)|SMC1A (p.Arg790Gln; 9.2%)|U2AF1 (p.Gln157Pro; MAF 51.3%)			yes		yes		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	1.502892052	1.817833197	1.945891382	3.925347124	6.243148638	-3.43132344	2.976790876	no	no	no	yes	yes	no	no	-2.385654471	NA	3.857663249	NA	-5.663511275	2.478959953	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.526611045
BA2066R	BA2066D	2066	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		KMT2A_re	62	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Other	4	"3+7 (Cytarabine, Daunorubicin)|MiDAC|Hydroxyurea|Fludarabine, Melphalan, TBI, ATG"	4	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Allogeneic - Child	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Fludarabine, Melphalan, TBI, ATG"	Allogeneic - Child	-1	Dead	317	Dead-Other	0	95	70	0	0	9.5	23.3	0	0.1	54	57	3.3	0.78	M5	27.4	9.1	"46,XX,t(1;11)(p36.1;q23),add(9)(p22)[13]/46,sl,del(2)(p21p23),del(20)(q11.2-13.1)[4]/46,sl,add(12)(p11.2)[2]"	861	93.2	"MLL: 85%  The t(1;11) with these breakpoints in not common, but has been associated with monoblastic leukemia"	26	FALSE	"CD4, partial CD11b, CD15, CD33, CD38, moderate CD45, partial CD56, CD64, CD123, partial CD117, and HLA-DR"	FALSE	TRUE	6.8	87.72	TRUE	negative	0	negative		ASXL1 (p.R693*; 19.8%)		ASXL1 (p.R693*; MAF 19%)|BCOR (p.S209L (possibly a benign germline polymorphism); MAF 48%)|FLT3 (p.A680V; MAF 17%)|FLT3 (p.I836delI (in-frame deletion of one amino acid in TK domain); MAF 11%)|NRAS (p.G12S; MAF 19%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.078289048	1.051640088	0.533230431	3.114422883	5.963452628	-3.328538012	1.205444399	no	no	no	no	no	no	no	-2.025465923	NA	-4.389557171	NA	0.229996126	2.243630984	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.539698832
BA2344R	BA2344D	2077	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			71	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Follicular lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	71	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	5	"7+3 (Cytarabine, Idarubicin)|Azacitidine|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)|Hydroxyurea|Mitoxantrone"	4	Hypomethylating/Low Dose Cytarabine|Induction|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	-1	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	-1	Dead	280	Dead-Disease	NA	82	66	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,del(7)(q22q36)[20]"	NA	NA	"ABNORMAL FISH RESULT 7cen (D7Z1), 7q31 (D7S486): deletion present"	NA	NA	"CD7, CD13, weak CD33, CD34, CD117, and HLA-DR"	TRUE	TRUE	NA	133.7	TRUE	negative	0	negative				FLT3-ITD (MAF 4%)|WT1 (c.1138delinsAA; MAF 31.2%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.893117073	1.748863993	0.591805791	0.986902066	4.712287788	-1.323528331	3.879547411	no	no	no	no	no	no	no	-0.242629542	NA	0.651027666	NA	1.129642799	2.468124354	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.524337299
BA2534R	BA2534D	2077	Waves1+2	no	no	no	no	Female	Female			White	3			71	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Follicular lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	72	249	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Supportive/Palliative Care	5	"7+3 (Cytarabine, Idarubicin)|Azacitidine|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)|Hydroxyurea|Mitoxantrone"	4	Hypomethylating/Low Dose Cytarabine|Induction|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	-1	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	-1	Dead	280	Dead-Disease	NA	95	99	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,del(7)(q22q36)[18]/46,sl,t(1;10)(p13;q24)[2]"	NA	NA	"- 3 copies of the MECOM locus at 3q26.2, suggestive of a  rearrangement or gain of this locus, in 156/200 (78.0  percent) cells scored.  - deletion 7q31 involving the D7S486 locus in 162/200 (81.0  percent) cells scored."	NA	NA		NA	NA	NA	20.39	FALSE	positive	0.315789474	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	0.754478887	-0.123773304	1.037245044	1.928060593	1.616173134	-2.895811665	-0.805003699	no	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.318051286
BA2459R	BA2459D	2350	Waves1+2	yes	yes	yes	no	Male	Male			White	2			55	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	8	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	8	Alive	45	Alive	0	91	61	0	NA	46.1	1.7	9.4	NA	391	343	2.8	0.74	M1	22.8	7.1	"92<4n>,XXYY[13]/46,XY[7]"	NA	NA	"The AML FISH panel analysis showed evidence of extra copies of the RUNX1T1 (8q24) and RUNX1 (21q22) genes in 95.5%, extra copies of the PML (15q24) and RARA (17q21.1) genes in 95.5%, and extra copies of the CBFB (16q22) gene in 96% of the cells examined.)"	34	TRUE	"CD2(-), CD4(partial dim +), CD7(-), CD11b (variably +), CD13(variably +), CD14(predominantly -), CD15(predominantly -/few scattered +), CD16(-), CD20(small subset +), CD33(partial +), CD34(variably +), CD36(small subset +), CD38(variably +), CD45(variably +), CD56(-), CD61 (-), CD64(-), (cont.above) (CD79a(small subset +), CD117(small subset +), HLA-DR(predominantly + and variable), TdT(+), MPO(-))"	TRUE	TRUE	5.8	9.4	FALSE	positive	0.234567901	negative				IDH1 (p.R132C; MAF unlisted)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	2.103605524	4.494181672	4.630331109	4.762863149	7.246478149	-1.613203891	3.872725884	no	yes	yes	yes	yes	no	no	-1.40826319	NA	4.871411248	NA	-3.390110983	-1.824599515	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.737139485
BA2229R	BA2229D	2240	Waves1+2	yes	yes	yes	yes	Female	Female			White	5			61	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Cyclophosphamide, Fludarabine, TBI|7+3 (Cytarabine, Idarubicin) plus Sorafenib"	2	Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Cyclophosphamide, Fludarabine, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	884	Alive	NA	40	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,del(5)(q31q33),der(21)(qter->q22::p11.2->qter),del(21)(q22)[19] "	NA	NA	"65% Loss 5q31; 14.5% Gain of 8 centromere, trisomy; Trisomy for 21q22  (40.5%), and trisomy for 8q22 and 21q22 (7.0%)"	26	TRUE	"positive CD13, CD34, dim CD45, CD117 and HLA-DR"	FALSE	FALSE	NA	4.8	FALSE	negative	0	negative				BCOR (p.1189_1192del; MAF 33.1%)|NRAS (p.G12D; MAF 10%)|SRSF2 (p.P95H; MAF 34.4%)		yes			yes	yes	Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.510748273	5.070596193	4.937870074	6.585715882	7.633935323	1.085955021	2.318122323	yes	yes	yes	yes	yes	yes	no	-1.955536108	NA	4.638015284	NA	-5.333991172	1.067938886	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.866567153
BA2559R	BA2559D	2329	Waves1+2	yes	yes	yes	yes	Female	Female			White	5			42	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	42	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"HiDAC|GCLAC (GCSF, Clofarabine & Cytarabine)|7+3 (Cytarabine, Idarubicin) plus Sorafenib|Fludarabine, Cyclophosphamide, TBI "	3	Induction|Re-induction|Double Umbilical Cord Blood Transplant (DUCBT)	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	878	Alive	NA	35	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XX[20]"	NA	NA	Normal	35	TRUE	"The immature cells were positive for CD13, CD33, and many showed aberrant expression of CD7. The myeloblast portion was positive for CD34, CD117, and HLA-DR.  The immature monocyte portion was negative for CD34 and CD117, and expressed variable CD64 (including some cells with bright CD64), CD11b, an"	TRUE	TRUE	NA	49.7	TRUE	positive	NA	negative				FLT3-ITD (MAF 34.8%)|RUNX1 (p.L29S; MAF 52.7%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	TRUE	2.952325074	4.842828655	6.043172961	3.601242914	6.512059957	0.10465675	6.576135588	yes	yes	yes	no	yes	yes	yes	4.287575485	NA	-0.49327106	NA	2.917025768	3.715132384	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.939331484
BA2093R	BA2093D	2343	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			51	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|SWOG S1203 (7+3 +/- Vorinostat)|Bu/Cy/TBI"	5	Consolidation|Salvage|Induction|Allogeneic - Mismatched Unrelated Donor|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Azacitidine	Salvage	62	Dead	628	Dead-Disease	0	90		0	0	85.8	1.9	8.5	0	25	25	3	0.93	M0	25.1	8.2	"60~61<3n>,XYY,-1,-2,-3,-4,-5,del(5)(q13q33),-6,-7,+8,-9,+11,-12,+13,-15,-16,-17,-18,+21,+22[cp15]/70~73,idem,+Y,+1,+2,+5,+del(5)(q13q33),+6,+9,+11,+12,+20,+20[cp4]/46,XY[1]"	634	81.8	"EGR-1/ D5S23, D5S721: 60/100 cells (60%) had a 1 red/ 2 green signal pattern, indicating a deleted 5q, consistent with the first clone, above; 38 cells (38%) had a 2 red/ 4 green signal pattern, consistent with two copies of the deleted 5q in the second clone."	77	TRUE	"partial CD7, CD13, dim partial CD22, CD33, CD3,  partial CD56, dim CD71, CD117, dim CD123, and dim HLA-DR "	TRUE	TRUE	6.5	0.5	FALSE	negative	0	negative			TP53 (p.X187_splice; 40.1%)|TP53 (p.X125_splice; 28.4%)	"NRAS (p.G13D; MAF ~40%)|TP53 (Splice site (3' splice site mutation, intron 5); MAF 42%)|TP53 (Splice site (5' splice site mutation in intron 4); MAF 44%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	2.009941064	1.568363935	-0.926284489	3.464121446	3.823409871	-1.485040412	0.438311265	no	no	no	no	no	no	no	-7.65978539	NA	5.589980015	NA	-5.377143181	-4.163737712	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.443610137
BA2000R	BA2000D	2304	Waves1+2	yes	yes	yes	yes	Female	Female			Asian	3	mono		24	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	24	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	6	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC|CLAG (Cladribine, Cytarabine, Filgrastim)|Azacitidine|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	5	Allogeneic - Sibling|Consolidation|Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	-1	Dead	633	Dead-Disease	NA	85		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"weak CD4, partial  CD7, partial CD11b, CD13, CD33, partial CD34, weak CD64,  CD117, MPO, and HLA-DR"	TRUE	TRUE	NA	NA	NA	positive	0.666666667	negative				CEBPA (p.Gln41fs; MAF 4%)|FLT3-ITD (p.Glu611_Phe612ins27; MAF 8%)|JAK3 (p.Gln865Glu; MAF 48.9%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	2.177847751	1.769172779	2.74304172	1.080685192	5.69915969	-2.067474047	6.57305438	no	no	yes	no	no	no	yes	-0.521355108	NA	-1.276772297	NA	3.10906774	2.988694749	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.476242237
BA2425R	BA2425D	2532	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			68	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|3+7 (Cytarabine, Daunorubicin)|MiDAC"	3	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	314	Dead-Disease	2.6		49	5.1	6.8	36.8	0.9	14.5	0.2	18	16	2.8	0.67		21.9	7.5	"43-45,XX,del(5)(q16q33),der(7)t(7;12)(q11.1;q12)ins(7;?)(q11.1;?),-12,der(21;22)(q10;q10),+mar[cp20]/46,XX[1] "	821	88.7		8	FALSE	"CD13, CD33, CD34, CD71, CD117, dimCD123, HLA-DR, and dim CD 64 positive (Peripheral Blood)"	TRUE	TRUE	7.2	11.01	FALSE	negative	0	negative			TP53 (p.L130Pfs*19; 33.3%)	TP53 (p.I254N; MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	3.473964059	4.612567835	2.140114298	4.706965601	6.353994761	1.245055059	5.434037796	yes	yes	no	yes	yes	yes	yes	0.914267851	NA	2.31995597	NA	1.57383205	-2.550124719	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.690668503
BA2905R	BA2905D	2019	Waves1+2	yes	yes	yes	no	Male	Male			White	5	N/A		77	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	77	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	3	AG-221|Azacitidine|Decitabine	3	Hypomethylating/Low Dose Cytarabine|Experimental|Maintenance			NA	Targeted Therapy - Other	AG-221	Experimental	-1	Dead	38	Dead-Disease	NA	70	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,+11[8]/46,XY[12]"	NA	NA	35% gain of 11q23	174	TRUE	"CD34, CD117, HLA-DR, CD13, and CD33. A subset of the myeloblasts showed aberrant co-expression of CD34 and myeloperoxidase.  A subset of the myeloblasts showed aberrant expression of CD56."	FALSE	TRUE	NA	33.1	TRUE	negative	0	negative				ASXL1 (p.G642fs; MAF 32.1%)|CEBPA (p.K90fs; MAF 39.1%)|EZH2 (p.F246fx; MAF 91.4%)|IDH2 (p.R140Q; MAF 49.2%)|RUNX1 (p.L29S; MAF 52.9%)|STAG2 (p.D884fs; MAF 89.8%)|TET2 (p.P1723S; MAF 48.4%)|TET2 (p.Y867H; MAF 50.3% )					no		Found	TRUE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	2.412118063	6.262496751	3.166388755	3.39561115	5.581951198	0.692902997	4.782928817	no	yes	yes	no	no	yes	yes	-1.575891286	0.666109664	3.135996091	3.066810485	-2.712378019	-3.960238957	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.622080612
BA2304R	BA2304D	2010	Waves1+2	yes	yes	yes	yes	Female	Female			White	3		MLLT3-KMT2A	52	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	52	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Fludarabine, Melphalan, ATG, Methotrexate"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Melphalan, ATG, Methotrexate"	Allogeneic - Matched Unrelated Donor	-1	Alive	804	Alive	NA	51		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XX,t(9;11)(p22;q23)[5]"	NA	NA	11q23 (MLL): rearrangement present (89.5%)	NA	NA	"The monocytic cells (percentages shown) are  atypical in that they express partial CD56 (about 50%  positive), but otherwise demonstrate phenotypically normal  expression of CD13, bright CD33, bright CD64, CD15, HLA-DR,  and partial myeloperoxidase (Flow cytometric analysis of the bone marrow aspirate  specimen indicates that 4% of the CD45 positive leukocytes  are lymphocytes, 89% are monocytic cells, and 7% are  myeloid cells.) | CD10, CD11b, CD13,  CD16, CD33, and CD64 (Myeloid (phenotypically normal))"	FALSE	TRUE	NA	NA	NA	negative	0	negative				KRAS (p.Gly13Asp; MAF 38.9%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	1.05672614	2.799233832	3.454052776	2.845540902	6.650696125	-0.730775878	4.95124374	no	no	yes	no	yes	yes	yes	5.702011227	NA	-5.825005588	NA	1.773899956	4.897482478	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.77260004
BA2976R	BA2976D	2494	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			85	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	85	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Maintenance			NA	Standard Chemotherapy	Azacitidine	Maintenance	232	Dead	80	Dead-Disease	0	36		0	8.7	20.2	27.2	20.2	1.6	24	23	3.4	0.88	M4	31.5	9.6	"46,XY,del(12)(p11.2p13)[20]"	200	95.7	"ETV6: 84% of cells were missing a signal for ETV6 (12p13), consistent with the deletion seen on metaphase analysis. "	46	FALSE	"CD34, CD117, dim CD123, CD33, dim HLA-DR, CD13, and CD58. (Blasts) | CD64, CD11b, CD33, CD15, dim HLA-DR, CD13, dim CD71, and CD58. (Monoblasts/promonocytes.)"	TRUE	TRUE	7	40.53	TRUE	negative	0	negative				NRAS (p.Q61R; MAF 30%)|U2AF1 (p.S34F ; MAF 50%)			yes		yes	yes	Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	4.515790051	5.991126785	4.417142448	4.135534194	6.903606205	1.740441011	7.137564015	yes	yes	yes	yes	yes	yes	yes	5.008779799	-0.137846828	1.937652888	-1.882640978	0.713619326	-0.492536071	Monocyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.809027947
BA2386R	BA2386D	2292	Waves1+2	yes	yes	yes	yes	Female	Female	Unknown		White	2			52	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	52	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	-1	Dead	633	Dead-Disease	0	83	48.6	0	NA	9.4	0.9	40.2	NA	21	47	3.3	0.55	M1	25.3	8.3	"46,XX[20]"	NA	NA	"nuc ish(D4Z1,D10Z1)x2[200],(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(ETV6,RUNX1)x2[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	48	TRUE	"CD2(-), CD4(dim +), CD7(-), CD11b(-), CD13(+ and dim +), CD14(-), CD15(+), CD16(-), CD25(-), CD33(slightly bright +), CD34(-), CD36(-), CD38(variably +), CD45(+), CD56(small subset +), CD64(-), CD117(dim and variably +), CD123(variably +), HLA-DR(+), TdT(-), MPO(+)."	TRUE	TRUE	6.6	22.1	TRUE	negative	0	positive				FLT3 (Foundation; A680V; MAF 6%)|FLT3 (Foundation; Y842C; MAF 2%)|KDM6A (Foundation; P738fs*2;MAF 31%)|NPM1 (Foundation; W288fs*10+; MAF 25%)|TET2 (Foundation; Q742*; MAF 45%)|TET2 (Foundation; R1712fs*6;MAF 44%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	4.292298686	5.321640442	3.567071468	3.060581114	5.151740137	-0.222304756	3.768072434	yes	yes	yes	no	no	yes	no	1.216639766	NA	-1.55178507	NA	2.757126699	-3.66610471	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.612757387
BA2879R	BA2879D	2292	Waves1+2	no	no	no	no	Female	Female	Unknown		White	2			52	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	53	462	Relapse	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	-1	Dead	633	Dead-Disease	NA	76	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA	"46,XX[20]"	NA	NA	"nuc ish(D4Z1,D10Z1)x2[200],(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(ETV6,RUNX1)x2[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	6.008008707	8.558132106	6.324521891	5.912828315	7.892577272	3.693921751	5.304224415	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.895169106
BA3400R	BA3400D	2292	Waves3+4	no	no	no	no	Female	Female	Unknown			2			52	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	54	616	Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	-1	Dead	633	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA	"46,XX[20]"	NA	NA	"nuc ish(D4Z1,D10Z1)x2[200],(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(ETV6,RUNX1)x2[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	NA	NA		NA	NA	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	5.478733315	4.919675605	1.035973365	5.747018905	5.724413092	0.502611742	3.731102732	yes	yes	no	yes	no	yes	no	NA	NA	NA	NA	NA	NA							0.598717371
BA2035R	BA2035D	2424	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	5	"Fludarabine, Melphalan|3+7 (Cytarabine, Daunorubicin)|MiDAC|Midostaurin|Hydroxyurea"	5	Allogeneic - Sibling|Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Maintenance	Complete Response	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Midostaurin	Maintenance	284	Alive	2182	Alive	0	92	98	0	0.8	2.6	0	0	0.1	35	23	3.2	0.86	M1	19.9	6.8		330	106.4	Normal	49	TRUE	"dim CD33, CD34, CD38, dim CD45, CD117, and MPO"	FALSE	TRUE	8	84.96	TRUE	positive	NA	negative				DNMT3A (p.R882H; MAF ~50%)|FLT3-ITD (MAF 40%)|IDH1 (p.R132S; MAF ~50%)|SRSF2 (p.P95L; MAF ~40% )		yes			yes		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.7723449	1.561191974	-0.097429914	3.281164924	3.024285183	-0.78853803	-0.871720723	no	no	no	no	no	yes	no	-10.70003585	NA	2.332643784	NA	-6.664483255	-5.34250764	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.209848184
BA2760R	BA2760D	2524	Waves1+2	yes	yes	yes	no	Female	Female			White	5			54	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	54	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin) plus Sorafenib"	1	Induction	Complete Response	Standard Chemotherapy	19	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin) plus Sorafenib"	Induction	19	Dead	36	Dead-Treatment	NA	75		NA	NA	NA	39	NA	NA	NA	NA	NA	NA		NA	NA	"50,XX,+8,+10,+12,+21[20]"	NA	NA	- Gain of chromosome 8 in 55% of cells - Gain of 8q22 (ETO) sequence in 77.8% of cells; 21q22 (AML1) gain in 12% and loss in 77.8% cells	9	TRUE	"CD11b, CD13, CD14 (subset), CD33, CD34 (subset), CD38, CD45, CD64 (subset), HLA-DR and MPO"	FALSE	TRUE	NA	37.2	TRUE	negative	0	negative	RUNX1 (p.D198N; 35.5%)			EZH2 (p.D146H; MAF 51.6%)|RUNX1 (p.D171N; MAF 19.8%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	6.852067908	6.777758501	5.073052837	4.184392873	6.043172961	-2.151569342	6.077366518	yes	yes	yes	yes	no	no	yes	4.981287132	NA	2.349886621	NA	-0.813194795	3.689063259	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.898955034
BA2201R	BA2201D	2291	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			68	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"HiDAC|3+7 (Cytarabine, Daunorubicin)|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	23	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Matched Unrelated Donor	-1	Dead	861	Dead-Other	0.9	86		0	0	2.6	20.8	0.9	0.2	20	28	2.9	1.49	M5	33	10.8	"46,XY[20]"	1211	95.9	Normal	83	TRUE	"Variable CD13, variable CD14, CD33, variable CD64, CD117, CD123, and partial HLA-DR positive"	FALSE	TRUE	7.2	134.36	TRUE	positive	NA	positive				FLT3-ITD (MAF 91%)|IKZF1 (p.Q156H; MAF 45%)|NPM1 (p.W288fs*; MAF 49%)|SF3B1 (p.K666Q; MAF 50%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	0.623156646	1.307417208	0.138726037	2.520079577	6.369828867	-0.697873876	4.802496495	no	no	no	no	yes	yes	yes	2.261934345	NA	-1.878053193	NA	2.940421905	2.085109255	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.606173375
BA2355R		2072	Waves1+2	yes	no	yes	no	Female	Female			White	5		KMT2A_re	83	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Squamous cell carcinoma|Lung Cancer	n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	83	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	n	n	y	n	n	1	Targeted Therapy - Other	1	AG-221	1	Experimental			NA	Targeted Therapy - Other	AG-221	Experimental	-1	Alive	112	Alive	NA	45		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,+8,-16,der(17)t(16;17)(p11.2;p11.1),del(19)(p13.3)[20]"	NA	NA	"FISH assays were positive for findings consistent with trisomy 8 in 79% to 90% of assayed cells, and positive for loss of 16q22 sequences in 91.5% of assayed cells."	133	TRUE	"positive for CD34, CD117, HLA-DR, and CD13, with aberrant loss of CD33, and with a subset of the blasts showing aberrant co-expression of CD34 and myeloperoxidase"	FALSE	TRUE	NA	2.2	FALSE	negative	0	negative				IDH1 (p.G105G; MAF 50%)|IDH2 (p.R140Q; MAF 37.8%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.11979904	5.012888439	4.935047944	7.08297551	6.938907739	2.71690838	6.613287827	yes	yes	yes	yes	yes	yes	yes	2.822275506	NA	1.041761181	NA	-1.224289416	-3.166469043	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.829584659
BA2113R	BA2113D	2088	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Induction	Unknown	Standard Chemotherapy	9	Standard Chemotherapy	Decitabine	Induction	9	Dead	25	Dead-Disease	1.8	41		0.9	0	79.6	0.9	14.2	0	21	19	2.7	0.98	M2	27.7	9.4	"45~46,XX,add(1)(q42),del(5)(q31q35),del(6)(q13),del(9)(q13q34),del(17)(p13),i(21)(q10)[cp12]/46~47,idem,+mar[cp6]/46,XX[2]"	404	88.5	"EGR1 (5q31): 73% of cells were missing a signal for EGR1 (5q31), consistent with the deletion seen on metaphase analysis.  TP53 (17p13.1): 71% of cells were missing a signal for TP53 (17p13.1), consistent with the deletion seen on metaphase analysis.  RUNX1 (21q22): 77% of cells had three signals fo"	6	FALSE	"CD13, dimCD33, CD34, CD38, CD58, partial CD64, CD117, CD123, and HLA-DR positive."	FALSE	TRUE	7.6	1.61	FALSE	negative	0	negative			TP53 (p.R248Q; 53.3%)	TP53 (p.R248Q; MAF 56%)|U2AF1 (p.Q157P; MAF 41%)			yes		yes	yes	Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	2.127913771	2.974501064	2.022587049	5.186215225	6.028194684	-2.335407551	4.002469856	no	no	no	yes	no	no	no	-1.211761424	NA	1.666611581	NA	-0.971983281	0.873854903	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.580979316
BA2155R	BA2155D	2402	Waves1+2	yes	yes	yes	yes	Female	Female	Unknown		White	2	bi		72	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	73	0	Relapse|Post-Chemotherapy	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine"	4	Hypomethylating/Low Dose Cytarabine|Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	-1	Supportive/Palliative Care	Azacitidine	Hypomethylating/Low Dose Cytarabine	112	Dead	565	Dead-Disease	0	81	94	0	NA	51	3	2	NA	11	16	4.5	0.99	M0	28.2	9.6	"46,XX,der(3)t(3;17)(q29;q21)[19]/46,XX,t(3;21)(q26.2;q22)[2]"	NA	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[199],(D7Z1, D7S522)x2[199],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200], (PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	10	FALSE	"CD2(-), CD4(-), CD7(partial +), CD11b(-), CD13(variably +), CD14(-), CD15(partial +), CD16(-), CD19 (-/few dim +), CD25(-), CD33(partial +), CD34(partial +), CD36(-), CD38(bright and variably +), CD45(+), CD56(variably +), CD64(-), CD117(variably +), CD123(-/few +), MPO(+), TdT(-/few dim +) (87% pop of med to large size cells) | HLA-DR(partial +)"	TRUE	TRUE	6.9	35	TRUE	negative	0	negative			TP53 (p.X187_splice; 30.4%)	CEBPA (Foundation; M1fs*60; MAF 34%)|CEBPA (Foundation; N307_V308insVETQQK; MAF 36%)|TP53 (Foundation; splice site 560-2insA; MAF 44%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	3.939719808	3.136004266	0.953128031	3.716958369	3.045215638	0.013944418	2.788235783	yes	no	no	no	no	yes	no	-6.405263395	NA	1.112427544	NA	-6.663663817	-3.539397903	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.458905233
BA2955R	BA2955D	2039	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			66	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	66	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	4	"3+7 (Cytarabine, Daunorubicin), Bortezomib|MiDAC|Fludarabine, Cytarabine|Ibrutinib"	4	Allogeneic - Sibling|Consolidation|Induction|Maintenance	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Ibrutinib	Maintenance	382	Alive	2175	Alive	0	60	52	0	0.9	29.8	54.4	1.8	0.5	23	19	2.5	0.84	M5	24.2	7.7	"47,XX,+6[6]/46,XX[19]"	453	104.8	"IGH/MAF: 74/100 cells (74%) had variant abnormal 0-1 red/ 1-4 green/ 2-7 yellow signal patterns reflecting IGH/MAF fusion. The majority of cells (56%) were 0 red/ 1 green/ 3 yellow. IGH: 68/100 (68%) cells scored had signal patterns consistent with IGH rearrangement and the 14;16 translocation,above | CDKN2C/CKS1B: 61/100 cells (61%) had 3-6 CKS1B (1q21) signals and 2 CDKN2C signals, reflecting gain of 1q. | The IGH/CCND1 and IGH/FGFR3 probe sets had extra IGH signals reflecting IGH involvement in the 14;16 "	92	TRUE	"dimCD4, CD11b, CD13, dimCD14, CD33, CD56, CD58, CD64, dimCD123 and HLA-DR positive; Minor subset of blasts with immunophenotype: CD13, CD33, CD34, CD58, CD117, dimCD123, HLA-DR and MPO positive."	FALSE	TRUE	7.4	14.94	FALSE	positive	NA	negative	RUNX1 (p.P240Qfs*22; 40.0%)			"BCOR (p.G1659E MAF ~10%,)|FLT3-ITD (MAF 38%)|NRAS (p.Q61R MAF ~5%)|RUNX1 (p.P240fs*22; MAF 37%)|RUNX1 (splice site [at invariant AG (G>A) splice acceptor site at end of Intron 6];  MAF 36% ))"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	TRUE	4.528023663	2.374829896	5.331375564	5.135490459	6.512059957	-2.767649574	2.702852354	yes	no	yes	yes	yes	no	no	2.110182751	-5.916901625	1.180309389	-3.410645241	-4.887419751	7.387507878	Monocyte_Like	Not_GMP_Like	HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.733367642
BA2502R	BA2502D	2328	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			50	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	50	0	Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Other	6	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|HAM (Cytarabine, Mitoxantrone)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Hydroxyurea"	5	Hypomethylating/Low Dose Cytarabine|Consolidation|Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Other	Hydroxyurea	Hypomethylating/Low Dose Cytarabine	365	Dead	302	Dead-Disease	0			0	2.6	8.8	17.6	2.6	0	NA	NA	NA	NA	M0	19.8	6.4	"48,XX,+11,+13[19]"	NA	93.4		31	TRUE		NA	NA	NA	206.64	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.607750351	1.80374794	4.566932164	1.295814481	6.180313632	-0.432864196	5.193067466	no	no	yes	no	yes	yes	yes	1.206446027	NA	-0.038365429	NA	2.945462361	6.180541206	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.665676716
BA2322R	BA2322D	2060	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	35	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	35	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	10	Standard Chemotherapy	HiDAC	Consolidation	112	Alive	1937	Alive	1.7	42		0.9	0	40	18.3	7.8	0.2	54	23	3.5	0.6	M2	20.3	6.8	"46,XX,inv(16)(p13.3q22)[21]"	319	102.5	"CBFB: æ83/100 cells (83%) had the abnormal 1 red/ 1 green/1 yellow signal  pattern, reflecting CBFB rearrangement and consistent with the inverted  chromosome 16 in the metaphase karyotype."	63	FALSE	"Partial CD2, CD33, CD34, CD38, CD117, CD123, partial HLA-DR, dim MPO and partial TdT positive."	FALSE	TRUE	6.7	12.78	FALSE	negative	0	negative				NRAS (p.Q61P; MAF 15% )					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.569227321	3.251004266	-0.877389165	4.648394391	6.330464962	-2.058224827	6.607923835	no	no	no	yes	yes	no	yes	2.609770543	NA	2.126338195	NA	-0.130795208	2.725239174	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.680658121
BA2020R	BA2020D	2065	Waves1+2	yes	yes	yes	no	Male	Male			HispNative	3			51	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Allogeneic - Sibling|Consolidation|Induction	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	-1	Alive	762	Alive	NA	78.5	71	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA	"CD13, partial CD15, CD33, CD117,  myeloperoxidase, and partial HLA-DR (\atypical cells with dim CD45\\ - 45% of leukocytes) | CD13,  bright CD33, and bright CD64 (Monocytic (19% of leukocytes)) | CD13, CD33, and CD64, with  a left shift (increased percentage that lack CD10, CD11b,  and CD16) (Myeloid (19% of leukocytes))\"""""	FALSE	TRUE	NA	12	FALSE	positive	NA	positive				FLT3-ITD (c.1775_1816dup; MAF 3%)|IDH2 (R140Q; MAF 42.3%)|NPM1 (c.860_863dup; MAF 14.5%)|PTPN11 (c.1507G>A; MAF 4%)|PTPN11 (c.1508G>A; MAF 15.4%)					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	0.128934221	0.891711786	-0.370236433	3.031621114	5.716289484	-2.590271627	3.367191354	no	no	no	no	no	no	no	-2.520111191	NA	-1.135505943	NA	-0.344948543	-2.363234673	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.382654818
BA2226R	BA2226D	2014	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			53	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	SWOG S1203 (7+3 +/- Vorinostat)	1	Induction	Complete Response	Standard Chemotherapy	153	Standard Chemotherapy	SWOG S1203 (7+3 +/- Vorinostat)	Induction	153	Alive	1833	Alive	0	93	80	0	1.7	19.3	20.2	13.2	0.6	47	37	3.1	0.79	M5	26.8	8.8	"46,XX[20]"	977	92.1	Normal	36	FALSE	"Blast immunophenotype: partial CD11b, CD13, CD33, CD38, CD58, partial CD64, partial CD117 and a subset with MPO - Blast/promonocyte immunophenotype: CD11b, CD13, partial CD14, CD15, CD33, CD38, CD58 and CD64"	FALSE	TRUE	6	42.34	TRUE	negative	0	positive				FLT3-D835 (p.D835Y; MAF: 40%)|NPM1 (p.W288fs*12; MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.875020429	3.280126954	2.359977024	3.747592183	6.660673206	-0.43050765	7.799569219	no	no	no	no	yes	yes	yes	4.158643529	NA	-2.165475187	NA	2.199999759	0.088691635	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.646223759
BA2376R	BA2376D	2513	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Alive	1891	Alive	0.4	68		0.1	3	17	62.6	16.9	0.1	29	17	3.7	1.51	M5	27.7	8.9	"46,XY[20]"	296	104.9	Normal	74	TRUE	"dim CD4, CD11b, partial CD14, CD15, dim CD33, CD38, CD56, CD58, CD64 and HLA-DR positive"	FALSE	TRUE	8	16.84	FALSE	negative	0	positive				DNMT3A (p.S714C; MAF 35%)|NPM1 (p.W288fs*12; MAF 40%)|NRAS (p.G13V; MAF 6%)|PTPN11 (p.A72V; MAF 10%)|TET2 (p.Q876*; MAF 6%)					no		Found	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	1.397328316	2.08727892	3.239117622	4.203319895	6.67058413	-2.104319609	4.359065242	no	no	yes	yes	yes	no	no	5.916343439	NA	-4.364026962	NA	2.099524276	4.472874761	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.721662075
BA2200R	BA2200D	2371	Waves1+2	yes	yes	yes	yes	Male	Male			White	3			59	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	59	0	Relapse|Post-Chemotherapy	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"Azacitidine, Sorafenib|5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Azacitidine, Sorafenib"	Re-induction	-1	Dead	256	Dead-Disease	NA	93.2	47.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,t(3;4)(p21;q25)[3]/46,XY[17]"	NA	NA		NA	NA	"CD4, CD7, CD11b, CD13,  CD33, partial CD34, CD117, HLA-DR, partial weak TdT and  partial CD64"	TRUE	TRUE	NA	42.91	TRUE	positive	NA	positive				DNMT3A (c.2251T>C; MAF 36.9% (33.1% on 3/13/15))|FLT3-ITD (c.1759_1800dup; MAF 24% (39% on 3/13/15))|NPM1 (c.860_863dup; MAF 9.9% (24% on 3/13/15))					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.174073432	3.418072141	4.318511396	1.569304273	5.901576141	-0.741570412	2.118428903	no	no	yes	no	no	yes	no	-1.043459856	NA	2.130161181	NA	-2.600358207	-1.233548141	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.425318321
BA2121R	BA2121D	2356	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1		RUNX1-RUNX1T1	36	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	36	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"HiDAC|3+7 (Cytarabine, Daunorubicin)|Hydroxyurea"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	103	Alive	552	Alive	0	25	38	0	3.4	29.1	2.6	23.9	0	32	39	2.3	0.7	M2	21	7.5	"45,X,-Y,t(8;2;21)(q22;p21;q22)[20]"	NA	104.5	RUNX1T1/RUNX1: (92%)	29	FALSE	"CD13, CD33, partial CD34, CD64, CD19 dim, CD71, CD117 partial, HLA-DR, dim CD123, CD58 and MPO"	TRUE	TRUE	6.7	24.98	TRUE	negative	0	negative				CBL (p.E369_Y371delinsH; MAF 31%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	2.541549483	4.700314162	3.287993363	4.257193785	6.646840272	0.471360863	8.070649986	no	yes	yes	yes	yes	yes	yes	1.19217724	NA	-2.937995168	NA	2.353526245	-0.847025771	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.566436266
BA2944R	BA2944D	2577	Waves1+2	yes	yes	yes	yes	Male	Male			White	3		RUNX1-RUNX1T1	23	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	23	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"7+3 (Cytarabine, Idarubicin)|Busulfan, Fludarabine, Cyclophosphamide, Thymoglobulin (Bu/Flu/Cy/ATG)"	2	Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine, Cyclophosphamide, Thymoglobulin (Bu/Flu/Cy/ATG)"	Allogeneic - Matched Unrelated Donor	-1	Alive	747	Alive	NA	88		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA	"46,XY,add(6)(q23),del(7)(q33),t(8;21)(q22;q22)[2]/46,sl,add(17)(p11.1)[5]/46,sdl1,add(16)(p11.2)[2]/46,sdl2,add(3)(q21)[8]/46,sdl3,add(20)(q11.2)[3]"	NA	NA	62% t(8;21) (RUNX1T1;RUNX1) translocation present	NA	NA	"CD13, CD33, CD34, CD38, CD117, HLA-DR, cMPO, CD19 and partial CD56"	FALSE	TRUE	NA	NA	NA	negative	0	negative				BRCA2 (c.6275_6276delTT; MAF unlisted)|BRCA2 (c.6859A>T; MAF unlisted)|FLT3-ITD (MAF unlisted)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	2.42106071	0.891711786	-1.583657597	4.328596221	5.961806565	-4.162213222	1.468121529	no	no	no	yes	no	no	no	-7.327313269	2.529469057	-0.931367186	2.539405541	-4.773562625	0.212114867	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.393593678
BA2033R	BA2033D	2432	Waves1+2	yes	yes	yes	yes	Male	Male			White	5			71	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Non-Hodgkins Lymphoma	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	71	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	Lenalidomide|Decitabine	2	Hypomethylating/Low Dose Cytarabine|Supportive/Palliative Care			NA	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	-1	Dead	11	Dead-Disease	NA	60	14	NA	NA	NA	7	NA	NA	NA	NA	NA	NA		NA	NA	"45,XY,add(3)(p10),add(5)(q11.2),psu dic(9;?;6)(6qter- > 6p22::?::9p22- > 9qter)[1]/44,sl,-add(3)(p10), +der(3;13)(q10;q10)[2]/48,sdl1,+8,+14,+21,+22[8]/42-44,sl,-add(3)(p10),add(4)(p15),-7,-8, add(12)(p11.2),+mar,+1-2r[cp7]/80-82 < 4n > ,slx2,-2,add(4)(q22)x2,-6,+8,+8,add(8)(p23)x2, (dic(8;11)(p12;p11.2)x2,-psu dic(9;?;6)(6qter- > 6p22::?::9p22- > 9qter),-10,der(10;17)(q10;q10), der(12;13)(p10;q10),der(14;17)(q10;q10),-16,-17,-18,add(20)(p11.2)[cp4])"	NA	NA	"FISH assays were positive for loss of 5q31 sequences in 85.5% of cells, positive for findings consistent with trisomy 8 in 49% of cells, and positive for findings consistent with monosomy 7 in around 8% of cells."	17	FALSE	"Flow cytometry was negative for increased myeloblasts. The flow showed a mild increase in   immature monocytic cells, but not to the degree seen in the marrow smears. This is likely   attributable to hemodilution of the sample received for flow cytometry. (Aberrant CD56, unusually dim CD38 - but only 3-4% assayed cells are myeloblasts)"	FALSE	FALSE	NA	21.6	TRUE	negative	0	negative			TP53 (p.P151H; 97.9%)	TET2 (p.G355D; MAF 33.8%)|TP53 (p.P19H; MAF 8.9%)					no		Found	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	4.225970129	6.894419142	6.077366518	6.100634402	7.151585592	3.901365441	6.489028524	yes	yes	yes	yes	yes	yes	yes	4.470009372	NA	-0.622870913	NA	6.097745912	1.326224279	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.996228436
BA2867R	BA2867D	2116	Waves1+2	yes	yes	yes	yes	Male	Male		NON-HISPANIC	White	2	mono		78	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	78	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Decitabine	Hypomethylating/Low Dose Cytarabine	-1	Dead	347	Dead-Disease	0.2	25	4	1	NA	25	10	60	NA	22	21	4.5	0.82		47.3	15.3	"46,XY[20]"	NA	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[199],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	15	TRUE	"CD2(-), CD7 (-), CD10(-), CD11b(-), CD13(dim +), CD14(-), CD15(+), CD16(-), CD19(-), CD22(partial +), CD33(-), CD34(bright +), CD36 (-), CD38(variably +), CD45(partial dim +), CD56(-), CD64(-), CD117(partial +), HLA-DR(partial +), MPO(-) and TdT(+) (Population #1 - 5.3%) | CD2(-), CD7(-), CD10 (-), CD11b(-), CD13(bright and variably +), CD14(-), CD15(-), CD16(-), CD22(-), CD33(partial +), CD34 (variably +), CD36(-), CD38(variably +), CD45(+), CD56(-), CD64(-), CD117(+), HLA-DR(partial +), MPO(partial +), and TdT (-). (Population #2 - 25%)"	TRUE	TRUE	7.5	5.79	FALSE	negative	0	negative	RUNX1 (p.P383Afs*217; 46.0%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	4.956785554	6.324087414	5.034672768	5.314673653	6.21316864	-0.030114731	4.904637332	yes	yes	yes	yes	yes	yes	yes	2.308357172	1.267047072	3.097874916	0.01980397	0.164500346	-0.049348819	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.715949775
BA2089R	BA2089D	2080	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			68	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	68	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	1	Standard Chemotherapy	2	"3+7 (Cytarabine, Daunorubicin)|Azacitidine"	2	Induction|Maintenance	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	7	Dead	122	Dead-Unknown	0		83	0	0.8	8.1	9.8	1.6	0.7	29	137	3.3	2.67	M5	35.5	11.4	"46,XY[20]"	3615	92.4	normal	104	TRUE		NA	NA	6.4	140.18	TRUE	negative	0	negative		ASXL1 (p.G645Wfs*12; 60.0%)		ASXL1 (p.G645fs*12; MAF 52%)|IDH1 (p.R132L; MAF 47%)|KRAS (p.G12A; MAF 36%)|MLL (Partial tandem duplication )|SRSF2 (p.P95H; MAF 49%)		yes			yes	yes	Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.543050372	2.197478723	2.638243536	3.05091544	6.230337807	-3.763766929	7.020524979	no	no	no	no	yes	no	yes	4.707018494	NA	-3.063562472	NA	1.284572185	-1.511531495	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.688649056
BA2034R	BA2034D	2080	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			68	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	68	72	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"3+7 (Cytarabine, Daunorubicin)|Azacitidine"	2	Induction|Maintenance	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	7	Dead	122	Dead-Unknown	0.8			0.9	0	9.3	0	0	0.5	12	14	2.5	0.9	M5	20.6	6.4	"46,XY[19]"	NA	90.4	normal	60	TRUE		NA	NA	6.3	6.21	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.971297835	1.639500738	1.058193018	4.480445281	2.439612557	-1.250448121	0.912935473	no	no	no	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.368645109
BA2224R	BA2224D	2202	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			62	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	Decitabine|Hydroxyurea	2	Induction|Re-induction	Complete Response i	Standard Chemotherapy	-1	Standard Chemotherapy	Hydroxyurea	Re-induction	263	Dead	424	Dead-Disease	0	21	2.5	1.7	0	68.3	1.7	25	0	22	9	3.2	0.81	M2	20.6	6.8	"46,XY,del(5)(q22q35),del(12)(q24.1q24.1),add(17)(p11.2)[19]/46,XY[1]"	NA	100.5	EGR1 (73.5%) ;  TP53: (85.5%)	174	TRUE	"CD7, CD34, CD117, HLA-DR, CD13, CD33, dim CD123, variable CD15 and subset MPO"	TRUE	TRUE	5.8	3.74	FALSE	negative	0	negative			TP53 (p.G266V; 65.7%)	JAK2 (p.V617F; MAF 1.5%)|SF3B1 (p.G742D; MAF 35%)|TP53 (p.G266V; MAF 55%)	yes				yes	yes	Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	5.060341068	6.274267782	3.12161169	7.243011976	6.38934322	-0.845075814	5.311827986	yes	yes	yes	yes	yes	yes	yes	0.876722234	NA	3.540809843	NA	0.961049215	-0.21318495	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.622442946
BA2470R	BA2470D	2202	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			62	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	412	Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	Decitabine|Hydroxyurea	2	Induction|Re-induction	Complete Response i	Standard Chemotherapy	-1	Standard Chemotherapy	Hydroxyurea	Re-induction	263	Dead	424	Dead-Disease	0.9			0	0	7.8	1.7	4.3	0.1	18	21	2.8	1.43	M2	25	8.2	"46,XY,del(5)(q22q35),del(12)(q24.1q24.1),add(17)(p11.2)[19]/46,XY[1]"	564	102.5	EGR1 (73.5%) ;  TP53: (85.5%)	139	TRUE		NA	NA	6.6	46.79	TRUE	negative	0	negative			TP53 (p.G266V; 91.4%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	5.533871004	5.096709014	1.106864199	2.542878314	4.752010161	-1.689535676	4.045934855	yes	yes	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.52420226
BA2046R	BA2046D	2265	Waves1+2	yes	yes	yes	no	Male	Male			White	2			61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Induction|Re-induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Re-induction	-1	Alive	496	Alive	0	45	48	2	NA	69	4	2	NA	12	15	3.8	NA		22.7	7.6	"46,XY[19]"	NA	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[199]"	27	FALSE	"CD2(-), CD4(-), CD7(subset +), CD11b(-), CD13(+), CD14(-), CD15(partial dim +), CD16(-), CD33(-), CD34(+), CD36(-), CD38(variably +), CD45(moderately +), CD56(-), CD64(-), CD117(+), HLA-DR(+)."	TRUE	TRUE	6.8	1.39	FALSE	negative	0	negative	RUNX1 (N260fs*223+; MAF 26%)			IDH1 (R132C; MAF 42%)|NF1 (N935H; MAF 49%)|RUNX1 (N260fs*223+; MAF 26%)|SRSF2 (P95L; MAF 38%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	1.746092473	3.653113355	0.500949085	5.806944625	5.574126984	-1.199077939	0.92389842	no	yes	no	yes	no	no	no	-3.778303224	NA	3.97251478	NA	-6.116142675	-0.207723898	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.482140548
BA2972R	BA2972D	2111	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	bi		40	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	40	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"HiDAC|3+7 (Cytarabine, Daunorubicin)|Treo/Flu/TBI (Treosulfan, Fludarabine, Total Body Irradiation)"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Treo/Flu/TBI (Treosulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Matched Unrelated Donor	-1	Alive	2163	Alive	0	80	27.8	0	0	62.6	4.4	5.2	0	26	22	3.9	0.78	M1	37.6	13.2	"46,XY[20]"	NA	91.7	normal	66	FALSE	"dim CD7, CD13, CD33, CD34, CD38, partial CD56 (25%), CD58, dim CD64, CD117, dim CD123, HLA-DR, and MPO+."	TRUE	TRUE	7.4	2.68	FALSE	negative	0	negative				CEBPA (p.K313_V314insK; MAF 39%)|CEBPA (p.S28fs*81; MAF 28%)|ZRSR2 (p.R378W; VAF 100%)				yes	yes		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	3.618031116	3.11268959	-0.161688881	4.651209228	4.591168879	-1.801268356	4.441539749	yes	no	no	yes	no	no	yes	-3.360216928	-0.838891885	-0.361880402	2.905323374	-2.543591043	1.441814727	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.508458302
BA2978R	BA2978D	2411	Waves1+2	yes	yes	yes	yes	Female	Female	Declined	HISPANIC	HispNative	1		RUNX1-RUNX1T1	14	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	14	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	DLI|Standard Chemotherapy|Bone Marrow Transplant	8	"Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)|COG-AAML1031 (IT/IV Cytarabine, Daunorubicin, Etoposide, Mitoxantrone +/- Bortezomib or Sorafenib)|Donor Lymphocyte Infusion|HiDAC|Azacitidine|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Busulfan, Cyclophosphamide|Clofarabine, Cytarabine"	4	Allogeneic - Sibling|Salvage|Induction|Re-induction	Complete Response	Standard Chemotherapy	189	Bone Marrow Transplant	Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)	Allogeneic - Sibling	-1	Alive	2083	Alive	NA	18		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"46,XX,t(8;21)(q21.3;q22)[17]/49,sl,+4,+15,+der(21)t(8;21)[2]/53,sdl,-4,+13,+18,+19,+20,+21[4]"	NA	NA	"All twenty-three metaphase cells examined were abnormal, with t(8;21), leading to RUNX1/RUNX1T1 fusion.   Two subclones, comprising 6 cells total, had an additional copy of the der(21)."	NA	NA	"CD13, CD33, CD34, CD38, CD56, CD58, dim/partial CD64, CD117, CD123, HLA-DR and MPO"	FALSE	TRUE	NA	NA	NA	negative	0	negative				FBXW7 (p.G79S; MAF 50%)|KIT (p.D816Y; MAF 45%)|NRAS (p.G12D; MAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	6.758313238	7.224594469	4.096766246	2.152706008	6.755974895	-0.77780812	7.798009391	yes	yes	yes	no	yes	yes	yes	5.221163516	5.028254437	-3.319571973	-5.657111111	2.986865652	0.442343061	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.674198966
BA2829R	BA2829D	2238	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			53	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	54	7	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	4	"HAM (Cytarabine, Mitoxantrone)|3+7 (Cytarabine, Daunorubicin)|Sorafenib|Hydroxyurea"	4	Induction|Experimental|Re-induction|Maintenance	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	49	Dead	168	Dead-Disease	0	9		1.7	0.9	6.1	8.8	43	0.4	38	29	3.4	0.71		27	9.1	"46,XY,add(3)(p24)[cp4]/46,XY[14]"	321	95.1	normal	170	TRUE	"CD117 (Initial diagnosis on 7/27/2015 BMBX: CD7, dim CD11b, CD13, CD33, partial CD34, CD58, CD117, CD123, dim MPO, and HLA-DR positive)"	TRUE	TRUE	6.7	16.65	FALSE	positive	NA	positive				CBL (p.I423N; MAF <0.5%)|DNMT3A (p.R882C; MAF 0.9%)|FLT3-ITD (MAF 2.9)|NPM1 (p.W288fs*12; MAF 0.7%)|TET2 (p.Q548*; MAF 0.7%)					no		Found	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	2.746624681	4.95229889	5.938987264	4.706267864	6.388882735	-0.03677844	1.956829098	no	yes	yes	yes	yes	yes	no	2.316501192	NA	0.949584572	NA	-1.563028657	0.628882187	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.558915134
BA2579R	BA2579D	2238	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			53	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	54	30	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	4	"HAM (Cytarabine, Mitoxantrone)|3+7 (Cytarabine, Daunorubicin)|Sorafenib|Hydroxyurea"	4	Induction|Experimental|Re-induction|Maintenance	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	49	Dead	168	Dead-Disease	0	8	1	4.7	0.9	40.6	10.4	43.4	0	40	34	3.8	0.73		20.2	7.1	"46,XY[12]"	235	93.5	normal	17	TRUE	"dim variable CD7, dim CD11b, CD13, CD33, CD34, CD58, CD117, and CD123"	TRUE	TRUE	6.8	1.06	FALSE	positive	NA	positive				"DNMT3A (p.R882C; MAF 6%)|FLT3-ITD (MAF 15-20%)|NPM1 (p.W288fs*12; MAF 6%)|TET2 (p.Q548*, MAF 6%)"					no		Found	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	5.87015045	6.655181197	2.739936638	9.650488945	7.06956103	-4.042783597	2.127913771	yes	yes	yes	yes	yes	no	no	NA	NA	NA	NA	NA	NA							0.752382028
BA2249R	BA2249D	2238	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			53	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	54	63	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	4	"HAM (Cytarabine, Mitoxantrone)|3+7 (Cytarabine, Daunorubicin)|Sorafenib|Hydroxyurea"	4	Induction|Experimental|Re-induction|Maintenance	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	49	Dead	168	Dead-Disease	1.8	48		3.6	6.2	23.2	18.7	17	1.3	29	41	3.6	1		20.9	6.9	"46,XY,t(7;17)(q22;q21)[3]/46,XY,t(2;4)(q33;q25),del(9)(q2?1;q3?2),add(17)(q21)[cp3]/46,XY,t(1;2)(q31;p25),inv(9)(q3?1q34)[2]/46,XY,t(13;14)(q14;q32)[cp2]/46,XY,add(3)(p24)[1]/46,XY[3]"	NA	96.3	normal	21	FALSE	"dimCD7, CD13, dimCD11b, CD33, variable CD34, CD58,  CD117, CD123, and HLA-DR positive"	TRUE	TRUE	6.8	20.77	FALSE	positive	9	positive				DNMT3A (p.R882C; MAF 45%)|FLT3-D835 (p.D835H; MAF 15%)|FLT3-ITD (MAF 78%)|NPM1 (p.W288fs*12; MAF 40%)|TET2 (p.Q548*; MAF 45%)					no		Found	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	2.292743766	2.27522744	5.87456316	4.736573817	6.084907283	-1.960119646	0.142551159	no	no	yes	yes	yes	no	no	NA	NA	NA	NA	NA	NA							0.624850429
BA2851R	BA2851D	2437	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			53	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	4	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Re-induction	7	Dead	128	Dead-Disease	0	45	50	0	19.4	6.4	1.6	11.3	0	73	83	3.3	0.88	M2	29.4	9.6	"46,XX[20]"	2008	109.3	Normal	33	TRUE	"partial CD7, CD13, CD33, CD34, variable CD38, CD117, CD123, partial HLA-DR and dim MPO"	TRUE	TRUE	6.8	137.54	TRUE	negative	0	negative				DNMT3A (p.R882H; MAF 45%)|FLT3-D835 (p.D835Y; MAF 3%)|MLL (Partial Tandem Duplication)|NRAS (p.G13D; MAF 35%)|NRAS (p.Q61R; MAF 3%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.301832464	2.920225731	0.316215163	3.350737912	5.42783553	-1.485040412	5.594015376	no	no	no	no	no	no	yes	-1.261397559	1.860433172	2.686023142	1.916894608	2.037289171	-0.403450812	Not_Monoctyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.468826741
BA2587R	BA2587D	2215	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1		CBFB-MYH11	64	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Esophageal Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	64	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	6	"Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)|7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MiDAC|Hydroxyurea|Cytarabine, Methotrexate"	5	Consolidation|Induction|Allogeneic - Child|CNS|Re-induction	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)	Allogeneic - Child	-1	Dead	629	Dead-Disease	0.9	90	60	4.3	0.9	9.6	44.3	13.9	0.1	31	45	2.6	0.79	M5	22.7	7.7	"46,XY,inv(16)(p13q22)[20]"	1151	93.8	CBFB (77%)	10	FALSE	"dim CD2, variable CD5, CD13, CD33, CD34, CD38, variable CD64, CD117, dim CD123, HLA-DR, and MPO (Blast immunophenotype) | dim CD4, CD11b, CD14, dim CD15, CD33, dim CD34, CD38, CD64, dim HLA-DR, and bright MPO (Monocytic/blast equivalent immunophenotype)"	FALSE	TRUE	5.5	24.64	TRUE	negative	0	negative				KIT (p.D816V; MAF 45% )					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.20914253	1.723828981	-0.618039918	4.005798942	6.29737759	-2.289783142	7.334352865	no	no	no	yes	yes	no	yes	3.798168091	NA	0.570779156	NA	0.461457361	2.968368402	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.647627603
BA2461R	BA2461D	2025	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			66	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	66	0	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|MiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Dead	231	Dead-Disease	0.8	0	0	0	2	18.6	9.3	69.3	0	NA	NA	NA	NA		32.1	10.2	"46,XY[20]"	NA	94.7	Normal	345	TRUE	The analysis was performed by flow cytometry on the bone marrow aspiratespecimen. The analysis shows CD34+ blasts account for 1% of CD45+ events. Maturing myeloid precursors and monocytic cells demonstrate a normal pattern of myelomonocytic antigen expression. | Lymphocytes account for 5% of CD45+ events and include 90% T cells and 7% NK cells. T cells demonstrate a CD4:CD8 ratio of 2.4:1 without aberrant antigen expression. B cells are essentially absent; no definitive monoclonal B cell population is identified	FALSE	FALSE	NA	8.94	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.177532604	7.128890623	5.179123533	7.235565982	7.34370808	0.943216526	6.896449932	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.856114285
BA2024R	BA2024D	2122	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			48	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	48	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"ADE (Cytarabine, Daunorubicin & Etoposide)"	1	Induction	Unknown	Standard Chemotherapy	7	Standard Chemotherapy	"ADE (Cytarabine, Daunorubicin & Etoposide)"	Induction	7	Dead	33	Dead-Disease	0.2	13		0	0.5	10.2	4.4	84.7	0	84	28	3.9	0.95		42.1	14	"46,XY[20]"	231	89.2	Normal	330	TRUE	"CD33, CD117 positive, negative for CD34 and HLA-DR"	FALSE	TRUE	8.2	6.3	FALSE	positive	NA	positive				FLT3-ITD (MAF 33%)|IDH2 (p.R140Q; MAF 40%)|NPM1 (p.W288fs*12; MAF 40%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	7.384595872	9.141008059	5.892417064	5.821912698	8.016169321	1.943401745	7.082279016	yes	yes	yes	yes	yes	yes	yes	6.378099384	NA	-3.415996044	NA	2.429899091	-3.13413087	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.779519797
BA2623R	BA2623D	2049	Waves1+2	yes	yes	yes	yes	Male	Male			White	3		CBFB-MYH11	72	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	72	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	2	Azacitidine|Momelotinib	2	Hypomethylating/Low Dose Cytarabine|Experimental			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	-1	Dead	188	Dead-Disease	NA		58	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,inv(16)(p13.1q22)[20]"	NA	NA		NA	NA		NA	NA	NA	8.21	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.791888684	2.241964451	1.69860807	2.324649572	6.022866999	-1.554571834	3.127144377	no	no	no	no	no	no	no	1.212501693	NA	2.314533959	NA	-1.378005409	-0.205531691	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.558300065
BA2426R	BA2426D	2511	Waves1+2	yes	yes	yes	no	Male	Male			White	5		CBFB-MYH11	62	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Non-Hodgkins Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Alive	26	Alive	NA	50	20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,inv(16)(p13.1q22)[20]"	NA	NA	positive for rearrangement of CBFB in 60.5% of cells.	32	FALSE	"positive for CD13, CD33, HLA-DR, CD34, and CD117, with partial aberrant expression of CD7. (Peripheral blood) | positive for CD34, CD117, HLA-DR, CD13, and CD33 (Marrow)"	TRUE	TRUE	NA	52.8	TRUE	negative	0	negative				EZH2 (p.D146H; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.051615298	1.575369363	2.376965905	3.419127662	5.879656655	-2.32040487	5.384709273	no	no	no	no	no	no	yes	1.781067398	NA	1.352724454	NA	-0.521510332	5.827342631	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.689177016
BA2271R	BA2271D	2386	Waves1+2	yes	yes	yes	yes	Male	Male	White	HISPANIC	HispNative	1			8	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid leukaemia associated with Down syndrome	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid leukaemia associated with Down syndrome	8	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	2	"ADE (Cytarabine, Daunorubicin & Etoposide)|Cytarabine"	2	Induction|CNS	Complete Response	Standard Chemotherapy	151	Intrathecal	Cytarabine	CNS	151	Alive	1957	Alive	10.8	70		0	1.8	8.1	13.5	8.1	0	13	25	3.2	0.72	M1	26.8	9.3	"47,XY,+21c[20]"	NA	90.5	RUNX1 (21q22): 89% of cells had three signals for RUNX1 (21q22) consistent with the three copies of chromosome 21 seen on metaphase analysis.	40	TRUE	"dim CD11b, variable CD13, dim variable CD14, CD15, CD38, CD58, dim CD64, and MPO"	FALSE	FALSE	8.2	67.53	TRUE	negative	0	positive				NPM1 (p.W288fs*12; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	3.153795923	3.150065299	0.846900161	4.313658527	6.016643958	0.229044512	7.019839091	yes	no	no	yes	no	yes	yes	4.518741428	NA	-4.504832871	NA	5.063859266	-3.923198937	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.697811345
BA3004R	BA3004D	2420	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			76	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	76	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"5+2 (Cytarabine, Idarubicin)|Decitabine"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	8	Standard Chemotherapy	"5+2 (Cytarabine, Idarubicin)"	Re-induction	4	Dead	26	Dead-Disease	0	95	54	0	0.9	16.8	3.5	24.8	1.1	23	22	3.5	1.33	M1	31.5	10.3	"46,XX[22]"	244	92.6	Normal	29	FALSE	"dimCD13, CD33, CD45, CD56, dimCD117 and MPO positive"	FALSE	TRUE	7	27.17	TRUE	positive	NA	positive				ASXL1 (p.G966delG; MAF 50%)|DNMT3A (p.R736H; MAF 45%)|FLT3-ITD (MAF 20%)|NPM1 (p.W288fs*12; MAF 35%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.761844554	5.344339074	2.989978183	6.116335963	5.717556877	-1.789188955	2.712388767	no	yes	yes	yes	no	no	no	0.05321771	-0.213492632	-0.436267001	0.892649054	-1.184578425	-3.764424673	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.53342152
BA3010R	BA3010D	2478	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	6			71	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Non-Hodgkins Lymphoma	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	71	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	Vidaza|Rituximab|Decitabine	2	Consolidation|Maintenance			NA	Standard Chemotherapy	Decitabine	Maintenance	86	Dead	51	Dead-Disease	NA	20	10	1	NA	22	48	16	NA	6	33	3.7	1.57		26	8.1	"46,XY[20]"	NA	91.9		13	FALSE	"Positive for CD34, CD117, HLADR, CD33, CD13 but negative for CD14, CD64, CD11b, CD19, and CD3 (Peripheral Immunophenotyping) | The blasts are positive for CD34 and CD117 (Bone marrow Immunophenotyping)"	FALSE	TRUE	7	44.8	TRUE	negative	0	negative	RUNX1 (p.R320*; 40.9%)	ASXL1 (p.G646Wfs*12; 39.4%)		BCOR (p.A603pfs*66; MAF55%)|KRAS (p.G12V; MAF 49%)|RUNX1 (pR320*; MAF 47%)|SRSF2 (p.P95H; MAF 49%)|STAG2 (p.Y636*; MAF 96%)		yes			yes	yes	Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	3.231321844	4.877972568	4.107911311	4.032176665	6.078619914	-1.883287015	6.23576327	yes	yes	yes	yes	yes	no	yes	1.825037146	3.594667933	-0.582195537	0.039063075	2.352354894	3.014712464	Monocyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	cDC_Like	0.579481893
BA2662R	BA2662D	2393	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			65	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Other	4	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|MiDAC|Hydroxyurea"	4	Consolidation|Unknown|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	1962	Alive	0	74	60	1.9	15.1	21.7	50	11.3	0	23	32	2.6	0.78	M5	21.6	7.2	"46,XX[20]"	905	100.5	Normal	150	TRUE		NA	NA	6.7	84.69	TRUE	positive	NA	positive				CEBPA (p.K298Q; MAF 25%)|DNMT3A (p.R882C; MAF 44%)|FLT3-ITD (MAF 25%)|IDH2 (p.R140Q; MAF 18%)|NPM1 (p.W288fs*12; MAF 46%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	1.167678203	2.839957645	1.303983845	2.442337728	6.780749834	-3.504103796	4.017591009	no	no	no	no	yes	no	no	4.53304298	NA	-3.380464328	NA	3.498274544	3.127261629	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.722514951
BA2280R	BA2280D	2044	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			72	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	72	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	3	"7+3 (Cytarabine, Idarubicin)|Sorafenib|Ponatinib"	2	Induction|Experimental	Refractory	Standard Chemotherapy	10	Targeted Therapy - Kinase Inhibitor(s)	Ponatinib	Experimental	15	Dead	118	Dead-Disease	0.9	90	78	0	0	2.7	3.6	17.3	1.4	28	23	2.8	0.56	M1	31.7	9.9	"46,XX[20]"	261	98.1	Normal	211	TRUE	"CD13, CD33, CD38, partial CD56, partialCD64, CD117, dimCD123, and MPO"	FALSE	TRUE	6.5	24.01	TRUE	positive	NA	positive				CEBPA (p.E163*; MAF 39%)|FLT3-ITD (MAF 40%)|NPM1 (p.W288fs*12; MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.611383287	2.874973591	5.584940928	3.130492746	5.582337795	-1.192589773	0.478564734	no	no	yes	no	no	no	no	-1.627252571	NA	-0.277018093	NA	-0.342516004	-2.904403827	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.407961548
BA2277R	BA2277D	2044	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			72	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	72	40	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	3	"7+3 (Cytarabine, Idarubicin)|Sorafenib|Ponatinib"	2	Induction|Experimental	Refractory	Standard Chemotherapy	10	Targeted Therapy - Kinase Inhibitor(s)	Ponatinib	Experimental	15	Dead	118	Dead-Disease	0		70	0	1.8	34.8	3.6	0.9	23.2	13	40	3.2	0.55	M1	22.7	7.5	"46,XX[5]"	339	89.7	Normal	32	FALSE		NA	NA	6.4	6.04	FALSE	positive	0.639344262	positive				CEBPA (p.E163*; MAF 40%)|FLT3-ITD (MAF 45%)|NPM1 (p.W288fs*12; MAF 32%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	2.537480043	2.907720138	3.313642911	6.010854323	5.479094529	-1.293321936	-2.361507728	no	no	yes	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.438095364
BA2658R	BA2658D	2218	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			24	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	24	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	7	"7+3 (Cytarabine, Idarubicin)|HAM (Cytarabine, Mitoxantrone)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|Decitabine|Fludarabine, Cyclophosphamide, TBI |Busulfan, Cyclophosphamide"	7	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor|Re-induction|Maintenance|Double Umbilical Cord Blood Transplant (DUCBT)	Refractory	Standard Chemotherapy	7	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	2133	Alive	0			1.8	0.9	23.9	23	7.9	0	37	28	3.7	0.95	M4	32.3	11.3	"46,XY[20]"	243	92.8	Normal	102	FALSE	"dimCD13, CD33, CD34, CD56, CD117, and  CD123"	FALSE	TRUE	7.1	21.84	TRUE	negative	0	negative				NRAS (p.G12C; MAF 40%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	4.44989843	3.829560943	2.914182331	4.223637826	6.099369759	-2.767649574	6.723551086	yes	yes	yes	yes	yes	no	yes	2.620861715	NA	1.036830678	NA	-1.321588674	1.48001371	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.684017039
BA2512R	BA2512D	2257	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			72	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Targeted Therapy - Other	1	SGN-CD33A	1	Experimental			NA	Targeted Therapy - Other	SGN-CD33A	Experimental	-1	Dead	179	Dead-Disease	NA	41		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA		NA	NA	Normal	NA	NA	"partial CD56, bright CD33, æCD13, bright CD64, HLA-DR (Monocytic cells)"	FALSE	TRUE	NA	NA	NA	negative	0	positive				DNMT3A (c.2645G>A; MAF 45.4%)|FLT3-D835 (c.2503G>T (D835Y); MAF 15.5%)|NPM1 (c.860_863dup; MAF 11%)|PTPN11 (c.178G>C; MAF 8.4%)|PTPN11 (c.211T>C; MAF 10%)|TET2 (c.3955-2A>G; MAF 45.4%)					no		Found	FALSE	TRUE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	1.968574969	2.98706375	3.839579969	3.874387353	7.120403646	-2.578208293	4.054423691	no	no	yes	yes	yes	no	no	6.865539516	NA	-5.333248515	NA	4.095047598	2.306015713	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.763614526
BA2394R	BA2394D	2381	Waves1+2	yes	yes	yes	yes	Male	Female;Male			White	3			73	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Lung Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	73	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	7	Dead	36	Dead-Disease	NA		79	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"45,X,-Y[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	19.64	FALSE	negative	0	negative	RUNX1 (c.319C>G; MAF 73.9%)	ASXL1 (c.1940dup; MAF 37.9%)		ASXL1 (c.1940dup; MAF 37.9%)|BCORL1 (c.3496dup: MAF 7.5%)|RUNX1 (c.319C>G; MAF 73.9%)|TET2 (c.3803+1G>A; MAF 39.3%)					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	4.337147741	2.350741185	1.30967693	3.424053486	7.54733362	-1.797092471	2.08727892	yes	no	no	no	yes	no	no	3.003694272	NA	3.523074506	NA	-1.81242192	1.287268376	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.651723676
BA2950R	BA2950D	2018	Waves1+2	yes	yes	yes	yes	Female	Female	Black		Black	6			44	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	47	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Targeted Therapy - Other	1	Radiation	1	Unknown			NA	Targeted Therapy - Other	Radiation	Unknown	14	Alive	1231	Alive	NA	90	45	0	NA	28	5	1	NA	30	41	3.3	0.82		29.3	9.6	"46,XX[20]"	NA	89.9	This test has not detected clonal abnormalities in the cells analyzed. Subtle structural changes cannot be ruled out due to the limitations of resolution. Small precentage of tumor cells with chromosome abnormalities may not be detected due to the cells examined.	5	TRUE	"The blasts are positive for HLA-DR, CD34, CD117 (PARTIAL), CD13, CD(PARTIAL/DIM), CD33, TDT (DIM, SUBSET) and are negative for CD11b, CD14, CD64, MPO and all B and T cell markers. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	7.3	6.5	FALSE	positive	1	negative	RUNX1 (p.L98Pfs*40; 46.8%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	TRUE	5.127020755	3.029932867	4.142129072	3.560468999	6.081487603	-1.833195787	4.638458209	yes	no	yes	no	yes	no	yes	0.122841244	-2.87403311	3.266468433	1.895899383	-1.795545277	2.805046721	Monocyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.670828158
BA2981R	BA2981D	2156	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	6			76	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	77	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Unknown	1	Azacitidine	1	Unknown			NA	Unknown	Azacitidine	Unknown	424	Dead	151	Dead-Unknown	NA	86	50	1	NA	14	5	20	NA	32	20	2.9	0.62		24.3	7.8	"48-51,XX,del(4)(q25),del(5)(q11.2),-17,-18,+22,+3-5mar[20]"	NA	84.1		27	TRUE	"POSITIVE FOR DIM CD45, HLADR, CD34, CD117, CD13, CD33, CD43, CD81, CD58. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	5.4	14.3	FALSE	negative	0	negative			TP53 (p.R175H; 91.7%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	3.936308447	5.654858379	5.194869177	2.449261563	6.151013721	0.821801311	6.988215383	yes	yes	yes	no	yes	yes	yes	0.405595663	3.129483241	1.362849646	-1.348155124	2.679583236	-2.607075872	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.646831661
BA2934R		2226	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			74	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Acute Myeloid Leukemia	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	74	0	Post-Chemotherapy	Remission	Peripheral Blood	y	n	n	y	n	n	1	Standard Chemotherapy	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|ATRA (Tretinoin)|MiDAC"	2	Consolidation|Induction	Refractory	Standard Chemotherapy	8	Standard Chemotherapy	MiDAC	Consolidation	3	Alive	2346	Alive	0.9			1.9	0.2	27.7	3.5	65.8	0	30	36	4.3	0.8		38.7	13	"46,XX[20]"	NA	102.9	normal	206	TRUE		NA	NA	7.3	4.26	FALSE		NA										no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.757935311	7.297771493	6.379758422	8.230611603	7.738613496	3.744495891	3.157087598	yes	yes	yes	yes	yes	yes	no	NA	NA	NA	NA	NA	NA							0.865659291
BA2539R	BA2539D	2351	Waves1+2	no	no	no	no	Female	Female			White	3			50	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	50	0	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|Azacitidine|SWOG S1203 (7+3 +/- Vorinostat)|MiDAC"	4	Consolidation|Induction|Re-induction|Maintenance	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	Azacitidine	Maintenance	8	Dead	425	Dead-Treatment	NA	0.5		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	"\showed multiple RUNX1 signals as well as a 3rd RUNX1 signal at 7p consistent with t(7;21)(p22;q22).\\\"""""	NA	NA		NA	NA	NA	10.08	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.646904341	7.008531958	5.079021687	5.583455719	7.290773911	2.862515491	7.394445933	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.852004202
BA2786R	BA2786D	2177	Both	no	no	no	no	Female	Female			AdmixedBlack	6		MLLT3-KMT2A	30	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	31	25	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response i	Standard Chemotherapy	27	Standard Chemotherapy	HiDAC	Consolidation	93	Alive	486	Alive	NA	79	64	NA	NA	2	15	1	NA	44	53	4	0.52		NA	9.6	"46,XX,t(4;15)(q31;q22),t(9;11)(p22;q23)[20]"	NA	89.4	"This test has detected t(4;15) and t(9;11) in 19 of 20 cells analyzed. Translocation t(9;11) was reported previously in this case as the primary abnormality. Translocation t(4;15) represents a secondary chromosome change, that was already reported on previous sample. (Cytogenetics)"	69	FALSE	"POSITIVE FOR CD33, CD11B, CD64, CD4 AND MPO (SUBSET/DIM) AND ARE NEGATIVE FOR CD117, CD13, CD34, HLA-DR AND TDT (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	20.3	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.23878428	1.324578069	2.026778569	2.477098644	5.650284391	-0.440199465	6.233428826	no	no	no	no	no	yes	yes	NA	NA	NA	NA	NA	NA							0.407968857
BA2256R	BA2256D	2074	Waves1+2	yes	yes	yes	yes	Female	Female			AdmixedBlack	6			25	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	26	49	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"Azacitidine, Sorafenib|7+3 (Cytarabine, Idarubicin)|HiDAC|Cladribine, Cytarabine, Idarubicin"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Azacitidine, Sorafenib"	Re-induction	67	Dead	324	Dead-Unknown	NA	98	95	NA	NA	2	3	NA	NA	46	30	4.1	0.54		27.2	8.9	"46,XX,t(7;12)(q22;p13)[12]/46,XX,t(7;17)(p10;q10),-9,+mar[7]/46,XX[1]"	NA	90.4	This test has detected a translocation between 7 and 12 in 12 cells; a translocation between 7 and 17 with loss of a chromosome 9 and a marker in 7 cells.	81	TRUE	"These are positive for CD34, CD117, HLADR, CD33 but negative for CD13 and CD11b. TdT and CD79a are partially expressed. (Bone Marrow Immunophenotyping)"	TRUE	TRUE	6.9	67.7	TRUE	positive	1	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.548359827	0.661526635	0.878502133	1.372923259	4.782579656	-0.720294248	3.432607551	no	no	no	no	no	yes	no	-7.812454517	NA	0.127849323	NA	-0.715371024	1.990991753	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.317671575
BA2483R	BA2483D	2172	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		KMT2A_re	63	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Cervical Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	64	44	Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Supportive/Palliative Care|Targeted Therapy - Other	6	"7+3 (Cytarabine, Idarubicin)|Cytarabine|Azacitidine|Sorafenib|Decitabine|Hydroxyurea"	5	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Experimental|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	-1	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	29	Dead	348	Dead-Disease	1.5	85	38.5	0	0	55	3.5	1.5	0	25	22	3.8	1.3		21.1	7.1	"48,XX,+8,+21[16]/46,XX[4]"	NA	91.3	"RUNX1/RUNX1T1/CEP8: 81% of cells had three signals for all probes, consistent with +8 and +21, as seen on metaphase analysis.  MLL: 68% of cells had a split signal pattern consistent with MLL (11q23) rearrangement. Disruption of MLL was not apparent on banded chromosomes and the partner remains unkn"	18	FALSE	"CD4, partial CD11b, partial CD13, CD33, CD34, CD38,  partial CD56, CD64, partial CD117, CD123, and dim HLA-DR positive | CD4, partial CD11b, partial CD13, CD33, CD34, CD38, partial CD56, CD64, partial CD117, CD123, and dim HLA-DR positive"	FALSE	TRUE	7.7	19.76	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.854132266	1.461683326	2.712388767	3.939719808	5.856949802	-0.047664079	4.920026519	no	no	no	yes	no	yes	yes	-5.45220431	NA	-1.806246332	NA	4.482306909	0.041529676	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.549411065
BA3002R	BA3002D	2172	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1		KMT2A_re	63	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Cervical Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	64	58	Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Supportive/Palliative Care|Targeted Therapy - Other	6	"7+3 (Cytarabine, Idarubicin)|Cytarabine|Azacitidine|Sorafenib|Decitabine|Hydroxyurea"	5	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Experimental|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	-1	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	29	Dead	348	Dead-Disease	0	85		0	0	12.6	0	0	0.2	16	36	3.1	1.57		20.9	7	"48,XX,+8,+21[16]/46,XX[4]"	887	89.7	"RUNX1/RUNX1T1/CEP8: 81% of cells had three signals for all probes, consistent with +8 and +21 MLL: 68% of cells had a split signal pattern consistent with MLL (11q23) "	21	FALSE	"CD4, partial CD11b, partial CD13, CD33, CD34, CD38, partial CD56, CD64, partial CD117, CD123, and dim HLA-DR positive"	FALSE	TRUE	7.3	49.93	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.213349457	0.734433805	2.208582508	2.903579561	5.599245037	0.02648616	4.415323236	no	no	no	no	no	yes	yes	NA	NA	NA	NA	NA	NA							0.552001298
BA2109R	BA2109D	2251	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			52	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	MissingKaryo	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	52	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	8	Standard Chemotherapy	HiDAC	Consolidation	81	Dead	585	Dead-Disease	0			30	13	9	21	19	0.1	54	50	2.2	0.84	M4	18.8	6.5		NA	98.9		21	TRUE		NA	NA	6.5	65.58	TRUE	negative	0	negative				NOTCH1 (p.K2181R ; MAF 50%)|SRSF2 (p.P95H ; MAF 50%)		yes			yes		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	4.414961877	6.561707	5.278283722	2.71568991	6.678377848	0.824641148	6.810861641	yes	yes	yes	no	yes	yes	yes	6.284530436	NA	-3.989933048	NA	5.972070826	-0.435938561	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.862974227
BA2242R	BA2242D	2507	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	6	"Fludarabine, Melphalan|Ruxolitinib|7+3 (Cytarabine, Idarubicin)|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|MiDAC|Ibrutinib"	5	Consolidation|Induction|Re-induction|Maintenance|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Ruxolitinib	Maintenance	-1	Alive	2027	Alive	0	>95		0	0	89.9	9.3	0.8	0	43	31	2.4	0.5	M1	19.5	6.5		313	92.4	normal	32	TRUE	"partial CD13, CD33, CD38, moderate CD45, CD56, CD58,  CD64, dim CD117, CD123 and MPO+"	FALSE	TRUE	5.8	67.36	TRUE	negative	0	positive				CREBBP (p.R2353Q; MAF 51%)|NPM1 (p.W288fs*12; MAF 46%)|TET2 (p.Q270*; MAF 90%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	5.53095273	3.872285406	-0.421061869	3.39251405	6.696930088	-0.752285877	-0.722823053	yes	yes	no	no	yes	yes	no	-2.723245485	NA	-0.924352649	NA	1.954195153	-6.860095232	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.435023573
BA2132R	BA2132D	2140	Waves1+2	yes	yes	yes	yes	Female	Female			White	6			70	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	70	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Induction	Unknown	Standard Chemotherapy	37	Standard Chemotherapy	Azacitidine	Induction	37	Alive	37	Alive	NA	90	17	NA	NA	20	18	2	NA	24	26	3.8	0.76		25	8.2	"46,XX,del(5)(q22q35)[20]"	NA	87.7	Positive for 5q deletion in 91% of cells.	35	TRUE	"POSITIVE FOR CD34, HLA-DR, CD117 AND CD33, AND NEGATIVE FOR MPO, TdT, CD13, CD19, CD20 AND CD10. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	6.2	7.7	FALSE	positive	0.333333333	negative				FLT3-ITD|MLL |U2AF1 (p.S34F; MAF 35%)			yes		yes		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	3.986494596	4.397367075	4.566214579	5.587977067	5.542826655	1.343606903	4.174488059	yes	yes	yes	yes	no	yes	no	1.401743913	NA	1.755248988	NA	0.675765049	3.502543709	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.680999683
BA2618R	BA2618D	2498	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			83	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	83	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	2	"AG-221|Azacitidine, SGN-CD33A"	2	Induction|Experimental	Refractory	Standard Chemotherapy	-1	Targeted Therapy - Other	AG-221	Experimental	-1	Dead	434	Dead-Disease	0.3	12	3	0	9.4	26.9	24.5	38.9	0	42	47	3.2	1.3		21.1	6.8	"46,XY[20]"	NA	87.9	Normal	213	TRUE		NA	NA	6	3.72	FALSE	negative	0	negative		ASXL1 (p.Y425*; 46.8%)		CREBBP (p.M2408V; MAF 48%)|IDH2 (p.R140Q; MAF 47%)|NRAS (p.G12D; MAF 49%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	0.140622878	6.866481118	4.168688371	3.772971773	6.728156545	-1.689535676	7.811010532	no	yes	yes	yes	yes	no	yes	2.653403552	NA	-1.299244741	NA	2.726406127	-1.063955565	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.6118936
BA2846R	BA2846D	2004	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			75	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Rectal Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	75	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Supportive/Palliative Care	2	Hydroxyurea|Decitabine	1	Supportive/Palliative Care			NA	Supportive/Palliative Care	Decitabine	Supportive/Palliative Care	4	Dead	17	Dead-Disease	0	90	90	0	0	5.1	0.8	0.9	1	23	51	2.9	0.97	M1	25.3	8.5	"46,XY[20]"	728	91.3	Normal	28	FALSE	"CD33, dim CD38, variable CD56, CD58, dim CD64, CD117, CD123, and MPO positive."	FALSE	TRUE	6.6	62.87	TRUE	negative	0	positive				IDH2 (p.R140Q; MAF 47%)|NPM1 (p.W288fs*12 (4 nt insertion with frameshift); MAF 17%)|SRSF2 (p.P95L; MAF 37%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.470181328	2.21458395	-0.342203265	3.965479708	4.683098974	0.839553071	0.011641161	no	no	no	yes	no	yes	no	-1.961494056	NA	-0.491735185	NA	0.450082026	-0.516147508	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.43069121
BA2521R	BA2521D	2433	Both	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			44	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	44	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	6	"Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Sorafenib|Hydroxyurea|Busulfan, Cyclophosphamide|7+3 (Cytarabine, Idarubicin) plus Dasatinib "	5	Allogeneic - Sibling|Induction|Experimental|Re-induction|Post-Transplant Relapse	Complete Response i	Standard Chemotherapy	28	Standard Chemotherapy	Azacitidine	Post-Transplant Relapse	81	Dead	319	Dead-Disease	0	75	80	0	7.7	10.3	22.2	6.8	0	21	25	2.4	1.25	M5	22.9	7.4	"46,XX[20]"	705	96.2	Normal	42	FALSE	"CD13, CD33, subset CD34, variable CD117, CD123, HLA-DR, and variable MPO positive - Monocytic/blast equivalent immunophenotype: CD11b, CD13, subset CD14, variable CD16, CD33, CD64, dim CD123, and HLA-DR positive"	FALSE	TRUE	6.2	69.84	TRUE	positive	2.333333333	positive				DNMT3A (p.R882H; MAF 48%)|FLT3-ITD (MAF 70%)|NPM1 (p.W288fs*12; MAF 46%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	1.997067626	0.229044512	3.484243087	2.400256357	6.335094336	-1.960119646	1.493354808	no	no	yes	no	yes	no	no	NA	NA	NA	NA	NA	NA							0.625370592
BA2885R	BA2885D	2139	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			81	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Skin cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	81	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Induction	Unknown	Standard Chemotherapy	6	Standard Chemotherapy	Azacitidine	Induction	6	Dead	14	Dead-Disease	0	90	70	0	0.8	6.1	72.2	12.2	0.4	62	50	2.9	4.22	M5	22.8	7.3	"46,XX[20]"	262	90.8	Normal	29	TRUE	"CD11b, variable CD13, variable CD14, CD33, CD56, CD64, dim CD123 and dim HLA-DR positive"	FALSE	TRUE	5.8	97.26	TRUE	negative	0	positive		ASXL1 (p.G645Vfs*58; 16.7%)		ASXL1 (p.W796fs*22; MAF 48%)|NPM1 (p.W288fs*12; MAF 40%)|TET2 (p.S825fs*1; MAF 49%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	3.177838623	3.842193862	2.925454618	1.972594566	6.839193485	-0.346863898	4.241980745	yes	yes	yes	no	yes	yes	no	5.307149406	NA	-5.918545057	NA	3.297564717	1.441330868	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.74453358
BA2639R	BA2639D	2368	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	36	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	36	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	6	"Dasatinib|7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)|Hydroxyurea|Busulfan, Cyclophosphamide"	5	Consolidation|Induction|Experimental|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	2075	Alive	0	40	60	1.7	0	33.4	5.1	18.8	0.1	38	28	3.2	0.53	M2	22.9	7.6	"46,XX,t(16;16)(p13.2;q22)[20]"	508	99.6	"CBFB: 191/200 cells (95.5%) had the abnormal 1 red/ 1 green/1 yellow signal pattern, reflecting CBFB rearrangement, consistent with the 16;16 translocation observed in the metaphase karyotype."	24	FALSE	"Immunophenotype: CD13, partial CD15, dim CD33, CD34, CD38, dim CD45, CD58, variable CD64, variable CD117, CD123, and dim HLA-DR positive."	FALSE	TRUE	7.3	20.44	FALSE	negative	0	negative				KIT (p.T417_D419delinsY; MAF 33%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.051640088	2.373440498	-0.90581406	3.768562536	5.598518426	-1.973748291	5.857340491	no	no	no	yes	no	no	yes	0.641164555	NA	0.712791077	NA	-0.158564963	0.303885339	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.55056878
BA2775R	BA2775D	2138	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	3			26	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	27	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	16	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	647	Alive	NA	35		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[15]"	NA	NA	Normal	NA	NA	"weak  CD13, CD33, partial CD117, and myeloperoxidase"	FALSE	TRUE	NA	NA	NA	negative	0	positive				IDH2 (p.Arg140Gln; MAF 45.9%)|NPM1 (p.Trp288fs; MAF 19.5%)					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	1.91542444	2.196776083	-0.725312818	2.428688675	6.436904567	-2.455611746	4.741829846	no	no	no	no	yes	no	yes	2.039237283	NA	-2.816632822	NA	5.45530244	-2.097256206	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.576069424
BA2402R	BA2402D	2410	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			82	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	82	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	268	Dead-Disease	0	50		0	1.8	42.8	0	5.4	3.7	13	18	2.8	1.03		27.7	9.2	"46,XX "	279	91.1	trisomy 8 in 5 of 20 metaphase cells 	44	TRUE		NA	NA	7	1.36	FALSE	negative	0	negative				DNMT3A (p.R882H; MAF 39%)|GATA1 (p.R191C; MAF 51%)|IDH2 (p.R172K; MAF 36%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.159512794	4.24387516	0.613009876	6.606345231	6.110395226	-0.051962346	5.130880915	no	yes	no	yes	yes	yes	yes	0.363113568	NA	1.188315673	NA	-0.479070245	-1.40669296	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.683063792
BA2097R	BA2097D	2201	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	4			77	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	77	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"Azacitidine, Sorafenib|Decitabine, Midostaurin"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	165	Standard Chemotherapy	"Azacitidine, Sorafenib"	Re-induction	-1	Alive	288	Alive	NA	41	18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	"CD15, AND PARTIAL CD56 -7/DEL(7q) TRISOMY #8MLL GENE REARRANGEMENTDEL(20q)"	NA	NA	"ABNORMAL CD34+ BLAST POPULATION EXPRESSING ABERRANT CD7,CD4, AND CD2, AND CD38, CD10, CD22, CD11C, HLA-DR, CD117,CD13, CD33,CD15, AND PARTIAL CD56"	TRUE	TRUE	NA	2.2	FALSE	positive	0.612903226	negative				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	3.655889099	4.660456932	3.509608409	6.877880914	5.67583098	-1.841836325	0.694434702	yes	yes	yes	yes	no	no	no	0.577224355	NA	1.387181824	NA	-2.333813597	3.325284361	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.72455249
BA2399R	BA2399D	2196	Waves1+2	yes	yes	yes	yes	Male	Male	Asian		AdmixedWhite	2			55	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"HiDAC|Cyclophosphamide|Fludarabine, Cyclophosphamide, TBI |7+3 (Cytarabine, Idarubicin) plus Crenolanib"	4	Consolidation|Induction|Allogeneic - Child|Maintenance	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	Cyclophosphamide	Maintenance	1	Alive	668	Alive	0	91	99.2	0	NA	0.8	0	0	NA	33	27	3	0.85		18.8	6.2	"46,XY[29]"	808	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[199],(D8Z2,D20S108)x2[199],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	28	FALSE	"CD2(-), CD4(partial dim +), CD7(-), CD11b(-), CD13(dim +), CD14(-), CD15(-/few dim +), CD16(-), CD33(+), CD34 (partial +), CD36(equivocal/small subset appears +), CD38(partial +), CD45(+), CD56(-), CD64(-/few dim +), CD117(+), HLA-DR(+ and variable), TDT(-), MPO(+)"	TRUE	TRUE	6.1	181.08	TRUE	positive	1	negative				FLT3-ITD (S584_S585INSSDNEYFYVDFRE; MAF 29.0%)|IDH1 (R132H; MAF 47.0%)|MLL (Foundation; MLL-PTD Exons 2-8; not GeneTrails)|TET2 (SPLICE SITE 3500+1G>A; MAF 48.0%)					no		Found	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	-1.536158945	-0.665131313	0.872750258	1.423405395	3.350737912	0.706893141	-0.755570371	no	no	no	no	no	yes	no	-10.74871591	NA	2.50468277	NA	-5.718399535	-2.014515834	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.235564738
BA2850R	BA2850D	2210	Waves1+2	yes	yes	yes	yes	Male	Male	Multiracial		White	6			50	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	50	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Allogeneic - Sibling|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	-1	Alive	576	Alive	NA	75	73	NA	NA	6	6	8	NA	44	20	3.5	1		24.8	8	"46,XY[20]"	NA	91.5		26	TRUE	"These are postive for CD34, CD117, HLADR, CD13 and CD33. These are negative for CD3, CD20, CD4, CD11b. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	5.8	17.1	FALSE	positive	1.5	negative	RUNX1 (p.E454Gfs*149; 21.4%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	-0.130727984	2.360639815	5.135128302	3.195873128	5.252833456	-0.017220903	-0.189052417	no	no	yes	no	no	yes	no	-6.101800036	NA	1.714929596	NA	-2.226154374	-0.048971159	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.358444206
BA2993R	BA2993D	2210	Waves1+2	no	no	no	no	Male	Male	Multiracial		White	6			50	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	50	30	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Allogeneic - Sibling|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	-1	Alive	576	Alive	NA		68	NA	NA	12	NA	3	NA	20	11	3.8	0.81		24.1	7.9	"46,XY[20]"	NA	89.6		39	TRUE		NA	NA	6.4	2.1	FALSE	positive	1.5	negative	RUNX1 (p.E454Gfs*149; MAF 51%)			DNMT3A (p.r882H; MAF 45%)|FLT3-ITD|MLL |RUNX1 (p.E454Gfs*149; MAF 51%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	1.677635095	2.092886706	4.179415296	3.958477395	5.281079317	-1.000558635	-0.320515318	no	no	yes	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.411103394
BA3322R	BA3322D	2009	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1			62	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	63	487	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	3	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|Azacitidine"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	Azacitidine	Re-induction	-1	Dead	581	Dead-Unknown	1.1	2		0.4	0.7	55.7	4.3	37.8	1.1	31	18	3.5	NA	M1	36.6	12.2	" 46,XY[20)"	NA	90.4		240	TRUE	"CD5, CD19, CD20 and dim surface kappa light chain + "	FALSE	FALSE	7.4	2.8	FALSE	negative	0	negative	RUNX1 (p.E223*; MAF 1%)	ASXL1 (p.S1028*; MAF 14%)		ASXL1 (p.S1028*; MAF 14%)|BCOR (p.Y1350*; MAF 6%)|FBXW7 (p.T15_G16insP; MAF 49%)|FLT3|RUNX1 (p.E223*; MAF 1%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	5.100726813	6.694658781	3.519358737	8.362662152	7.118172349	-2.183717161	5.194507623	yes	yes	yes	yes	yes	no	yes	NA	NA	NA	NA	NA	NA							0.697063323
BA2174R	BA2174D	2341	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	Asian	1			46	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Anaplastic Astrocytoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	46	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	7	"7+3 (Cytarabine, Idarubicin)|HAM (Cytarabine, Mitoxantrone)|Azacitidine|Hydroxyurea|Decitabine|ME (Etoposide, Mitoxantrone)|Fludarabine, Melphalan, ATG"	4	Consolidation|Induction|Re-induction|Double Umbilical Cord Blood Transplant (DUCBT)	Refractory	Standard Chemotherapy	1	Bone Marrow Transplant	"Fludarabine, Melphalan, ATG"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Dead	637	Dead-Disease	0.9	25	16	1.7	4.3	6.1	32.2	48.7	0.2	14	15	3.1	0.64		32	9.5	"46,XX,del(3)(p25),add(6)(p22),t(10;12)(p15;q13)[5]/46,XX[18]"	440	80.6	Normal	92	TRUE	"Immunophenotype: CD13, CD34, CD38, CD58, CD117, CD123, HLA-DR and TdT-positive; small subset of blasts also express CD19, CD22, and CD79a"	TRUE	FALSE	6.8	42.57	TRUE	negative	0	negative				DNMT3A (p.I824V; VAF 50%)|GATA1 (p.S412R; MAF 60%)|NRAS (p.G13R; MAF 50%)|RUNX1 (p.T196I ; MAF 50%)|U2AF1 (p.I24T; MAF 5%)			yes		yes		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	4.650152755	6.12052955	4.579773911	3.406263516	6.88614747	-1.273558253	7.54856624	yes	yes	yes	no	yes	no	yes	5.528314851	NA	1.749311814	NA	1.112053507	4.996576247	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.760881421
BA2004R	BA2004D	2136	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			77	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	77	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	Azacitidine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	253	Dead	341	Dead-Unknown	0.8			2.5	0	15.8	0	70.9	0	62	28	3.3	1.01	M2	24.2	7.9		241	87.7	"EGR-1/ D5S23, D5S721: 58/200 cells (29%) had a 1 red/ 2 green signal pattern, consistent with a deleted 5q. D7S522/CEP 7: 38/200 cells (19%) had a 1 red/ 2 green signal pattern, consistent with a deleted 7q. CBFB: 40/200 cells (20%) had a single signal indicating deleted 16q22. TP53/CEP 17: 12/200 c"	16	FALSE		NA	NA	8	8.29	FALSE	negative	0	negative			TP53 (p.V272_R273insL; MAF 75%)	DNMT3A (p.E285D; MAF 40% )|KDM6A (p.Y215fs*2; MAF 40%)|TP53 (p.V272_R273insL; MAF 75%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	5.050466637	7.036239006	5.044099214	6.963529976	6.669439488	0.452698305	4.516515295	yes	yes	yes	yes	yes	yes	yes	5.448688852	NA	1.521077513	NA	-0.529723352	0.732663434	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.807298563
BA3001R	BA3001D	2344	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			51	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"HiDAC|Hydroxyurea|7+3 (Cytarabine, Idarubicin) plus Sorafenib"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	2	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	1910	Alive	0	95	95	0	0	7.8	0	3.1	0.1	22	12	2.9	0.93	M1	20.6	6.6	"46,XX[20]"	189	112.6	Normal	57	FALSE	"Immunophenotype: CD7, CD13, CD33, CD38, CD117, CD123 and MPO positive"	TRUE	TRUE	6.5	25.02	TRUE	negative	0	positive				CBL (p.R420Q; MAF ~20%)|FLT3 (p.N841K; MAF ~30%)|IDH2 (p.R140Q; MAF ~30%)|NPM1 (p.W288fs*12; MAF ~25%)					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.67574341	1.024968216	0.277265118	2.024179375	3.823850351	-1.330559403	2.419637195	no	no	no	no	no	no	no	-7.280694051	0.204264294	-0.178907103	4.839740796	-2.587429026	-5.200295391	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.170897984
BA2911R	BA2911D	2090	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			24	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Hodgkin Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	24	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Leukapheresis	y	y	n	y	y	n	3	Standard Chemotherapy|Targeted Therapy - Other|Targeted Therapy - Kinase Inhibitor(s)	6	"AG-120|ATRA (Tretinoin)|HiDAC|3+7 (Cytarabine, Daunorubicin)|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|5+2 (Ara-C, Daunorubicin)"	5	Consolidation|Salvage|Induction|Experimental|Re-induction	Complete Response	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	AG-120	Salvage	77	Dead	861	Dead-Disease	0	N/A	97	0	0	1.9	0	1.9	0.2	14	18	2.7	0.51		19.6	6.2		364	108.3	normal	15	FALSE	"CD13, CD33, CD38, CD58, CD117 and CD123 positive."	FALSE	TRUE	6.4	181.66	TRUE	positive	NA	positive				FLT3 (p.V592G; MAF 6%)|FLT3-ITD ((57 bp in-frame insertion); MAF 3% )|IDH1 (p.W288fs*12; MAF 50%)|NPM1 (p.W288fs*12; MAF 50% )					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.44373455	0.711453578	-0.218006257	1.387451292	4.24387516	-0.610774085	0.792123208	no	no	no	no	no	yes	no	-8.060305484	NA	1.327703154	NA	-0.908219081	-5.718753767	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.178968342
BA2311R	BA2311D	2222	Waves1+2	yes	yes	yes	yes	Female	Female		HISPANIC	HispNative	2			53	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Supportive/Palliative Care	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Cyclophosphamide|Fludarabine, Cyclophosphamide, TBI "	4	Consolidation|Induction|Allogeneic - Child|Maintenance	Complete Response	Standard Chemotherapy	-1	Supportive/Palliative Care	Cyclophosphamide	Maintenance	1	Alive	653	Alive	0	20	8	0	NA	37	20	30	NA	18	23	3.3	0.86	M4	20	6.2	"46,XX[20]"	426	105.3	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	38	FALSE	"CD34(+), CD13(dim +), CD15(partial +), CD33(dim to partial +), CD34(+), CD38(variably +), CD45(dim +), CD56(-), CD64 (small subset +), CD117(+), HLA-DR(partial +), other myeloid and lymphoid antigens(-)."	FALSE	TRUE	7	6.63	FALSE	negative	0	negative				IDH2 (R140Q; MAF 51.0%)|KMT2A (Foundation; MLL-PTD exons 2-10)|PAX5 (V26G; MAF 1.0%)|SRSF2 (R94_S101DEL; MAF 40.0%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	4.032569117	5.486858128	3.368217022	4.413131336	6.972507264	-1.098384096	5.877330099	yes	yes	yes	yes	yes	no	yes	5.722486957	NA	-1.891100547	NA	2.107038571	5.411952487	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.786976771
BA3040R	BA3040D	2183	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	4			69	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	7	Dead	238	Dead-Disease	NA	39	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"45,XY,add(1)(p13),del(5)(q13q33),add(6)(q13),-7,del(7)(q11.2),der(9)t(1;9)(p13;q22),add(12)(p13),-15,-16,-17,+3mar[19]/43~45,idem,der(3)t(3;17)(p21;q11.2),-17[cp3]"	NA	NA	"COMPLEX DEL(5q)/DEL(7q)/-7 CLONE OBSERVED, CONSISTENT WITH AML"	NA	NA	"Positive (ABNORMAL CD34+ BLAST POPULATION, 29%, EXPRESSINGMYELOPEROXIDASE (VARIABLE), CD34, CD38, CD117, CD33, CD4, HLA-DR,CD13 (PARTIAL), CD56 (dim minor subset), AND CD61 (dim subset))"	FALSE	TRUE	NA	1.6	FALSE	negative	0	negative			TP53 (p.Y220C; 48.0%)|TP53 (p.F113V; 39.4%)						no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	4.089140122	5.241408937	5.212198639	4.08953411	5.333999446	-0.065358812	5.039283443	yes	yes	yes	yes	no	yes	yes	1.088499996	1.755416894	0.886148801	-0.725362969	1.04205938	-4.295061799	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.587432163
BA2724R	BA2724D	2041	Waves1+2	yes	yes	yes	yes	Female	Female	White		White	2			67	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Decitabine	Supportive/Palliative Care	-1	Alive	34	Alive	0.8	85	7.7	0	NA	5.1	42.7	40.2	NA	27	41	1.9	0.66		28.7	9.5	"46,XX[20]"	670	102.5	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	42	TRUE	"CD2(-), CD4(partial dim +), CD7(few dim +), CD11b(-), CD13 (variably +), CD14(-), CD15(partial +), CD16(-), CD19(partial dim +), CD33(variably +), CD34(-), CD36(-), CD38(+), CD45 (moderate +), CD56(-), CD64(partial dim +), CD117(+), HLA-DR(+), MPO(+). (Population #1; 6.5% medium-sized cells) | CD2(dim +), CD4(dim +), CD11b(variably +), CD13(variably +), CD14(partial +), CD15(variably +), CD16(partial +), CD33(slightly bright +), CD34(-), CD36(+), CD38 (variably +), CD45(+), CD64(+), CD117(-), HLA-DR(partial +), MPO(+). (Population #2; 42% medium-sized to large monocytic cells)"	TRUE	TRUE	5.7	56.03	TRUE	negative	0	positive				NPM1 (W288FS*10+; MAF 37.0%)|NRAS (Q61K; MAF 43.0%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.926992939	5.266736944	5.075872486	3.406263516	6.964195782	0.47308433	5.614781358	yes	yes	yes	no	yes	yes	yes	5.303216023	NA	-0.783510375	NA	2.555007869	3.36413844	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.752506391
BA2837R	BA2837D	2322	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	2			78	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Esophageal Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	80	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"AG-120|5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine"	4	Consolidation|Induction|Experimental|Maintenance	Complete Response	Standard Chemotherapy	7	Targeted Therapy - Other	AG-120	Experimental	-1	Dead	605	Dead-Disease	0		70	0	NA	7	3	9	NA	11	57	2.6	1.28		25.6	8.1	"45,XY,-7[2]/45,XY,t(6;8)(q21;q21.2),-7,del(10)(q24q26),t(12;15)(p13;q15)[19]"	1897	NA	"nuc ish(D5S2064,D5S630,EGR1)x2 [200],(D7Z1x2,D7S522x1)[1/200]/(D7Z1,D7S522)x1[185/200],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2[200], (5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	23	TRUE	"CD2(subset +), CD4(dim +), CD7(partial +), CD11b(partial +), CD13(+), CD14(-), CD15(partial +), CD16(-), CD33(variably +), CD34(partial +), CD38(variably +), CD45(+), CD56(partial +), CD64(-), CD117(+), HLA-DR(partial +). (63% population)"	TRUE	TRUE	4.3	240.43	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.774309834	4.837243032	2.620925516	3.139900593	5.227135906	0.230814198	6.245015852	yes	yes	no	no	no	yes	yes	2.35321224	NA	2.49822524	NA	1.990617896	-0.52790606	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.642019363
BA2821R	BA2821D	2145	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			37	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	37	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"HiDAC|3+7 (Cytarabine, Daunorubicin)|Azacitidine|Hydroxyurea"	4	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction|Re-induction	Refractory	Standard Chemotherapy	8	Standard Chemotherapy	Azacitidine	Consolidation	-1	Dead	542	Dead-Disease	1.7	95	74	2.5	0.8	13.6	14.4	10.2	0.4	23	14	3.1	0.46	M0/M1	27.9	9.2	"46,XX[20]"	NA	89.4	Normal	49	TRUE	"variable CD11b, CD13, dim CD19, dim CD33, CD34, variable CD64, CD117, CD123, and HLA-DR"	FALSE	TRUE	7	26.57	TRUE	negative	0	negative				ASXL1 (p.A1312V; MAF 50%)|KRAS (p.K117N; MAF 48%)|WT1 (p.L378P; MAF 48%)|WT1 (p.R380fs*69 (1 bp deletion with frameshift); MAF 48%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.538021511	2.279702339	1.713581132	1.618024569	5.214325428	-3.932857166	5.325945105	no	no	no	no	no	no	yes	0.159286548	NA	-0.176916575	NA	0.603472105	2.796733768	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.456051412
BA2363R	BA2363D	2337	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			79	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	79	35	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Supportive/Palliative Care|Targeted Therapy - Other	4	Azacitidine|Decitabine|Hydroxyurea|V212	2	Hypomethylating/Low Dose Cytarabine|Supportive/Palliative Care			NA	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	-1	Dead	152	Dead-Disease	1.7		35	0	0	0.9	64.4	8.7	0.2	9	22	3.1	2.11		25.5	7.8	"46,XY[22]"	722	95.5	Normal	438	TRUE	"CD13, dim CD33, bright CD34, CD38, CD117, dim HLA-DR positive"	FALSE	TRUE	5.8	116.52	TRUE	negative	0	negative	RUNX1 (p.R320*; 44.9%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	3.97176537	4.143662647	4.481898898	5.012515218	5.627552587	-1.347175804	5.201166098	yes	yes	yes	yes	no	no	yes	4.432138815	NA	1.907836765	NA	0.362275558	4.987149885	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.75710469
BA2233R	BA2233D	2316	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	4			72	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	CPX-351 (Liposomal Cytarabine + Daunorubicin)|Hydroxyurea	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	CPX-351 (Liposomal Cytarabine + Daunorubicin)	Induction	-1	Alive	95	Alive	NA	97	96	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA	"46,XY[5]"	NA	NA	"D5S721, EGR1 ædel(5q)/monosomy 5, D7Z1, D7S522  del(7q)/monosomy 7, D8Z2 trisomy #8, D20S108, 20qter del(20q)   "	NA	NA	"CD117, MPO,CD38(PARTIAL), CD33(DIM) AND NOT EXPRESSING CD34 AND HLA-DR"	FALSE	TRUE	NA	125.9	TRUE	negative	0	positive				"FLT3 (p.D839G; MAF~45%)|IDH2 (p.R140L; MAF ~50%)|MLL2 (p.V2338I; MAF ~50%)|NPM1 (p.W288fs*12;MAF ~35%)|SRSF2 (p.P95H, MAF~55%)"		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	1.617109534	2.273772977	-0.899929858	3.731965881	4.141343766	-1.039441945	0.332971491	no	no	no	no	no	no	no	-5.184482213	NA	1.287965267	NA	-1.359740121	-5.075363249	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.273197102
BA2744R	BA2744D	2232	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			76	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	76	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	1	Supportive/Palliative Care	1	Hydroxyurea	1	Supportive/Palliative Care			NA	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	7	Dead	8	Dead-Unknown	0		96	0	0.7	4.7	0	1.3	0.6	23	43	2.3	0.46	M1	31	10.4	"46,XY[20]"	839	93.9	Normal	17	FALSE	"CD13, CD33, CD38, variable CD56, CD58, CD117 and MPO positive"	FALSE	TRUE	5.1	230.05	TRUE	positive	0.176470588	positive				FLT3-ITD (MAF 45%)|NPM1 (p.W288fs*12; MAF 50%)|TET2 (p.W564*; MAF 50%)					no		Found	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.98186111	3.05091544	0.074223775	5.506457351	5.298043939	0.851196224	-0.457686839	yes	no	no	yes	no	yes	no	-4.610314083	NA	-2.06484777	NA	0.99987061	-3.906188533	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.366173683
BA2501R	BA2501D	2031	Waves1+2	yes	yes	yes	yes	Male	Male			White	3		PML-RARA	36	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	36	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"Methotrexate, Mercaptopurine, Tretinoin|ATRA, Idarubicin|ATRA, Cytarabine, Idarubicin"	3	Consolidation|Induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Methotrexate, Mercaptopurine, Tretinoin"	Maintenance	-1	Alive	604	Alive	NA	91.8	95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M3	NA	NA	"46,XY,t(15;17)(q24;q21)[18]/46,XY[2]"	NA	NA	Normal	NA	NA	"weak partial CD2, CD13, CD33, CD64, CD117, and  myeloperoxidase"	FALSE	TRUE	NA	55.42	TRUE	positive	0.25	negative				"CEBPA (c.935A>G; MAF 45%, except VUS)|FLT3-ITD (c.1780_1800dup; MAF 17%)"					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.669643049	1.658156906	5.322687427	2.487143399	6.041136857	-1.643725905	4.797679617	no	no	yes	no	no	no	yes	-5.613808733	NA	-3.436915233	NA	2.222902314	-1.600875675	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.425992873
BA2301R	BA2301D	2197	Waves1+2	yes	yes	yes	no	Female	Female	White		White	5			42	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	42	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	673	Alive	0	90		0	NA	17	NA	20	NA	17	13	3.6	0.98		21.7	7.3	"46,XX[19]"	NA	NA	Normal	71	TRUE	"Positive (\A large blastic population is noted, positive for CD45 and CD64. A small subset of blasts also express CD13 and CD14. The blasts are negative for CD10, CD16, CD19, CD34 and CD117.\\)\"""""	FALSE	FALSE	6.6	18.3	FALSE	negative	0	positive				NPM1 (c.859_860insTCTG; p.W288fs)|WT1 (c.933_934ins10; p.R312fs; c.938_939insCGGTC; p.A314fs)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	1.923986914	4.588348156	2.069949345	3.736005732	6.47025473	-1.59483904	4.769590699	no	yes	no	no	yes	no	yes	4.996993635	NA	-2.219241896	NA	3.415808895	1.926585014	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.843745468
BA2880R	BA2880D	2568	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	5			85	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Not specified	n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	85	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Alive	34	Alive	1.5	2		24	NA	11.5	8	55	NA	4	8	3.7	1.2		48.8	16.1	"46,XY[20]"	NA	NA	Normal	141	TRUE		NA	NA	6.3	11.4	FALSE	negative	0	negative				EZH2 (c.436G>C; p.D146H)|TET2 (c.5182G>T; p.E1728X)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.634367702	7.299680564	5.272497823	5.194136031	7.438268726	1.854032931	7.356734551	yes	yes	yes	yes	yes	yes	yes	5.294499093	NA	-3.360263524	NA	3.74766403	0.139600038	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.698381349
BA2621R	BA2621D	2347	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	6			74	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	74	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	14	Dead-Disease	NA	19	7	4	NA	12	2	51	NA	29	38	3.7	0.86		24.2	7.8	"45,XY,-7,del(12)(p11.2p13)[20]"	NA	90.6	Monosomy 7 is detected in 87% of cells.	35	FALSE		NA	NA	6.6	47.5	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.600053419	7.199856835	3.541155842	3.714256536	7.171167869	-0.79132187	6.07264657	no	yes	yes	no	yes	yes	yes	5.054117358	NA	-1.415923284	NA	2.556571444	0.115467491	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.783097856
BA2852R	BA2852D	2436	Waves1+2	yes	yes	yes	no	Male	Male	White		White	6			74	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	75	0	Post-Chemotherapy|Relapse	Relapse	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	"Azacitidine, MLN4924"	1	Induction	Complete Response	Standard Chemotherapy	498	Standard Chemotherapy	"Azacitidine, MLN4924"	Induction	498	Alive	539	Alive	NA	6		3.8	NA	48.1	9.5	38.1	NA	41	25	4.4	0.73		36.5	12.7	"48,XY,+8,del(20)(q11.2),+21[14]/46,XY[6]"	NA	94.8	"This test has detected a 20q deletion, trisomy 8, and trisomy 21 in 14 cells. All these abnormalities are commonly seen in AML and MDS."	43	FALSE	"These are positive for CD34, CD117, HLA-DR, and CD33. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	6.4	2.1	FALSE	negative	0	negative	RUNX1 (p.G165Dfs*2; 11.1%)								no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	5.004479882	6.442273424	2.671935251	7.701971419	6.761232861	-0.03465796	0.614695128	yes	yes	no	yes	yes	yes	no	2.414030801	NA	1.70197081	NA	-3.387175966	0.486747748	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.820771264
BA2133R	BA2133D	2383	Waves1+2	no	no	no	no	Female	Female	White		White	6			73	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	73	0	Post-Chemotherapy	Remission	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	4	Ruxolitinib|AG-221|Cytarabine|Azacitidine	4	Induction|Experimental|Maintenance|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	90	Standard Chemotherapy	Cytarabine	Supportive/Palliative Care	8	Dead	560	Dead-Unknown	NA			0.5	NA	39.2	7.5	52.5	NA	10	21	4.5	0.87		34.1	10.9		NA	92.4		6	FALSE		NA	NA	7.6	3.8	FALSE	negative	0	positive				IDH2 (p.R140Q; MAF 32%)|JAK2 (p.V617F; MAF 30%)|NPM1 (p.W288Cfs*12; MAF 35%)|SRSF2 (p.R94dup; MAF 31%)|WT1 (p.R440Tfs*14; MAF 29%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.397803331	9.247041739	2.786952278	5.998072506	8.023245235	1.192150153	4.414601973	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.872616375
BA2473R	BA2473D	2383	Both	no	no	no	no	Female	Female	White		White	6			73	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	73	56	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	4	Ruxolitinib|AG-221|Cytarabine|Azacitidine	4	Induction|Experimental|Maintenance|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	90	Standard Chemotherapy	Cytarabine	Supportive/Palliative Care	8	Dead	560	Dead-Unknown	NA	5		NA	NA	NA	1	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20] "	NA	NA	This test has not detected clonal abnormalities in the cells analyzed. Subtle structural changes cannot be ruled out due to the limitations of resolution. Small percentage of tumor cells with chromosome abnormalities may not be detected due to the limited number of cells examined. (Cytogenetics)	24	FALSE	"CD34 positive blasts are rare, <1% (Bone Marrow Immunophenotyping)"	FALSE	FALSE	NA	1.8	FALSE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	1.737768256	5.478733315	1.401613392	3.74312437	5.665134154	-2.155980085	5.43585497	no	yes	no	no	no	no	yes	NA	NA	NA	NA	NA	NA							0.473527152
BA2866R	BA2866D	2465	Waves1+2	yes	yes	yes	no	Male	Male			HispNative	4			58	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	58	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	4	"Sorafenib|Hydroxyurea|7+3 (Cytarabine, Idarubicin) plus Sorafenib|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Induction|Experimental	Complete Response	Standard Chemotherapy	1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Alive	192	Alive	NA	57	24	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"47,XY,t(8;22)(p11.2;q11.2),+19[20] "	NA	NA	"t(8;22) clone observed, consistent with a neoplastic process "	NA	NA	Positive (CD34-Dim)	FALSE	FALSE	NA	100.2	TRUE	negative	0	negative	RUNX1 (p.S322Ffs*278; 45.9%)			"ATM (p.P604S; VAF ~50%)|PHF6 (p.G306R; VAF ~75%)|RUNX1 (p.S322fs*278 (Single base pair insertion, frame shift  mutation); MAF ~40%)"					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	3.211050099	4.200618381	4.438222665	2.453272792	6.219334679	1.279235877	6.882992955	yes	yes	yes	no	yes	yes	yes	1.857376654	NA	2.194242311	NA	1.76733069	-1.380797726	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.582914108
BA2212R	BA2212D	2035	Waves1+2	yes	yes	yes	yes	Male	Male	Asian		Asian	2			75	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	75	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"Vidaza|Decitabine|Fludarabine, Cytarabine"	2	Salvage|Supportive/Palliative Care			NA	Standard Chemotherapy	"Fludarabine, Cytarabine"	Salvage	-1	Dead	159	Dead-Disease	0	27	2	0	NA	60.2	8.4	29.4	NA	12	15	4.8	0.98		30.7	9.3	"46,XY,t(1;12)(p32;p13)[3]/46,XY[17]"	215	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[197],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[194],(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[199],(PML,RARA)x2[199],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[198]"	121	TRUE	"CD2(-), CD4(-),CD7(-), CD10(partial +), CD11b(-), CD13(dim +), CD14(-), CD38(variably +/small subset -), CD45(dim to moderately +), CD56(-), CD64(-), CD117(variably +), HLA-DR(variably +). | Population #2 (0.48% of total events) comprises small cells with the following immunophenotype: CD5(- to partial dim +),CD10(-), CD19(slighty bright +), CD20(bright +), CD38(-), CD45(+), kappa(-), lambda(dim +)."	TRUE	FALSE	7.5	3.09	FALSE	negative	0	negative		ASXL1 (p.G646Wfs*12; 39.3%)		ASXL1 (G646fs*12; MAF 37.0%)|BCOR (S1608*; MAF 3.0%)|KRAS (G12R; MAF 5.0%)|STAG2 (Q932fs*6; MAF 91.0%)|SUZ12 (E601fs*10; MAF 38.0%)|TET2 (C127fs*92; MAF 6.0%)|TET2 (S1870*; MAF 45.0%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	-0.054271382	5.085166296	4.37379318	3.634576735	4.359065242	-1.987265845	6.025763653	no	yes	yes	no	no	no	yes	0.463390852	NA	2.547209759	NA	1.951323828	-0.470546713	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.589081697
BA2477R	BA2477D	2219	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			67	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	5	"AG-120|Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MiDAC"	5	Consolidation|Salvage|Induction|Experimental|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	864	Dead-Other	0	93	94	0	0	1	2.8	1.9	0.1	20	30	2.4	1.23	M4	31.2	10.1	"46,XY[20]"	NA	96.3	Normal	30	TRUE	"partial CD7, CD13, dim CD15, CD33, CD38, CD58, CD117, dim CD123, HLA-DR and partial MPO+. (BM) | dim CD4, CD11b, variable CD13, partial CD14, dim CD15, variable CD16, CD33, CD38, CD58, CD64, CD123 and HLA-DR. (Promonocyte/blast equivalents)"	TRUE	TRUE	NA	125.16	TRUE	negative	0	positive				DNMT3A (p.R882H; MAF 46% )|FLT3 (p.V592D; MAF 43% )|IDH1 (p.R132H; MAF 46%  )|NPM1 (p.W288fs*12 MAF 47% )|SETBP1 (p.K459E; MAF 50% )					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.212748832	0.770833241	-0.662300846	1.679457033	5.68342897	-0.252053019	4.064014872	no	no	no	no	no	yes	no	-0.071455735	NA	-0.209140622	NA	2.28945731	-1.598388241	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.436098683
BA2244R	BA2244D	2219	Waves1+2	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			67	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	68	261	Post-Chemotherapy	Remission	Leukapheresis	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	5	"AG-120|Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MiDAC"	5	Consolidation|Salvage|Induction|Experimental|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	864	Dead-Other	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XY,t(4;8)(q21;p23)[2]/46,XY[18]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	positive		ASXL1 (p.G645Vfs*58; 10.0%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	0.639030692	-0.902763299	1.170183876	1.087265128	6.931528555	-3.531597099	1.727517542	no	no	no	no	yes	no	no	NA	NA	NA	NA	NA	NA							0.56321955
BA3089R	BA3089D	2219	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1			67	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	68	429	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	5	"AG-120|Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MiDAC"	5	Consolidation|Salvage|Induction|Experimental|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	864	Dead-Other	0	75	68	1.7	0	17.4	0.9	12.2	0	21	22	3.4	0.9	M4	40.6	13.6	"46,XY[20] "	NA	95.8	Normal	91	TRUE	"CD7, CD13, CD33, CD38, CD58, CD117, CD123, partial MPO+ "	TRUE	TRUE	6.4	20.31	FALSE	negative	0	positive				"DNMT3A (p.R882H; MAF 46%)|FLT3 (p.V592D; MAF 39%)|IDH1 (p.R132H, MAF 39%)|IDH2 (p.R140Q; MAF 39%)|NPM1 (p.W288fs*12; MAF 41%)|NRAS (p.Q61P; MAF 40%)|SETBP1 (p.K459E; MAF 40%)"					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.861265344	2.195311478	-0.19780801	4.845288281	4.866758077	-1.536158945	1.420183931	yes	no	no	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.357895233
BA2685R	BA2685D	2266	Waves1+2	yes	yes	yes	no	Male	Male			White	6			67	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Not specified	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	67	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	4	"Vidaza|Cytarabine|3+7 (Cytarabine, Daunorubicin)|Decitabine"	4	Consolidation|Salvage|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	8	Standard Chemotherapy	Decitabine	Salvage	83	Dead	230	Dead-Unknown	NA	60		NA	NA	NA	0	NA	NA	NA	NA	NA	NA		NA	NA	"46, XY, del (3) (q12q21) [2]/47, idem, +8[11]/47, idem, der (15) t (1;15) (q21;p11.2) [7]"	NA	NA	Trisomy 8 is detected in 28% of cells.	NA	NA	"Positive for CD34, CD117, HLADR, CD33, CD13 and Negative for CD11b and CD64 (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	NA	NA	negative	0	negative		ASXL1 (p.G646Wfs*12; 28.0%)		BCOR (p.KB39Qfs*5; MAF 45%)|KIT (p.T916A; MAF 50%)|NRAS (p.G12A; MAF 24%)|SRSF2 (p.P95R; MAF 40%)		yes			yes	yes	Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	1.142242428	5.268147981	3.555177543	4.757286868	5.284347448	-0.452652967	5.519507027	no	yes	yes	yes	no	yes	yes	-1.86929058	NA	1.345810662	NA	-0.309419371	-5.111729838	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.52871349
BA2273R	BA2273D	2544	Waves1+2	yes	yes	yes	no	Male	Male			White	6			67	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"Cytarabine|3+7 (Cytarabine, Daunorubicin)"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	Cytarabine	Consolidation	35	Dead	165	Dead-Unknown	NA	80	10	2	NA	68	4	8	NA	8	10	3.9	0.85		21.2	7.2	"46,XY[20]"	NA	110.4	The translocations commonly seen in AML are not detected. Loss of RARA and CBFB genes are detected in 14-39% of cells.	84	FALSE	"These are positive for CD34, CD117, HLADR, CD33, CD13, CD14 and CD11b. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	5.9	0.9	FALSE	negative	0	negative			TP53 (p.Y220C; 42.0%)	BCOR (MAF 49%)|IDH1 (p.R132C MAF 12%)|JAK2 (p.V617F; MAF 43%)|MLL |NF1 (MAF 18%)|TP53 (p.Y220C; MAF 35%)					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	2.360639815	2.685933155	3.915315683	4.815490798	4.53948778	-4.259329304	1.547916899	no	no	yes	yes	no	no	no	-3.136748761	NA	2.964278048	NA	-3.849925814	-2.11926571	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.603377612
BA2659R	BA2659D	2057	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	mono		86	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	86	0	Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	3	AG-221|Azacitidine|Hydroxyurea	3	Hypomethylating/Low Dose Cytarabine|Consolidation|Experimental			NA	Standard Chemotherapy	Hydroxyurea	Consolidation	55	Dead	596	Dead-Disease	0	23		0	0.8	8.6	19	59.5	0	16	15	3.4	1.52		27.8	9	"47,XY,+8[20]"	398	97.5	"(FISH) was performed with a chromosome 8 probe, listed below. 95/100 (95%) interphase cells scored had three signals, consistent with trisomy 8 and the metaphase karyotype. "	299	TRUE	"dimCD7, CD13, dimCD14, dimCD20, CD33, CD34, CD117, CD123, dim HLA-DR and MPO positive"	TRUE	TRUE	7.6	10	FALSE	negative	0	negative				BCOR (p.S1139*; MAF 80%)|CEBPA (p.R343fs*79; MAF 40%)|DNMT3A (p.E285*; MAF 45%)|DNMT3A (p.G707fs*72; MAF 45%)|IDH2 (p.R140Q; MAF 40%)|SRSF2 (p.P95H; MAF 40%)		yes			yes	yes	Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	1.236826765	6.12729526	4.349464211	4.250005997	6.66836925	1.701306886	6.872750383	no	yes	yes	yes	yes	yes	yes	4.668485416	NA	0.649798362	NA	2.630329301	0.58893217	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.711824864
BA2124R	BA2124D	2310	Waves1+2	yes	yes	yes	yes	Male	Male			White	3			67	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Skin cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|IDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	IDAC	Consolidation	-1	Alive	579	Alive	NA	71.5	56	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA	"CD33, CD38, CD56, CD117, and myeloperoxidase"	FALSE	TRUE	NA	16.24	FALSE	negative	0	positive				NPM1 (p.Trp288fs; MAF 16.4%)|TET2 (p.Leu1081fs; MAF 42.3%)|TET2 (p.Leu1780fs; MAF 46.3%)|ZRSR2 (p.Arg126*; MAF 97.7%)				yes	yes		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.403935493	2.882795628	0.600021705	2.611627168	4.185154904	0.246524714	1.210297225	no	no	no	no	no	yes	no	-2.17245693	NA	-3.481666933	NA	3.247267041	-6.770271171	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.262758871
BA2369R	BA2369D	2276	Waves1+2	yes	yes	yes	yes	Male	Male			White	6			75	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	75	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Vidaza	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Vidaza	Supportive/Palliative Care	-1	Alive	302	Alive	NA	60	50	NA	NA	NA	2	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA		NA	NA	"These are positive for HLA-DR, CD34,CD117, CD33, CD11B, CD64 but Negative for CD13, CD14, CD16, MPO, TDT and all B and T cell markers (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	25	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.949324617	4.588703973	0.901900098	3.893597131	6.258542764	2.476413292	6.856405817	yes	yes	no	yes	yes	yes	yes	4.69825902	NA	2.078047063	NA	1.479771708	2.876555803	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.756513071
BA2400R	BA2400D	2426	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			44	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	44	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"HiDAC|3+7 (Cytarabine, Daunorubicin)"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	8	Standard Chemotherapy	HiDAC	Consolidation	99	Alive	1856	Alive	0	65	11.2	3.5	0	76.7	0	8.6	0	19	11	2.8	0.53	M2	23.7	7.8		197	100.4	Normal	222	TRUE	"CD13, CD33, CD117, CD123, dim HLA-DR and MPO | CD11b, CD13, CD33, CD117, CD64, CD123, and dim HLA-DR. (Blasts with monocytic differentiation (about 10% of blasts).)"	FALSE	TRUE	6.1	2.41	FALSE	negative	0	positive				FLT3-ITD (MAF 2%)|IDH1 (p.R132H; MAF 44%)|NPM1 (p.W288fs*12; MAF 44%)|PTPN11 (p.R265Q; MAF 3%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.416935615	2.084960335	-1.082918838	4.455039293	5.412822002	-1.99997129	1.862032036	no	no	no	yes	no	no	no	-3.024002788	NA	0.764230773	NA	1.710249537	0.054122154	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.514399553
BA2762R	BA2762D	2061	Waves1+2	yes	yes	yes	yes	Female	Female	White		White	2			22	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	22	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	3	"Fludarabine, Melphalan|Crenolanib|7+3 (Cytarabine, Idarubicin) plus Crenolanib"	3	Allogeneic - Sibling|Induction|Experimental	Complete Response	Standard Chemotherapy	39	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Sibling	-1	Alive	603	Alive	0	63	42	0	NA	32.7	4.4	26.6	NA	27	39	3.1	0.68		19.3	6	"46,XX[20]"	NA	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[199],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2[199],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con3'CBFBx2)[200]"	176	TRUE	"CD2(-), CD4(partial dim +), CD7(variably +), CD11b(-), CD13(+), CD14(-), CD15(partial +), CD16(-), CD33(variably +), CD34(partial+), CD36(-), CD38(variably +), CD45(variably +), CD56(-), CD64(-), CD117(+), HLA-DR(partial +)."	TRUE	TRUE	6.3	22.01	TRUE	positive	0.666666667	positive				FLT3-ITD (K602_W603INSCEYDLK; MAF 33.0%)|NPM1 (K292FS*6+; MFA 35.0%)|TCL1A (E54FS*28; MAF 44.0%)|WT1 (A382FS*4; MAF 40.0%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	1.941731631	4.062012542	0.935170536	3.905948463	5.343262872	0.25032345	4.267009067	no	yes	no	yes	no	yes	no	0.742463452	NA	1.971513747	NA	1.332976384	0.288457773	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.582672285
BA2312R	BA2312D	2537	Waves1+2	yes	yes	yes	yes	Female	Female			White	3	mono		62	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	7	Dead	169	Dead-Disease	NA	20.4		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"partial weak  CD7, CD13, CD33, CD34, CD117, myeloperoxidase, and partial  HLA-DR"	TRUE	TRUE	NA	NA	NA	negative	0	negative				CEBPA (c.68dup; MAF 21%)|DNMT3A (c.2645G>A; MAF 43.9%)|NRAS (c.35G>A; MAF 30.2%)|WT1 (c.1140dup; MAF 4%)|WT1 (c.1142C>A; MAF 36.4%)					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	3.22332801	5.440675948	1.956829098	5.709483968	6.015816515	-0.586590828	3.107132192	yes	yes	no	yes	no	yes	no	2.659654122	NA	3.4196977	NA	-1.925012677	0.229135137	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.63641531
BA2813R	BA2813D	2206	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	5			64	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	64	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"7+3 (Cytarabine, Idarubicin)|Fludarabine, Cyclophosphamide, Thiotepa, TBI"	2	Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	41	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, Thiotepa, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	636	Alive	0	83	74	0	NA	13	0	13	NA	15	45	4	1.27		25.2	8.7	"46,XY[20]"	NA	NA	Normal	39	FALSE	"Positive (\The large majority of cells (around 90%) are an abnormal population of myeloblasts. The myeloblasts are positive for CD33, CD13, HLA-DR, and CD117, and show uniform aberrant expression of CD7. A subset of the blasts are positive for myeloperoxidase, and a smaller subset shows dim aberrant expression of CD19. The blasts are almost entirely negative for CD34.\\)\"""""	TRUE	TRUE	6	53.3	TRUE	positive	0.428571429	positive				DNMT3A (c.2645G>A; p.R882H)|FLT3-ITD (FLT3-ITD 63bp insertion)|NPM1 (c.859_860insTCTG; p.W288fs)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	0.179956005	2.325358651	2.573099734	3.032175147	5.256419896	0.314328185	2.650421025	no	no	no	no	no	yes	no	-3.878992673	NA	1.173357504	NA	-1.643183634	-1.743892595	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.40878348
BA2211R	BA2211D	2471	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"Azacitidine|7+3 (Cytarabine, Idarubicin) plus Sorafenib"	2	Consolidation|Induction	Complete Response i	Standard Chemotherapy	17	Standard Chemotherapy	Azacitidine	Consolidation	34	Dead	142	Dead-Disease	0	95	92.9	0	0.7	3.6	1.4	1.4	0.1	101	55	3.2	0.83	M1	37	12.4	"46,XX[20]"	697	95.1	normal	42	TRUE	"CD13, CD33, CD38, CD56, CD58, partial CD64, CD117, CD123, and MPO positive"	FALSE	TRUE	6.3	166.91	TRUE	positive	1	positive				FLT3-ITD (MAF 50%)|NPM1 (p.W288fs*12; MAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.933230346	2.703472537	4.717894908	3.113839381	5.628284641	1.250811855	1.064894854	no	no	yes	no	no	yes	no	-2.540251309	NA	-1.547782045	NA	-2.590122307	-5.760219166	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.421283887
BA2171R	BA2171D	2321	Waves1+2	yes	yes	yes	yes	Female	Female	Unknown	UNKNOWN	White	1			73	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	3	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	3	Dead	4	Dead-Disease	0	90	98.4	0	0	0.8	0	0.8	0.1	18	36	2.9	1.44	M1	25.9	8.2	"46,XX[20]"	NA	90.6	Normal	19	FALSE	"CD13, CD33, CD38, CD58, dim CD64, CD117, CD123, and MPO"	FALSE	TRUE	7.7	122.89	TRUE	positive	0.428571429	positive				DNMT3A (p.R326P; MAF 50%)|FLT3-ITD (MAF 46%)|IDH2 (p.R140Q; MAF 40%)|NPM1 (p.W288fs*12; MAF 40%)					no		Found	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.892973411	2.219669733	2.386926302	2.856433488	6.127736219	-1.205668621	0.53157569	no	no	no	no	yes	no	no	-4.150171378	NA	-0.132338062	NA	-0.443297346	-4.222833239	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.407330904
BA2746R	BA2746D	2522	Waves1+2	yes	yes	yes	yes	Female	Female		HISPANIC	HispNative	5			56	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	56	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|GCLAC (GCSF, Clofarabine & Cytarabine)|Fludarabine, Cyclophosphamide, Thiotepa, TBI"	4	Consolidation|Salvage|Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	27	Standard Chemotherapy	"GCLAC (GCSF, Clofarabine & Cytarabine)"	Salvage	-1	Dead	323	Dead-Disease	0	1.5	2	0	NA	23	57	13	NA	67	33	3	1.87		29	9.5	"46,XX[19]"	NA	NA	Normal	28	FALSE	"Positive (\Approximately 55% of assayed cells are an abnormal population of immature monocytic cells (consistent with monoblasts and promonocytes). Approximately 30% of assayed cells are mature monocytes. Both the immature and mature monocytic cells show uniform aberrant expression of CD56. A small population of myeloblasts (CD117+/CD34neg) is present, accounting for less than 5% of assayed cells.)\""	FALSE	FALSE	7.5	58.7	TRUE	positive"""	NA	NA	NA	NA	NA		0.111111111	positive				ASXL1 (c.1954G>A; p.G652S)|DNMT3A (c.2644C>T; p.R882C)|FLT3 (c.2503G>T; p.D835Y)|FLT3-ITD (FLT3-ITD 21 bp insertion)|NPM1 (c.859_860insTCTG; p.W288fs)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	2.101386714	2.772192643	2.622837124	3.943512255	6.506985455	-0.894523655	5.456367319	no	no	no	yes	yes	yes	yes	5.888637667	NA	-2.748515357	NA	2.913840632	4.8292569	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.738604804
BA2798R	BA2798D	2395	Waves1+2	yes	yes	yes	no	Male	Male	White		White	6	N/A		71	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	71	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	5	"AG-120|KB004|Lenalidomide|Venetoclax (ABT-199), Azacitidine|Decitabine"	4	Salvage|Induction|Experimental|Maintenance	Refractory	Standard Chemotherapy	32	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Salvage	77	Dead	548	Dead-Unknown	NA	75	26	2	NA	15	8	43	NA	118	53	3.8	1.26		22.9	7.7	"46,XY,del(7)(q32),add(13)(p11.2)[15]"	NA	81.8	"This test has detected 7q deletion and an abnormal chromosome 13 in all 15 metaphase cells analyzed. 7q deletion is the most cp,,om abnormality in MDS and other types of myeloid malignancies."	24	TRUE	"These are positive for CD34, CD117, HLADR, CD33 and CD13 (Bone Mrrow Immunophenotyping)"	FALSE	TRUE	8.7	5	FALSE	negative	0	negative	RUNX1 (p.G408Vfs*193; 34.8%)	ASXL1 (p.Q428*; 43.9%)		ASXL1 (p.Q428*; MAF 44%)|CEBPA (p.A4S; MAF 47%)|IDH1 (p.R132C; MAF 45%)|JAK2 (p.V617F; MAF 57%)|MLL |RUNX1 (p.G406Vfs*193; MAF 39%)|TET2 (p.R1366S; MAF 40%)					no		Found	TRUE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	2.4904206	4.371994177	2.569227321	5.165316956	6.043172961	-0.349152177	4.540203293	no	yes	no	yes	no	yes	yes	0.495608622	NA	2.981371069	NA	-2.996519295	-0.256000905	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.647899325
BA2883R	BA2883D	2395	Waves1+2	no	no	no	no	Male	Male	White		White	6	N/A		71	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	71	57	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"AG-120|KB004|Lenalidomide|Venetoclax (ABT-199), Azacitidine|Decitabine"	4	Salvage|Induction|Experimental|Maintenance	Refractory	Standard Chemotherapy	32	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Salvage	77	Dead	548	Dead-Unknown	NA	33		NA	NA	NA	8	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,del(7)(q32),add(13)(p11.2)[20]"	NA	NA	"This test has detected 7q deletion and an abnormal chromosome 13 in all 15 metaphase cells analyzed. 7q deletion is the most cp,,om abnormality in MDS and other types of myeloid malignancies."	22	FALSE	"They are positive for CD34, HLADR, CD117, CD13 and MPO and negative for TDT. (Bone Marrow Immunophenotyping)"	FALSE	FALSE	NA	NA	NA	negative	0	negative	RUNX1 (p.G408Vfs*193; 20.4%)	ASXL1 (p.Q428*; 43.4%)							no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	5.177720843	5.594015376	4.345336792	3.990593815	6.802398673	-0.015069307	5.186215225	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.681423074
BA2288R	BA2288D	2515	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	HispNative	7			72	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	unknown	73	0	Residual Disease	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA	20		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.089140122	5.817641949	4.731934169	4.929432752	5.927537475	-2.269707889	6.038533661	yes	yes	yes	yes	no	no	yes	-0.040928846	NA	0.342175045	NA	1.474707582	-0.341666993	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.631824852
BA2801R	BA2801D	2146	Waves1+2	no	no	no	no	Male	Male		NON-HISPANIC	White	6			72	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	y	Lung Cancer	y	n	y	n	n	n	n	n	MYELODYSPLASTIC SYNDROMES	"Myelodysplastic syndrome, unclassifiable"	NonAML	MYELODYSPLASTIC SYNDROMES	"Myelodysplastic syndrome, unclassifiable"	73	0	Residual Disease		Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Vidaza	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Vidaza	Supportive/Palliative Care	268	Dead	292	Dead-Unknown	NA		4	1	NA	13	5	23	NA	13	57	2.5	1.83		25	8.2		NA	105.9		32	TRUE		NA	NA	5.8	66.7	TRUE	negative	NA	negative	RUNX1 (p.S322Nfs*277; 44.4%)	ASXL1 (p.R693*; 38.7%)		"ASXL1 (p.R693* MAF 48%)|EZH2 (p.1131T, MAF 71%)|EZH2 (p.C565R MAF 27%)|JAK2 (p.V617F, MAF 26%)|KRAS (p.Q61P, MAF 13%)|RUNX1 (p.S322Nfs*277, MAF 42%)|TET2 (p.Q1813*, MAF 51%)|TET2 (p.Q866Rfs*14, MAF 39%)|ZRSR2 (p.R295*, MAF 97%)"				yes	yes		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	7.165478419	7.406090488	6.051098104	-0.720294248	6.92625028	1.26748234	6.203141395	yes	yes	yes	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.740005187
BA3407R	BA3407D	2691	Waves3+4	no	no	no	no	Female	Female		HISPANIC		6		KMT2A_re	29	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	29	38	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Bu/Cy/ATG|HiDAC|3+7 (Cytarabine, Daunorubicin)|Etoposide, Mitoxantrone|Clofarabine, Cytarabine"	4	Consolidation|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"Clofarabine, Cytarabine"	Re-induction	6	Dead	246	Dead-Disease	NA	1		NA	NA	NA	2	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,t(6;11)(q27;q23)[18]/46,XX[2]"	NA	NA	"This test has detected  a 6;11 translocation in 18 of 20 metaphase cells analyzed. The translocation has led to rearrangement of the MLL gene as shown by FISH. This result is consistent with the diagnosis of AML. (Cytogenetics) | Except for 9;11 translocation, all translocations involving the MLL gene in AMLare associated with an unfavorable prognosis. (Cytogenetics (Continued))"	NA	NA	"Myeloblasts 1% positive for CD34, CD117, HLADR, CD13, CD33, for TDT and all B and T-cell markers. (Bone marrow Immunophenotyping)"	FALSE	TRUE	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.520106979	6.593112181	6.454558035	6.125525069	6.888677084	1.802030755	6.010467076	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.857884897
BA3030R	BA3030D	2046	Waves1+2	no	no	no	no	Female	Female	Unknown	UNKNOWN	White	1			70	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	n		n	n	n	n	y	n	n	n	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	"Atypical chronic myeloid leukaemia, BCR-ABL1 negative"	NonAML	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	"Atypical chronic myeloid leukaemia, BCR-ABL1 negative"	70	0	Unknown		Bone Marrow Aspirate	y	y	y	y	y	y	1	Targeted Therapy - Kinase Inhibitor(s)	1	Hydroxyurea	1	Induction	Unknown	Targeted Therapy - Kinase Inhibitor(s)	-1	Targeted Therapy - Kinase Inhibitor(s)	Hydroxyurea	Induction	-1	Dead	33	Dead-Disease	1.6	13	6.8	0.8	0	5.7	2.5	72.1	5.7	24	36	2.9	0.95		29.1	8.9	"46,XX[20]"	953	105.1	Normal	208	TRUE	"CD13, CD33, CD34, partial CD117, CD123, HLA-DR"	FALSE	TRUE	6.7	109.77	TRUE	positive	0.428571429	negative				FLT3-ITD (MAF 45%)|IKZF1 (p.N159S ; MAF 45%)|SF3B1 (p.K666N ; MAF 45%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	5.106296016	7.021254246	1.914616164	2.908910573	7.060209939	2.151148373	7.054988955	yes	yes	no	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.617247039
BA2588R	BA2588D	2441	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			59	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	59	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)|MiDAC"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	Re-induction	4	Dead	597	Dead-Disease	0	30	10.5	0	0	19.7	0.9	71.4	0	77	27	3.4	1.01	M2	26.4	8.9	"46,XY[20]"	479	96.4	Normal	101	TRUE	"CD13, CD33, CD117, CD123, and HLA-DR"	FALSE	TRUE	6.4	4.4	FALSE	negative	0	positive				DNMT3A (p.R882C; MAF 40%)|NPM1 (p.W288fs*12 ; MAF 40%)|PTPN11 (p.K70R; MAF 40%)|SOCS1 (p.Q210H ; MAF 55%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.945305298	3.897466876	-0.673357481	6.324521891	5.948759191	1.700409312	6.72932018	yes	yes	no	yes	no	yes	yes	2.798860036	NA	0.18649779	NA	0.799103192	-2.019135299	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.678833199
BA2296R	BA2296D	2497	Waves1+2	yes	yes	yes	yes	Female	Female	White	HISPANIC	HispNative	1	bi		46	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	46	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	120	Alive	1950	Alive	NA	40		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"46,XX[19] "	NA	NA	Normal	NA	NA	"CD13, CD33, CD34, partial CD64, CD71, CD117, CD123, and HLA-DR "	TRUE	TRUE	NA	NA	NA	negative	0	negative				CEBPA (p.R297P ; MAF 50%)|CEBPA (p.T98fs*10 ; MAF 40%)|TET2 (p.Q758*; MAF 45%)					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	2.069173226	3.83567059	1.958438172	4.633164221	5.740905628	-1.709760183	6.609553378	no	yes	no	yes	no	no	yes	0.46893509	NA	-0.807525767	NA	0.800662931	1.744121854	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.53424193
BA2300R	BA2300D	2037	Waves1+2	yes	yes	yes	yes	Male	Female;Male			White	3			79	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	79	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	1	Dead-Disease	NA	86	87	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"43-45,X,-Y,del(5)(q22q35),del(7)(q22),+8,-9,add(9)(p13),+11,-13,-14,add(16)(q24),-17,-18,del(20)(q11.2q13.2),+2-3mar[cp21]"	NA	NA	5q31 (EGR1): deletion present  8q22 (RUNX1T1): gain present  11q23 (KMT2A; also known as MLL): gain present 	27	FALSE		NA	NA	NA	70.01	TRUE	negative	0	negative			TP53 (p.X225_splice; 93.2%)	KIT (p.Asp816Val; MAF 44.4%)|TP53 (p.?; MAF 91%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	2.146516301	1.687013274	3.253586287	2.578363439	5.444974816	-3.774925246	6.188149436	no	no	yes	no	no	no	yes	-0.453491204	NA	1.980559195	NA	1.145422329	4.699747774	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.470625428
BA2903R	BA2903D	2161	Waves1+2	yes	yes	yes	yes	Male	Male		HISPANIC	HispNative	6			59	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	59	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	6	"HiDAC|Lenalidomide|3+7 (Cytarabine, Daunorubicin)|Azacitidine|Etoposide, Mitoxantrone|Cytarabine, OXi4503"	5	Salvage|Induction|Experimental|Frontline|Re-induction	Refractory	Standard Chemotherapy	8	Targeted Therapy - Other	"Cytarabine, OXi4503"	Experimental	4	Dead	207	Dead-Unknown	NA		1	9	NA	1	6	58	NA	135	44	3.2	0.79		21.6	7.3		NA	85		22	TRUE		NA	NA	5.9	9.1	FALSE	negative	0	negative		ASXL1 (p.G646Wfs*12; 50.0%)		"NRAS (p.Q61H, MAF 21%)|RAD21 (p.G273V ,MAF 64%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	8.311287425	7.988988042	5.940210255	2.46818634	8.504123649	2.126420627	6.480130797	yes	yes	yes	no	yes	yes	yes	7.586259578	NA	-2.71095414	NA	3.121220847	0.394052054	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.932152512
BA2545R	BA2545D	2488	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			37	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Not specified	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	37	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Unknown	Standard Chemotherapy	24	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Mismatched Unrelated Donor	-1	Alive	1894	Alive	1.1	1		2.8	0.2	30.3	5.2	60.4	0	34	20	4.2	0.93		39.2	14.4	"46,XY[20]"	154	94.9	Normal	162	TRUE		NA	NA	7.5	5.35	FALSE	negative	0	negative				TET2 (p.L307R; MAF 51%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	4.209889629	7.138312311	4.803929087	6.490027958	7.431381976	0.2866572	7.364357915	yes	yes	yes	yes	yes	yes	yes	3.202228932	NA	-2.52010234	NA	3.067219867	0.755291089	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.668665732
BA2840R	BA2840D	2468	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			78	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	78	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	3	"Ruxolitinib|Hydroxyurea|Decitabine, Ruxolitinib"	3	Induction|Experimental|Maintenance	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"Decitabine, Ruxolitinib"	Induction	7	Dead	24	Dead-Unknown	0	60		0	1.6	43.7	9.4	29.7	5.5	27	39	2	0.41	M7	26.2	8.2	"46,XX,t(7;13)(q22;q12),del(20)(q11.2)[1]/46,sl,dup(1)(p25),del(2)(q21q23),add(8)(q13q22)[3]/46,sdl,add(5)(p15)[8]/46,sdl,add(12)(p13)[3]/46,sdl,add(12)(p13),add(13)(p12)[4]/46,XX[1]"	1024	89.4	"RUNX1T1 (8q21.3): 35% of cells had three signals for RUNX1T1 on 8q. No evidence for t(8;21). | FISH was also performed with a probe for chromosome 20, so that the stemline clone and all subclones could be followed by interphase FISH. 88/100 cells were missing a signal for D20S108 (20q12), consistent with the deletion of 20q seen in all abnormal cells above."	17	FALSE	"CD33, CD34 (subset), CD41, CD58, CD61 and Factor-8 positive"	FALSE	TRUE	5.5	6.28	FALSE	negative	0	negative				GATA1 (p.M1V; MAF 32%)|MPL (p.S505N; MAF 70%)|TET2 (p.V636fs*3; MAF 46%)					no		Found	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	2.389783263	5.229620367	3.113215168	3.004847012	3.905121215	1.123151257	-0.783198133	no	yes	yes	no	no	yes	no	-3.614447976	NA	-1.216998225	NA	-10.03921007	-3.911735854	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.589749061
BA2528R	BA2528D	2531	Waves1+2	yes	yes	yes	no	Male	Male	Declined	NON-HISPANIC	White	1			75	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|Azacitidine"	3	Induction|Frontline|Maintenance	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	Azacitidine	Maintenance	-1	Alive	1936	Alive	0	23	rare	1	NA	51	11.2	36.8	NA	23	16	3.4	0.55	M2	27.1	9.1	"46,XY[19]"	178	88	Normal	28	FALSE	"CD13, CD33, CD34, CD38, CD117, CD123, dim HLA-DR, TdT, and MPO positive"	FALSE	TRUE	6.4	1	FALSE	negative	0	negative				DNMT3A (p.R882H; MAF 41%)|SF3B1 (p.K700E; MAF 43%)	yes				yes		Found	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	2.207866474	5.251435933	1.863751888	5.930389564	6.06971778	-1.160989408	6.804250513	no	yes	no	yes	yes	no	yes	1.519290718	NA	0.440771747	NA	2.286113282	-2.698604555	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.58000844
BA2646R	BA2646D	2535	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1		PML-RARA	62	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"ATRA, Arsenic Trioxide"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Induction	-1	Alive	1719	Alive	0	90		0.9	3.5	35.7	1.7	5.2	0.7	28	24	2.8	1.12	M3	19.8	7	"46,XY,t(3;16)(p13;q22),t(13;14)(q32;q24),t(15;17)(q22;q21)[20]"	519	85.7	"PML/RARA: 98/100 cells (98%) had a 1 red/ 1 green/ 2 yellow signal pattern, reflecting PML/RARA fusion and consistent with the 15;17 translocation observed in the metaphase karyotype."	38	TRUE	"CD13, CD33, CD38, CD58, CD64, dim CD71, CD123, CD117, MPO positive -FISH for t(15;17)"	TRUE	TRUE	5.4	9.87	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.815821027	1.164885487	4.944501719	2.953485987	6.028575157	-3.311376794	6.138977429	no	no	yes	no	no	no	yes	-5.782549339	NA	-2.66633258	NA	2.406596753	-3.974045796	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.446559981
BA2240R	BA2240D	2181	Waves1+2	yes	yes	yes	yes	Female	Female	White	HISPANIC	HispNative	1			61	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Sorafenib|Hydroxyurea"	4	Consolidation|Induction|Experimental|Re-induction	Complete Response	Standard Chemotherapy	7	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Experimental	61	Dead	263	Dead-Disease	0			0	0	30.8	10.3	0	0.3	195	75	3.6	0.68		25.4	8.2		1033	95.5		49	TRUE		NA	NA	6.7	73.28	TRUE	positive	9	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.475379471	1.712530596	1.419082296	3.58320105	6.143736481	-2.183717161	-1.50723867	no	no	no	no	yes	no	no	-7.036156197	NA	2.320685064	NA	-3.930103674	-0.537382499	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.310445669
BA2926R	BA2926D	2185	Waves1+2	yes	yes	yes	no	Male	Male			White	3			58	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	58	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Supportive/Palliative Care	3	"7+3 (Cytarabine, Idarubicin)|CLAG (Cladribine, Cytarabine, Filgrastim)|Azacitidine"	3	Salvage|Induction|Symptom Control	Refractory	Standard Chemotherapy	10	Supportive/Palliative Care	Azacitidine	Symptom Control	-1	Dead	278	Dead-Disease	NA	44.6		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"[46,XY]"	NA	NA	Normal	NA	NA	"Increased CD117 positive, partial CD34 positive myeloblasts representing approximately 61% of the leukocytes most consistent with acute myeloid leukemia"	FALSE	FALSE	NA	4.17	FALSE	negative	0	negative				ASXL2 (p.Val1277Ala; MAF 89.5%)|DNMT3A (p.Trp297* (NM_175629.2); MAF 82.1%)|IDH1 (p.Arg132Cys (NM_005896.3); MAF 39.1%)					no		Found	TRUE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.285608345	4.188676371	1.459629216	3.12161169	6.877880914	-0.888905434	3.842618375	no	yes	no	no	yes	yes	no	1.272715312	NA	0.330004536	NA	0.17781668	-1.161771793	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.512126253
BA2272R	BA2272D	2052	Waves1+2	yes	yes	yes	yes	Male	Male	White	HISPANIC	HispNative	1			12	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	12	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	4	"Cytarabine|Sorafenib|Cytarabine, Daunorubicin, and Etoposide|Busulfan, Cyclophosphamide"	3	Induction|Allogeneic - Mismatched Unrelated Donor|Re-induction	Refractory	Standard Chemotherapy	0	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Mismatched Unrelated Donor	-1	Alive	1905	Alive	0	70	85	0	1.8	14.7	51.4	8.3	50	28	150	3.7	0.64	M4	14.3	4.6	"47,XY,+8[19]/46,XY[1]"	NA	132.4	RUNX1T1 signal consistent with the trisomy 8 clone 	49	FALSE	"dimCD11b, dimCD13, CD14, dimCD33, CD64, variable CD123, HLA-DR CD13,dimCD33, dim variable CD34, CD117, CD123, HLA-DR"	FALSE	TRUE	7.1	214.49	TRUE	positive	0.538461538	negative				FLT3-ITD (~16 amino acid insertion; MAF 11%)|FLT3-ITD (~8 amino acid insertion; MAF 20%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	0.352673545	1.132098452	3.714700688	3.257945688	6.398787397	-1.891543094	1.817833197	no	no	yes	no	yes	no	no	2.805659749	NA	-0.958881587	NA	2.329566726	6.221074156	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.630938313
BA2306R		2085	Waves1+2	yes	no	yes	yes	Male	Male	Black		AdmixedBlack	6		RUNX1-RUNX1T1	50	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	50	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	n	y	y	n	y	1	Standard Chemotherapy	2	"HiDAC|3+7 (Cytarabine, Daunorubicin)"	2	Consolidation|Induction	Refractory	Standard Chemotherapy	20	Standard Chemotherapy	HiDAC	Consolidation	182	Alive	424	Alive	NA	70	91	0	NA	7	2	0	NA	23	25	2.4	0.66		26.6	8.7	"46,XY,t(8;21)(q22;q22)[20]"	NA	94.7		28	TRUE		NA	NA	6.3	71.1	TRUE	negative	0	negative				"ASXL1 (p.P581R, MAF 46%)|PDGFRB (p.D111N, MAF 52%)|SMC1A (p.R586Q, MAF 96%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.341422887	0.777022585	1.144899545	1.891315265	5.53793534	-1.082918838	8.247178934	no	no	no	no	no	no	yes	-1.92157512	NA	-2.896464076	NA	2.072579693	-0.086911357	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.395638552
BA2842R	BA2842D	2085	Waves1+2	no	no	no	no	Male	Male	Black		Black	6		RUNX1-RUNX1T1	50	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	50	21	Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"HiDAC|3+7 (Cytarabine, Daunorubicin)"	2	Consolidation|Induction	Refractory	Standard Chemotherapy	20	Standard Chemotherapy	HiDAC	Consolidation	182	Alive	424	Alive	NA	8	0	0	NA	12	29	54	NA	19	9	2.3	0.51		22.8	7.5	"46,XY,t(8;21)(q22;q22)[20]"	NA	88.7	RUNX1/RUNX1T1 fusion positive in 6.5% of cells	224	TRUE		NA	NA	5.1	6.8	FALSE	negative	0	negative				"ASXL1 (p.P581R, MAF 46%)|PDGFRB (p.D111N, MAF 52%)|SMC1A (p.R586Q, MAF 96%)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.452819975	6.099369759	4.777012625	5.239657954	7.140703761	-0.224671623	5.843531338	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.925291573
BA2855R	BA2855D	2085	Waves1+2	no	no	no	no	Male	Male	Black		Black	6			50	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	50	73	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"HiDAC|3+7 (Cytarabine, Daunorubicin)"	2	Consolidation|Induction	Refractory	Standard Chemotherapy	20	Standard Chemotherapy	HiDAC	Consolidation	182	Alive	424	Alive	NA	0		NA	NA	NA	0	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	RUNX1/RUNX1T1 fusion negative	126	TRUE	No morphological evidence of acute leukemia (Bone Marrow Immunophenotyping)	FALSE	FALSE	NA	7.7	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.233205037	7.677514287	8.937521285	6.536463494	7.326799017	1.91123401	6.487059292	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.980639801
BA2040R	BA2040D	2085	Both	no	no	no	no	Male	Male	Black		Black	6			50	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	51	249	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"HiDAC|3+7 (Cytarabine, Daunorubicin)"	2	Consolidation|Induction	Refractory	Standard Chemotherapy	20	Standard Chemotherapy	HiDAC	Consolidation	182	Alive	424	Alive	NA	1		NA	NA	NA	6	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	RUNX1/RUNX1T1 fusion negative (Cytogenetics)	94	FALSE	"Positive for CD34, CD117, HLADR, CD13 AND CD33.  (Bone Marrow Immunphenotyping)"	FALSE	TRUE	NA	6.6	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.914065789	8.035502485	5.29947262	6.388882735	7.340820172	2.702852354	6.562768988	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.867132928
BA2765R	BA2765D	2550	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			39	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Leiomyosarcoma	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	40	0	Post-Chemotherapy|Post-Transplant|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|Azacitidine|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	5	Allogeneic - Sibling|Salvage|Induction|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	30	Standard Chemotherapy	Azacitidine	Salvage	4	Dead	232	Dead-Treatment	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,der(7)t(3;7)(q26;q21)[9]/46,XX[11]"	NA	NA		NA	NA	"Increased atypical CD34 positive, CD7 positive myeloblasts"	TRUE	FALSE	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	7.789593022	7.965774198	5.659386122	1.513525492	8.257644209	0.176035548	7.312123905	yes	yes	yes	no	yes	yes	yes	6.28338954	NA	-1.510815882	NA	2.958090143	-1.574034991	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.714073284
BA2904R	BA2904D	2450	Waves1+2	yes	yes	yes	yes	Female	Female			White	3		CBFB-MYH11	60	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Adenocarcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	61	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|IDAC"	2	Consolidation|Induction	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	IDAC	Consolidation	-1	Dead	336	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,inv(16)(p13q22)[20]"	NA	NA		NA	NA	Increased atypical CD34+myeloblasts representing 80%of leukocytes suggestive of recurrent AML.	FALSE	FALSE	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.636696948	3.620454057	0.203542587	4.924859873	6.910045469	-0.282070647	5.952758223	yes	yes	no	yes	yes	yes	yes	2.880415141	NA	1.451133551	NA	-1.161319054	2.97477906	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.750093463
BA2726R	BA2726D	2309	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1			29	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Basal Cell Carcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	29	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Supportive/Palliative Care	5	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Hydroxyurea|Decitabine|Fludarabine, Cyclophosphamide, TBI |Trametinib"	3	Induction|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	5	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	2	Dead	129	Dead-Disease	0	98		2	1	60	13	24	1.7	393	350	2.5	0.69	M5	27.2	9.4	"47,XX,+8,i(8)(q10),del(9)(q21.2q22.3),der(10)t(1;10)(q11;q22)[cp12]/47,idem,add(17)(p13)[8]"	NA	105.4	Normal	18	TRUE	"CD11b, CD13, CD14, CD33, CD56 and bright CD64+"	FALSE	TRUE	5.4	2.42	FALSE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	7.52879494	6.328233409	4.491279927	5.754917397	6.07014346	-1.921727906	3.499478656	yes	yes	yes	yes	yes	no	no	6.531818369	NA	-5.760513886	NA	2.662656909	-0.548336326	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.782345315
BA2234R	BA2234D	2247	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		KMT2A_re	72	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Non-Hodgkins Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	72	1	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	4	"3+7 (Cytarabine, Daunorubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Hydroxyurea"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)"	Salvage	5	Dead	148	Dead-Disease	0	90	90	1.9	0	4.6	89.8	3.7	0.2	NA	NA	2.8	0.93	M5	37.1	11.9	"46,XX,t(1;11)(p32;q23)[20]"	NA	96.6	MLL: 94/100 cells (94%) had the abnormal 1 red/ 1 green/1 yellow signal	33	TRUE	"dim CD4, CD11b, partial CD13, partial CD14, CD15, CD33, partial CD56, CD58, bright CD64, partial CD123 and HLA-DR-positive"	FALSE	TRUE	NA	104.44	TRUE	negative	0	negative				DNMT3A (p.E283*; MAF 30%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	-0.150393344	1.052935154	0.965478501	2.104391455	6.727032134	-3.047881897	4.010295971	no	no	no	no	yes	no	no	3.389457381	NA	-5.605971077	NA	5.93561616	3.461916754	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.629224253
BA2022R	BA2022D	2318	Waves1+2	yes	yes	yes	yes	Female	Female			White	3		PML-RARA	33	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	33	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"ATRA, Arsenic Trioxide"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Consolidation	-1	Alive	559	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M3	NA	NA		NA	NA	This analysis showed evidence of a PML-RARA rearrangement in 177/200 (88.5 percent) interphase cells scored.	26	TRUE	"Large population of CD117pos, CD34neg, HLA-DR neg myeloblasts, representing 78% of leukocytes consistent w/AML."	FALSE	FALSE	NA	12.75	FALSE	positive	0.923076923	negative				FLT3-ITD (p.Leu601_Lys602ins9; MAF 15%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	1.802030755	2.612282525	5.636295267	2.966955875	5.843149236	-3.638332397	5.786532742	no	no	yes	no	no	no	yes	-5.693766203	NA	-4.186576489	NA	1.281585748	-3.649600372	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.455079679
BA2228R	BA2228D	2572	Waves1+2	yes	yes	yes	yes	Female	Female	White		White	2			60	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	60	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"HiDAC|AG-221|3+7 (Cytarabine, Daunorubicin)|Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)"	4	Consolidation|Salvage|Induction|Experimental	Complete Response	Standard Chemotherapy	-1	Targeted Therapy - Other	AG-221	Experimental	-1	Dead	259	Dead-Disease	2	2	0	1	NA	12	12	71	NA	27	NA	4.4	0.99		33.5	11.4	"46,XX[20]"	NA	95.4	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1, RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	219	TRUE	The study reveals a minute subset of myeloblasts with mild immunophenotypic variation; the significance of this finding is unclear and it is not diagnostic for recurrent or persistent myeloid neoplasia. (No evidence of disease by flow)	FALSE	FALSE	7.1	5.54	FALSE	negative	0	positive				FLT3 (R311Q; MAF 48%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.122684804	6.47025473	6.331419499	6.175982737	7.155572213	1.895537678	6.585177155	yes	yes	yes	yes	yes	yes	yes	4.460696314	NA	-1.314699253	NA	2.134023971	0.600105123	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.819104243
BA2037R	BA2037D	2182	Waves1+2	yes	yes	yes	yes	Male	Male	White	HISPANIC	HispNative	1		GATA2-MECOM	34	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	34	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	5	"7+3 (Cytarabine, Idarubicin)|ATRA (Tretinoin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|anti-CD33|Azacitidine"	3	Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	anti-CD33	Experimental	-1	Dead	291	Dead-Disease	0	60	40	0	2.1	44.3	8.2	16.5	5.5	117	61	3.9	1	M1	35.6	11.7	"46,XY,t(3;3)(q21;q26),der(7)del(7)(p11.1)del(7)(q11.1)[13]/45,idem,-der(7)[6]/46,XY[1]"	424	96	D7S522/CEP 7: 65/100 cells (65%) had a signal pattern consistent with the deleted chromosome 7 long arm from the small marker observed in the metaphase karyotype; 9 cells (9%) had a signal pattern consistent with the monosomy 7 sideline observed in the metaphase karyotype.	916	TRUE	"CD2, CD11b, CD13, CD33, CD34, CD38, CD56, CD58, CD117,  CD123, and HLA-DR positive"	FALSE	TRUE	7.7	6.13	FALSE	negative	0	negative				NRAS (p.Q61H; MAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.68783329	2.177847751	0.384865965	4.51687771	5.326293841	-1.613203891	3.411879356	no	no	no	yes	no	no	no	-1.306517382	NA	4.516892648	NA	-3.890774703	1.111679961	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.553726308
BA2184R	BA2184D	2320	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	bi		47	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"HiDAC|Cyclophosphamide, Fludarabine, TBI|3+7 (Cytarabine, Daunorubicin)|MEC (Cytarabine, Etoposide, Mitoxantrone)"	4	Allogeneic - Sibling|Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	"Cyclophosphamide, Fludarabine, TBI"	Allogeneic - Sibling	-1	Dead	582	Dead-Disease	0	75		0	0	20.3	3.4	3.4	6.9	49	21	3.5	1.08	M1	42.6	15	"46,XY[20]"	353	86.8	Normal	34	FALSE	"CD7, CD13, CD33, CD34, CD38, CD58, CD117, dim CD123 HLA-DR and MPO+ ,"	TRUE	TRUE	7.4	8.98	FALSE	negative	0	negative				CEBPA (p.D320_N321ins22; MAF 50%)|CEBPA (p.R35fs*125; MAF 50%)|CREBBP (p.P505L; VAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.81345519	2.535382122	-0.649189872	2.924849329	4.627848107	-2.231372974	2.757998845	yes	no	no	no	no	no	no	-5.907358615	NA	0.122307414	NA	-4.330091742	-0.4407292	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.329835336
BA3009R	BA3009D	2213	Waves1+2	yes	yes	yes	yes	Female	Female	Asian	NON-HISPANIC	Asian	1			26	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	26	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"HiDAC|Cyclophosphamide, Fludarabine, TBI|3+7 (Cytarabine, Daunorubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	4	Consolidation|Induction|Re-induction|Double Umbilical Cord Blood Transplant (DUCBT)	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	"Cyclophosphamide, Fludarabine, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	1610	Alive	0	75		0	0	45.5	9.8	4.5	0.2	32	58	3.1	0.69	M0	22.3	7.4	"46,XX,r(2)(p23q31),der(4)t(4;16)(q21;q12-13)del(16)(q22q22),der(16)t(4;16)(q21;q12-13),add(18)(p11.2),del(20)(q13.2)[16]/46,XX[4]"	NA	97.8	"CBFB: 88% of cells were missing a signal for CBFB, consistent withdeletion associated with the unbalanced t(4;16) seen on chromosome analysis. No evidence for disruption. This probe will be useful in following this abnormal clone."	154	FALSE	"CD13, partial CD15, CD34, CD38, partial CD56, CD58, partial CD117 and CD123+"	FALSE	FALSE	5.8	9.27	FALSE	negative	0	negative				PTPN11 (p.D61G; MAF 15%)|TET2 (p.S1039L; MAF 50%)					no		Found	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.031586332	3.053154818	1.873189912	4.313658527	5.046216457	-2.017582884	1.714487914	no	no	no	yes	no	no	no	0.884532177	NA	2.735186275	NA	-0.36895499	0.461795032	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.705977434
BA2442R	BA2442D	2549	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			66	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	66	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	UNKNOWN	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	13	Dead-Treatment	NA		16	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XX,+8[18]"	NA	NA	Normal	NA	NA	"Large population of CD117 pos myeloblasts, representing 80% of leukocytes, consistent w/ AML."	FALSE	FALSE	NA	129.5	TRUE	positive	0.428571429	negative				FLT3-ITD (p.Tyr591_Val592ins16; MAF 10%)|WT1 (p.Val379fs; MAF 13%)|ZRSR2 (p.Arg415Trp; MAF 48.9%)				yes	yes		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	3.222269335	2.920787546	3.120495315	1.794969448	5.750230366	-0.848175605	4.574417205	yes	no	yes	no	no	yes	yes	-2.094106758	NA	1.879221993	NA	2.318626143	0.667492663	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.425854012
BA2882R	BA2882D	2463	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	HispNative	1		MLLT3-KMT2A	29	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Non-Hodgkins Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	29	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)"	2	Induction|Re-induction	Complete Response	Standard Chemotherapy	19	Standard Chemotherapy	HiDAC	Re-induction	4	Dead	65	Dead-Unknown	0.9	82	20	0	2.6	26.3	33.4	7.9	3.6	40	19	3.1	0.84	M5	27.3	9.1	"46,XY,t(9;11)(p22;q23)[20]"	324	89.5	"94/100 cells (94%) had the abnormal 1 red/ 1 green/1 yellow signal pattern, consistent with MLL rearrangement and the 9;11 translocation observed in the metaphase karyotype."	52	FALSE	"CD11b, varibleCD13, CD14, brightCD33, CD64, and HLA-DR positive"	FALSE	TRUE	6.7	3.88	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.549896912	4.216728734	2.339523285	5.787315567	6.812038677	-1.841836325	5.282569218	yes	yes	no	yes	yes	no	yes	5.969690576	NA	-2.534816252	NA	1.219937657	4.288794323	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.891343694
BA2656R	BA2656D	2553	Waves1+2	yes	yes	yes	yes	Male	Male			White	7			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	20	2	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	3.02765231	1.517595728	1.173829282	1.997067626	4.193320616	0.600021705	1.083150467	yes	no	no	no	no	yes	no	-7.486431452	NA	0.131705812	NA	-3.751399822	-4.43831734	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.337088074
BA2705R	BA2705D	2100	Waves1+2	yes	yes	yes	no	Male	Male	White		White	5			39	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	40	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	"Unknown|GCLAC (GCSF, Clofarabine & Cytarabine)"	2	Induction|Re-induction	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	"GCLAC (GCSF, Clofarabine & Cytarabine)"	Re-induction	-1	Alive	82	Alive	0	41	14	0	NA	5	5	76	NA	12	17	3.6	0.83		29.4	10.2	"46,XY[15]"	NA	NA	Negative	24	FALSE	"Positive (CD7, CD11b, CD13, CD33, dim CD34, CD38, dim CD45, CD117, HLA-DR)"	TRUE	TRUE	5.9	3.6	FALSE	positive	0.923076923	positive				FLT3-ITD (ITD (39bp ins); VAF 39%)|NPM1 (c.859_860insTCTG; p.W288fs)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	3.667038503	5.445691048	4.42479494	5.320141831	6.801167204	-0.006757303	4.35795466	yes	yes	yes	yes	yes	yes	no	3.74415211	NA	1.036411254	NA	-1.958820309	1.854671307	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.910636788
BA2379R	BA2379D	2440	Waves1+2	no	no	no	no	Male	Male	White		White	6			62	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	n	n	n	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	Chronic myelomonocytic leukaemia	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	62	81	Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Azacitidine|Fludarabine, Melphalan, ATG"	2	Unknown|Allogeneic - Matched Unrelated Donor			NA	Bone Marrow Transplant	"Fludarabine, Melphalan, ATG"	Allogeneic - Matched Unrelated Donor	-1	Alive	281	Alive	NA	9		NA	NA	NA	7	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[12]"	NA	NA	The abnormalities normally seen in MDS are not detected.	NA	NA	A very dim/negative CD45 population was also detected by the flow analysis. This population is negative for all the myeloid and lymphoid markers including CD34. This is mentioned here for documentation purposes but we believe that they do not represent blasts. (Bone Marrow Immunophenotyping)	FALSE	FALSE	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	6.201401582	8.29387857	8.81177413	7.028413971	7.511915959	3.313642911	7.418896467	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							1.146730412
BA2663R	BA2663D	2519	Waves1+2	no	no	no	no	Male	Male			White	7			67	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	n		y	n	n	n	y	y	n	n	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	Chronic myelomonocytic leukaemia	NonAML	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	Chronic myelomonocytic leukaemia	66	0	Residual Disease		Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	Cytarabine|Decitabine	2	Induction|Supportive/Palliative Care	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	Cytarabine	Induction	-1	Alive	304	Alive	NA	17	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA	Trisomy 8	NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.R166*; 44.9%)			ASXL1|EZH2|PTPN11|RUNX1|STAG2					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	5.031864213	7.071035687	5.18332908	4.446279887	7.032670382	1.914616164	7.374848472	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.89096588
BA2570R	BA2570D	2367	Waves1+2	yes	yes	yes	yes	Male	Male		HISPANIC	HispNative	2			46	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	46	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	9	Dead-Disease	NA	92	75	NA	NA	5	19	1	NA	NA	NA	2.8	1.13		18.4	6.2	"46,XY[20]"	NA	113.6	"nuc ish(RUNX1T1,RUNX1)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	31	TRUE	"CD2(+), surface CD3(-),  cytoplasmic CD3(dim +), CD4(-), CD7(partial +), CD11b(partial +),  CD13(variably +), CD14(few +), CD15(-), CD16(-),  CD33(-), CD34(partial +), CD36(-), CD38(bright +), CD45(dim  +), CD56(small subset +), CD64(-), CD117(+), HLA-DR(partial +), MPO(partial +), TdT(partial dim+)"	TRUE	TRUE	NA	151.6	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.201191924	2.676940951	2.786952278	3.649876598	5.489509861	-1.532441724	6.273328259	no	no	yes	no	no	no	yes	2.57525478	NA	-1.042376474	NA	0.6141053	0.012051557	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.701333154
BA2764R	BA2764D	2209	Waves1+2	no	no	no	no	Male	Male	White		White	7			77	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	79	0	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Decitabine	Induction	-1	Alive	500	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA	Translocation between the long arm of chromosome 3 and short arm of chromosome 12.	NA	NA		NA	NA	NA	NA	NA	positive	NA	positive				FLT3-ITD|NPM1					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	TRUE	TRUE	5.271786407	8.614232128	5.884445658	6.138089797	7.900374739	1.526734388	5.762180197	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.831558292
BA2209R	BA2209D	2363	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	5			59	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	64	0	Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"7+3 (Cytarabine, Idarubicin)|Fludarabine, Cyclophosphamide, TBI "	2	Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Dead	1824	Dead-Disease	0	59.5	12	0	NA	55	3	29	NA	37	22	4.1	NA		25.2	8.3	"47,XY,+13[2]/94,slx2[2]/46,XY[19]"	NA	NA	"5p15.2/5q31(EGR1), 7 centromere/7q31, 8 centromere/20q12, 12 centromere/13q14 D13S319/13q34 (13qter)"	46	TRUE	"Negative (CD10, CD19, CD20, CD22, Cyt CD79a, Cyt CD3, CD7, CD16, CD56, CD11b, CD14, CD15, CD33, CD64, MPO) | Positive (CD38, CD13, CD34, Dim CD45, Dim CD117, HLA-DR, TdT)"	TRUE	TRUE	6.4	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.869352842	5.957254663	4.896614647	5.458564986	7.198169246	0.297751187	3.104347426	yes	yes	yes	yes	yes	yes	no	0.728232024	NA	5.977284566	NA	-2.051882615	-2.141679239	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.772979036
BA2989R	BA2989D	2332	Waves1+2	yes	yes	yes	yes	Male	Male	White		HispNative	2			70	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	71	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	Azacitidine|Decitabine	1	Hypomethylating/Low Dose Cytarabine			NA	Standard Chemotherapy	Azacitidine	Hypomethylating/Low Dose Cytarabine	98	Alive	305	Alive	0	44	31	2	NA	46	0	14	NA	41	18	3.7	0.91		21.6	7.1	"47,XY,+21[19]/46,XY[1]"	91	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],"	35	TRUE	"CD2(-), CD4(dim +), CD7(-), CD10(-), CD11b(-), CD13(bright +), CD14(-), CD15(partial +), CD16(-), CD22(-), CD19(partial +), CD33(partial +), CD34(+), CD36(-), CD38(bright and variably +), CD45(+), CD56(-), CD64(-), CD79a(-), CD117(+), HLA-DR(predominantly + and variable), TdT(partial +), and MPO(-) | In addition, there is a 0.92% population of CD117(bright +)/CD34(-)/CD45(dim +)/CD33(- to dim +) small cells with low orthogonal light scatter. The exact identity of these cells is uncertain"	TRUE	TRUE	7.7	5.05	FALSE	positive	0.086956522	negative	RUNX1 (p.I366Vfs*231; 65.5%)			BCOR (Foundation; R1480*; MAFs: 88%)|BCORL1 (Foundation; P304fs*117; MAFs: 72%)|FLT3-ITD|NF1 (Foundation; I679fs*21; MAFs: 5%)|NF1 (Foundation; V2649fs*31 (subclonal); MAFs: 12%)|PHF6 (Foundation; R225*; MAFs: 87%)|PTPN11 (Foundation; A72T; MAFs: 8%)|RUNX1 (Foundation; I366fs*114+; MAFs: 57%)|TET2 (Foundation; Q742*; MAFs: 41%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	TRUE	3.281164924	3.225997109	1.148665991	4.960565492	6.654599047	-2.69590525	6.736374381	yes	no	no	yes	yes	no	yes	-0.857081752	NA	3.579976033	NA	0.898975225	-1.940643106	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.763895841
BA2261R	BA2261D	2528	Waves1+2	yes	yes	yes	yes	Female	Female	White		White	2			62	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	62	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	4	"Vidaza|7+3 (Cytarabine, Idarubicin)|Lenalidomide|Hydroxyurea"	3	Hypomethylating/Low Dose Cytarabine|Induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	7	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	-1	Dead	198	Dead-Disease	0.8	34	3.3	1.6	NA	14.9	5	68.6	NA	13	11	2.6	0.5		32.4	10.7	"46~47,XX,del(5)(q15q35),i(8)(q10),add(11)(q23),add(17)(p11.2),add(21)(q22),+2~3mar[cp3]/47~49,idem,add(7)(q11.2),-add(11),+11,+14,-20[cp4]/45~49,idem,del(7)(q22q36),-add(11),+11,+14,-20[cp2]/45~48,idem,der(7)del(7)(q22q31)dic(7;20)(q36;q11.2),-add(11),+11,+14["	304	NA	"nuc ish(D5S2064x2,D5S630x2,EGR1x1)[184/200],(D7Z1x2,D7S522x1)[115/200],(D8Z2x2,D20S108x1)[142/200],(RUNX1T1x3,RUNX1x2)[180/200],(5'MLL amp,3'MLL amp)(5'MLL con 3'MLL amp)[66/200],(PML,RARA)x2[197],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	36	FALSE	"CD2(-), CD4(-), CD7(partial +), CD11b(-), CD13(+), CD14(-), CD15(partial +), CD16(-), CD33(+), CD34(+), CD36(-), CD38(partial +), CD45(+),CD56(+), CD64(-), CD117(partial +), HLA-DR(partial +). | In addition, there is a 0.01% population of small cells with the following immunophenotype: CD5(+), CD10(-), CD19(+), CD20(dim+), CD38(-), CD45(+), lambda(dim +), and kappa(-)."	TRUE	TRUE	5.3	8.35	FALSE	negative	0	negative			TP53 (p.R213Dfs*34; 85.5%)	TP53 (R213fs; MAF 34%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	6.427186081	8.244844502	7.164698232	4.972472721	8.369065651	2.322556438	6.832787643	yes	yes	yes	yes	yes	yes	yes	5.568153394	NA	3.533537124	NA	2.847048963	0.091260865	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	1.02430027
BA2721R	BA2721D	2556	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			69	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)|Targeted Therapy - Other	8	"7+3 (Cytarabine, Idarubicin)|Sorafenib|MEC (Cytarabine, Etoposide, Mitoxantrone)|MiDAC|IMGN779 (Immunogen Trial)|Fludarabine, Cyclophosphamide, Thiotepa, TBI|ALRN-6924|Azacitidine, Midostaurin, Ponatinib"	4	Salvage|Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	6	Targeted Therapy - Other	IMGN779 (Immunogen Trial)	Salvage	-1	Dead	565	Dead-Disease	1.8		40	0.9	8.8	10.5	9.6	26.3	2.8	27	22	3.4	0.64	M2	23.5	7.1	"46,XX[20]"	399	103.5	normal	12	FALSE	"CD13, CD34, CD58, CD117, partial MPO and HLA-DR +"	FALSE	FALSE	6.5	61.22	TRUE	positive	1	negative	RUNX1 (p.A187T; MAF 42%)			CREBBP (p.S893L; MAF 41%)|FLT3-ITD (MAF 47%)|RUNX1 (p.A187T; MAF 42%)|SF3B1 (p.K700E; MAF 51%)|TET2 (p.K751fs*61; MAF 44%)	yes				yes		Found	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	FALSE	5.171688369	5.820000639	4.753808985	5.173810012	6.439296181	-0.659685538	7.037793486	yes	yes	yes	yes	yes	yes	yes	4.62795914	NA	1.87866151	NA	2.50374223	3.461224427	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.701489432
BA2728R	BA2728D	2094	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1		GATA2-MECOM	58	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Basal Cell Carcinoma|Squamous cell carcinoma	y	n	y	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	58	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Azacitidine|SWOG S0919 (Ida/Ara+Pravastatin) |Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Induction|Maintenance	Complete Response	Standard Chemotherapy	70	Standard Chemotherapy	Azacitidine	Maintenance	102	Alive	1911	Alive	0	21	0	0	2.3	41.7	25.9	30.1	0.1	NA	NA	NA	NA	M2	35.1	11	"46,XX,t(3;3)(q21;q26)[20]"	NA	107	"98/100 (98%) interphase cells scored had a 1 red/ 1 green/ 2 yellow signal pattern, interphase cells scored had a 1 red/ 1 green/ 2 yellow signal pattern, consistent with RPN1/MECOM fusion. Two metaphases showed a fusion signal on one derivative 3 and red, yellow and green signals on the other deriv"	360	TRUE	"variable CD11b, CD13, dim CD33, CD34, CD58, CD117, CD123"	FALSE	TRUE	NA	13.83	FALSE	negative	0	negative				NRAS (p.G12D; MAF 47%)|SF3B1 (p.K666N; MAF 47%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	4.927710471	5.743185276	1.499693009	4.759714994	6.310689736	-0.997814662	7.645111524	yes	yes	no	yes	yes	no	yes	6.274118691	NA	1.029723094	NA	-0.849428051	1.042972103	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.853362192
BA2715R	BA2715D	2192	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	2			81	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	81	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Supportive/Palliative Care	2	Vidaza|Decitabine	2	Hypomethylating/Low Dose Cytarabine|Supportive/Palliative Care			NA	Supportive/Palliative Care	Decitabine	Supportive/Palliative Care	3	Dead	97	Dead-Disease	NA	33	8	4	NA	28	24	44	NA	22	20	4.1	1.07		27.5	9.5	"45,XY,add(5)(q11.2),der(6)t(5;6)(p13;p23),der(8)t(8;8)(p23;q11.2),-13,-16,der(22)t(16;22)(q22;q11.2),+r[cp11]/44,idem,-18[cp4]/46,XY[5]"	333	NA	"nuc ish(D5S2064x3,D5S630x3,EGR1x1)[97/200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1x3,RUNX1x2)[110/200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5ÍCBFB con 3ÍCBFB dimx1,5ÍCBFB con 3ÍCBFBx1)[200]"	28	TRUE	"CD4(+), CD5(partial +), CD7(partial +), CD11b(-), CD13(+), CD14(-), CD15(predominantly -), CD16(-), CD33(+), CD34(+), CD36(-),CD38(variably +), CD45(variably +), CD56(predominantly -), CD64(partial +), CD117(+), HLA-DR(predominantly + and variable),MPO(-), TdT(-)."	TRUE	TRUE	6.6	2.2	FALSE	negative	0	negative			TP53 (p.R273H; 39.7%)|TP53 (p.L206Wfs*41; 32.4%)	EP300 (Foundation; EP300-ZNF205 fusion)|TP53 (Foundation; L206fs*41; MAFs: 31%)|TP53 (Foundation; R273H; MAFs: 38%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	3.790674813	5.148257346	4.6657703	5.141234257	6.426240855	3.078139365	4.513253679	yes	yes	yes	yes	yes	yes	yes	0.13596031	NA	3.022666929	NA	0.266123602	-1.796068699	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.717840027
BA2116R	BA2116D	2192	Waves1+2	no	no	no	no	Male	Male	White		White	2			81	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	81	41	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Supportive/Palliative Care	2	Vidaza|Decitabine	2	Hypomethylating/Low Dose Cytarabine|Supportive/Palliative Care			NA	Supportive/Palliative Care	Decitabine	Supportive/Palliative Care	3	Dead	97	Dead-Disease	0	N/A	70	0	NA	3	1	36	NA	25	33	4.1	1.26		24.1	8.1	"45,XY,add(5)(q11.2),der(6)t(5;6)(p13;p23),der(8)t(8;8)(p23;q11.2),-13,-16,der(22)t(16;22)(q22;q11.2),+r[cp11]/44,idem,-18[cp4]/46,XY[5] "	853	98	"nuc ish(D5S2064x3,D5S630x3,EGR1x1)[97/200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1x3,RUNX1x2)[110/200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5ÍCBFB con 3ÍCBFB dimx1,5ÍCBFB con 3ÍCBFBx1)[200]"	74	FALSE		NA	NA	NA	39.12	TRUE	negative	0	negative			TP53 (p.R273H; 56.3%)|TP53 (p.L206Wfs*41; 40.7%)						no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	4.637395934	5.464101314	4.802496495	2.888284158	5.42640917	0.128934221	6.520209577	yes	yes	yes	no	no	yes	yes	NA	NA	NA	NA	NA	NA							0.694719695
BA2469R	BA2469D	2530	Waves1+2	yes	yes	yes	yes	Female	Female		HISPANIC	White	6			50	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	51	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Busulfan, Fludarabine|5+2 (Cytarabine, Idarubicin)|HiDAC|7+3 (Cytarabine, Idarubicin, Bortezomib"	3	Unknown|Induction|Re-induction	Unknown	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Unknown	-1	Alive	716	Alive	NA	12		NA	NA	NA	17	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		16	FALSE	"FLT3 (ITD) Not detected. Not detected for the FLT3 TKD Mutation. Pathogenic alterations are detected in the BCOR, IDH2 and WT1 genes. Positive for CD34, HLADR, CD117, CD13, CD33 and CD43 and negative for CD11B, CD14, CD64, TDT and MPO. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	1.5	FALSE	negative	0	negative				"BCOR (p.E1348Ifs, MAF 32%)|IDH2 (p.R172K, MAF 41%)|WT1 (p.T171Cfs*116, MAF 39%)"					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	5.290487594	7.039864526	2.725593384	3.774309834	7.442425211	-2.305703239	2.913586334	yes	yes	no	yes	yes	no	no	-0.389684594	NA	-1.169896442	NA	0.56251935	-5.94230935	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.547077127
BA2269R	BA2269D	2033	Waves1+2	yes	yes	yes	yes	Female	Female		HISPANIC	HispNative	6			34	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	34	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	3	"7+3 (Cytarabine, Idarubicin)|Cytarabine|Etoposide, Mitoxantrone"	3	Unknown|Induction|Re-induction	Refractory	Standard Chemotherapy	35	Intrathecal	Cytarabine	Unknown	6	Dead	157	Dead-Unknown	NA	15		NA	NA	NA	12	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		426	TRUE		NA	NA	NA	26.4	TRUE	negative	0	negative			TP53 (p.R282Q; 46.6%)	"CSF3R (p.A470V, MAF 51%)|DNMT3A (p.R882C, MAF 51%)|NRAS (p.G13R, MAF 48%)|TP53 (p.R282Q, MAF 51%)"					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	5.529492035	7.687752193	7.719997827	4.047954382	6.806034507	2.739328747	6.272022849	yes	yes	yes	yes	yes	yes	yes	6.21447447	NA	-1.479461164	NA	-0.204308508	-0.22147576	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	1.065198316
BA2098R	BA2098D	2414	Waves1+2	yes	yes	yes	yes	Female	Female	White	UNKNOWN	White	1			61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|MiDAC|7+3 (Cytarabine, Idarubicin) plus Sorafenib"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	1830	Alive	0	83		1.8	1.8	13.3	63.7	7.9	0.1	69	35	3	0.87	M5	34.7	11.6	"46,XX[20]"	337	95.6	Normal	146	TRUE	"Positive (dim CD4, CD11b, variable CD13, partial CD14, CD33, variable CD56, bright CD64, dim CD123 and HLA-DR-positive, comprising ~75% of WBCs. There is also about 5% of blasts are positive for CD117, CD13, CD33, HLA-DR, CD123, amd CD11b. Lymphocytes account for 13% of WBCs and include 74% T cells, 19% B cells and 7% NK cells. T cells show a CD4:CD8 ratio of 5:1 without aberrant antigen expression.) | Positive (B cells are polytypic by surface light chain expression with a kappa to lambda ratio of 1.2:1.)"	FALSE	TRUE	6.1	44.83	TRUE	negative	0	positive				IDH1 (p.R132H; MAF 37%)|NPM1 (p.W288fs*12; MAF 40%)|NRAS (p.G13D; MAF 38%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.495560261	3.222269335	0.708403649	3.710231589	6.842210925	-2.113199232	2.867800292	no	no	no	no	yes	no	no	4.129467152	NA	-2.534528132	NA	4.93506001	4.628219433	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.762719964
BA2951R	BA2951D	2228	Waves1+2	yes	yes	yes	yes	Female	Female			White	3		GATA2-MECOM	65	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	65	3	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Alive	27	Alive	NA	59.4		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XX,+X,inv(3)(q21q26.2),-7,+22[2]/48,sl,+21[18]"	NA	NA	evidence of monosomy 7 in 191/200 (95.5 percent) cells scored	NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.D198G; 66.7%)			CALR (p.Leu367fs; MAF 24%)|CBL (p.? ; MAF 16.5%)|DNMT3A (p.Ala571Pro; MAF 51.5%)|EZH2 (p.Pro636Ala; MAF 94.7%)|FLT3 (p.Val579Ala; MAF 2.3 %)|PTPN11 (p.Gly60Ser; MAF 49.1%)|RUNX1 (p.Asp198Gly; MAF 63.7%)					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	1.984753428	1.014003384	0.523162664	4.025719727	4.094742478	-2.169486987	2.718149952	no	no	no	yes	no	no	no	-0.705663689	NA	4.155599887	NA	-3.588555314	-1.638723785	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.488012657
BA2778R	BA2778D	2083	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			60	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	6	"Fludarabine, Melphalan|Ruxolitinib|7+3 (Cytarabine, Idarubicin)|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|MiDAC|Hydroxyurea"	5	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor|Re-induction|Maintenance	Refractory	Standard Chemotherapy	18	Targeted Therapy - Kinase Inhibitor(s)	Ruxolitinib	Maintenance	496	Alive	1801	Alive	0	75	44	0	0.9	28.7	46.1	24.3	0	18	13	2.9	1.19	M5	26.4	8.8	"46,XX[20]"	222	96.4	Normal	175	TRUE	"Positive (CD11b, variable CD13, CD14, CD33, dim CD56, bright CD64, and HLA-DR+)"	FALSE	TRUE	6.9	34.6	TRUE	negative	0	positive				FBXW7 (p.T15_G16insP; MAF 48%)|NPM1 (p.W288fs*12; MAF 40%)|NRAS (p.G12S; MAF 40%)|TET2 (p.H437fs*7; MAF 42%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.137121042	3.473964059	3.012381411	4.499563156	7.202313187	-0.90581406	5.750230366	no	yes	yes	yes	yes	yes	yes	8.58626087	NA	-3.582045503	NA	2.065628024	4.042434993	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.867915328
BA2163R	BA2163D	2129	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1			67	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	67	0	Residual Disease	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Fludarabine, Melphalan|Azacitidine|Hydroxyurea|Idarubicin and Cytarabine"	3	Allogeneic - Sibling|Induction|Re-induction	Refractory	Standard Chemotherapy	1932	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Sibling	-1	Dead	452	Dead-Disease	2.6	42.5	54	0.9	0	44.2	2.7	0.9	0	21	15	2	2.62		23.1	7.9	"45,XY,+5,dic(5;8)(q11.2;p12)x2,del(7)(q22q32),-18,del(20)(p11.2)[cp20]"	NA	91.7	"5p/5q: 88/100 (88%) cells had one signal for EGR1 (5q31) and three signals for 5p, consistent with the metaphase karyotype; 5 cells (5%) had one EGR1 signal and four 5p signals, consistent with a previous sideline with three copies of the dicentric 5;8 chromosome.   | BCR: 15/200 (7.5%) cells had three signals for BCR (22q11.2) consistent with a previous sideling that had trisomy 22 (the same sideline with three copies of the dicentric 5;8 chromosome). There was no evidence for BCR/ABL fusion. "	22	TRUE	"Positive (CD7, CD13, dimCD33, CD34, variable CD38, CD56, dim CD58, variable CD117, dimCD123 and dim HLA-DR positive)"	TRUE	TRUE	5.3	1.27	FALSE	negative	0	negative			TP53 (p.K132R; 39.4%)|TP53 (p.X126_splice; 51.3%)	DNMT3A (p.G570E; MAF 44%)|JAK2 (p.V617F; MAF 3%)|TP53 (Intron 4 3' splice site mutation; MAF 42%)|TP53 (p.K132R; MAF 45%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	5.335031781	4.168688371	1.625555128	4.608642877	5.946021508	-1.018860382	3.885475295	yes	yes	no	yes	no	no	no	1.992005401	NA	6.015855654	NA	-4.372218647	0.043153073	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.585917738
BA3153R	BA3153D	2664	Waves3+4	yes	yes	yes	yes	Male	Male	Black			5	mono		49	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	Intermediate	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	49	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"7+3 (Cytarabine, Idarubicin)|Fludarabine, Cyclophosphamide, Thiotepa, TBI"	2	Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, Thiotepa, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	455	Alive	0	15	50	1	NA	10	2	40	NA	37	34	3.4	NA		NA	12.2	"46,XY[20] "	NA	NA	Normal	210	TRUE	"Positive (CD38, CD7, CD2) | Negative (CD10, CD19, CD22, CD16, CD56, CD13, CD14, CD15, CD33, CD34, CD117, MPO, HLA-DR) | Dim Positive (cCD3, CD11b, CD64)"	TRUE	TRUE	NA	7.9	FALSE	negative	0	negative				CEBPA ([c.937A>C; c.940G>A; c.941T>A;c.943C>G] p.K313_V314_L315delinsQKV)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.011476133	7.35026488	4.637752326	5.88838394	6.401706175	0.168253562	2.17326302	yes	yes	yes	yes	yes	yes	no	1.770729288	NA	-0.041680195	NA	-3.616665708	-3.859107172	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.707995604
BA2817R	BA2817D	2557	Waves1+2	yes	yes	yes	yes	Male	Male	Black		Black	2			73	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	77	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Supportive/Palliative Care|Targeted Therapy - Other	6	Vidaza|AG-221|Bortezomib|Cytarabine|Lenalidomide|Decitabine	3	Hypomethylating/Low Dose Cytarabine|Experimental|Supportive/Palliative Care			NA	Targeted Therapy - Other	AG-221	Experimental	267	Dead	1490	Dead-Disease	NA	95	48	1	NA	42	6	2	NA	14	14	3.5	1.1		27.3	9.4	"88<4n>,XXYY,+del(1)(p22p36),i(2)(p10),-5,-7,-7,-21,-21[12]"	453	NA	"nuc ish(RUNX1T1x4,RUNX1x2)[200],(5'MLL,3'MLL)x4(5'MLL con 3'MLLx4)[200],(PML,RARA)x4[200],(5'CBFB,3'CBFB)x4(5'CBFB con 3'CBFBx4)[174/200]"	23	TRUE	"92% population of variably-sized cells with the following immunophenotype: CD2(-), CD4(-), CD7(-), CD11b(-), CD13(-), CD14(-), CD15(+), CD16(-), CD33(-), CD34(+), CD36(-), CD38(variably +), CD45(variably +), CD56(-), CD64(-), CD117(variably +), HLA-DR(partial +)."	TRUE	TRUE	6.5	3	FALSE	negative	0	negative	RUNX1 (loss)			IDH2 (R140Q)|PTPN11 (E76Q)|RUNX1 (loss)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	7.863751333	5.298738865	6.829082162	6.206134519	7.155572213	-2.969312096	1.97497142	yes	yes	yes	yes	yes	no	no	0.913132431	NA	1.742632044	NA	-3.000689549	-1.252029136	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.884219651
BA2820R	BA2820D	2542	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			73	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"S0919 Trial (Pravastatin, Idarubicin, Cytarabine)|Hydroxyurea"	1	Induction	unknown	Standard Chemotherapy	167	Standard Chemotherapy	"S0919 Trial (Pravastatin, Idarubicin, Cytarabine)"	Induction	21	Dead	28	Dead-Disease	0	88	38	0	1.7	20.9	60.9	1.7	0.1	27	40	3	1.2	M4	33	11.2	"46,XY[20]"	NA	105.8	normal	55	FALSE	"Positive (Myeloid blast immunophenotype: CD13, CD33, dim CD64, CD117, CD123 (+) Monocytic/monoblastic immunophenotype: bright CD11b, CD13, bright CD14, CD33, bright CD64, HLA-DR (+))"	FALSE	TRUE	7.5	58.97	TRUE	positive	1	positive				DNMT3A (p.R882H; MAF 42%)|EP300 (p.N674D; MAF 50%)|EP300 (p.V2140I; MAF 50%)|FLT3-ITD (MAF ~48%)|MLL2 (p.M3398V; MAF 51%)|NPM1 (p.W288fs*12; MAF 43%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	1.072877628	1.452270628	1.830428143	3.985714208	6.35117267	-3.190298081	3.840442769	no	no	no	yes	yes	no	no	5.001953425	NA	-2.318940628	NA	0.543141916	2.686661552	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.660487373
BA2704R	BA2704D	2255	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	3	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Hydroxyurea	1	Induction	Unknown	Standard Chemotherapy	8	Standard Chemotherapy	Hydroxyurea	Induction	8	Dead	8	Dead-Disease	0	93	85	0.8	0	16.5	0.8	1.6	0.2	19	21	2.7	0.78	M1	21.1	7.1	"46,XX[20]"	360	84.4	Normal	43	TRUE	"partial CD13, CD33, dim/partial CD56, CD58, dim CD117, CD123 and MPO"	FALSE	TRUE	5.7	30.54	TRUE	positive	0.851851852	positive				FLT3-ITD (MAF ~50%)|IDH2 (p.R140Q; MAF ~50%)|NPM1 (p.W288fs*12; MAF ~50%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.570289375	1.727517542	5.500924243	3.757086099	5.575225759	-2.54523938	-0.067402502	no	no	yes	no	no	no	no	-5.710863178	NA	-0.049544685	NA	-0.516390591	-4.926238163	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.286521143
BA2723R	BA2723D	2390	Waves1+2	yes	yes	yes	no	Male	Male	White	HISPANIC	White	6			25	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	26	0	Relapse|Post-Chemotherapy|Post-Transplant	Relapse	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Bu/Cy/ATG|HiDAC|3+7 (Cytarabine, Daunorubicin)|Decitabine|Clofarabine, Cytarabine"	5	Consolidation|Salvage|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	Decitabine	Salvage	9	Dead	463	Dead-Disease	NA		14	8	NA	17	2	54	NA	39	49	3.2	0.79		19.3	6.5		NA	101		33	FALSE		NA	NA	4.9	1.6	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	7.531974918	7.475249779	5.031507263	4.642018332	7.218781277	1.959385001	5.765268232	yes	yes	yes	yes	yes	yes	yes	3.797677075	NA	2.233064978	NA	-2.01589806	-4.259387741	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.89810351
BA2492R	BA2492D	2390	Waves1+2	no	no	no	no	Male	Male	White	HISPANIC	AdmixedHispNative	6			25	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	26	28	Residual Disease|Post-Chemotherapy|Post-Transplant	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Bu/Cy/ATG|HiDAC|3+7 (Cytarabine, Daunorubicin)|Decitabine|Clofarabine, Cytarabine"	5	Consolidation|Salvage|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	Decitabine	Salvage	9	Dead	463	Dead-Disease	NA	70	8	NA	NA	NA	4	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,-3,del(5)(q31q35),der(7)t(7;?)(p11.2;?),+der(11)(q23),-12,+mar[20]"	NA	NA		10	FALSE	"MONOBLASTS, 61%. These are dim45positive and also express CD13, CD33, CD11b, CD14, CD64  but lack CD16, CD34, CD117, HLADR  (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	30.2	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	6.226758821	4.622854601	6.188149436	3.36108005	5.683055971	2.088005274	5.061743266	yes	yes	yes	no	no	yes	yes	NA	NA	NA	NA	NA	NA							0.835262708
BA2088R	BA2088D	2153	Waves1+2	no	no	no	no	Female	Female	Black	NON-HISPANIC	Black	6			45	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	46	0	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	4	"HiDAC|CLAG (Cladribine, Cytarabine, Filgrastim)|3+7 (Cytarabine, Daunorubicin)|Cyclophosphamide, Etoposide, Cytarabine"	4	Consolidation|Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	25	Standard Chemotherapy	"CLAG (Cladribine, Cytarabine, Filgrastim)"	Salvage	23	Alive	465	Alive	NA	3		NA	NA	NA	4	NA	NA	NA	NA	NA	NA		NA	NA	"45,XX,-7[4]/46,sl,+mar[2]/46,XX[14]"	NA	NA		69	TRUE	MLL-PTD is not detected. FLT3-ITD not detected. FLT3-TKD mutation not detected. Pathogenic alterations are detected in the DNMT3A and IDH1 genes. Genomic alteration of uncertain significance is detected in the DNMT3A gene. (Bone Marrow Immunophenotyping)	FALSE	FALSE	NA	1.3	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.720754837	7.393491269	5.334684491	7.490427551	7.831303827	2.380512748	7.085217417	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.75194925
BA3202R		2153	Waves3+4	no	no	no	no	Female	Female	Black	NON-HISPANIC		6			45	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	47	148	Post-Chemotherapy	Remission	Bone Marrow Aspirate	y	n	n	y	n	n	1	Standard Chemotherapy	4	"HiDAC|CLAG (Cladribine, Cytarabine, Filgrastim)|3+7 (Cytarabine, Daunorubicin)|Cyclophosphamide, Etoposide, Cytarabine"	4	Consolidation|Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	25	Standard Chemotherapy	"CLAG (Cladribine, Cytarabine, Filgrastim)"	Salvage	23	Alive	465	Alive	NA	2		NA	NA	NA	9	NA	NA	NA	NA	NA	NA		NA	NA	"45,XX,-7[4]/46,sl,+mar[2]/46,XX[14]"	NA	NA		64	TRUE	"POSITIVE FOR CD34, CD117, HLADR, CD33 AND CD13. (Bone Marrow Immunophenotype)"	FALSE	TRUE	NA	2.1	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.947672108	6.874033854	4.053621247	6.270162389	6.646840272	3.213182977	5.455987778	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.830400247
BA3139R	BA3139D	2618	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			30	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	y	Dyskeratosis congenita	y	n	y	y	n	n	n	n	MYELODYSPLASTIC SYNDROMES	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	31	504	Post-Chemotherapy|Post-Transplant|Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine|Fludarabine, Cytarabine"	4	Induction|Re-induction|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"Fludarabine, Cytarabine"	Re-induction	5	Dead	475	Dead-Disease	0	87		0	NA	10.4	3.5	1.7	0.4	23	29	3.3	0.77		23.8	8	"40~42,X,-Y,dic(5;12)(q13;p11.2),del(7)(q22q36),add(9)(q31),add(13)(q22),ins(?;14)(?;q11.2),-15,add(15)(p11.2),del(16)(q11.1),-17,-18,add(19)(q13.4),-20,der(21)t(3;21)(q22.3;q13),+mar[cp12]/40~41,sl,add(2)(q31)[cp7]/46,XY[1] "	532	102.1	"84.5% of cells were missing a signal for EGR1, consistent with 5q deletion, and as seen previously. "	36	FALSE		NA	NA	6.2	19.23	FALSE	negative	0	negative			TP53 (p.M340Cfs*5; 41.0%)|TP53 (p.R273H; 47.8%)	BCL6 (p.C475R; VAF 6%)|TP53 (p.M340fs*5; MAF 42%)|TP53 (p.R273H; MAF 47%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	6.192998322	2.027552303	3.953026894	1.722045083	5.469187797	-3.286356894	2.982452792	yes	no	yes	no	no	no	no	-6.938941313	NA	1.762338785	NA	-1.61583532	-9.405884219	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.409644218
BA3285R	BA3285D	2618	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1			30	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Dyskeratosis congenita	y	n	y	y	n	n	n	n	MYELODYSPLASTIC SYNDROMES	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	31	573	Post-Chemotherapy|Post-Transplant|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine|Fludarabine, Cytarabine"	4	Induction|Re-induction|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"Fludarabine, Cytarabine"	Re-induction	5	Dead	475	Dead-Disease	1.8			1.8	NA	14.7	8.3	0	0	65	64	2.2	0.77		22.9	7.5	"39~41,X,-Y,dic(5;12)(q13;p11.2),del(7)(q22q36),add(9)(q31),add(13)(q22),ins(?;14)(?;q11.2),-15,add(15)(p11.2),del(16)(q11.1),-17,-18.add(19)(q13.4),-20,der(21)t(3;21)(q22.3;q13)[cp16]/46,XY[5] "	NA	90.5	"84.5% of cells were missing a signal for EGR1, consistent with 5q deletion, and as seen previously. "	9	FALSE		NA	NA	5.2	10.63	FALSE	negative	0	negative			TP53 (p.M340Cfs*5; 50.0%)|TP53 (p.R273H; 42.2%)						no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	5.103864345	1.046216879	3.398698076	3.366669274	4.751664549	-4.122159479	2.548688708	yes	no	yes	no	no	no	no	NA	NA	NA	NA	NA	NA							0.420217801
BA2584R	BA2584D	2422	Waves1+2	yes	yes	yes	yes	Male	Male			White	3		KMT2A_re	42	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	42	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|HiDAC|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	4	Allogeneic - Sibling|Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	-1	Alive	427	Alive	NA	80		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"45,XY,t(3;17)([21;q11.2),add(4)(q21),add(5)(p15),ins(10;11)(p12;q23q13),der(12;18)(q10;q10)[19]/46,XY[1]"	NA	NA	11q23 rearrangement involving the  KMT2A (MLL) locus in 184/200 (92.0 percent) cells scored | One cell line showed the following clonal abnormalities in 19/20 (95%) cells: an apparent insertion of material form the long arm of chromosome 11 into the short arm of chromosome 10;  a translocation between chromosomes 3 and 17; added material on the long arm of chromosome 4 and on the short arm of chromosome 5; an unbalanced whole arm rearrangement between the long arms of chromosomes 12	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	3.234423629	3.566571456	0.244476134	5.704115252	5.853417339	-2.671580925	0.294138846	yes	yes	no	yes	no	no	no	-2.933904651	NA	-2.641537745	NA	1.916318451	1.113871422	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.46368912
BA3079R	BA3079D	2830	Waves3+4	yes	yes	yes	yes	Male	Male				3			68	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Alive	23	Alive	NA	67		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"45,XY,+1,der(1;14)(p10;q10),add(3)(p25),-5,del(12)(p11.2p13)[6]/44,XY,sl,del(7)(q11.2),der(8)del(8)(p21)t(8;17)(q24;q21),-17,+19,-22[cp10]/63<3n>,sdl1,-3,-4,-6,+8,del(8)(p21)x2,+9,+13,-15,-18,-21[cp4]"	NA	NA	"5p15.2 (D5S23): gain present  5q31 (EGR1): deletion present  7cen (D7Z1), 7q31 (D7S486): deletion and monosomy present  | t(8;21)(q22;q22) (RUNX1T1;RUNX1): gain present  11q23 (KMT2A; also known as MLL): gain present  16q22 (CBFB): gain present  17q21 (RARA): gain present  "	NA	NA		NA	NA	NA	NA	NA	negative	0	negative			TP53 (p.N239*; 57.9%)	TP53 (p.Asn239*; MAF 58.4%)|TP53 (p.Ser166_Gln167del; MAF 12%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	NA	TRUE	TRUE	4.313273136	4.814802299	2.741167694	5.593630248	5.676959233	-1.453400325	4.572293286	yes	yes	yes	yes	no	no	yes	2.422726127	NA	4.463425874	NA	-0.01443758	2.956131972	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.826418928
BA2417R	BA2417D	2333	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	2			70	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	70	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"Vidaza|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Hypomethylating/Low Dose Cytarabine|Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Vidaza	Hypomethylating/Low Dose Cytarabine	4	Alive	486	Alive	0	85	77.8	0	NA	7.4	0	11.1	NA	12	32	2.8	0.62		21.8	7		1195	NA		103	TRUE	"CD11b(partial +), CD13(equivocal), CD15(bright +), CD16(-), CD33(bright +), CD34(-), CD36(-), CD38(bright +), CD45(bright +), CD56(+),CD64(bright+), CD117(-), and HLA-DR(+)."	FALSE	TRUE	5.2	25.85	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	0.005525587	1.805651937	2.085728775	3.375923648	5.123863957	-2.962318066	5.159914129	no	no	no	no	no	no	yes	-2.861076065	NA	-5.428749833	NA	7.179365927	-0.371161726	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.602489331
BA2361R	BA2361D	2444	Waves1+2	yes	yes	yes	yes	Female	Female	White		White	5			55	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"7+3 (Cytarabine, Idarubicin) plus Enasidenib|Busulfan, Cyclophosphamide"	2	Allogeneic - Sibling|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Alive	428	Alive	1	30	0	0	NA	31	4	6.8	NA	10	11	4.3	NA		32.4	9.9	"46,XX,del(5)(q22q35)[2]/46,XX,+8,-16,der(17)t(16;17)(p11.2;p11.2)[14]/46,XX[3]"	NA	NA	Probe: 8 centromere/20q12 | Normal (5p15.2/ 5q31 (EGR1); 7 centromere/ 7q31)	83	TRUE	Negative (CD19) | Negative (CD22) | Positive (CD38) | Negative (CD7) | Negative (CD56) | Negative (CD11b) | Positive (CD13) | Negative (CD14) | Negative (CD15) | Negative (CD33) | Positive (CD34) | Negative (CD45) | Negative (CD64) | Negative (CD117) | Negative (MPO) | Positive (HLA-DR)	TRUE	TRUE	7.2	10.6	FALSE	negative	0	negative				ASXL1 (c.190 0_1922 delAGAGAGGCGGCCACCACTGCCAT; p.R634Rfs; MAF 33%)|IDH2 (c.419G>A; P.R140Q; MAF 46%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.127725495	6.490027958	5.420214121	5.754917397	6.753097394	2.527421199	6.882321322	yes	yes	yes	yes	yes	yes	yes	4.938405943	NA	-0.180484375	NA	2.933162454	-0.105202918	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.784424686
BA2450R	BA2450D	2284	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			46	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	46	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	5	"7+3 (Cytarabine, Idarubicin)|Sunitinib|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin) plus Sorafenib|Hydroxyurea"	4	Consolidation|Salvage|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	32	Standard Chemotherapy	Sunitinib	Consolidation	2	Dead	269	Dead-Disease	0			0	0	20.4	0	66.7	1	58	44	3.3	1.04		23.8	8.1		401	88.5	"metaphases positive for 45XX monosomy chromosome 17,20/22 metaphases positive for 46XX diploid"	14	FALSE		NA	NA	7.3	6.18	FALSE	positive	0.25	positive									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	3.892320955	5.057913863	6.151013721	4.043120925	6.802992445	-0.166328551	0.068042127	yes	yes	yes	yes	yes	yes	no	1.431954309	NA	0.451475829	NA	-4.492561953	-5.024379068	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.547614323
BA2994R	BA2994D	2284	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			46	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	14	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	5	"7+3 (Cytarabine, Idarubicin)|Sunitinib|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin) plus Sorafenib|Hydroxyurea"	4	Consolidation|Salvage|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	32	Standard Chemotherapy	Sunitinib	Consolidation	2	Dead	269	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA	"metaphases positive for 45XX monosomy chromosome 17,20/22 metaphases positive for 46XX diploid"	NA	NA		NA	NA	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	2.338146061	1.628561585	6.051520711	2.597407025	6.011722493	1.285270689	0.015882881	no	no	yes	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.3426945
BA2824R	BA2824D	2284	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			46	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	23	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	5	"7+3 (Cytarabine, Idarubicin)|Sunitinib|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin) plus Sorafenib|Hydroxyurea"	4	Consolidation|Salvage|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	32	Standard Chemotherapy	Sunitinib	Consolidation	2	Dead	269	Dead-Disease	0	90	90	0	0	5	0	0	0	27	43	1.6	0.93		22.5	7.9		NA	82.1	Positive	43	TRUE	"variable CD7, CD13, dim CD33, partial CD34, CD38,dim CD58, partial and variable CD117 and CD123 positive"	TRUE	TRUE	5.1	18.38	FALSE	positive	0.515151515	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	3.526693218	0.593397427	6.4471016	1.940033158	6.142350741	0.86708053	2.858883093	yes	no	yes	no	yes	yes	no	NA	NA	NA	NA	NA	NA							0.396836438
BA2079R	BA2079D	2224	Waves1+2	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1			52	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	52	34	Post-Chemotherapy	Remission	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	5	"MiDAC|Idarubicin and Cytarabine|FLAG-IDA plus Midostaurin|Azacitidine, Midostaurin, Ponatinib|7+3 (Cytarabine, Idarubicin) plus Dasatinib "	4	Consolidation|Salvage|Induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Idarubicin and Cytarabine	Salvage	3	Dead	559	Dead-Disease	1.4	1.5		0.2	NA	9.2	24.3	64.9	NA	119	151	3.2	0.76	M5	28.4	9.2	"46,XX[20] "	380	93.4	Normal	395	TRUE		NA	NA	6.6	6.5	FALSE	negative	0	negative				DNMT3A (p.R882C; MAF 14%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.762518142	7.394445933	5.701461832	5.761816992	7.506472225	2.887058862	5.607300013	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.937777678
BA3099R	BA3099D	2224	Waves3+4	no	no	no	no	Female	Female	White	NON-HISPANIC		1			52	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	53	383	Post-Chemotherapy|Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	5	"MiDAC|Idarubicin and Cytarabine|FLAG-IDA plus Midostaurin|Azacitidine, Midostaurin, Ponatinib|7+3 (Cytarabine, Idarubicin) plus Dasatinib "	4	Consolidation|Salvage|Induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Idarubicin and Cytarabine	Salvage	3	Dead	559	Dead-Disease	0		78	0	0	14.9	7	10.5	0	40	99	2.3	0.43	M5	25.6	8.5	"46,X,t(X;7)(q21;q32)[20] "	NA	94.1	Normal	5	FALSE	"variable CD7, CD13, CD33, partial CD34, CD38, CD58,  CD117, CD123 and HLA-DR  (Immunophenotypic shift is noted from the prior leukemic blast  population.)"	TRUE	TRUE	5.5	7.66	FALSE	positive	13.28571429	positive				DNMT3A (p.R882C; MAF 46%)|FLT3-ITD (MAF ~90%)|NPM1 (p.W288fs*12; MAF 44%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	1.479667395	1.334643814	2.338146061	3.209378832	5.148973137	-0.497690291	2.006070673	no	no	no	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.434744003
BA2552R	BA2552D	2203	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	6			67	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	69	0	Relapse|Post-Chemotherapy|Post-Transplant	Relapse	Peripheral Blood	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	6	"AG-120|7+3 (Cytarabine, Idarubicin)|Cytarabine|Decitabine|ME (Etoposide, Mitoxantrone)|Fludarabine, Melphalan, ATG"	6	Consolidation|Salvage|Induction|Experimental|Post-Transplant Relapse|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Cytarabine	Post-Transplant Relapse	3	Dead	944	Dead-Unknown	NA		94	0	NA	3	0	1	NA	18	52	3.2	1.03		24.6	8.6		NA	93.5		28	FALSE		NA	NA	5.7	108.9	TRUE	positive	0.666666667	positive				"IDH1 (p.R132S, MAF 46%)|NPM1 (p.W288Cfs*12, MAF 57%)"					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.836556065	1.619820405	1.767407463	3.034466258	4.292298686	0.643937104	-1.681775566	no	no	no	no	no	yes	no	-6.592876519	NA	-1.507379597	NA	-1.252223311	-7.778093503	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.301540609
BA2472R	BA2472D	2546	Waves1+2	yes	yes	yes	yes	Male	Male	Asian		Asian	2			78	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	78	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Supportive/Palliative Care	5	"7+3 (Cytarabine, Idarubicin)|Decitabine|7+3 (Cytarabine, Idarubicin) plus Azacitidine|IDAC|Etoposide, Cytarabine"	4	Induction|Re-induction|Maintenance|Supportive/Palliative Care	Refractory	Supportive/Palliative Care	-1	Standard Chemotherapy	"Etoposide, Cytarabine"	Supportive/Palliative Care	-1	Dead	372	Dead-Disease	0	20	3.8	7.8	NA	40	5.2	40	NA	9	49	3.1	1.41		25.7	8.5	"46,XY[20]"	675	NA	"nuc ish(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	30	TRUE	"CD2(-), CD3(-), CD4(dim +), CD10(-), CD11b(-), CD13(+), CD14(-), CD15(small subset+), CD16(-), CD19(-), CD20(-), CD33(+), CD34(+),CD36(-), CD38(dim+), CD45(dim +), CD56(-), CD64(variably+), CD117(+), HLA-DR(dim +), MPO(partial +), and TdT(-)."	FALSE	TRUE	6.9	4.9	FALSE	negative	0	negative	RUNX1 (p.L89Pfs*49; 15.8%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	0.516290469	8.524458909	4.47428452	4.437859289	6.151874776	-2.141896136	5.420214121	no	yes	yes	yes	yes	no	yes	2.769996727	NA	-1.424153154	NA	1.737861886	-1.403888681	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.58460117
BA2047R	BA2047D	2467	Waves1+2	yes	yes	yes	no	Female	Female	White	NON-HISPANIC	White	1		PML-RARA	69	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	69	1	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	2	"ATRA, Idarubicin|ATRA, Arsenic Trioxide"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Consolidation	-1	Alive	1542	Alive	1.7	90		1.7	0.8	13.5	5	6.7	0.9	45	41	3.4	1.09	M3	24.1	8.6	"46,XX,t(15;17)(q24;q21)[20]"	NA	92.7	PML/RARA fusion	39	TRUE	"dim CD2, CD13, dim CD15, CD33, CD38, CD58, CD64, CD117, CD123, variable HLA-DR and bright MPO positive"	FALSE	TRUE	6.5	34.36	TRUE	positive	0.851851852	negative				FLT3-ITD (MAF 42%)|NOTCH1 (p.P2438L ; MAF 47%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	3.894447216	3.535754772	4.404015632	3.937987222	6.041136857	-1.685486464	5.066367503	yes	yes	yes	yes	no	no	yes	-2.689979201	NA	-4.728179981	NA	3.174267935	-5.19381433	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.485674553
BA2101R	BA2101D	2483	Waves1+2	yes	yes	yes	no	Male	Male	White	NON-HISPANIC	White	1		CBFB-MYH11	68	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Alive	35	Alive	0	24	10	0.9	0	81.8	4.6	10.9	0	27	26	4.1	1	M2	33.6	11.9	"46,XY,del(7)(q22),inv(16)(p13.1q22)[18]/46,XY[2]"	330	106.7	"CBFB, D7S486/ CEP 7"	106	TRUE	"CD5, CD19, dim CD20, dim CD22, CD23 and light chain negative"	FALSE	FALSE	6.9	2.16	FALSE	negative	0	negative				FLT3-ITD (MAF 3%)|FLT3(p.D839G; MAF 3%)|DNMT3A(p.R882H; MAF 16%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.928054213	6.191203758	1.100327312	8.172322159	8.218326993	-1.620833694	2.755444874	yes	yes	no	yes	yes	no	no	2.042529065	NA	0.363091118	NA	-4.964119702	3.00209812	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.828309552
BA2082R	BA2082D	2126	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	2			61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		0	48	6	0	NA	31	14	47	NA	27	27	4.2	0.86		36.9	12.6	"47,XY,t(8;19)(q24.1;q13.1),+10[17]/46,XY[3]"	294	NA	"nuc ish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200], (D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2) [200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	175	TRUE		NA	NA	7	2.43	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.991674807	4.573349844	2.850431866	4.835477816	5.688339943	-1.500222088	3.222806159	yes	yes	yes	yes	no	no	no	1.212865103	NA	-0.080521343	NA	-1.590192517	2.155765263	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.609626107
BA2456R	BA2456D	2481	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	2			65	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Skin cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Cytarabine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Cytarabine	Supportive/Palliative Care	-1	Dead	2	Dead-Unknown	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA	"nuc ish (PML,RARA)x2[199]"	NA	NA		NA	NA	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.081970801	4.130497691	2.121525013	5.139762211	6.280519951	-3.589558873	1.343606903	yes	yes	no	yes	yes	no	no	1.774061166	NA	-4.356411964	NA	4.761818958	2.578517314	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.803415756
BA2175R	BA2175D	2382	Waves1+2	yes	yes	yes	yes	Female	Female	White		White	2			72	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Decitabine	Supportive/Palliative Care	-1	Alive	373	Alive	NA	30	5	NA	NA	NA	NA	NA	NA	37	93	NA	NA		NA	NA	"45,XX,der(5)inv(5)(p13q15)del(5)(q15q33),-16,-17,der(17)t(17;17)(p13;q11.2),der(18;22)(q10;q10),+22,+r[cp20] .ish r(MLL+)[2]"	NA	NA	"nuc ish(D4Z1,D10Z1)x2[200],(D5S2064x2,D5S630x2,EGR1x1)[196/200],(D7Z1,D7S522)x2[200], (D8Z2,D20S108)x2[197],(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x3(5'MLL con 3'MLLx3) [142/200],(ETV6,RUNX1)x2[200],(PML,RARA)x2[200],(5'CBFB,3'CBFB)x1(5'CBFB con 3'CBFBx1)[200]"	16	FALSE		NA	NA	NA	44.63	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	4.820092091	6.38934322	5.179884837	3.389554257	7.33705133	2.270921354	7.125055625	yes	yes	yes	no	yes	yes	yes	1.853448945	NA	0.121140064	NA	3.461091077	-5.593514287	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.630254022
BA2507R	BA2507D	2377	Waves1+2	yes	yes	yes	yes	Male	Male	Black		Black	5		CBFB-MYH11	33	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	33	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	402	Alive	0	72	95	0	NA	3	0	1	NA	29	24	3.4	NA		19.8	6.5	"46,XY,inv(16)(p13.1q22)[20]"	NA	NA	Positive for CBFB rearrangment for 91% of cells	31	TRUE	"Positive (CD38, CD13, CD33, CD34, CD45, CD117, MPO, HLA-DR) | Negative (CD19, CD22, Cyt CD79a, Cyt CD3, CD7, CD56, CD11b, CD14, CD15, CD64, TdT)"	TRUE	TRUE	6.6	93.2	TRUE	negative	0	negative				TET2 (c.652G>A; p.V218M; MAF 50%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	1.479667395	1.500750377	-1.095598922	3.253090301	4.722146376	-3.122130162	2.474301282	no	no	no	no	no	no	no	-3.926105827	NA	3.534457312	NA	-5.009999722	1.162850323	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.400717608
BA2563R	BA2563D	2493	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	3			61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|IDAC plus Midostaurin|7+3 (Cytarabine, Daunorubicin) plus Sorafenib"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Matched Unrelated Donor	-1	Alive	398	Alive	NA	86	89	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	57	TRUE		NA	NA	NA	115.15	TRUE	positive	0.063829787	positive				DNMT3A (p.Arg326Cys; MAF 44.5%)|FLT3-ITD (p.Phe594_Asp600dup; MAF 45%)|NPM1 (p.Trp288fs; MAF 20.7%)|TET2 (p.Ala911fs; MAF 40.6%)|TET2 (p.His1036fs; MAF 39.4%)					no		Found	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.395932963	1.128145264	4.683098974	1.616173134	5.618173087	-3.011807357	0.560432478	no	no	yes	no	no	no	no	-5.278841517	NA	0.214865578	NA	-3.555164066	-6.558110767	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.309727655
BA3164R	BA3164D	2194	Waves3+4	no	no	no	no	Female	Female	Multiracial	HISPANIC		1			46	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	124	Relapse|Post-Chemotherapy|Post-Transplant	Relapse	Peripheral Blood	y	y	y	y	y	y	4	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal|Targeted Therapy - Kinase Inhibitor(s)	7	"Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)|Dasatinib|7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)|Sorafenib|Methotrexate"	6	Allogeneic - Sibling|Consolidation|Induction|Experimental|CNS|Re-induction	Complete Response i	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Dasatinib	Experimental	-1	Dead	360	Dead-Disease	0	85	50	0	0	7.1	4.4	41.6	0.4	25	56	3.7	1		31.9	10.5	"46,XX,t(10;16)(q22;q24)[10]/46,X,t(X;1)(q23;q44),t(10;16)(q22;q24)[3]/46,X,t(X;13)(p21;q14),t(3;22)(q13.2;p11.1),t(5;6)(q31;q24),add(9)(q13),t(10;16)(q22;q24)[2]/46,sl,der(1)t(1;2)(p32;q32)t(1;15)(q23;q24),der(2)t(1;2)(p32;q32),der(15)t(1;15)(q23;q24)[2]/46,sl,der(1)t(1;2)(p13;q11.2),-2, (der(3)t(3;5)(q12;p15),del(6)(q13q23),+22[2]/46,XX[1])"	1199	93	Normal	63	TRUE	"partial CD7, CD13, CD33, partial CD34, CD38,  CD58, CD71, partial CD117, CD123, and HLA-DR +"	TRUE	TRUE	6.6	23.68	TRUE	positive	11.5	positive				DNMT3A (p.R882H; MAF 43%)|FLT3-ITD (Internal tandem duplication (~75 bp; in-frame); MAF 79%)|JAK3 (p.H529R; MAF 50%)|NPM1 (p.W288fs*12; MAF 36%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	3.709785016	1.275802676	6.645188941	3.697153947	5.954796535	0.576990346	0.28485128	yes	no	yes	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.409230908
BA3235R	BA3235D	2194	Waves3+4	no	no	no	no	Female	Female	Multiracial	HISPANIC		1			46	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	168	Residual Disease|Post-Chemotherapy|Post-Transplant	Residual	Peripheral Blood	y	y	y	y	y	y	4	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal|Targeted Therapy - Kinase Inhibitor(s)	7	"Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)|Dasatinib|7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)|Sorafenib|Methotrexate"	6	Allogeneic - Sibling|Consolidation|Induction|Experimental|CNS|Re-induction	Complete Response i	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Dasatinib	Experimental	-1	Dead	360	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,t(10;16)(q22;q24)[cp12]/46,sl,t(1;4)(q41;q33),t(7;9)(p15;q32)[5]/46,sl,t(X;1)(q23;q44)[2]/46,sl,der(1)t(1;2)(p32;q32)t(1;15)(q23;q24),der(2)t(1;2)(p32;q32),der(15)t(1;15)(q23;q24)[1]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	15.66666667	positive				FLT3-ITD (ITD; MAF 60%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	TRUE	FALSE	2.116097354	3.072543248	5.082584874	4.184010337	6.449953852	-0.517131786	4.205597741	no	no	yes	yes	yes	yes	no	NA	NA	NA	NA	NA	NA							0.782124377
BA2984R	BA2984D	2520	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			81	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	81	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Vidaza, BI836858 (anti-CD33)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Vidaza, BI836858 (anti-CD33)"	Induction	-1	Dead	581	Dead-Disease	0	80	80	0	7	7.8	0	6.9	0.5	31	42	3.2	1.3	M1	25.1	8.8	"46,XY[19]"	665	85.1	Normal	16	FALSE	"dim CD13, CD33, CD38, CD58, dim CD64, CD71, dim CD117 and CD123-positive"	TRUE	TRUE	7.2	33.81	TRUE	negative	0	positive				CSF3R ( p.T640N; MAF: 14%)|EZH2 (p.G709D; MAF: 17%)|EZH2 (p.R684C; MAF: 4%)|IDH2 (p.R140Q; MAF: 46%)|KDM6A (Splice site-Intron 5 3' end mutation; MAF:3%)|NPM1 (p.W288fs*12; MAF: 39%)					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.195311478	1.459629216	0.10465675	3.420105908	4.830238718	-3.647851047	3.510084808	no	no	no	no	no	no	no	-4.229247196	NA	-1.313286083	NA	3.240373312	-7.318289968	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.380753751
BA2414R	BA2414D	2307	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	5			50	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Hodgkin Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	50	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"GCLAC (GCSF, Clofarabine & Cytarabine)|Fludarabine, Cyclophosphamide, Thiotepa, TBI"	2	Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, Thiotepa, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Dead	201	Dead-Unknown	0	75	82	2	NA	4	0	8	NA	39	45	3.7	NA		20.1	6.5	"46,XY,add(1)(p11),del(5)(q15q33),del(7)(q22q36),der(11)t(1;11)(p31;p12-14)[20] "	NA	NA	Loss of 5q31 sequences for 99% of total cells | Loss of 7q31 sequences for 96% of total cells	12	TRUE	"Positive: CD38, CD56, CD13, CD34, CD45, CD117, HLA-DR | Partially positive: CD7, CD11b, CD33, CD64 | Negative: CD19, CD22, Cyt CD79a, Cyt CD3, CD14, CD15, MPO, TdT"	TRUE	TRUE	6.3	119.6	TRUE	positive	0.818181818	negative				BCOR (C.3067T>C; p.F1023L)|FLT3-ITD|NOTCH1 (c.7625G>A; p.S2542N)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.578373928	3.157635869	2.109065935	1.435245391	4.94485332	-2.590271627	4.398469402	no	no	no	no	no	no	no	0.083887468	NA	3.532447208	NA	-0.004019825	3.670921455	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.456768825
BA2697R	BA2697D	2168	Waves1+2	yes	yes	yes	yes	Female	Female			White	3			65	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	65	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Vidaza|Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)"	3	Induction|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	338	Alive	NA	20.6		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"45,XX,-7[20]"	NA	NA	"7cen (D7Z1), 7q31 (D7S486): monosomy present "	NA	NA		NA	NA	NA	NA	NA	negative	0	negative				DNMT3A (p.Gln231fs; MAF 33.2%)|IDH2 (p.Arg140Gln; MAF 44.2%)|NRAS (p.Gln61Glu; MAF 47.8%)					no		Found	TRUE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	4.744288309	5.851824996	3.651261861	2.846785231	7.629252349	0.275450535	6.101902147	yes	yes	yes	no	yes	yes	yes	7.204585408	NA	-1.689206481	NA	1.771889023	3.013123726	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.838433201
BA2999R	BA2999D	2117	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1			53	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	54	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	7	"AG-120|7+3 (Cytarabine, Idarubicin)|Azacitidine|MGD006 (CD123 x CD3) |MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine|Incyte trial (azacitidine and JAK 1 inhibitor)"	5	Salvage|Induction|Experimental|Re-induction|Maintenance	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Incyte trial (azacitidine and JAK 1 inhibitor)	Salvage	-1	Dead	543	Dead-Disease	0	75	90	0	0	22.1	6.2	1.8	0	19	33	1.8	0.84		25.5	8.1	"46,XY,t(4;12)(q12;p13)[10]/46,XY[10] "	706	91.4	"42/100 (42%) interphase cells scored were positive for  ETV6 rearrangement. æMetaphase FISH showed part of the ETV6 signal (red) on  the long arm of chromosome 4. æBased on the breakpoint, ETV6/CHIC2 fusion  is predicted, consistent with AML"	25	TRUE	"partial CD7, CD13, CD33, CD38, CD34, CD58, CD117, CD123,  HLA-DR positive "	TRUE	TRUE	6.6	118	TRUE	negative	0	negative	RUNX1 (p.R166*; 41.5%)			DNMT3A (p.R882H; MAF 49%)|IDH1 (p.R132S; MAF 48%)|RUNX1 (p.R166*; MAF 50%)|SRSF2 (p.P95H; MAF 50%)		yes			yes		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	4.423363574	4.771018257	1.207948541	1.825110857	5.613299821	-1.316820856	3.655457998	yes	yes	no	no	no	no	no	1.337061263	NA	6.044304519	NA	-3.238123946	1.565083568	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.450582941
BA2644R	BA2644D	2280	Waves1+2	no	no	no	no	Male	Male	White		White	3			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin) plus Crenolanib|IDAC"	3	Consolidation|Induction|Allogeneic - Child	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Child	-1	Alive	306	Alive	NA	26.3	12	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[11]  "	NA	NA	Normal	69	TRUE		NA	NA	NA	9.28	FALSE	negative	0	negative				BCOR (p.Tyr354*; MAF 72.2%)|DNMT3A (p.Phe755Ser; MAF 38.6%)|DNMT3A (p.Thr835Met; MAF 47%)|IDH1 (p.Arg132Cys; MAF 2.9%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.761083856	4.623216308	2.599429395	6.609010906	6.779521012	-2.203211143	4.410920735	yes	yes	no	yes	yes	no	no	NA	NA	NA	NA	NA	NA							0.808981464
BA2011R	BA2011D	2280	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	3			63	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	1	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin) plus Crenolanib|IDAC"	3	Consolidation|Induction|Allogeneic - Child	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Child	-1	Alive	306	Alive	NA	26.3		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[11] "	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative				BCOR (p.Tyr354*; MAF 72.2%)|DNMT3A (p.Phe755Ser; MAF 38.6%)|DNMT3A (p.Thr835Met; MAF 47%)|IDH1 (p.Arg132Cys; MAF 2.9%)					no		Found	TRUE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.626425024	5.047682741	4.220970819	6.325461091	6.814535931	-0.926284489	3.79421628	yes	yes	yes	yes	yes	yes	no	5.380700144	NA	0.320881785	NA	-1.439214522	4.288886835	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.9403176
BA2217R	BA2217D	2538	Waves1+2	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC	White	1	bi		47	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	HiDAC	Consolidation	116	Alive	214	Alive	0	83	82	3.4	0	23.1	3.4	0	1.6	23	11	3.5	0.95	M1	31.1	10.2	"46,XY[20]"	290	88.9		24	FALSE	"CD7, CD13, CD33, CD34, CD38, partial CD56,  CD58, dim CD64, CD117, CD123, HLA-DR, and cMPO "	TRUE	TRUE	6.5	18.71	FALSE	negative	0	negative				"CEBPA (p.I68fs; MAF 50%)|CEBPA (p.K313_V314insK; MAF 50%)|EZH2 (p.S519P; MAF 51%)|NRAS (p.G13D, MAF 3%)|WT1 (p.M392fs*10; MAF 13%)|WT1 (p.R458*; MAF 23%)"					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.59566377	2.561914578	0.341831953	2.770346183	2.648493357	-3.699774364	2.7956563	yes	no	no	no	no	no	no	-7.862787147	NA	-0.472876048	NA	-5.626287029	-0.48169429	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.22591986
BA2454R	BA2454D	2234	Waves1+2	yes	yes	yes	yes	Male	Male	White		White	2			73	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Decitabine	Supportive/Palliative Care	-1	Dead	31	Dead-Unknown	NA	83	59	NA	NA	NA	NA	NA	NA	21	23	NA	NA		NA	NA	"46,XY[20]"	NA	NA	"nuc ish(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[195],(PML, RARA)x2[200],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	22	TRUE		NA	NA	NA	24.23	TRUE	negative	0	negative	RUNX1 (p.S322*; 51.4%)	ASXL1 (p.R693*; 50.0%)							no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	2.129469225	1.831261238	-2.004195872	2.666080347	4.425174556	-3.11501734	-0.301248948	no	no	no	no	no	no	no	-5.956626382	NA	4.822901931	NA	-5.518433375	-0.461997526	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.285324604
BA2776R	BA2776D	2431	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			61	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Supportive/Palliative Care	1	Hydroxyurea	1	Supportive/Palliative Care			NA	Supportive/Palliative Care	Hydroxyurea	Supportive/Palliative Care	-1	Dead	316	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"CD13, CD33, CD38, CD56, CD58, CD117, CD123 and dim MPO positive"	FALSE	TRUE	NA	NA	NA	positive	9	positive				FLT3-ITD (30 bp insertion; MAF 70%)|NPM1 (p.W288fs*12; MAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	1.530824428	1.067565112	2.071535077	2.019295974	5.292721338	-1.126239505	0.49238161	no	no	no	no	no	no	no	-6.608299546	NA	-2.243488475	NA	-1.326455477	-8.019240694	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.224125863
BA2218R	BA2218D	2282	Waves1+2	yes	yes	yes	yes	Female	Female	White	HISPANIC	HispNative	6			39	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	40	0	Relapse|Post-Chemotherapy	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|ME (Etoposide, Mitoxantrone)|Decitabine"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	39	Standard Chemotherapy	Decitabine	Salvage	69	Dead	433	Dead-Unknown	NA		91	NA	NA	9	NA	NA	NA	21	34	3.8	0.49		29.3	9.9		NA	93.6		66	TRUE		NA	NA	5.8	73	TRUE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.231884909	-1.330559403	-0.286763973	1.782959625	4.517605999	-0.728077925	2.437508634	no	no	no	no	no	yes	no	-7.325879964	NA	0.125181927	NA	-0.037870029	-7.1907659	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.359483197
BA2135R	BA2135D	2547	Waves1+2	yes	yes	yes	yes	Female	Female			HispNative	6			73	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Decitabine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Decitabine	Supportive/Palliative Care	-1	Alive	122	Alive	NA	71	3	1	NA	68	8	11	NA	11	23	2.9	0.51		24.9	7.8	"46,XX,del(1)(p22),der(15)t(15;?)(q15;?),-17,+mar[19]/46,XX[1]"	NA	110.7	Loss of RARA gene at 17q21 is detected in 69% of cells Gain of MLL gene at 11q23 is detected in 8% of cells.	95	TRUE	"blasts 55% of all events; they are positive for cd34, hla-dr, cd117, cd13, cd33, and negative for cd11b, cd14, cd64, tdt and mpo"	FALSE	FALSE	4.8	63.4	TRUE	negative	0	negative		ASXL1 (p.G646Wfs*12; 32.6%)							no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.420360525	4.243521333	3.820771229	3.806896357	5.570413316	-1.377359964	5.205808118	no	yes	yes	yes	no	no	yes	0.726127267	NA	4.018515252	NA	-1.827248245	-1.766052059	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.68248863
BA2914R	BA2914D	2508	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1			38	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	38	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	HiDAC	Consolidation	106	Alive	1586	Alive	NA	47		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"CD117, dimCD4, æheterogeneous CD13, CD33, dimCD64 and  MPO positive  (Myeloid Blast Population) | heterogeneous CD13, bright CD33, dimCD4,  dimCD14, bright CD64 positive  (Monocytes/promonocytes Population)"	FALSE	TRUE	NA	46.27	TRUE	negative	0	positive				DNMT3A (p.R882H; MAF 46%)|IDH1 (p.R132H; MAF 25%)|KRAS (p.Q61L; MAF 10%)|NPM1 (p.W288fs*12; MAF 51%)|NRAS (p.G13D; MAF 24%)					no		Found	TRUE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	3.248339325	5.668574383	2.346537472	3.572854403	8.245096155	-1.283519723	7.062347959	yes	yes	no	no	yes	no	yes	7.289269094	NA	-2.754963935	NA	2.084530174	-2.111223705	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.769979626
BA2500R	BA2500D	2120	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		PML-RARA	59	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	59	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"ATRA, Arsenic Trioxide, Idarubicin"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"ATRA, Arsenic Trioxide, Idarubicin"	Induction	-1	Alive	28	Alive	0.9	90	90	1.7	44	8.6	0	6	1.5	110	255	2.4	0.86	M3	19.8	6.7	"46,XX,t(15;17)(q22;q21)[20]"	NA	88.4	86/100 cells (86%) had the 1r/1g/2f dual fusion signal pattern consistent  with PML/RARA fusion and with t(15;17) as seen on metaphase analysis. 	30	FALSE	"CD13, CD33, CD58, CD64, CD117, CD123, MPO"	FALSE	TRUE	5.4	47.35	TRUE	negative	0	negative				ASXL1 (p.M1050V; MAF 51%)|FLT3-ITD (MAF 46%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.658225584	1.755411239	5.458930499	3.515474683	6.954112232	-2.048875085	6.41081514	no	no	yes	no	yes	no	yes	-3.36980941	NA	-4.305613505	NA	2.895686978	-5.662335243	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.465599745
BA2406R	BA2406D	2143	Waves1+2	yes	yes	yes	no	Male	Male	White		White	6			64	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Hodgkin Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	64	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	80	Dead-Unknown	NA	17		NA	NA	NA	5	NA	NA	NA	NA	NA	NA		NA	NA	"42,XY,-3,-7,der(12)t(12;?)(q24.3;?)-17,der(17)t(17;?)(p13;?),-21,der(22)t(22;?)(p11.2:?)[10]/46,XY[10] "	NA	NA		43	TRUE	"NOT DETECTED for the MLL partial tandem duplication (PTD). NOT DETECTED for the FLT3 Internal Tandem Duplication (ITD)-Signal Ratio (SR). NOT DETECTED for the FLT3 TKD Mutation. Pathogenic alterations are DETECTED in the DNMT3A, NF1 and TP53 genes.  (Bone Marrow Immunophenotyping) | positive for CD34, CD117, HLA-DR, CD13, and CD33, negative for monocytic markers CD11b, CD14 and CD64, negative for specific B and T cell markers. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	2.2	FALSE	negative	0	negative			TP53 (p.E204*; 52.3%)	"DNMT3A (c.2635_2651delAACATGAGCCGCTTGGC; p.N879Efs*36c.2656C>T; pQ886*MAF 43%, 36% )|NF1 (c.2192_2199delTCTTGCCC; p.L731Qfs*3  MAF 38%)|TP53 (c.610G>T;p.E204*MAF 51%)"					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	4.688714884	5.507935528	5.190893709	5.470281866	7.093391326	1.436266854	6.208728417	yes	yes	yes	yes	yes	yes	yes	5.923736878	NA	-0.024622933	NA	1.431148981	0.941519319	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.848661031
BA2830R	BA2830D	2268	Waves1+2	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	72	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	74	0	Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Targeted Therapy - Kinase Inhibitor(s)	1	Dasatinib	1	Experimental			NA	Targeted Therapy - Kinase Inhibitor(s)	Dasatinib	Experimental	16	Alive	808	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	3.100390587	0.195731849	0.800942945	1.755411239	5.529127847	-1.0246717	4.711575242	yes	no	no	no	no	no	yes	-5.002596482	NA	2.99938441	NA	-3.184853001	-0.480239399	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.440309774
BA2353R	BA2353D	2268	Both	no	no	no	no	Female	Female	White	NON-HISPANIC	White	1		CBFB-MYH11	72	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	74	33	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Targeted Therapy - Kinase Inhibitor(s)	1	Dasatinib	1	Experimental			NA	Targeted Therapy - Kinase Inhibitor(s)	Dasatinib	Experimental	16	Alive	808	Alive	2.6	90	74	0	0	6	2.6	2.6	0	12	22	2.7	0.69		19.5	6.5	"46,XX,inv(16)(p13q22)[18]/46,XX[2] "	807	86.7	CBFB: æ79/100 cells (79%) reflecting CBFB rearrangement and the inverted chromosome 16 observed in the metaphase karyotype. 	9	FALSE	"CD13, CD33, CD34, variable CD38, CD117,  CD123, and HLA-DR +."	FALSE	TRUE	5.8	34.76	TRUE	negative	0	negative				KIT (p.D816H; MAF 44%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	3.177838623	1.322350874	-0.263481968	2.507231447	5.712931628	-2.882174423	5.468460933	yes	no	no	no	no	no	yes	NA	NA	NA	NA	NA	NA							0.48278093
BA3108R	BA3108D	2673	Waves3+4	yes	yes	yes	no	Female	Female	White	NON-HISPANIC		1			72	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Other	4	"Vidaza, BI836858 (anti-CD33)|Azacitidine|Enasidenib|Incyte trial (azacitidine and JAK 1 inhibitor)"	3	Salvage|Induction|Maintenance	Refractory	Standard Chemotherapy	185	Targeted Therapy - Other	Enasidenib	Salvage	28	Alive	1640	Alive	0	47	0	0	0.9	74.3	0	13.3	0	15	8	2.9	0.51	M2	29.1	9.4	"48,XX,+8,+8,add(9)(q22)[1]/50,idem,+15,+18[5]/46,XX[14] (Six of twenty metaphase cells analyzed comprised two related hyperdiploid clones.)"	85	101.7	Results were consistent with tetrasomy 8 (RUNX1T1/CEP8) and trisomy 15 (PML) in approximately 50% of cells scored. æAll other probe results were within normal limits with no evidence for rearrangements or deletions. 	57	TRUE	"CD13, CD33, CD34, CD38, moderate-dim  CD45, and CD117+ "	FALSE	TRUE	5.7	1.62	FALSE	negative	0	negative				IDH2 (p.R140Q; MAF 43%)|U2AF1 (p.Q157P; MAF 17%)			yes		yes	yes	Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.061925636	3.742671226	0.792123208	6.354451923	5.200819479	-0.651755834	2.126420627	no	yes	no	yes	no	yes	no	-5.188349209	NA	2.366986438	NA	-7.37852473	-3.194213391	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.362520326
BA2924R	BA2924D	2475	Both	no	no	no	no	Male	Male	White		White	6			66	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	67	0	Relapse|Post-Chemotherapy	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	23	Standard Chemotherapy	HiDAC	Consolidation	63	Alive	300	Alive	NA		8	1	NA	14	19	46	NA	15	22	4.3	0.88		38.3	12.5		NA	97.2		165	TRUE		NA	NA	6.2	9	FALSE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.766798496	4.866393511	3.287448061	6.809027973	6.12729526	0.450991498	4.189053376	yes	yes	yes	yes	yes	yes	no	NA	NA	NA	NA	NA	NA							0.719508946
BA3192R	BA3192D	2475	Waves3+4	no	no	no	no	Male	Male	White			6			66	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	67	80	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	23	Standard Chemotherapy	HiDAC	Consolidation	63	Alive	300	Alive	NA	90		NA	NA	NA	0	NA	NA	NA	NA	NA	NA		NA	NA	"49,XY,+4,+8,+14[9]/49,sl,del(4)(q21q31.1)[11]"	NA	NA		41	FALSE	"POSITIVE FOR CD117, HLA-DR, CD13, CD33, CD14 AND MPO AND NEGATIVE FOR CD34, CD11B, CD64, CD10 AND TDT. (Bone Marrow Immunophenotype)"	FALSE	TRUE	NA	13	FALSE	positive	NA	positive				DNMT3A (c.2645G>A; p.R882H MAF 42%)|FLT3-ITD|KIT (c.2447A>T; p.D816V MAF 81%)|NPM1 ((NPM1) c.860_863dupTCTG; p.W288Cfs*12  MAF 51%)|SETBP1 (c.3209C>T; p.P1070L MAF 46%)|TET2 (c.3638T>G; p.V1213G MAF 87%)					no		Found	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	0.846900161	0.534938899	1.660015572	2.200430448	5.155284096	0.191709371	-1.042293361	no	no	no	no	no	yes	no	NA	NA	NA	NA	NA	NA							0.362124164
BA2303R	BA2303D	2570	Both	no	no	no	no	Female	Female			White	3			39	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Cervical Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	39	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC + Midostaurin|Fludarabine, TBI"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, TBI"	Allogeneic - Sibling	-1	Alive	296	Alive	NA	70	80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		NA	NA	"Large pop. of promonocytes/monoblasts representing approx 57% of total leukocytes and increased atypicalCD117 pos, partial CD34 pos myeloblasts (partial CD7 pos) representing approx 6% of leukocytes consistent w/AMLw/monocytic differentiation."	TRUE	FALSE	NA	190	TRUE	positive	5.666666667	positive				DNMT3A (p.Arg882His; MAF 41.8%)|FLT3 (p.Tyr572Cys; MAF 1.2%)|FLT3 (p.Val581_Arg595dup; MAF 22%)|FLT3-ITD|NPM1 (p.Trp288fs; MAF 21.2%)					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	0.433070764	1.4606712	3.418602136	3.077577922	6.450425588	-2.975956175	3.39199853	no	no	yes	no	yes	no	no	NA	NA	NA	NA	NA	NA							0.687144943
BA2160R	BA2160D	2216	Both	no	no	no	no	Male	Male			White	3			74	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Bladder Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	74	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|Azacitidine"	2	Induction|Supportive/Palliative Care	UNKNOWN	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Dead	58	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA	"Large population of CD117pos, CD34 neg, HLA-DR neg myeloblasts, representing approx 68% of leukocytes, consistent w/ residual/recurrent AML."	FALSE	FALSE	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	2.445112797	1.452270628	-1.021805683	3.464588667	5.213971195	-2.584830924	-1.460562837	no	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.320887021
BA2590R	BA2590D	2131	Both	no	no	no	no	Male	Male			HispNative	5			55	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	3	"Midostaurin|Fludarabine, Cyclophosphamide, Thiotepa, TBI|7+3 (Cytarabine, Idarubicin) plus Enasidenib"	3	Induction|Double Umbilical Cord Blood Transplant (DUCBT)|Maintenance	Complete Response	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Midostaurin	Maintenance	44	Dead	282	Dead-Disease	0	88.5	64	0	NA	25	4	7	NA	34	36	3.3	NA		31.3	10.9	"46,XY[19]"	NA	NA	Normal	54	TRUE	"Negative (CD19, CD22, Cyt CD3, CD7, CD56, CD11b, CD13, CD14, CD34, CD64, CD117, TdT) | Positive (CD38, Cyt CD79a, CD15, CD33, MPO) | Dim (CD45, HLA-DR)"	TRUE	TRUE	7.4	24.9	TRUE	positive	1	positive				FLT3 (c.1811_1812insl8; p.E604_P605insYDLKWE; MAF 32%)|IDH1 (c.395G>A; p.R132H; 44%)|NPM1 (c.863_864insTCTG; p.W288fs; MAF 42%)|SRSF2 (c.284_307del; p.P95_R102del; MAF 45%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.463015517	1.323460801	0.502611742	3.938851014	4.472838845	-0.976484324	0.203542587	no	no	no	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.418640065
BA3195R	BA3195D	2827	Waves3+4	yes	yes	yes	yes	Male	Male				5			77	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	77	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Targeted Therapy - Kinase Inhibitor(s)|Targeted Therapy - Other	4	"Venetoclax, Idasanutlin|anti-CD123, Decitabine|Enasidenib|cd47mAb"	3	Salvage|Induction|Experimental	Refractory	Targeted Therapy - Kinase Inhibitor(s)	-1	Targeted Therapy - Kinase Inhibitor(s)	Enasidenib	Salvage	-1	Alive	322	Alive	0	90	92	0	NA	4	1	3	NA	17	22	3.8	NA		24.7	7.4	"46,XY[19]"	NA	NA	Normal	72	TRUE	"Positive (CD38, CD15, CD34, MPO, HLA-DR) | Negative (CD19, CD22, Cyt CD79a, Cyt CD3, CD7, CD56, CD11b, CD13, CD14, CD33, CD64, TdT) | Dim Positive (CD45, CD117)"	TRUE	TRUE	6.4	224.2	TRUE	negative	0	negative	RUNX1 (p.L98Pfs*40; 52.3%)|RUNX1 (p.N434Kfs*166; 32.4%)			DNMT3A (c.2644C>T; p.R882C; MAF 47%)|IDH2 (c.419G>A; p.R140Q; MAF 48%)|JAK2 (c.1849G>T; p.V617F; MAF 50%)|RUNX1 (c.1289_1290insTGCC; p.P430fs; MAF 17%)|RUNX1 (c.1301 1302insA; p.N434£s; MAF 21%)|RUNX1 (c.292_293insC; p.L98fs; MAF 45%)|SRSF2 (c.284C>A; p.P95H; MAF 48%)		yes			yes	yes	Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	0.94047208	3.083073131	0.732935263	4.360158605	5.201166098	-0.058990543	2.378403438	no	no	no	yes	no	yes	no	-1.542223147	NA	6.251914356	NA	-5.896790024	0.196906582	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.468908223
BA2516R	BA2516D	2500	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	1			70	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	70	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	4	"Imatinib|Cytarabine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Decitabine"	4	Salvage|Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	61	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone)"	Salvage	-1	Dead	362	Dead-Disease	0		15	0	16.2	16.2	8.1	6.3	4.5	20	45	4.6	1.5		31.5	9.8	"46,XY[20]"	851	92.6	Normal	14	FALSE		NA	NA	7.6	92.55	TRUE	negative	0	negative		ASXL1 (p.E635Dfs*22; 42.9%)		BCOR (p.S1024; MAF 5%)|NRAS (p.G13D; MAF 34%)|PTPN11 (p.G60V; MAF 3%)|SRSF2 (p.P95H; MAF 40%)		yes			yes		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.514564435	3.997914584	3.719189331	2.963491679	7.10458055	-2.16506181	6.792868793	no	yes	yes	no	yes	no	yes	NA	NA	NA	NA	NA	NA							0.5061283
BA3036R	BA3036D	2372	Both	no	no	no	no	Female	Female	Black		Black	2			43	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	43	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Alive	35	Alive	NA		48	NA	NA	NA	NA	NA	NA	30	21	NA	NA		NA	NA	"46,XX[20]"	NA	NA	"nucish(D5S2064,D5S630,EGR1)x2[200],(D7Z1,D7S522)x2[200],(D8Z2,D20S108)x2[200],(RUNX1T1,RUNX1)x2[200],(ABL1,BCR)x2[200],(5'MLL,3'MLL)x2(5'MLL con 3'MLLx2)[200],(PML,RARA)x2[199],(5'CBFB,3'CBFB)x2(5'CBFB con 3'CBFBx2)[200]"	27	FALSE		NA	NA	NA	41.91	TRUE	positive	0.492537313	negative				FLT3-D835					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	3.885891201	3.478880777	1.585498509	3.906826772	5.022707919	0.570510286	3.98610923	yes	yes	no	yes	no	yes	no	NA	NA	NA	NA	NA	NA							0.426167377
BA2971R	BA2971D	2086	Both	no	no	no	no	Male	Male	White	NON-HISPANIC	White	6			57	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	57	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)|HiDAC|3+7 (Cytarabine, Daunorubicin)"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)"	Allogeneic - Matched Unrelated Donor	13	Alive	307	Alive	NA	20		NA	NA	NA	3	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA		49	TRUE	"THESE ARE POSITIVE FOR CD34, CD117, HLADR, CD13, AND CD33. (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	19.3	FALSE	negative	0	negative	RUNX1 (p.D198N; 47.6%)|RUNX1 (p.P113L; 42.7%)			DNMT3A (c.2644C>T; p.R882C MAF 47%)|JAK2 (c.1849G>T; p.V617F MAF 91%)|RUNX1 (c.338C>T; p.P113L  MAF 42% c.592G>A; p.D198N MAF 46%)|SETBP1 (c.883G>A; p.V1295M MAF 47%)|SRSF2 (c.284C>A; p.P95H MAF 47%)		yes			yes		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	6.067617302	8.232437589	5.896032759	7.304115114	7.437298899	-0.949108598	4.794166584	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.951022061
BA3410R	BA3410D	2695	Waves3+4	yes	yes	yes	no	Male	Male	White	NON-HISPANIC		8			63	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Supportive/Palliative Care	2	"7+3 (Cytarabine, Idarubicin)|Decitabine"	2	Induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	8	Supportive/Palliative Care	Decitabine	Supportive/Palliative Care	67	Dead	250	Dead-Disease	NA		5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"43-48,XY,add(2)(q11.2),add(3)(p13),add(3)(q29),del(5)(q15q33),der(7)add(7)(p11.2)add(7)(q22),?hsr(8)(q24),+10,+11, add(12)(p11.2),-13,add(14)(p13),add(15)(p12),add(15)(p13),-16,?hsr(16)(q22),-17,-20,+21,add(21)(q22),idic(21)(q22),-22, add(22)(p12),+mar1-5[cp22]/87-88,idem[cp2]"	NA	NA		79	TRUE		NA	NA	NA	1.9	FALSE	negative	0	negative			TP53 (p.R248Q; 58.8%)						no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	6.180746339	7.257903471	5.742443266	5.799143575	7.182352914	1.443763947	6.294106234	yes	yes	yes	yes	yes	yes	yes	4.755099847	3.409018581	3.188635064	-1.492053905	2.781271309	-1.114780834	Monocyte_Like	GMP_Like	HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.794990073
BA3118R	BA3118D	2709	Waves3+4	yes	yes	yes	yes	Female	Female	Asian			2		CBFB-MYH11	45	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	45	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	92	Alive	279	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative				MYH11 (CBFB-MYH11 fusion)|NRAS (G12D)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	2.595440926	3.241815013	0.488936421	4.252284013	6.0760803	-1.858497948	4.47937234	no	no	no	yes	yes	no	yes	0.836609012	NA	0.928592981	NA	-1.075664559	3.550703897	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.690091865
BA3206R	BA3206D	2668	Waves3+4	yes	yes	yes	yes	Female	Female	White	HISPANIC		1		RUNX1-RUNX1T1	35	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	35	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Decitabine, Venetoclax"	4	Consolidation|Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"Decitabine, Venetoclax"	Salvage	165	Dead	1220	Dead-Disease	0	60	10	0	0.9	88.7	0.9	9.5	0	34	12	3	0.8	M2	22	7.8	"45,X,-X,t(8;21)(q22;q22)[20] "	334	93.2	"RUNX1T1(8q21.3)/RUNX1(21q22): æ 64% of cells had an atypical 1r/2g/1f  signal pattern, a fusion pattern consistent with t(8;21) as seen on metaphase analysis.  | All twenty metaphase cells examined were abnormal, with monosomy X and  t(8;21)."	34	FALSE	"CD13, dim CD19, dim CD33, CD34, CD38, CD56, CD58, CD117, dim CD123, HLA-DR and MPO+ "	FALSE	TRUE	7	4.73	FALSE	negative	0	negative				FLT3-ITD (MAF 5%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.469501228	4.702067507	1.517595728	4.596171504	6.51154576	-1.463854919	8.030156765	no	yes	no	yes	yes	no	yes	-1.449674339	NA	0.003951827	NA	0.608605904	0.341072035	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.518841133
BA3217R	BA3217D	2624	Waves3+4	yes	yes	yes	yes	Male	Male	White			5			60	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)"	2	Allogeneic - Sibling|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Sibling	-1	Alive	293	Alive	NA	95	70	NA	NA	27	1	2	NA	37	32	3.2	NA		29.2	9.9	"46,XY[20]"	NA	NA	Normal	48	TRUE	"Positive (CD38, CD33, CD34, MPO, HLA-DR) | Negative (CD19, CD22, Cyt CD79a, Cyt CD3, CD7, CD56, CD13, CD14, CD15, CD117, TdT) | Dim (CD11b, CD45, CD64)"	TRUE	TRUE	6	25.5	TRUE	positive	0.960784314	negative				"FLT3-ITD (ITD, c.1769_1770ins42; p.Y589_F590insl4 (MAF 38%))|IDH2 (c.419G>A; p.R140Q (MAF 48%))|STAG2 (c.3034delC; p.R1012fs (MAF 92%))"					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	1.177475595	0.893117073	1.357423296	3.091012395	3.966753841	-3.80664195	0.798083757	no	no	no	no	no	no	no	-7.364834563	NA	-0.138375234	NA	-2.765909003	2.788431888	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.374116822
BA3405R	BA3405D	2701	Waves3+4	yes	yes	yes	no	Male	Male				3			67	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|7+3 (Cytarabine, Idarubicin)|Cytarabine"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Matched Unrelated Donor	-1	Alive	177	Alive	NA	35		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	NA	NA		NA	NA		NA	NA		NA	NA	NA	35.04	TRUE	negative	0	negative	RUNX1 (p.D198G; 94.2%)	ASXL1 (p.G646Wfs*12; 30.1%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	2.162634089	1.348487816	4.113475444	3.625607199	6.549782764	-3.320087538	1.166223357	no	no	yes	no	yes	no	no	5.167115563	-2.631046201	-1.351690382	-3.712016602	-0.778225982	5.421278744	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	cDC_Like	0.694831333
BA3306R	BA3306D	2811	Waves3+4	yes	yes	yes	yes	Female	Female	White			5			26	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	26	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Fludarabine, Cyclophosphamide, Thiotepa, TBI"	3	Consolidation|Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, Thiotepa, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	289	Alive	0	89.5	88	0	NA	7	2	3	NA	10	21	3	NA		23.1	7.6		NA	NA	Normal	19	FALSE	"Dim Positive (CD13, MPO) | Dim Partial positive (CD34) | Variable partial positive (CD117)"	FALSE	FALSE	5.2	138.2	TRUE	positive	19	positive				"FLT3-ITD (ITD, c.l815_1816ins30; p.F605_P606insl0 (MAF 49%))|IDH1 (c.395G>A; p.R132H (MAF 45%))|NPM1 (c.863_864insTCTG; p.W288fs (MAF 43%))"					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	1.008641924	2.654167603	4.716819501	2.183881732	4.407287194	1.3401803	1.593428932	no	no	yes	no	no	yes	no	-3.507270025	NA	0.288167229	NA	-1.305820329	-7.586078257	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.441052689
BA3371R	BA3371D	2809	Waves3+4	yes	yes	yes	no	Female	Female	White	NON-HISPANIC		8			21	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	21	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	4	"HiDAC|7+3 (Cytarabine, Idarubicin)|Unknown|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)"	4	Consolidation|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	2	Bone Marrow Transplant	Unknown	Allogeneic - Matched Unrelated Donor	-1	Dead	678	Dead-Disease	NA	13		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	"Negative for RUNX1/RUNX1T1, KMT2A (MLL), CBFB"	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	2.503291261	4.054020947	3.379465735	5.017398767	6.476208088	1.205444399	6.866481118	no	yes	yes	yes	yes	yes	yes	-0.973442097	3.907865197	-0.850765488	0.395908871	4.085926888	-4.293178829	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.568607938
BA3413R	BA3413D	2666	Waves3+4	yes	yes	yes	no	Female	Female	White			3	bi		31	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	31	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|CLAG (Cladribine, Cytarabine, Filgrastim)|7+3 (Cytarabine, Idarubicin, Dexamethasone)"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Matched Unrelated Donor	-1	Alive	153	Alive	NA	80	69	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,del(9)(q13q22)[5]/46,sl,del(11)(q13q23)[14]  /46,sdl,t(2;4;7)(q33;q21;p15),add(8)(p11.2)[2]"	NA	NA		18	FALSE		NA	NA	NA	11.23	FALSE	negative	0	negative				CEBPA (p.Ala111fs; MAF 44.5%)|CEBPA (p.Ser319_Asp320del; MAF 32.9%)|CSF3R (p.Thr618Ile; MAF 1.6%)|GATA2 (p.Arg330Gln; MAF 46%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.157635869	3.047602763	0.86284772	2.273109776	4.88469315	-1.60211287	5.963860714	yes	no	no	no	no	no	yes	-2.793833879	0.802943553	-0.892509079	3.380805915	-2.35327471	0.677013542	Not_Monoctyte_Like	GMP_Like	Not_HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.453589411
BA3411R	BA3411D	2615	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			48	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	48	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	351	Alive	0	25	7	0	2.6	47	9.6	36.5	0	NA	NA	NA	NA	M4	19.5	6.7	"47,XX,+8,del(8)(q11.2q22)[20]"	NA	89.4	"CEP 8: æ73/100 cells (73%) had three signals, consistent with the extra chromosome 8 in the metaphase karyotype"	21	TRUE	"CD13, CD33, CD34, CD38, CD56, CD58,ævariable CD64, CD71, CD117, dim CD123, HLA-DR, MPO  (Myeloid Blasts) | CD11b, CD13, CD15, CD33, CD56, CD64, HLA-DR (Abnormal Monocytes)"	TRUE	TRUE	NA	4.8	FALSE	negative	0	negative		ASXL1 (p.L823*; 45.9%)		ASXL1 (p.L823; MAF 47%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	1.638400218	7.289891995	4.648394391	3.206719524	6.386940213	-1.674034464	7.81832288	no	yes	yes	no	yes	no	yes	3.51170442	3.710719477	-1.749692172	-1.131618905	3.353318249	-0.140414627	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	Not_cDC_Like	0.63895811
BA3133R	BA3133D	2747	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			61	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Skin cancer	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Vidaza	1	Induction	Unknown	Standard Chemotherapy	-1	Standard Chemotherapy	Vidaza	Induction	-1	Dead	51	Dead-Disease	0	25	26	0	11.5	9.7	7.1	43.4	0.1	23	33	3.6	0.8	M2	22	7	"45,XY,del(5)(q13q33),-7,add(8)(q24.3),add(9)(q34),add(10)(q23),del(17)(p13)  ,add(18)(q23)[3]/47-49,sl,+2-4mar[cp12]/44,sl,-2,add(3)(p21),t(6;11)(p22;q1  4),-add(8)(q24.3),add(8)(p22),-9,add(9)(q33),-10,-13,add(21)(q21),+2mar[8] "	855	116.4	"TP53 (17p13.1):  83% of cells were missing a signal for TP53, consistent with the 17p deletion seen on metaphase analysis.  | RUNX1 (21q22):  15.5% of cells were missing a signal for RUNX1. æNo  evidence for RUNX1/RUNX1T1 fusion.  | MECOM (3q26.2): æ33% of cells had six (6) signals for MECOM. On available  metaphases, the extra MECOM signals hybridized to the small marker  chromosomes. æNo evidence for MECOM/RPN1 fusion. "	166	TRUE	"CD13, CD33, CD34, CD38, CD58, CD71, CD117,  CD123, HLA-DR + "	TRUE	TRUE	6.7	19.22	FALSE	negative	0	negative	RUNX1 (p.X170_splice; 26.1%)		TP53 (p.Q167*; 91.3%)	BCOR (p.Q1658H; MAF 100%)|RUNX1 (Splice Site; MAF 17%)|SF3B1 (p.K666M; MAF 47%)|SRSF2 (p.R180G; MAF 54%)|TP53 (p.Q167; MAF 65%)	yes	yes			yes	yes	Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	TRUE	FALSE	3.696690741	4.308377901	3.097641081	3.261219191	5.735529047	-0.015069307	5.464844015	yes	yes	yes	no	no	yes	yes	0.805762987	NA	3.430591504	NA	-0.245434895	-0.344565835	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.639499904
BA3451R	BA3451D	2780	Waves3+4	yes	yes	yes	yes	Female	Female	White	UNKNOWN		1			47	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	95	Alive	1181	Alive	0	85	70	0.4	0.4	27.1	63.8	5.3	0.1	14	15	2.8	1.39	M5	19.8	6.5	"46,XX[20]"	355	97.5	Normal	48	TRUE	"CD4, CD11b, CD13, CD33, variable CD14, CD38,  dim CD56, CD58, bright CD64, dim CD123, HLA-DR, and partial MPO +"	FALSE	TRUE	7.7	58.66	TRUE	negative	0	positive				KRAS (p.G13D; MAF 36%)|NPM1 (p.W288fs*12; MAF 44%)|TET2 (p.Q897*; MAF 39%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	2.039588559	2.110674448	2.512677778	4.604015526	7.337966067	-3.11501734	5.654115006	no	no	no	yes	yes	no	yes	6.090107583	-1.984168852	-4.197669229	-5.841147301	3.508917887	3.636776312	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.749742824
BA3286R	BA3286D	2645	Waves3+4	yes	yes	yes	yes	Female	Female	Declined	NON-HISPANIC		1			45	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	45	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Daunorubicin) plus Sorafenib|HIDAC + Sorafenib|7+3 (Cytarabine, Idarubicin) plus Sorafenib"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	HIDAC + Sorafenib	Consolidation	-1	Alive	104	Alive	0	85	70	0	2.6	6	25.6	4.3	0.1	110	114	3.8	0.8	M1	23.3	7.4	"46,XX[20] "	2504	104	Normal	59	FALSE	"dimCD7, dimCD13, CD33, CD34, CD38, variable CD64, dimCD117, CD123, HLA-DR, and MPO positive "	TRUE	TRUE	6.4	185.9	TRUE	positive	0.298701299	negative				FLT3-ITD (123 bp insertion; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.426179252	1.67183175	2.822467378	1.853194187	6.191690629	-2.929213789	6.680708328	no	no	yes	no	yes	no	yes	2.14331448	NA	-1.52737328	NA	3.131584966	4.341378207	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.525376345
BA3221R	BA3221D	2645	Waves3+4	no	no	no	no	Female	Female	Declined	NON-HISPANIC		1			45	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	45	29	Post-Chemotherapy	Remission	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Daunorubicin) plus Sorafenib|HIDAC + Sorafenib|7+3 (Cytarabine, Idarubicin) plus Sorafenib"	3	Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	HIDAC + Sorafenib	Consolidation	-1	Alive	104	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA	"46,XX[20] "	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative				"CRLF2 (p.P224L; MAF 49%)|FLT3-ITD (MAF 2%)|KMT2D (p.R863P; MAF 48%)|PTPN11 (p.A72V; MAF 6%)|SETBP1 (p.P1134T, MAF 51%)"					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	5.217076666	6.622989664	4.383737923	7.318485143	7.696669483	-1.000558635	5.976084382	yes	yes	yes	yes	yes	no	yes	NA	NA	NA	NA	NA	NA							0.894922651
BA3212R	BA3212D	2727	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			0	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	0	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Cytarabine, Daunorubicin, and Etoposide|Busulfan, Cyclophosphamide|Etoposide, Cytarabine"	5	Consolidation|Induction|Intensification|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)"	Re-induction	4	Dead	855	Dead-Disease	0		82	0	NA	23.1	63.1	5.8	0.6	55	179	3.2	0.26	M0	15.5	5.6	"46,XX,der(1)t(1;9)(p36.1;q22),t(5;17)(p13;q21),der(5;9)(p10;p10),+8[12]/47,  sl,+20[7]64~69<3n>,XXX,+1,der(1)t(1;9)(p36.1;q22)x2,+5,t(5;17)(p13;q21)x2,+  6,-9,-11,+21[cp3] "	8707	85.2	"EGR-1/ D5S23, D5S721: 175/200 cells had a 1 red/æ2 green signal  pattern, indicating a deleted 5q. Five cells had a 2 red/ 4 green signal pattern consistent with the  two normal chromosomes 5 and the two derivative chromosomes (5;9),  resulting in loss of 5q, present in the near-triploid clone. | RUNX1T1/ RUNX1: 155/200 cells had a 3 chromosome 8 signals,  consistent with the trisomy 8 observed in the metaphase karyotype. æFour cells had 4 chromosome 21 signals (in addition to trisomy 8),  consistent with the tetrasomy 21 observed in the near-triploid clone. No evid for RUNX1T1/RUNX1 fusion. | ETV6/ RUNX1: æ 5/200 cells (2.5%) had a 4 red/ 3 green signal pattern,  consistent with the near-triploid clone with trisomy 8 and tetrasomy 21.  There was no evidence for ETV6/ RUNX1 fusion. "	28	FALSE	"CD4, CD7, partial CD13, CD33, CD71, partial CD117, CD123 and dim HLA-DR-positive "	TRUE	TRUE	5.7	133.39	TRUE	negative	0	negative				NRAS (p.G12D; MAF 29%)|NRAS (p.Q61K; MAF 6%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	4.705922511	1.922265649	0.211372803	2.33239311	5.687232659	-3.522808474	0.445765644	yes	no	no	no	no	no	no	-2.163503038	NA	-0.788734781	NA	-7.249765471	-4.458512018	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.391480972
BA3103R	BA3103D	2790	Waves3+4	yes	yes	yes	no	Female	Female	White			2		CBFB-MYH11	49	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	49	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	225	Alive	NA	58	44	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,inv(16)(p13.1q22)[18]/46,XX[2]"	NA	NA		32	TRUE		NA	NA	NA	57.75	TRUE	negative	0	negative				KIT|KRAS|MYH11 (CBFB-MYH11 fusion)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.337972581	1.596330494	0.932435558	4.624628601	5.78970451	-2.315491525	6.519178195	no	no	no	yes	no	no	yes	1.404396461	NA	2.333035492	NA	-1.727131682	4.397364819	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.693507104
BA3271R	BA3271D	2792	Waves3+4	yes	yes	yes	yes	Female	Female	White	HISPANIC		1			62	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Unknown	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	23	Dead-Disease	0	81	43	7.5	NA	20.6	16.8	8.4	0.8	21	33	2.3	2.79	M5	26.5	8.6	"46,XX[20]"	487	106.4	Normal	73	TRUE	"dim CD4, dim CD7, CD13, CD33, CD38, CD58, CD117, CD123, HLA-DR, and dim partial MPO (Myeloid Blast Population) | CD4, CD11b, CD13, dim CD14, dim CD15, CD16, CD33, CD38, CD58, CD63, CD123, HLA-DR  (Promonocyte/Monocyte Blast Population)"	TRUE	TRUE	6.5	28.53	TRUE	positive	0.666666667	positive				FLT3-ITD (ITD; MAF 45%)|IDH2 (p.R140Q; MAF 38%)|NPM1 (p.W288fs*12; MAF 41%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.571791266	2.951152346	2.29933994	3.806896357	6.867086307	-1.391022067	1.854913955	no	no	no	yes	yes	no	no	3.469238805	NA	-0.717844323	NA	-0.057049529	3.211053839	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.58620598
BA3152R	BA3152D	2758	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			74	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	74	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Azacitidine	Supportive/Palliative Care	3	Dead	5	Dead-Disease	0	42	4	0	9.1	3.8	44.7	38.6	0.5	27	23	2.3	1.64	M5	23.8	7.7	"43~44,XY,der(5)t(5;15)(q22;q11.2),add(6)(p23),-15,-16,-17,add(18)(q21),add(  19)(q13.1),-21,+mar1,+mar2[cp20]"	387	93.3	"Approximately 95% of cells had abnormal signal patterns consistent with the metaphase karyotype and reflecting deleted 5q, monosomy 16, monosomy 17, and monosomy 21. "	93	TRUE	"partial CD11b, CD13, partial CD14, CD33, CD34, partial CD64, CD117, HLA-DR and dim MPO (+)"	FALSE	TRUE	6	29.15	TRUE	negative	0	negative			TP53 (p.Y220C; 90.9%)	TP53 (p.Y220C;  MAF 91%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	4.139771589	5.303048469	5.504984843	3.03620368	7.250085084	-1.978278599	6.469282832	yes	yes	yes	no	yes	no	yes	5.705591614	NA	-0.6324647	NA	1.489370034	2.489064666	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.686348296
BA3095R	BA3095D	2626	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			27	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	27	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	7	"Ruxolitinib|7+3 (Cytarabine, Idarubicin)|HiDAC|MEC (Cytarabine, Etoposide, Mitoxantrone)|Sorafenib|Busulfan, Cyclophosphamide|Ibrutinib"	5	Consolidation|Induction|Re-induction|Maintenance|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Ruxolitinib	Maintenance	-1	Alive	1512	Alive	0	61	82	0	0	11.5	0.9	1.8	1.9	17	33	3.5	0.64	M1	20.5	7.1	"47,XX,+8[19]/46,XX[1]"	440	96.2	RUNX1T1 (8q21.3): æ 93% of cells had three signals for RUNX1T1 (8q21.3)  consistent with trisomy 8 as seen on metaphase analysis.	53	FALSE	"dim CD7, CD13, CD33, dimCD34, dimCD64, dim CD117, CD123, and dim HLA-DR+ "	TRUE	TRUE	5.9	24.3	TRUE	positive	0.818181818	negative				FLT3-ITD (MAF 50% )					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	0.408469253	1.085955021	3.382570859	2.766615078	4.391090553	1.047571678	2.236016563	no	no	yes	no	no	yes	no	-7.185553305	NA	3.558665396	NA	-2.414362796	0.875826993	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.378319711
BA3251R	BA3251D	2815	Waves3+4	yes	yes	yes	yes	Female	Female	White			5			75	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Unknown	Standard Chemotherapy	4	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	4	Dead	14	Dead-Disease	0	80.5	60	0	NA	16	22	1	NA	61	75	3.7	NA		33.7	11.1	"46,XX[20]"	NA	NA	Normal	35	FALSE	"Positive (CD38, CD13, CD33, CD117, MPO, HLA-DR) | Negative (CD19, CD22, Cyt CD79a, Cyt CD3, CD7, CD56, CD11b, CD14, CD15, CD34, CD64, TdT, Glyc A) | DIM (CD45, CD71)"	TRUE	TRUE	6.5	142.8	TRUE	positive	0.5625	negative				FLT3-ITD (c.1829_1830ins51; p.N609_L610ins17; MAF 19%)|IDH2 (c.419G>A; p.R140Q; MAF 48%)|RUNX1 (c.1041G>A; p.M347I; MAF 50%)					no		Found	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	TRUE	1.838221879	2.756059184	3.649876598	0.815922221	5.457840149	-1.10749691	4.349830471	no	no	yes	no	no	no	no	2.635675753	NA	0.509761711	NA	2.874871867	1.669358524	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.538599345
BA3362R	BA3362D	2655	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			72	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"3+7 (Cytarabine, Daunorubicin)"	1	Induction	Unknown	Standard Chemotherapy	-1	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	-1	Dead	24	Dead-Disease	0	85	75	0	0	14.8	7.8	1.7	0.5	31	63	3.4	0.89	M5	23.7	7.7	"46,XX,der(1)t(1;1)(p36.3;q21),t(8;16)(p11.2;p13.3),add(15)(q24)[20]"	4853	96.7	"In 95/100 cells (95%), three  signals for chromosome 1q25 were observed, and only two signals for 1p36  were observed, consistent with gain of 1q by der(1)t(1;1)"	144	TRUE	"CD4, CD11b, partial CD13, CD33, CD56, bright CD64, partial CD117, CD123, HLA-DR and partial MPO-positive"	FALSE	TRUE	6.6	95.49	TRUE	negative	0	negative			TP53 (p.R175H; 55.0%)	FLT3 (p.D835E; MAF 42%)|TP53 (p.R175H; MAF 43%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	-0.389690037	0.855575139	1.685176012	2.545441967	4.883659381	-3.122130162	5.945200408	no	no	no	no	no	no	yes	-5.106206855	-0.778835345	-2.949881284	-4.39727986	5.382278023	4.243731275	Not_Monoctyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.480384723
BA3135R	BA3135D	2733	Waves3+4	yes	yes	yes	yes	Male	Male	Black			8			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	7	Alive	48	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA		NA	NA		NA	NA	dim CD56 | dim CD15 | dim CD123	FALSE	FALSE	NA	NA	NA	positive	0.315789474	positive				FLT3-ITD					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	1.979844907	2.005229944	2.430680124	3.417574064	4.92208575	-2.429529426	-1.147913254	no	no	no	no	no	no	no	-4.158018677	NA	-0.203120265	NA	0.570162111	-4.873794032	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.417660703
BA3408R	BA3408D	2689	Waves3+4	yes	yes	yes	no	Female	Female	White			8			64	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	64	1	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	3	Standard Chemotherapy|Bone Marrow Transplant|Supportive/Palliative Care	4	"Ruxolitinib|7+3 (Cytarabine, Idarubicin)|Azacitidine|Busulfan, Cyclophosphamide"	4	Allogeneic - Sibling|Salvage|Induction|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	-1	Supportive/Palliative Care	Ruxolitinib	Salvage	6	Dead	269	Dead-Treatment	NA	30		NA	NA	62	NA	30	NA	10	18	4.5	NA		NA	6.9	"46,XX,der(2)del(2)(p23)inv(2)(p22q31),add(3)(p?14),der(12)add(12)(p11.2)t(3;12)(p?13;q?15)[12]/46,idem,der(7)t(7;11)(q11.2;q13)[7]/46,XX[1]"	NA	NA		71	FALSE		NA	NA	NA	1.8	FALSE	negative	0	negative		ASXL1 (p.G646Wfs*12; 12.8%)		KMT2A					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	4.899068958	7.912674818	3.241245784	8.088842717	7.660153579	-0.330243421	3.856883413	yes	yes	yes	yes	yes	yes	no	3.388451534	-3.05156514	-0.293082329	-2.741843807	-3.044118494	-0.344374017	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.796935963
BA3187R	BA3187D	2823	Waves3+4	yes	yes	yes	yes	Male	Male	White			8		CBFB-MYH11	76	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	78	0	Relapse	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Decitabine"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	Decitabine	Salvage	81	Alive	901	Alive	NA	10		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	42.5	14.6	"46,XY,inv(16)(p13.1q22.1) [16]/46,idem,del(7)(q32)[ 4]"	NA	97.7	POSITIVE for CBFB gene locus rearrangement (separated by chromosome 16 inversion)	47	TRUE		NA	NA	NA	13.3	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	3.490618108	4.511101373	0.361335821	3.440981737	6.687553419	-0.157247813	7.545125612	yes	yes	no	no	yes	yes	yes	2.382448411	NA	-1.076269606	NA	3.091910574	1.710858723	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.614472522
BA3098R	BA3098D	2630	Waves3+4	yes	yes	yes	yes	Male	Male	White			3		CBFB-MYH11	44	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	44	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Fludarabine, Thymoglobulin (Bu/Flu/ATG)"	Allogeneic - Matched Unrelated Donor	-1	Alive	119	Alive	NA	74.8	83	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,der(7)t(7;11)(q22;q13), inv(16)(p13.1q22)[15]/46,XY[5]"	NA	NA	"7cen (D7Z1), 7q31 (D7S486): deletion present | 11q23 (KMT2A; also known as MLL): gain present | 16q22 (CBFB): rearrangement present"	23	FALSE		NA	NA	NA	102.09	TRUE	negative	0	negative				KIT (p.Tyr418_Arg420delinsArgTrpGly; MAF 10%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.994577085	2.040360716	1.15112171	3.165860999	5.890863178	-1.293321936	5.250383209	no	no	no	no	no	no	yes	1.205323883	NA	1.832917379	NA	0.853526906	3.774321785	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.58251511
BA3435R	BA3435D	2613	Waves3+4	yes	yes	yes	no	Male	Male	White	NON-HISPANIC		1			79	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	79	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	2	"Decitabine|Azacitidine, BI 836858 (anti-CD33)"	2	Salvage|Induction	Refractory	Standard Chemotherapy	50	Standard Chemotherapy	Decitabine	Salvage	37	Dead	135	Dead-Disease	0	85	49	0	0	42.4	0.8	6.8	0.1	20	20	3.6	1.6	M1	26.7	9	"47,XY,+8[18]/46,XY[2] "	NA	89	"CEP8 and RUNX1T1 (8q21.3): ~90% of cells had an extra signal for chromosome 8 probes, consistent with trisomy 8, as seen on metaphase analysis."	97	TRUE	"partial CD13, partial CD33, CD34, CD117, CD123, partial HLA-DR, and partial MPO"	FALSE	TRUE	7.3	20.17	FALSE	positive	0.111111111	negative	RUNX1 (p.T246Hfs*15; 25.0%)	ASXL1 (p.G646Wfs*12; 30.2%)		FLT3-ITD (MAF 16%)|IDH1 (p.R132C; MAF 46%)|JAK2 (p.V617F; MAF 12%)|RUNX1 (p.T246fs*15; MAF 50%)|U2AF1 (p.Q157P; MAF 48%)			yes		yes		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	1.068948967	2.367694063	3.572854403	4.165183053	5.957254663	-2.264986433	-0.644074447	no	no	yes	yes	no	no	no	-3.35331328	-5.907684377	5.520169955	2.622916113	-8.146401337	0.116758982	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.436583729
BA3261R	BA3261D	2633	Waves3+4	yes	yes	yes	yes	Male	Female	White	NON-HISPANIC		1	bi		61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Dead	289	Dead-Treatment	0	40	25	0	0	27	0	46	0	30	14	3.9	0.84	M2	22.8	8.1	"45,X,-Y,del(11)(q12)[20]"	NA	98.3	"95/100 cells (95%) had a single signal, consistent with the deleted 11q in the metaphase karyotype. There was no evidence for MLL rearrangement."	35	TRUE	"CD7, partial CD13, dim CD33, CD34, CD28, CD58, CD71, CD117, HLA-DR and MPO "	TRUE	TRUE	6.9	4.17	FALSE	negative	0	negative		ASXL1 (p.A752Lfs*20; 43.9%)		"ASXL1 (p.A752fs*20; MAF 46%)|CEBPA (D105Vfs*64; MAF 45%)|CEBPA (H236Rfs*78; MAF 35%)|EP300 (p.R1627W ; MAF 46%)|IDH2 (p.R140Q, MAF 50%)|KMT2D (p.P647Q; MAF 43%)"					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.834328217	6.279172432	3.756625678	3.758389918	5.944312861	-0.103804888	6.897101925	yes	yes	yes	no	no	yes	yes	1.224990104	NA	-1.558558587	NA	0.566277677	-0.752983343	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.425837943
BA3203R	BA3203D	2767	Waves3+4	yes	yes	yes	yes	Male	Male	Unknown	HISPANIC		6			62	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|HiDAC|3+7 (Cytarabine, Daunorubicin)"	3	Allogeneic - Sibling|Consolidation|Induction	Refractory	Standard Chemotherapy	7	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	6	Dead	310	Dead-Disease	NA	35	39	1	NA	36	2	9	NA	83	69	2.8	0.99		NA	7		NA	102.9	The translocations commonly seen in AML are not detected. 3 copies of RUNX1T1 gene at 8q22 are detected in 56% of cells. Loss of RUNX1 and RARA genes at 21q22 and 17q21 are detected in about 58% of cells Gain of MLL gene at 11q23 are detected in 82% of cells. (Cytogenetics)	50	FALSE	"THESE ARE POSITIVE FOR HLA-DR, CD117, CD34, CD33 AND CD13. POSITIVE FOR HLA-DR, CD117, CD34, CD33 AND CD13. (Bone Marrow Immunnophenotype)"	FALSE	TRUE	NA	44.8	TRUE	negative	0	negative			TP53 (p.P153Afs*28; 75.8%)						no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	TRUE	3.469063941	5.192706803	4.327458333	4.135925763	6.659580884	0.442049234	6.799311741	yes	yes	yes	yes	yes	yes	yes	2.173964396	NA	3.066999939	NA	3.185304793	0.058307562	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.734974912
BA3174R	BA3174D	2652	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		8			61	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	61	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	4	"Vidaza|7+3 (Cytarabine, Idarubicin)|Cytarabine, OXi4503|Velcade"	3	Salvage|Induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	Velcade	Salvage	41	Dead	283	Dead-Disease	NA	14		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		26	9.2	"46,XY,del(5)(q13q33)[1]/4 7,idem,+21[14]/46,idem,id ic(21)(p12)[cp4]/47,idem, +21,idic(21)[1]"	NA	81.5	POSITIVE for chromosome 5q copy number loss	34	FALSE		NA	NA	NA	6.5	FALSE	negative	0	negative	RUNX1 (p.R107H; 59.2%)	ASXL1 (p.E635Rfs*15; 24.3%)							no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	4.401805917	5.238920025	5.305276161	4.444083349	7.358634829	-0.976484324	5.497259405	yes	yes	yes	yes	yes	no	yes	5.106365982	NA	1.324561089	NA	1.333712519	4.323112181	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.855998174
BA3299R	BA3299D	2608	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		6			47	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Busulfan, Fludarabine|HiDAC|3+7 (Cytarabine, Daunorubicin)"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Fludarabine"	Allogeneic - Sibling	11	Alive	263	Alive	NA	70		2.3	NA	18.3	72.7	6.2	NA	17	17	3.1	0.62		NA	9.5	"46,XX[20]"	NA	97.7	"An apparently NORMAL KARYOTYPE was observed in all 20 mitotic cells analyzed. Specifically, there was no significant numerical chromosomal abnormality and no clonal structural aberration of any chromosome detectable within the limits of resolution.  (Cytogenetics)"	237	TRUE	"positive for CD117, HLADR, CD33, CD11b, CD64 and MPO (partial).  (Bone Marrow Immunophenotyping)"	FALSE	TRUE	NA	66.7	TRUE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.953485987	2.88584558	4.608642877	3.418072141	6.516570572	-1.313393676	2.71690838	yes	no	yes	no	yes	no	no	5.360015254	NA	-2.289961985	NA	5.091513463	1.725275141	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.840114159
BA3347R	BA3347D	2708	Waves3+4	yes	yes	yes	yes	Female	Female	White			5			68	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	-1	Alive	233	Alive	0	85	30	3	NA	35	21	11	NA	16	15	2.8	NA	M5	32.4	10.3	"46,XX[20] "	NA	NA	Normal	131	TRUE	"Neagtive (CD10, CD19, CD16, CD14, CD34, CD117) | Bright Positive (CD64)"	FALSE	FALSE	5.2	22	TRUE	negative	0	positive				DNMT3A (c.2311T>C; p.R771X; MAF 40%)|NPM1 (c.863_864insTCTG; p.W288fs; MAF 38%)|TET2 (c.2827C>T; p.Q943X; MAF 80%)					no		Found	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	0.043485771	2.46546171	4.327828449	3.757523282	6.170343149	1.210297225	4.07639219	no	no	yes	no	yes	yes	no	5.486525229	NA	-3.591229052	NA	6.787864679	2.006667266	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.735247563
BA3126R	BA3126D	2686	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		KMT2A_re	66	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	66	2	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Mismatched Unrelated Donor	-1	Alive	1580	Alive	0	61		0	1.5	3.6	87.8	7.1	0.2	22	39	1.7	1.52	M5	24.4	7.8	"46,XY[20]"	607	87.8	MLL: 86% of cells had a split signal pattern consistent with MLL rearrangement.	14	FALSE	"CD11b, CD13, CD14, CD33, bright CD64, HLA-DR and partial MPO-positive "	FALSE	TRUE	5	67.35	TRUE	negative	0	negative				FLT3 (p.D835Y; MAF 35%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.402861071	4.675316918	3.134359782	3.168114613	6.531455436	-2.203211143	4.738691635	yes	yes	yes	no	yes	no	yes	6.836406908	NA	-2.933121934	NA	-0.989870936	3.186726617	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.756698936
BA3380R	BA3380D	2766	Waves3+4	yes	yes	yes	yes	Male	Male		HISPANIC		7			21	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	23	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Alive	520	Alive	NA		96	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	Normal	NA	NA		NA	NA		NA	NA	NA	55	TRUE	positive	5.666666667	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.321131818	0.92389842	4.315929227	2.702852354	4.973175475	0.567085952	1.103017612	no	no	yes	no	no	yes	no	-6.09932479	-3.449969043	2.409228852	3.732802987	-1.653138687	3.059433092	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	cDC_Like	0.326009804
BA3114R	BA3114D	2631	Waves3+4	no	no	no	no	Female	Female	White	NON-HISPANIC		8	mono		75	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Endometrial cancer|Lobular carcinoma in situ	y	n	n	n	y	y	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	75	0	Post-Chemotherapy	Remission	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)"	1	Induction	Unknown	Standard Chemotherapy	4	Standard Chemotherapy	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)"	Induction	4	Dead	93	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal (Clonal aberrations were not identified in metaphase cells examined by conventional cytogenetic techniques* or for any loci examined by FISH methods.)	NA	NA		NA	NA	NA	NA	NA	negative	0	positive				CEBPA (biallelic)|NPM1|PTPN11|TET2					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.886421954	4.950488895	1.977408253	2.322556438	6.415555152	-1.030400299	6.753097394	yes	yes	no	no	yes	no	yes	NA	NA	NA	NA	NA	NA							0.772482471
BA3109R	BA3109D	2835	Waves3+4	yes	yes	yes	yes	Female	Female	White			2			56	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Residual Disease|Post-Chemotherapy	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	4	"Azacitidine, Sorafenib|7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine, Trametinib"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Azacitidine, Trametinib"	Salvage	-1	Alive	2929	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,der(22)t(1;22)(q12;p11.2)[1]/46,XX[19]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	positive	RUNX1 (p.S100Lfs*38; 45.6%)								no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	5.395695395	6.667811052	4.630331109	4.147611483	6.870253974	0.219029255	6.267933176	yes	yes	yes	yes	yes	yes	yes	5.174448315	NA	1.429192192	NA	0.22001719	2.457401014	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.869501769
BA3452R	BA3452D	2835	Waves3+4	no	no	no	no	Female	Female	White			2			56	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	64	455	Relapse	Relapse	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	4	"Azacitidine, Sorafenib|7+3 (Cytarabine, Idarubicin)|HiDAC|Azacitidine, Trametinib"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Azacitidine, Trametinib"	Salvage	-1	Alive	2929	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XXder(22)t(1;22)(q12;p11.2)[1]/46,XX[19]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.S100Lfs*38; 47.8%)								no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	5.064918128	5.411730589	3.14677833	5.112204865	5.54057324	-1.613203891	3.502344577	yes	yes	yes	yes	no	no	no	NA	NA	NA	NA	NA	NA							0.778640122
BA3418R	BA3418D	2824	Waves3+4	yes	yes	yes	yes	Male	Male	Asian	NON-HISPANIC		8		GATA2-MECOM	72	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	7	Dead	24	Dead-Disease	NA	50		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		29.3	10.3	"45-46,X,-Y,t(3;3)(q21;q26 .2),del(4)(q12),-5,del(6) (q21),del(9)(q22),del(11) (p11.2),ins(15;5)(q12;p15 .2p15.2),add(16)(q22),-17,-20,-21,-22,+mar1-5[c p18]/ 46,XY[2]"	NA	85.5		40	TRUE		NA	NA	NA	2.2	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	5.467341038	4.941727089	2.777145453	5.69101988	6.858955929	-1.64731513	3.470017001	yes	yes	yes	yes	yes	no	no	-0.462488778	-1.54724223	4.147662733	2.17895046	-2.596587386	-1.943681423	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.829864328
BA3245R	BA3245D	2829	Waves3+4	yes	yes	yes	yes	Female	Female	White			5			62	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Fallopian Tube Cancer	y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	62	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Targeted Therapy - Kinase Inhibitor(s)	1	Decitabine	1	Supportive/Palliative Care			NA	Targeted Therapy - Kinase Inhibitor(s)	Decitabine	Supportive/Palliative Care	-1	Alive	53	Alive	0	50.5	53	0	NA	12	3	25	NA	19	19	2.2	NA		NA	8	"47,XX,psu dic(5;7)(q13;p10),r(7)(p12q11.2),+8,der(12)del(12)(p11.2p13)add(12)(q24.1)[2]/ 44,sl,add(3)(q12),-r(7)(p12q11.2),-8,-der(12)del(12)(p11.2p13)add(12)(q24.1),idic(22)(p11.2), +der(?)(7qter- > 7q11.2::?- > cen- > ?::12q11- > 12qter)[16]/ 45,sdl1,+der(?)(7qter- > 7q11.2::?- > cen- > ?::12q11- > 12qter)[2]"	NA	NA	"5p15.2/ 5q31 (EGR1) (ABNORMAL - Loss of 5q31 sequences) | 7 centromere/ 7q31 (ABNORMAL - Loss of 7q31 sequences, see interpretation) | 8 centromere/ 20q12 (ABNORMAL - Gain of chromosome 8 centromere, Normal 20q12) | RUNX1 (21q22.12)/ RUNX1T1(8q22) (Negative rearrangement, ABNORMAL - Gain of 8q22 sequences)"	30	TRUE	"Negative (CD19, CD22, CD56, CD14, CD15, CD64, MPO) | Positive (CD38, CD7, CD13, CD33, CD34, HLA-DR) | Dim (CD11b, CD45, CD117)"	TRUE	TRUE	NA	18	FALSE	negative	0	negative			TP53 (p.L257Q; 84.5%)	IDH2 (c.419G>A; p.R140Q; MAF 5%)|NRAS (c.!82A>T; p.Q61L; MAF 26%)|TP53 (c.770T>A; p.L257Q; MAF 92%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	4.076001538	5.774883482	4.039910955	3.229168161	5.652987859	2.350741185	5.253852829	yes	yes	yes	no	no	yes	yes	0.985007948	NA	2.523589639	NA	-0.428996542	-3.131556248	Monocyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.714013094
BA3085R	BA3085D	2785	Waves3+4	yes	yes	yes	no	Female	Female	White	NON-HISPANIC		1		RUNX1-RUNX1T1	14	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	14	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	2	Standard Chemotherapy|Intrathecal	3	"ADE (Cytarabine, Daunorubicin & Etoposide)|HiDAC|Cytarabine"	2	Induction|Intensification	Complete Response	Standard Chemotherapy	17	Standard Chemotherapy	HiDAC	Intensification	9	Alive	1523	Alive	0		60	0	3.5	24.3	6.1	15.7	0	21	26	3.7	0.78		18.5	6.4	"45,X,-X,t(8;21)(q22;q22)[20] "	NA	93.9	"RUNX1T1/RUNX1: æ92/100 cells (92%) had a 1red/ 1 green/ 2 yellow fusion signal pattern, reflecting RUNX1T1/RUNX1fusion"	80	TRUE	"dim CD13, dim CD19, CD33, CD34, CD38, CD58, CD117,  CD123, HLA-DR and MPO"	FALSE	TRUE	7.5	13.58	FALSE	negative	0	negative				NRAS (p.G12D; MAF 6%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.444616701	3.675402895	0.842405831	3.611530287	6.065110115	1.14352835	7.967445329	yes	yes	no	no	yes	yes	yes	-2.140851458	NA	-1.505029354	NA	1.04529263	-0.524949696	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.520210679
BA3128R	BA3128D	2596	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		8			33	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	33	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	4	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|CECA (Cyclophosphamide, Etoposide, Carboplatin, Cytosine)|Cytarabine, OXi4503"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"Cytarabine, OXi4503"	Salvage	-1	Alive	255	Alive	NA		18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		23.6	8.4	Normal	NA	NA	Normal	59	TRUE		NA	NA	NA	5.8	FALSE	positive	NA	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	2.054788152	2.019295974	1.445944489	3.618965428	5.169609388	-1.982860036	0.823208844	no	no	no	no	no	no	no	-6.194516729	NA	2.003703469	NA	-1.559395212	2.499177788	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.474809734
BA3423R	BA3423D	2605	Waves3+4	yes	yes	yes	yes	Female	Female		HISPANIC		6			49	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	50	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Unknown	Standard Chemotherapy	28	Standard Chemotherapy	HiDAC	Consolidation	114	Alive	345	Alive	NA	90	96	NA	NA	2	1	2	NA	43	32	3.7	0.67		NA	8.7		NA	84.8		78	FALSE	"Positive for CD34, CD117, HLADR, CD33 and CD13.  (Bone Marrow Immunophentyping)"	FALSE	TRUE	NA	19	FALSE	negative	0	positive				FLT3-TKD					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.473648115	2.289865922	0.91026955	2.665472463	5.036420551	0.354427733	2.923107349	no	no	no	no	no	yes	no	-9.236205723	-1.265943401	1.02979756	5.596850201	-3.334178607	-6.948182439	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.213994934
BA3173R	BA3173D	2784	Waves3+4	yes	yes	yes	no	Female	Female	Black			6		RUNX1-RUNX1T1	45	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(8;21)(q22;q22); RUNX1-RUNX1T1	46	0	Residual Disease	Residual	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"CLAG-M (Cladribine, Cytarabine, Mitoxantrone, Filgrastim)"	Salvage	4	Dead	457	Dead-Unknown	NA		97	NA	NA	3	NA	NA	NA	151	37	3.5	0.49		22.5	7.7	"46,XX,t(8;21)(q22;q22)[15]/46-47,sl,+6,add(13)(p11.2),add(15)(q26),-16,+19,+22[cp5]"	NA	88.9		23	FALSE		NA	NA	6.5	9.3	FALSE	positive	0.075268817	positive									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	4.056409867	4.182104012	0.686505344	2.029156318	4.944501719	-0.112757807	3.305398914	yes	yes	no	no	no	yes	no	-5.408989761	NA	-0.507413095	NA	-2.178953572	0.501512461	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.506072665
BA3171R	BA3171D	2719	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			55	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|Decitabine|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	9	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Dead	402	Dead-Treatment	0	60		0	6.8	19.7	20.5	15.4	1.5	NA	NA	NA	NA	M4	29.8	9.6	"43,XY,dic(5;12)(q11.2;p13),der(7)t(7;13)(q11.2;q12),i(8)(q10),+9,dup(11)(q2  3q23),-13,-15,-16,der(17)t(15;17)(q22;q23),-21,+mar[20]/46,XY[5] "	NA	101.4	"RUNX1T1/RUNX1: æ86/100 cells (86%) reflecting the isochromosome 8q and the monosomy 21. æNo evidence for RUNX1T1/RUNX1fusion | EGR-1/ D5S23, D5S721: æ89/100 cells (89%) consistent with missing 5q in the dicentric 5;12 | PML/RARA: æSignal patterns were within normal limits with no evidence for  PML/RARA fusion. æOne metaphase cell shows the PML (15q22) signal on the derivative 17, consistent with the metaphase karyotype | BCR/ABL/ASS: æ72/100 cells (72%) consistent the trisomy 9 in the metaphase karyotype. æNo evidence  for BCR/ABL fusion.  | D7S486/ CEP 7: æ79/100 cells (79%) consistent with missing 7q in the derivative 7 | DEK/NUP: æ79/100 cells (79%) reflecting the trisomy 9 in the metaphase karyotype. æNo evidence for  DEK/NUP fusion. | MLL: æ61/100 cells (61%) had three intact MLL signals. One metaphase cell  shows two signals on the duplicated 11q. æThere was no evidence for MLL rearrangement."	21	FALSE	"CD11c, CD13, CD33, CD34, CD38, CD56, CD64, CD117,æHLA-DR; negative TdT, CD19 and CD10 (from bmbx 5/3/17)"	FALSE	TRUE	NA	17.99	FALSE	negative	0	negative			TP53 (p.X125_splice; 75.0%)	KRAS (p.G12D; MAF 35%)|TP53 (Splice site (5' splice site mutation in intron 4); MAF 69%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	3.956413745	4.57299501	4.448430503	5.133689563	6.312054448	0.128934221	6.147180299	yes	yes	yes	yes	yes	yes	yes	1.530014535	NA	3.01716366	NA	3.19143635	-2.397617764	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.629442968
BA3277R	BA3277D	2818	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		5			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	-1	Alive	211	Alive	0	66.5	37	2	NA	24	6	31	NA	23	25	2.6	NA	M4	26.3	8.1	"46,XY[20] "	NA	NA	Normal	101	TRUE	"positive (CD38 dim, CD33 dim, CD45 dim, CD117 var, MPO var) | negative (CD10, CD19, CD20, CD22, CD23, Surf Kappa, Surf Lambda, FMC7, CD3, CD5, CD7, CD56, CD13, CD14, CD15, CD34) | PP (CD11b VAR, CD64 VAR, HLA-DR VAR)"	TRUE	TRUE	6	8.6	FALSE	negative	0	positive				IDH2 (c. 419G>A; p.R140Q; MAF 47%)|NPM1 (C.863_864insTCTG; p.W288fs; MAF 34%)|SRSF2 (c. 284C>A; p.P95H; MAF 47%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	1.370676648	4.428116689	2.048335989	4.657239738	5.360004718	0.402949581	4.281019838	no	yes	no	yes	no	yes	no	0.634854844	NA	-0.685861131	NA	3.99889827	-0.175166673	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.592861167
BA3210R	BA3210D	2644	Waves3+4	yes	yes	yes	yes	Female	Female	White			2			74	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	75	0	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"3+7 (Cytarabine, Daunorubicin)"	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"3+7 (Cytarabine, Daunorubicin)"	Induction	-1	Alive	305	Alive	NA	65	30	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XX,+8,del(9)(q13q22),t(12;22)(p13;q13)[12]/46,XX[8]"	NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.L429Pfs*171; 82.9%)	ASXL1 (p.G646Wfs*12; 36.4%)		BCORL1 (K632fs*33)|CSF3R (T6181)|ETV6 (MN1-ETV6 fusion)|IDH2 (R140Q)|IDH2 (p.Arg140Gln)|PHF6|PTPN11 (E69K)|RUNX1 (L429fs*171)					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	4.218279723	5.681928757	6.07391847	5.393866082	7.589913929	0.230814198	8.143215126	yes	yes	yes	yes	yes	yes	yes	4.175810369	NA	1.916765273	NA	0.155023559	0.014108217	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.894167102
BA3157R	BA3157D	2614	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			60	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Basal Cell Carcinoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"HiDAC|3+7 (Cytarabine, Daunorubicin)|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Alive	1425	Alive	0	87	83	0	0	13.4	0.8	8.3	0.3	125	74	2.3	0.79	M1	26.3	9.2	"46,XY,del(9)(q13q22)[20]"	823	89.5	Normal	146	TRUE	"CD13, CD33, variable CD34, CD38, CD58, CD117,  CD123, HLA-DR, variable MPO"	FALSE	TRUE	6.1	23.32	TRUE	negative	0	positive				NPM1 (p.W288fs*12; MAF 41%)|NRAS (p.G13D; MAF 41%)|SF3B1 (p.T663I; MAF 50%)	yes				yes		Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.164885487	-0.152736587	-0.730775878	3.143933558	4.768514002	-2.990147787	1.444850418	no	no	no	no	no	no	no	-5.390092674	NA	0.293155668	NA	-2.922442266	-1.634160061	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.319917645
BA3433R	BA3433D	2681	Waves3+4	yes	yes	yes	yes	Male	Male				5			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin) plus Midostaurin"	2	Allogeneic - Sibling|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Sibling	-1	Alive	215	Alive	0	92	96	0	NA	3	0	1	NA	30	16	3.3	NA	M0	24.8	8.5	"46,XY[20]"	NA	NA	Normal	51	TRUE	"negative (CD19, CD22, CD7, CD11b, CD13, CD14, CD15, CD34, CD64, HLA-DR) | Dim (CD38, CD45) | Positive (CD56, CD33, CD117, MPO)"	TRUE	TRUE	6.5	52.1	TRUE	negative	0	positive				FLT3 (c.1818_1819ins26; p.P606_R607insCREYEYDLKWEFP; MAF 7%)|NPM1 (c.863_864insTCTG; p.W288fs; MAF 45%)|TET2 (C.3379C>t; p.Q1127X; MAF 44%)					no		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	2.17709681	0.18384673	1.420183931	2.158727516	5.039283443	0.26190263	-2.87599727	no	no	no	no	no	yes	no	-4.200597188	-3.049043526	0.39864197	3.538378664	-2.014333742	-6.201017523	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.405719183
BA3374R	BA3374D	2617	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		KMT2A_re	21	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	21	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	6	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |ADE (Cytarabine, Daunorubicin & Etoposide)|HiDAC|Venetoclax (ABT-199), Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Cytarabine, Methotrexate"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	4	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Salvage	26	Dead	316	Dead-Disease	0	91	90	0	0	27.3	0	2.7	0	70	152	2.2	1.35	M5	19.9	6.8	"47~49,XY,+8[cp13]/46,XY[7]"	2767	96.6	RUNX1T1/CEP8: 140/200 cells (70%) reflect the trisomy 8 in the metaphase karyotype; 20 cells (10%) reflect extra centromere signals only. It is possible the G-banded cell with two small markers reflects a small clone containing extra copiesæof a derivative chromosome 8. | MLL: 88/100 cells (88%) had a variant. A green signal appears on the short arm of a chromosome 10 with a red/small green signal retained on the chromosome 11q. It is unclear whether the material translocated disrupts MLL.	54	FALSE	"CD4, partial CD11b, CD13, CD33, dim CD22, CD34, variable CD56, variable CD64, CD117, HLA-DR, dim PAX5+"	FALSE	TRUE	5.5	55.69	TRUE	negative	0	negative				KRAS (p.G13R; MAF 37%)|U2AF1 (p.S34F; MAF 39%)			yes		yes		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	-2.624636946	-0.078273268	1.940888905	0.821801311	5.279352426	-1.485040412	2.829120724	no	no	no	no	no	no	no	-2.126182628	NA	-5.35698321	NA	1.19657783	4.500449365	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.424612932
BA3403R	BA3403D	2617	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1		KMT2A_re	21	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	22	99	Relapse|Post-Chemotherapy	Relapse	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	6	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |ADE (Cytarabine, Daunorubicin & Etoposide)|HiDAC|Venetoclax (ABT-199), Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Cytarabine, Methotrexate"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	4	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Salvage	26	Dead	316	Dead-Disease	0	95	95	0	0	4.5	6.3	0	0	31	75	3.1	0.8	M5	30	9.9	"49,XY,+8,+mar1,+mar1[cp13]/49,idem,del(6)(q13q21)[8] "	1612	92.9	"RUNX1T1/CEP8: æ95/100 cells (95%) had an abnormal 3 red/ 3 aqua signal  pattern, reflecting the trisomy 8 in the metaphase karyotype and previously  observed. There was no evidence for RUNX1T1/RUNX1 fusion. | MLL: æ93/100 cells (93%) had a variant abnormal 0 red/ 1 green/ 1 yellow  (red/small green)/ 1 yellow (red/green) signal pattern, reflecting MLL rearrangement and previously observed. | MECOM/RPN1: æ84/100 cells (84%) had an abnormal 5-6 red/ 2 green signal  pattern, reflecting extra copies of MECOM (3q26.2) and gain of 3q.  Metaphase FISH shows the extra signals to be on the two markers. There was  no evidence for MECOM/RPN1 fusion."	42	FALSE	"CD4, CD11b, CD13, variable CD14, CD15, CD33, CD34, variable CD38, CD56, CD58, CD64, variable CD117, and HLA-DR"	FALSE	TRUE	5.8	60.51	TRUE	negative	0	negative				KRAS (p.G13R; MAF 52%)|U2AF1 (p.S34F; MAF 49%)			yes		yes		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	-1.163931911	-1.780799809	2.483864615	0.810049122	5.530220226	-3.018968201	1.476380914	no	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.509884017
BA3222R	BA3222D	2617	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1		KMT2A_re	21	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	22	267	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	6	"GCLAM (G-CSF, Cladribine, Cytarabine, and Mitoxantrone) |ADE (Cytarabine, Daunorubicin & Etoposide)|HiDAC|Venetoclax (ABT-199), Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Cytarabine, Methotrexate"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	4	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Salvage	26	Dead	316	Dead-Disease	0	43	0	1.7	NA	13.3	13.3	70	0	41	26	3.5	0.9	M5	25.4	8.5	"49,XY,del(4)(q21),add(6)(q27),-17,add(19)(p13.3),+mar1X2,+mar2,+mar3 [cp13]/49,XY,add(4)(q21),-6,+8,+mar1X2,+mar4[cp6]/46,XY[1] "	229	85.2	"51% had an abnormal signal pattern, reflecting the trisomy 8 in the metaphase karyotype and previously observed.  There was no evidence for RUNX1T1/RUNX1 fusion.  | 61% had a variant abnormal signal pattern, reflecting MLL rearrangement and previously observed.  | 72% had an abnormal signal pattern, reflecting extra copies of MECOM (3q26.2) and gain of 3q, previously observed.  Metaphase FISH shows the extra signals to be on  two markers.  There was no evidence for MECOM/RPN1 fusion. "	57	TRUE	"dim CD4, CD13, CD33, CD34, dim CD56, CD64, HLA-DR+"	FALSE	TRUE	5.7	0.6	FALSE	negative	0	negative				KRAS (p.G13R; MAF 24%)|U2AF1 (p.S34F; MAF 24%)			yes		yes		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	-0.175707025	2.796856029	2.308021862	0.667672635	4.755882325	-1.825294369	3.63957788	no	no	no	no	no	no	no	NA	NA	NA	NA	NA	NA							0.350878692
BA3450R	BA3450D	2627	Waves3+4	yes	yes	yes	no	Female	Female	White			7			68	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Dead	22	Dead-Unknown	NA	74		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46~47,XX,add(3)(p13),del(5)(q13q33),der(14)t(14;17)(q32;q11.2),del(16)(q22),-17,-22,+2~4mar[cp19]/46,XX[1]"	NA	NA		NA	NA	"positive for CD13, CD33, CD34, CD38, partial HLA-DR, CD117, and a minor population is also positive for MPO"	FALSE	TRUE	NA	NA	NA	negative	0	negative			TP53	JAK2|TP53					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	NA	FALSE	TRUE	4.353907806	5.234953808	4.756557293	2.131669073	5.72978047	0.142551159	5.829718495	yes	yes	yes	no	no	yes	yes	0.058905955	1.108081812	3.577595587	0.800728286	0.112948752	-2.160064721	Monocyte_Like	GMP_Like	HSC_Like	Progenitor_Like	Promono_Like	Not_cDC_Like	0.555790811
BA3167R	BA3167D	2704	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		2		MLLT3-KMT2A	38	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with t(9;11)(p22;q23); MLLT3-MLL	38	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	162	Alive	NA	94	55	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,t(9;11)(p22;q23),inv(9)(p11q12)"	NA	NA		NA	NA		NA	NA	NA	25.29	TRUE	negative	0	negative				BCOR (D1006fs*16)|FLT3-D835|MLL (MLL-MLLT3 (AF9) Fusion)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	1.047571678	4.022025266	4.753808985	4.510389059	5.519901753	-3.467916029	-0.979592395	no	yes	yes	yes	no	no	no	-0.820676846	NA	-2.749038377	NA	-1.984445909	2.695487395	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.600983839
BA3269R	BA3269D	2622	Waves3+4	yes	yes	yes	no	Female	Female	White			5			66	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	66	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	2	AG-221|Azacitidine	1	Supportive/Palliative Care			NA	Standard Chemotherapy	Azacitidine	Supportive/Palliative Care	6	Dead	61	Dead-Disease	0	75	86	0	NA	10	2	2	NA	14	28	2.4	NA	M0	24.3	7.7	"46,XX[19] "	NA	NA	Normal	66	TRUE	"negative (CD19, CD22, Cyt CD79a, Cyt CD3, CD7, CD56, CD14, CD15, CD34, CD64 TdT) | positive (CD38, CD13, CD33, CD117, MPO, HLA-DR) | dim (CD11b, CD45)"	TRUE	TRUE	6.2	70.1	TRUE	negative	0	positive				DNMT3A (c.1903C>G; p.R635G (COSM144550) MAF 44%)|IDH2 (c.419G>A; p.R140Q (COSM41590) MAF 44%)|NPM1 (c.863_864insTCTG; p.W288fs (COSM158604) MAF 37%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	2.604590742	3.32910698	3.168114613	3.00083017	5.550257601	-1.709760183	1.765539754	no	no	yes	no	no	no	no	-1.294488169	NA	1.383500753	NA	-1.22255705	2.413460277	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.560661149
BA3110R	BA3110D	2713	Waves3+4	yes	yes	yes	yes	Male	Male		HISPANIC		2			51	TRUE	FALSE	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	121	Dead-Unknown	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	5.185464587	3.184308639	0.706893141	2.975653725	5.32125965	-1.991691508	2.582486896	yes	no	no	no	no	no	no	-1.617014168	NA	-0.186045187	NA	-4.171235958	2.844258867	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.545539769
BA3156R	BA3156D	2702	Waves3+4	yes	yes	yes	no	Male	Male				8			65	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute erythroid leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute erythroid leukaemia	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Dead	50	Dead-Disease	NA	25		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M6	NA	NA	"45,XY,del(7)(p13),-9[7]/4 5-47,idem,+13,-15,add(19) (p13.3),+20[cp11]/ 46,XY[2]"	NA	NA	POSITIVE for ABL1 gene locus copy number loss | POSITIVE for PML gene locus copy number loss	NA	NA		NA	NA	NA	NA	NA	negative	0	negative			TP53 (p.R273C; 67.5%)						no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	NA	TRUE	TRUE	3.420105908	3.586470655	2.957075737	3.725172889	6.464310176	-2.528601933	-0.442714222	yes	yes	yes	no	yes	no	no	0.24962661	NA	-1.012009707	NA	-6.758620299	-4.183726186	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.602017933
BA3226R	BA3226D	2734	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			75	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	75	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	37	Dead-Disease	0	73	79	0	0	11.4	1.8	7.9	0.4	42	41	2.8	0.66	M2	22.9	7.5	"46,XX[20]"	NA	97.9	Normal	45	TRUE	"dim CD11b, CD13, CD33, partial CD34, partial CD38, dim CD45, partial CD64, CD58, partial CD117, CD123 and partial MPO positive"	FALSE	TRUE	6.9	88.2	TRUE	positive	0.960784314	positive				FLT3-ITD (MAF 44%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	3.393553061	2.224894915	4.13786445	2.58046845	5.70373801	0.373939766	4.285915398	yes	no	yes	no	no	yes	no	-2.659304558	NA	1.510827068	NA	-0.264334786	-2.551885535	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.479548651
BA3421R	BA3421D	2659	Waves3+4	yes	yes	yes	yes	Female	Female	White			5			52	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	52	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	3	"7+3 (Cytarabine, Idarubicin) plus Midostaurin|Midostaurin|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Targeted Therapy - Kinase Inhibitor(s)	Midostaurin	Maintenance	13	Alive	181	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA	Normal/Negative Rearrangement	NA	NA		NA	NA	NA	NA	NA	positive	0.724137931	positive				"DNMT3A (MAF 47%)|FLT3-ITD (2 on separate alleles: p.E604_F605insYDLKWE, MAF 19%; p.L601_K602ins18, MAF 9%)|NPM1 (MAF 44%)"					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	TRUE	TRUE	3.618031116	6.014988949	5.256419896	5.425300186	6.933559364	-1.821572113	5.50055254	yes	yes	yes	yes	yes	no	yes	6.345358418	0.18785246	-0.332892535	-3.286224628	2.703571253	4.509998899	Monocyte_Like	GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	0.993942019
BA3232R	BA3232D	2714	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			36	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	36	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	4	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal|Targeted Therapy - Other	6	"Azacitidine, Sorafenib|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|SY-1425 (Tamibarotene) plus Daratumumab|7+3 (Cytarabine, Idarubicin) plus Midostaurin|Busulfan, Cyclophosphamide|Cytarabine, Methotrexate"	5	Allogeneic - Sibling|Induction|Experimental|Re-induction|Maintenance	Complete Response	Standard Chemotherapy	-1	Targeted Therapy - Other	SY-1425 (Tamibarotene) plus Daratumumab	Experimental	28	Dead	370	Dead-Disease	0	30	40	0	9.6	13.9	0.9	36.5	0.1	14	25	3.5	0.77	M4	13.3	4.6	"46,XX[20]"	NA	100	Normal	58	TRUE	"dim CD7, partial CD11b, variable CD13, CD33, CD64,  CD117, dim CD123, dim HLA-DR and partial MPO positive"	TRUE	TRUE	6.6	59.05	TRUE	positive	0.265822785	positive				BCOR (p.V89D; MAF 54%)|DNMT3A (p.R882H; MAF 51%)|FLT3-ITD (MAF 15%)|NPM1 (p.W288fs*12; MAF 48%)|NRAS (p.G12S; MAF 20%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.057901585	4.138984655	1.133368614	2.658017302	6.136398279	0.871276132	7.309488343	no	yes	no	no	yes	yes	yes	2.519381747	NA	-1.479610305	NA	2.431171648	-2.30905411	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.503060802
BA3289R	BA3289D	2677	Waves3+4	yes	yes	yes	yes	Male	Male	White			5			61	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Kinase Inhibitor(s)	3	"7+3 (Cytarabine, Idarubicin)|Midostaurin|Fludarabine, Cyclophosphamide, Thiotepa, TBI"	3	Induction|Double Umbilical Cord Blood Transplant (DUCBT)|Supportive/Palliative Care	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, Thiotepa, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	177	Alive	NA	65		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M0	NA	NA		NA	NA	Normal	179	TRUE		NA	NA	NA	111.5	TRUE	positive	0.587301587	negative				DNMT3A|FLT3-ITD|TET2					no		Found	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	3.16307489	5.366195551	7.825499288	4.472838845	7.11072301	1.614088204	6.195633156	yes	yes	yes	yes	yes	yes	yes	7.427346712	NA	0.017164295	NA	2.075714213	3.704344716	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	1.099258499
BA3430R	BA3430D	2728	Waves3+4	yes	yes	yes	no	Female	Female	White			5		MLLT3-KMT2A	60	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	60	1	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Dead	1	Dead-Disease	NA	90	87	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA	"positive for CD11b, CD13, CD14, CD15, CD33, CD38, CD45, CD64, HLA-DR and MPO"	FALSE	TRUE	NA	166.8	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.15195512	3.827308739	7.564367019	2.736165519	6.995836048	1.555068977	7.753715808	no	yes	yes	no	yes	yes	yes	7.187939655	-0.583924717	-2.416548201	-5.721655703	1.78097601	2.582538207	Monocyte_Like	Not_GMP_Like	Not_HSC_Like	Not_Progenitor_Like	Promono_Like	cDC_Like	1.027742834
BA3399R	BA3399D	2643	Waves3+4	no	no	no	no	Male	Male	White			5			57	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	y	Rectal Cancer	y	y	n	n	y	n	n	n	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	unknown	NonAML	MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS	unknown	57	1			Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Alive	78	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,+21[19]"	NA	NA		NA	NA	"positive for CD11b, CD13, CD33, CD34, CD38, dim CD45, CD117 and HLA-DR with aberrant expression of CD56"	FALSE	TRUE	NA	NA	NA	negative	NA	negative		ASXL1 (p.E865*; 39.7%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	5.689865904	6.576700867	6.908146214	5.106982964	7.42721767	3.861979815	6.062989253	yes	yes	yes	yes	yes	yes	yes	NA	NA	NA	NA	NA	NA							1.032747385
BA3384R	BA3384D	2736	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1		KMT2A_re	39	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	39	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	4	DLI|Standard Chemotherapy|Bone Marrow Transplant|Other	7	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Azacitidine|Radiation|Busulfan, Cyclophosphamide"	5	Consolidation|Unknown|Induction|Maintenance|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	1512	Alive	0	>90	90	0	0	9.7	28.3	0	0	NA	NA	2.4	0.57	M4	20.5	6.7	"47,XX,del(11)(q23),+21[20]"	540	109.6	"MLL: æ97/100 cells (97%) had a 0 red/ 1 green/ 1 yellow signal pattern,  partially deleting the MLL region of 11q23 and consistent with the deleted 11q in the metaphase karyotype. | RUNX1T1/RUNX1: æ95/100 cells (95%) had a 2 red/ 3 green signal pattern, consistent with the trisomy 21 in the metaphase karyotype. There was no evidence for RUNX1T1/RUNX1fusion."	12	TRUE	"partial CD11b, dim CD13, CD33, partial CD34, variable CD64, CD117, CD123, HLA-DR+ "	FALSE	TRUE	NA	173.2	TRUE	negative	0	negative	RUNX1 (p.P49T; MAF 69%)			MLL (Possible subclone with partial tandem duplication)|RUNX1 (p.P49T; MAF 69%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	0.842405831	-0.437848975	0.420734247	1.685176012	5.473970121	0.521473783	4.214052862	no	no	no	no	no	yes	no	-0.403528324	NA	-2.259213702	NA	3.164501459	-0.203293862	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.434304162
BA3427R	BA3427D	2807	Waves3+4	yes	yes	yes	no	Male	Male	Unknown	UNKNOWN		1			67	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Dead	117	Dead-Disease	1.7	20	7	0	0	80	7	10.4	0	26	17	3.5	0.87		29.3	10	"45,XY,-4,-5,del(6)(p24),add(7)(q21),der(9)t(9;14)(q12;q11.2),-14,-21,+22,ad  d(22)(p11.2)x2,+2mar[20]"	251	96.1	"EGR1/5p: æ 77% of cells were missing a signal for both probes, consistent  with monosomy, as seen on metaphase analysis.  | D7S486 (7q31): æ73% of cells were missing a signal for D7S486 (7q31),  consistent deletion and with the add(7) seen on metaphase analysis. | NUP214 (9q34): æ 64% of cells were missing a signal for NUP214 (9q34), consistent with deletion due to the der(9) seen on metaphase analysis.  (Also, deletion of 9q34 was observed using the ABL+ASS probe set on a parallel study, GL17-02579.)  | RUNX1 (21q22): æ 55% of cells had four signals for RUNX1 (21q22); another  28% of cells had three signals. æOne of the four signals was on what  appeared to be a larger submetacentric chromosome, possibly the larger of  the two marker chromosomes observed on metaphase analysis. "	18	TRUE	"CD13, CD33, variable CD34, CD117, partial HLA-DR"	FALSE	TRUE	7	1.88	FALSE	negative	0	negative			TP53 (p.H179N; 16.9%)|TP53 (p.I195Mfs*13; 9.9%)|TP53 (p.I195Yfs*14; 11.4%)	TP53 (p.H179N; MAF 63%)|TP53 (p.I195fs*52; MAF 39%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	4.916854372	6.268811498	1.636402799	7.630415169	7.832683892	-2.039805595	4.36276075	yes	yes	no	yes	yes	no	no	4.152339699	NA	-0.164261125	NA	-0.913107078	2.686471882	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.893052233
BA3449R	BA3449D	2609	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		8		GATA2-MECOM	55	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	55	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	Vidaza|Decitabine	2	Salvage|Supportive/Palliative Care			NA	Standard Chemotherapy	Decitabine	Salvage	-1	Dead	1	Dead-Disease	NA	80	67	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		30.1	10.4	"49,XY,dup(1)(p22.1p32.1), inv(3)(q21.3q26.2),+8,+12 ,+21[20]"	NA	83.7	POSITIVE for RUNX1T1 and RUNX1 copy number gains	31	TRUE		NA	NA	NA	43.7	TRUE	negative	0	negative	RUNX1 (p.R76Pfs*62; 66.7%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	3.233410025	3.581263056	1.683273442	3.505300341	6.112516582	-0.90581406	2.977939339	yes	yes	no	no	yes	yes	no	-1.181146247	-2.209500482	2.492010127	2.25932271	-4.168311816	-0.601853339	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.583906324
BA3163R	BA3163D	2638	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1		MLLT3-KMT2A	43	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	43	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	Azacitidine|Mitoxantrone	2	Induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Mitoxantrone	Supportive/Palliative Care	0	Dead	62	Dead-Disease	0	80	55	0.9	2.5	8.5	61	25.4	0.3	198	685	2.7	1.18	M5	34.2	11.4	"46,XX,t(9;11)(p22;q23)[15]/47,idem,+8[2]/46,XX[3]"	5919	99.1	"MLL: æ57/100 cells (57%) had the abnormal 1 red/ 1 green/1 yellow signal  pattern, reflecting MLL (11q23) rearrangement, consistent with the 9;11  translocation observed in the metaphase karyotype. | RUNX1T1/RUNX1: æ6/200 cells (3%) had a 3 red/ 2 green signal pattern,  reflecting an extra RUNX1T1 (8q21.3) signal, consistent with the trisomy 8  clone observed in the metaphase karyotype. | CEP 8: æ5/200 cells (2.5%) had three signals, reflecting an extra  chromosome 8 centromere signal, consistent with the trisomy 8 clone observed in the metaphase karyotype."	120	TRUE	"dim CD4, CD11b, CD13, partial CD14, CD33,  CD38, variable CD56, CD58, CD64, dim CD71, dim CD123, and HLA-DR+"	TRUE	TRUE	5	91.72	TRUE	negative	0	negative				DNMT3A (Splice site mutation (invariant splice donor at end of exon 14; likely pathogenic); MAF 20%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	5.393479498	6.294574842	4.807111451	3.91283292	7.26424109	2.22641256	6.719507651	yes	yes	yes	yes	yes	yes	yes	7.994262054	NA	-3.960819469	NA	-0.583898939	2.775137282	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.887202762
BA3158R	BA3158D	2646	Waves3+4	yes	yes	yes	yes	Male	Male				3		RUNX1-RUNX1T1	68	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Non-Hodgkins Lymphoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	68	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	NA		NA		NA				NA				NA	Unknown	0		NA	90.8		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,t(8;21)(q22;q22)[8]46,sl,del(9)(q13q22)[4]/47,sdl,+21[2]/47,sl,+21[4]/46,XY[2] "	NA	NA	"This analysis showed evidence of t(8;21)(q22;q22) (RUNX1T1-RUNX1 translocation) in 196/200 (98.0 percent) cells scored. Of these cells, 20/200 (10.0 percent) showed the translocation accompanied by an additional copy of the RUNX1 locus. "	NA	NA		NA	NA	NA	27.1	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	4.328596221	2.126420627	0.332971491	2.911844261	5.806944625	-2.713314441	4.994253175	yes	no	no	no	no	no	yes	-2.867781078	NA	-1.169003662	NA	-1.885587882	0.203271783	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.462659595
BA3436R	BA3436D	2755	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1	mono		23	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	23	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|FLAG-IDA, Gemtuzumab|Busulfan, Cyclophosphamide"	4	Consolidation|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	1510	Alive	0.9	80		0	0	11.6	0	10.7	0.3	17	7	3	0.68	M1	26.7	8.9	"46,XX[8]"	145	90.8	Normal	54	FALSE	"CD13, CD33, partial CD34, CD38, CD58, dim CD71, CD117,  CD123, and cMPO+ "	TRUE	TRUE	6.9	29.58	TRUE	negative	0	positive				CEBPA (p.A199fs*114; MAF 50%)|EZH2 (p.R288*; MAF46%)|GATA2 (p.A372T; MAF 31%)|NPM1 (p.W288fs*12; MAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	4.906047114	1.946720599	-0.143707385	1.362836848	4.808852579	0.18384673	1.586439704	yes	no	no	no	no	yes	no	-5.703277046	-1.23775515	0.267792305	4.606889133	-2.613982023	-7.663393524	Not_Monoctyte_Like	Not_GMP_Like	HSC_Like	Progenitor_Like	Not_Promono_Like	Not_cDC_Like	0.223647141
BA3154R	BA3154D	2768	Waves3+4	yes	yes	yes	yes	Female	Female	White			7			29	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	n	n	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, B/myeloid, NOS"	Adverse	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, B/myeloid, NOS"	29	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	256	Dead-Other	NA	95		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"30~35<1n>,XX,+1,+2,+6,+10,+11,+12,+18,+19,+21,+22[cp6]/46XX[20]"	NA	NA	Negative for 9;22 and MLL	NA	NA	"positive for dim CD2 (aberrant), CD11b (aberrant), CD13, CD33, CD34, CD38, CD117, HLA-DR, and dim nTdT (aberrant)"	FALSE	TRUE	NA	NA	NA	negative	0	negative			TP53 (p.V122Dfs*26; 87.5%)	CREBBP|NF1|TP53					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	TRUE	FALSE	FALSE	NA	FALSE	TRUE	0.939178617	3.205066262	0.672430985	3.136590123	5.899601259	-0.923451509	2.290576585	no	no	no	no	no	yes	no	-6.403387894	NA	-0.434223075	NA	-7.60624828	-3.493140323	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.459926707
BA3162R	BA3162D	2740	Waves3+4	yes	yes	yes	yes	Male	Male	White			2		CBFB-MYH11	20	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	20	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	-1	Alive	99	Alive	NA	50		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,inv(16)(p13.1q22)[20]"	NA	NA	Evidence of a CBFB [inv(16)] gene rearrangement in 98% of the cells.	16	FALSE	"CD2(-), CD4(-), CD5(-), CD7(-), CD8(-),CD10(-), CD11b(dim +), CD13(dim +),CD14(dim +), CD15(dim+CD16(-), CD20(-), CD22(-), CD25(dim +), CD33(dim +), CD34(+), CD38(+), CD36(subset +), CD56(-), CD64(subset +), CD79a +)(-), CD123(dim +), MPO(dim +), TdT(-), and surface kappa lambda light chain(-).,"	TRUE	TRUE	NA	68.59	TRUE	negative	0	positive				KIT (Y418_R420>RW; MAF 10.2%)|NRAS (G12s; MAF45.4%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	5.143335632	5.783422865	4.682385721	4.960217595	7.183986361	-1.576683205	6.855214047	yes	yes	yes	yes	yes	no	yes	2.010687547	NA	2.845301766	NA	-0.633179975	5.260022035	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.787890389
BA3352R	BA3352D	2699	Waves3+4	yes	yes	yes	yes	Male	Male	White			2			73	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Dead	22	Dead-Disease	NA	90	94	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA	"CD34(-), CD13(predominantly -), CD33(+), CD38(partial +), CD45(dim +), CD56(variably +), CD64(partial dim +), CD117(+),HLA-DR(-), MPO(+), TdT(-), other myeloid and lymphoid antigens(predominantly -)."	FALSE	TRUE	NA	64.4	TRUE	positive	1.222222222	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	6.745019897	3.73776361	2.573099734	2.80605986	5.636295267	0.808663201	1.773838516	yes	yes	no	no	no	yes	no	-4.400624267	NA	0.980180363	NA	-3.549438119	-8.009054138	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.422181896
BA3084R	BA3084D	2694	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		KMT2A_re	22	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	22	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HAM (Cytarabine, Mitoxantrone) + Midostaurin|Busulfan, Cyclophosphamide"	3	Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	-1	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Dead	328	Dead-Disease	0	92	91	0.9	0	9.8	1.8	0	0.1	22	35	2.5	0.71	M4	27.8	9.5	"46,XY,t(10;11)(p13;q23)[20]"	1186	102.2	"MLL: 88% of cells had a 1g/0r/2f signal pattern, where the lone green signal was small and the green component suggesting a disruption of MLL (11q23) within the green portion of  the probe. æThis result is consistent with MLL rearrangement and with the t(10;11) seen on metaphase analysis."	95	TRUE	"Immunophenotype 1(15% WBCs): dim CD4, variable CD13, CD33, bright  CD34, CD58, CD64, CD117, CD123, variable MPO  | Immunophenotype 2 (79% WBCs): dim CD4, CD11b, variable CD13, CD33, CD38, CD58, CD64, CD117, CD123"	FALSE	TRUE	7	82.99	TRUE	negative	0	negative				FLT3-D835 (MAF: 31%)|KRAS (p.G12D; MAF 4%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.14745815	1.159882037	-0.988728384	1.447019767	4.756916671	-1.443287764	2.36558501	no	no	no	no	no	no	no	-6.747336418	NA	-1.593994616	NA	0.572127415	-5.200934149	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.295442891
BA3149R	BA3149D	2597	Waves3+4	yes	yes	yes	no	Female	Female	White			5			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"Azacitidine, BI 836858 (anti-CD33)"	1	Supportive/Palliative Care			NA	Standard Chemotherapy	"Azacitidine, BI 836858 (anti-CD33)"	Supportive/Palliative Care	6	Dead	27	Dead-Disease	NA	85	54	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA	Normal	NA	NA	"positive for CD13, CD33, CD34, dim CD45, CD38, CD117, HLA-DR and MPO"	FALSE	TRUE	NA	9.4	FALSE	negative	0	negative	RUNX1 (p.M267Ifs*44; 77.6%)	ASXL1 (p.E635Rfs*15; 16.4%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	5.018107595	5.510547415	8.406645502	4.040294898	7.299680564	0.989571292	6.542042629	yes	yes	yes	yes	yes	yes	yes	6.087057622	NA	3.809144757	NA	-2.484808247	2.000532173	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.955712132
BA3169R	BA3169D	2662	Waves3+4	yes	yes	yes	yes	Female	Female	White			5		KMT2A_re	88	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Uterine Sarcoma	n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	88	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	5	Dead-Disease	NA	80	24	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XX,+8[4]/47,sl,add(10)(q22)[10]/89~94,sdlx2[cp3]/55,sl,+X,+6,+8,+ 8,+9,+13,+21,+22[2]/46,XX[1]"	NA	NA	MLL (KMT2A) rearrangement in 94% of 200 cells | gain of 8q22 sequence in 94% of 200 cells	NA	NA	"positive for CD11b, dim CD7, CD13, CD14, CD33, CD38, CD15, CD45, CD56, CD64 and HLA-DR"	TRUE	TRUE	NA	23.4	TRUE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	4.10392328	6.120110353	4.860426245	3.759325547	5.671271189	-0.000612478	4.020426385	yes	yes	yes	yes	no	yes	no	3.526903584	NA	-4.620786038	NA	4.324469241	1.879651492	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.867938952
BA3180R	BA3180D	2770	Waves3+4	yes	yes	yes	no	Male	Male	White			5			27	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	27	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Fludarabine, Cyclophosphamide, Thiotepa, TBI|7+3 (Cytarabine, Idarubicin) plus Azacitidine"	2	Induction|Double Umbilical Cord Blood Transplant (DUCBT)	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, Thiotepa, TBI"	Double Umbilical Cord Blood Transplant (DUCBT)	-1	Alive	116	Alive	NA		60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	0.886792453	positive				FLT3-ITD|IDH2					no		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	1.756346932	2.571135775	0.604875403	2.829756115	5.077654647	0.456125459	2.487808788	no	no	no	no	no	yes	no	-5.288615784	NA	1.596146469	NA	-2.789698435	-7.278198192	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.321984394
BA3255R	BA3255D	2725	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			55	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	55	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"7+3 (Cytarabine, Idarubicin)|HiDAC + Midostaurin|Decitabine, Sorafenib |Busulfan, Cyclophosphamide"	4	Allogeneic - Sibling|Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"Decitabine, Sorafenib "	Salvage	61	Dead	272	Dead-Disease	0	90	80	0	2.6	9.6	22.6	5.2	0.4	21	25	3	0.9	M0	22.3	7.4	"46,XY[20] "	1037	85.8	Normal	234	TRUE	"dim partial CD4, dim partial CD7, dim CD11b, CD13, CD33,  partial CD34, CD38, CD58, dim CD71, CD117, CD123 and HLA-DR+ "	TRUE	TRUE	7.7	118.21	TRUE	positive	3	positive				DNMT3A (Splice site (start of intron 18; likely pathogenic); MAF 47%)|FLT3-ITD (p.E598delinsDYVDFREYE; MAF 60%)|NPM1 (p.W290fs*10; MAF 45%)|WT1 (p.D464N; MAF 46%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	2.430680124	1.891315265	1.637454821	3.533388782	5.605796852	0.340080739	2.521438608	no	no	no	no	no	yes	no	0.848088221	NA	2.122440817	NA	-0.334101557	3.17403377	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.606423531
BA3438R	BA3438D	2834	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		KMT2A_re	53	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)"	2	Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"5+2 (Cytarabine, Idarubicin)"	Re-induction	4	Dead	65	Dead-Disease	3.5	95		1.7	NA	69.8	0.9	15.5	4.5	30	24	3.3	0.87	M1	25.1	8.4	"47,XY,der(5)t(5;17)(q12;q12),+8,+15,der(15)t(11;15)(q22;q24)dup(11)(q25q22)  ,del(16)(q22q24),-17,der(20;21)(p10;q10),+mar[16]/46,idem,der(10)t(10;11)(q  25;q23)t(5;11)(q12;q25),-mar[3]/46,XY[1] "	399	88.4	"EGR1: æ90% of cells were missing a signal for EGR1 (5q31), consistent with  the der(5) seen on metaphase analysis.  | MLL (11q23): æ 97% of cells had two normal intact signals and a many other  intact signals per cells, suggesting amplification.  (On available metaphase  cells, there was clustering of amplified fused signals on two chromosomes:  in the first clone, amplified signals clustered on the der(15) and on the  marker chromosome; in the second clone, amplified signals clustered on the  der(15) and on the der(10).) | CBFB (16q22): æ 94% of cells were missing a signal for CBFB, consistent  with del(16q) as seen on metaphase. | RUNX1/RUNX1T1+CEP8: 92% of cells had three signals for chromosome 8 probes (CEP8 and RUNX1T1) and only one signal for RUNX1 (21q22), consistent with trisomy 8. Results with the RUNX1 probe on chromosome 21 suggest that the interpretation of the chrom results as der(20;21) may be more complicated."	23	TRUE	"CD4, dim CD20, dim CD11b, CD13, CD33, CD34, CD38, CD58,  variable CD64, partial dim CD117, MPO"	FALSE	TRUE	6.8	3.81	FALSE	negative	0	negative			TP53 (p.R248Q; 80.3%)	MLL |TP53 (p.R248Q; MAF 82%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	0.0226043	1.356321008	1.885307826	2.744259442	6.051520711	-2.44012195	2.704174995	no	no	no	no	no	no	no	-5.600305688	NA	0.358556352	NA	1.09145766	-5.35492173	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.356804108
BA3345R	BA3345D	2775	Waves3+4	yes	yes	yes	yes	Female	Female	Black	NON-HISPANIC		8			59	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	59	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	4	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	4	Alive	57	Alive	NA	3		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	21.7	7.4	"47,XX,+8[20]"	NA	87.2	POSITIVE for RUNX1T1 copy number gain	51	FALSE		NA	NA	NA	3.7	FALSE	negative	0	negative	RUNX1 (p.S100F; 39.6%)								no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	4.548427325	7.014073463	4.649804262	6.816896301	7.066658956	0.422707743	5.206509325	yes	yes	yes	yes	yes	yes	yes	6.852871283	NA	-2.043714164	NA	1.335523401	3.692035434	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.993529864
BA3431R	BA3431D	2647	Waves3+4	yes	yes	yes	yes	Female	Female	White			7			45	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	45	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Alive	68	Alive	NA	69		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	46[XX]	NA	NA		NA	NA	"positive for CD11b, CD11c, CD14, CD64, CD33, CD38, HLA-DR and partial for CD13, CD15, cMPO"	FALSE	TRUE	NA	NA	NA	negative	0	positive				FLT3-TKD (MAF 1%)|NPM1 (MAF 39%)|PTPN11 (likely pathogenic)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	2.856998521	3.809409837	3.579365566	4.565501714	6.500544402	-0.067402502	4.462655538	yes	yes	yes	yes	yes	yes	yes	4.267408447	NA	-0.004634863	NA	2.769454882	2.912011228	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.891651129
BA3181R	BA3181D	2667	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		8			60	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Myeloid sarcoma	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin, Dexamethasone)"	2	Allogeneic - Sibling|Induction	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Sibling	-1	Alive	212	Alive	NA	7		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative		ASXL1 (p.R634Kfs*24; 38.6%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	2.832758499	6.098088773	4.176802245	5.319763325	6.430469141	-2.151569342	6.345947139	no	yes	yes	yes	yes	no	yes	4.647302309	NA	-1.274347304	NA	1.322211475	2.122001826	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.734836096
BA3341R	BA3341D	2628	Waves3+4	yes	yes	yes	yes	Female	Female	White			2			62	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	62	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Targeted Therapy - Other	1	Enasidenib	1	Induction	Refractory	Targeted Therapy - Other	-1	Targeted Therapy - Other	Enasidenib	Induction	-1	Alive	52	Alive	NA	48	26	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,del(7)(q22q32)[cp4]/46,XX[16]"	NA	NA	Evidence of deletion of the BCR (22q11.2) gene in 7% of the cells examined.	NA	NA		NA	NA	NA	NA	NA	negative	0	negative				DNMT3A|IDH2 (p.172Arg>Lys)|KMT2A					no		Found	TRUE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.066934169	6.451504312	2.376965905	4.729831272	6.028967268	-1.891543094	3.672488407	yes	yes	no	yes	no	no	no	-1.251833629	NA	2.169717752	NA	-2.656219681	-1.368492891	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.63970807
BA3191R	BA3191D	2700	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		CBFB-MYH11	46	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	46	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	5	"5+2 (Cytarabine, Idarubicin)|Azacitidine|Gemtuzumab|MiDAC|Decitabine"	5	Consolidation|Salvage|Induction|Re-induction|Maintenance	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Gemtuzumab	Salvage	-1	Dead	546	Dead-Disease	1.7	36	28	1.7	2.5	21.8	34.5	21.8	0	24	16	3.1	0.88	M4	37.4	12.7		593	82.9	"Positive for CBFB rearrangement. (96/100 cells (96%) reflected a loss of the distal green portion of one break-apart signal. Presence of an  inverted chromosome 16 was confirmed. æIn addition, metaphase FISH showed a  normal chromosome 16 with a yellow (red/green) signal in the long arm and the inverted chromosome 16 with the proximalæred signal in the short arm and the green signal missing.)"	42	TRUE	"CD13, dim CD33, CD34, CD38, CD117, CD123, HLA-DR  and dim MPO+. (Blast Immunophenotype) | CD11b, CD13, dim CD14, CD33, CD38, CD64,  HLA-DR, dim CD117, CD123 and dim MPO+ (Monocytic Immunophenotype)"	FALSE	TRUE	6.3	47.64	TRUE	negative	0	negative				GATA2 (p.T356A; MAF 41%)|NRAS (p.Q61K; MAF 41%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	3.259095318	2.518752341	2.068364918	3.939719808	6.821881978	-0.899929858	6.501038925	yes	no	no	yes	yes	yes	yes	4.601732364	NA	-0.672387003	NA	0.831461986	3.678196847	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.724063219
BA3197R	BA3197D	2738	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			47	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	10	Dead-Disease	0		95	0	0	1.7	0	0	0.1	190	80	3.4	0.83	M1	30.2	10.3		730	93.5	PML/RARA: Negative	22	TRUE	"partial CD13, CD33, CD38, partial CD56, CD58, CD117,  CD123, and MPO positive "	FALSE	TRUE	6.5	134.63	TRUE	positive	0.785714286	positive				FLT3-ITD (p.F605delinsTGSSDNEYFYVDFREYEYDLKWEF; MAF 46%)|IDH1 (p.R132G; MAF 47%)|NOTCH1 (p.E1555V; MAF 51%)|NPM1 (p.W288fs*12; MAF 50%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.339102202	1.400496911	1.567397786	2.697833452	4.803575886	-0.827405877	-0.231575701	no	no	no	no	no	yes	no	-7.314463951	NA	-1.961990449	NA	-1.295066317	-7.313842942	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.197818602
BA3448R	BA3448D	2752	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1		KMT2A_re	27	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	27	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	Bellicum Trial (Flu/Cy/TBI + ATG + Rituximab then BPX-501)	Allogeneic - Sibling	-1	Alive	1455	Alive	0	90	85	0	0	30.2	0	0	0	23	16	2.2	0.81	M0	25.5	8.3	"46,XX,t(6;11)(q27;q23)[25] "	496	91.1	"MLL: æ92/100 cells (92%) had the abnormal 1 red/ 1 green/1 yellow signal  pattern, reflecting MLL rearrangement and consistent with the 6;11  translocation observed in a companion bone marrow G-banded chromosome  study. One metaphase cell showed the 6;11 rearrangement."	16	FALSE	"CD13 , CD33 , partial CD34 , CD38 , CD58 , CD64 , CD71 , CD117 , CD123 and HLA-DR positive"	TRUE	TRUE	5.5	22.95	TRUE	negative	0	negative				KRAS (p.G12D; MAF 16%)|MLL (PTD)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	-0.215560842	0.170321229	-1.485040412	2.305093894	4.234712366	-0.117309475	2.633114022	no	no	no	no	no	yes	no	-8.454856323	NA	1.167582198	NA	-3.086248089	-0.440058508	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.238780772
BA3453R	BA3453D	2764	Waves3+4	yes	yes	yes	no	Female	Female	White			5			76	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	76	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Targeted Therapy - Kinase Inhibitor(s)	1	Decitabine	1	Supportive/Palliative Care			NA	Targeted Therapy - Kinase Inhibitor(s)	Decitabine	Supportive/Palliative Care	9	Alive	19	Alive	NA	90	85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA		NA	NA	"A large blastic population, positive for CD13, CD15, CD33, CD38, dim CD45, dim CD64, CD117, HLA-DR, and MPO"	FALSE	TRUE	NA	44.4	TRUE	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.609716319	3.042413784	3.555655758	2.284892989	6.277840771	0.821801311	5.215680434	no	no	yes	no	yes	yes	yes	1.236409484	NA	0.319848755	NA	1.809271742	-1.38954497	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.654002007
BA3406R	BA3406D	2796	Waves3+4	yes	yes	yes	yes	Male	Male				3			33	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	33	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	UNKNOWN	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Alive	30	Alive	NA	69	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46, XY[20]"	NA	NA	Normal	70	TRUE		NA	NA	NA	4.52	FALSE	positive	0.492537313	negative				BCOR (p.G1n1626; MAF 62.2%)|FLT3-ITD (p.Glu598_Tyr599ins9)|WT1 (p.Arg370fs; MAF 27.7%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	2.026778569	3.507187124	3.845655809	5.070932999	6.791584377	-0.807899034	3.464121446	no	yes	yes	yes	yes	yes	no	-3.0577899	NA	1.516465713	NA	0.33411148	3.977452452	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.524426436
BA3308R	BA3308D	2772	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			78	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	78	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Supportive/Palliative Care|Targeted Therapy - Kinase Inhibitor(s)	4	AG-221|Imatinib|Midostaurin|Interferon	3	Salvage|Maintenance|Supportive/Palliative Care			NA	Targeted Therapy - Kinase Inhibitor(s)	AG-221	Salvage	191	Dead	319	Dead-Disease	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,del(6)(q13),+8[8]/47,idem,-8,+13[2]/46,XY,del(13)(q14q22),del(20)(q11.2)[6]/46,XY[4] "	NA	NA	"RUNX1T1: æ22/200 cells (11%) had a 3 red/ 2 green signal  pattern, reflecting an extra RUNX1T1 (8q21.3) signal, consistent with the  trisomy 8 clone observed in the metaphase karyotype | RUNX1: 18/200 cells (9%) had a 2  red/ 3 green signal pattern, reflecting an extra RUNX1 (21q22) signal. æThe  extra chromosome 21 material was not apparent in the G-banded karyotype.  There was no evidence for RUNX1T1/RUNX1 fusion. | CEP8:  29/200 (14.5%) cells  scored with the CEP 8 probe had three signals, consistent with trisomy 8.  | D20S108/20p subtel: æ6/200 cells (3%) had a 1 red/ 2 green signal pattern,  consistent with the deleted 20q in the metaphase karyotype. "	NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.R162S; 84.5%)	ASXL1 (p.G646Wfs*12; 34.3%)	TP53 (p.X187_splice; 9.3%)	IDH2 (p.R140Q; MAF 45%)|KRAS (p.Q61R; MAF 5%)|NOTCH1 (p.P2412L; MAF 57%)|RUNX1 (p.R162S; MAF 74%)|SRSF2 (p.P95H; MAF 54%)|TP53 (Splice site; MAF 9%)		yes			yes	yes	Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	TRUE	TRUE	FALSE	NA	FALSE	FALSE	1.242680414	2.195311478	0.581773503	4.111448431	4.940687389	-2.221671142	2.265641923	no	no	no	yes	no	no	no	-3.580345573	NA	4.344594677	NA	-5.897724134	1.078065858	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.394652128
BA3186R	BA3186D	2743	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			68	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	70	0	Relapse|Post-Chemotherapy|Post-Transplant	Relapse	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Supportive/Palliative Care	3	"Fludarabine, Melphalan|Azacitidine|MiDAC"	3	Symptom Control|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor			NA	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Dead	980	Dead-Disease	0	79	56	0	0	14.6	4.5	8.2	2.6	31	58	2.9	0.69		33.5	11.8	"45,XY,add(3)(p22),-7,t(8;22)(q11.2;q11.2),add(11)(q23),-13,-15,-16,  der(17)t(7;17)(q11.2;p11.2),+3mar[cp3]/44~46,sl+der(8)t(8;21)(q11.2;q11.2),  -18[cp15]/44,sl,-add(3)(p22),+10,+13,+15,-18,-3mar[2] "	3293	92.5	"MLL: æ97/100 cells (97%) had the variant abnormal 0 red/ 1 green/1 yellow  signal pattern, reflecting MLL (11q23) rearrangement and previously  observed.  | TP53/CEP 17: æ99/100 cells (99%) had a 1 red/ 2 green signal pattern,  reflecting TP53 deletion, previously observed and consistent with the  derivative 17 in the metaphase karyotype. | RUNX1T1/RUNX1: æ93/100 cells (93%) had a 2-3 red/ 3-4 green signal pattern,  reflecting an extra copies of RUNX1T1 and RUNX1. æThere was no evidence for  RUNX1T1/RUNX1 fusion.  | CBFB: æ96/100 cells (96%) had a single intact signal, reflecting CBFB  (16q22) loss and consistent with the monosomy 16 in the metaphase  karyotype.  | D7S486/ CEP 7: æ99/100 cells (99%) had a 2 red/ 1 green signal pattern,  indicating loss of a chromosome 7 centromere signal with 7q material  attached to the derivative 17 in the metaphase karyotype.  | CEP 8: æ66/100 cells (66%) had three signals, consistent with the clone  having an extra copy of the derivative 8. "	28	FALSE	"dim CD4, dim CD7, dim CD33, CD34, dim CD56, CD58, dim  CD123, CD117 and HLA-DR positive"	TRUE	TRUE	NA	49.48	TRUE	negative	0	negative			TP53 (p.R248W; 71.9%)	JAK2 (p.V617F; MAF 88%)|SF3B1 (p.G740V; MAF 41%)|TET2 (p.E692fs*8; MAF 40%)|TP53 (p.R248W; MAF 78%)	yes				yes	yes	Found	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	7.458669758	3.139900593	6.882992955	2.202007581	5.176998147	1.694555777	0.878502133	yes	no	yes	no	no	yes	no	-3.04059072	NA	1.692795234	NA	-4.480674354	-5.049976048	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.524183573
BA3334R	BA3334D	2640	Waves3+4	yes	yes	yes	yes	Female	Female	White			2			76	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	76	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Targeted Therapy - Other	1	Entospletinib	1	Experimental			NA	Targeted Therapy - Other	Entospletinib	Experimental	-1	Alive	47	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative		ASXL1 (p.C687Yfs*30; 45.2%)		ASXL1|FLT3 (N841K)|SRSF2|STAG2		yes			yes		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.934276996	6.840394913	5.402952286	3.903889208	6.363758413	-1.340913836	7.071808265	yes	yes	yes	yes	yes	no	yes	3.599326731	NA	0.731967229	NA	2.019831518	3.367980997	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.85210863
BA3447R	BA3447D	2669	Waves3+4	yes	yes	yes	no	Male	Male	White			7			67	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Dead	249	Dead-Disease	NA	82		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	NA	NA	46XY	NA	NA		NA	NA	"positive for CD13, CD33, CD34, CD38, CD117, HLA-DR, cytoplasmic myeloperoxidase (subset), and TdT (subset)"	FALSE	TRUE	NA	NA	NA	negative	0	negative				FLT3-ITD|NRAS|U2AF1			yes		yes		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	-0.041105053	0.4136809	-1.064561294	0.943216526	5.615495263	-2.32040487	2.262756705	no	no	no	no	no	no	no	0.316487179	NA	-0.475449855	NA	-0.103607366	1.644242084	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.567110476
BA3116R	BA3116D	2810	Waves3+4	yes	yes	yes	no	Female	Female	White			5			65	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"Azacitidine, BI 836858 (anti-CD33)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Azacitidine, BI 836858 (anti-CD33)"	Induction	-1	Alive	83	Alive	NA	40		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative				ASXL1|TET2					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.948480229	4.789631377	5.488344205	3.411402903	6.104973667	0.706893141	5.825802632	yes	yes	yes	no	yes	yes	yes	6.856129902	NA	-1.722385826	NA	1.313608315	2.367655946	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.779815266
BA3280R	BA3280D	2648	Waves3+4	yes	yes	yes	no	Male	Male	White			5	N/A		51	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	-1	Alive	82	Alive	NA	80	85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA		NA	NA	"positive for CD117, CD13, CD33, and HLA-DR. Roughly half of the blasts were positive for CD34, roughly half of the blasts showed aberrant dim expression of CD7, and roughly half of the cells showed aberrant dim expression of CD19."	TRUE	TRUE	NA	NA	NA	positive	0.136363636	positive				ASXL1|CEBPA|FLT3-ITD|NPM1|NRAS|PTPN11|STAG2					no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	1.177475595	3.042413784	0.23878428	3.972999486	5.596625022	0.725196498	0.643937104	no	no	no	yes	no	yes	no	-6.045901881	NA	1.614782508	NA	-3.539213405	-4.480855095	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.402182799
BA3185R	BA3185D	2769	Waves3+4	yes	yes	yes	yes	Male	Male	White			5			75	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Kinase Inhibitor(s)	2	"Entospletinib, Azacitidine|Entospletinib"	2	Induction|Re-induction	Refractory	Targeted Therapy - Kinase Inhibitor(s)	-1	Standard Chemotherapy	"Entospletinib, Azacitidine"	Re-induction	-1	Alive	75	Alive	NA	90		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,+13[20]/47,XY,+8[1]"	NA	NA	Low level gain of chromosome 8 sequences (trisomy). Loss of 21q22 sequences (monosomy)	NA	NA	"CD13, CD33, HLA-DR, and CD34"	FALSE	TRUE	NA	NA	NA	negative	0	negative	RUNX1 (p.H105Afs*33; 41.2%)|RUNX1 (p.T104R; 53.3%)	ASXL1 (p.G646Wfs*12; 33.3%)		ASXL1|RUNX1|SRSF2|TET2		yes			yes		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	NA	FALSE	TRUE	4.867454474	3.299070264	3.734565851	4.390354398	5.97158629	-2.701609364	-2.03573425	yes	no	yes	yes	no	no	no	-3.279974981	NA	2.90214789	NA	-4.362668324	3.141291155	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.590274613
BA3094R	BA3094D	2660	Waves3+4	yes	yes	yes	yes	Male	Male	White	UNKNOWN		1		KMT2A_re	23	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	23	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Alive	1386	Alive	0	95	85	0	0	12.4	0.9	1.8	0	68	83	2.8	0.78	M5	25.5	8.6	"46,XY,der(10)t(10;11)(p13;q23),der(11)t(10;11)(p13;q23)inv(11)(q13q23)[20]"	2144	87.9	"MLL:  60% of cells had a split signal pattern consistent with MLL rearrangement. On available metaphase cells, there was a distal signal on chromosome 10p and the proximal signal was close to the chromosome 11 centromere, consistent with t(10;11) and inv(11), as seen on chromosome analysis."	56	TRUE	"CD4, variable CD13, CD33, CD38, variable CD56, CD58,  CD64, dim CD71, dim CD117, dim CD123 and HLA-DR+ "	TRUE	TRUE	7.7	98.29	TRUE	negative	0	negative				NRAS (p.G12A; MAF 4%)|NRAS (p.Q61H; MAF 30%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.442049234	0.821801311	0.526516613	2.109065935	5.524613364	-2.922698139	-1.163931911	no	no	no	no	no	no	no	-6.053722444	NA	-4.474336786	NA	2.56429108	3.900769184	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.379543926
BA3318R	BA3318D	2593	Waves3+4	yes	yes	yes	yes	Female	Female				2			83	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	83	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Alive	13	Alive	NA	80		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX,-15,+dic(1;15)(p11;p11)[10]/47,idem,+11[10]"	NA	NA	67.5% of cells had an extra copy of MLL(11q23)	78	TRUE		NA	NA	NA	14.17	FALSE	negative	0	negative				IDH2 (p.172Arg>Lys)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	2.041877603	2.194521977	3.468562018	3.355942775	5.512416769	-3.034003292	1.953482863	no	no	yes	no	no	no	no	-1.164025461	NA	5.292519962	NA	-6.393100698	-2.411478147	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.541050329
BA3216R	BA3216D	2632	Waves3+4	yes	yes	yes	yes	Female	Female	White			5	mono		73	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	16	Dead-Disease	NA	85	79	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		44	FALSE		NA	NA	NA	123.2	TRUE	positive	0.428571429	negative				FLT3-ITD (suspicious for D835 as well)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	2.550005513	4.586554956	2.031586332	3.836545919	5.527632033	0.608034603	1.961163612	no	yes	no	yes	no	yes	no	0.952716739	NA	0.982824009	NA	1.079721913	-0.896353627	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.640731494
BA3332R	BA3332D	2748	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		7			26	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	26	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Daunorubicin) plus Gemtuzumab Ozogamicin plus Midostaurin"	1	Induction	Complete Response	Standard Chemotherapy	8	Standard Chemotherapy	"7+3 (Cytarabine, Daunorubicin) plus Gemtuzumab Ozogamicin plus Midostaurin"	Induction	8	Alive	720	Alive	NA	41		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX"	NA	NA	Normal	NA	NA	"CD117(+) myeloid precursors comprise 26%æof total events and are positive for dim CD7, CD13, CD33, CD38, CD117, HLA-DR, and cyMPO. æThey are negative for CD34. æ"	TRUE	TRUE	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	1.811757206	3.142212496	-0.130727984	3.324007032	5.582337795	-0.758732188	6.118052395	no	no	no	no	no	yes	yes	-2.897484128	NA	-2.034732603	NA	0.713324394	-4.304604899	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.380901091
BA3214R	BA3214D	2820	Waves3+4	yes	yes	yes	yes	Female	Female				7			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	51	0	Unknown	Unknown	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	2.305093894	2.707295745	0.199795112	4.420087818	3.336426929	-1.797092471	1.913743172	no	no	no	yes	no	no	no	-2.125567561	NA	5.589914545	NA	-9.096203515	-1.376546229	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.536728303
BA3141R	BA3141D	2831	Waves3+4	yes	yes	yes	yes	Female	Female				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NA	0	Unknown	Unknown	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	21.7	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.545441967	-0.851051273	-0.665131313	0.911625629	5.329201957	0.506007011	6.815699908	no	no	no	no	no	yes	yes	-8.272421635	NA	-1.758856788	NA	2.415200235	-5.770755756	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.255813804
BA3373R	BA3373D	2680	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1		GATA2-MECOM	67	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		n	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	67	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	49	Dead-Unknown	0	70	88	2.6	0.9	14.8	0	3.5	0	21	24	3.2	0.81	M1	26.9	9.1	"45,XX,t(3;3)(q21;q26),del(5)(q22q35),-7[20]"	643	88.5	"EGR-1/ D5S23, D5S721: æ96/100 cells (96%) had a 1 red/ 2 green signal  pattern, reflecting a deleted 5q, consistent with the metaphase karyotype. | D7S522/ CEP 7: æ98/100 cells (98%) had a 1 red/ 1 green signal pattern,  reflecting monosomy 7, consistent with the metaphase karyotype. | MECOM/ RPN1: æ97/100 cells (97%) had a 1 red/ 1 green/ 2 yellow signal  pattern, reflecting MECOM/RPN1 fusion, consistent with the 3;3  translocation in the metaphase karyotype. "	85	TRUE	"dim CD5, CD7, æpartial CD11b, CD13, CD33, CD34, variable  CD38, variable CD56, CD58, ædim CD71, CD117, dim CD123, dim HLA-DR and MPO+"	TRUE	TRUE	6.3	44.52	TRUE	negative	0	negative				DNMT3A (p.R882H; MAF 48%)|NRAS (p.Q61R; MAF 29%)|PTPN11 (p.E69K; MAF 9%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.347222129	0.340080739	1.118173983	3.571931921	4.340872757	-1.474596182	1.30967693	no	no	no	no	no	no	no	-3.808688699	NA	4.224159064	NA	-6.910867115	-0.678135269	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.415955914
BA3319R	BA3319D	2707	Waves3+4	yes	yes	yes	yes	Male	Male	Pacific Islander	NON-HISPANIC		1		CBFB-MYH11	22	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	22	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	106	Alive	1409	Alive	0	61	12	2.7	0	16.1	72.3	2.7	0.2	63	28	2.3	0.87	M4	24.1	8.2	"46,XY,inv(16)(p13;q22)[20]"	482	94.5	"CBFB: æ 39% of cells had a 1r/1g/1f split signal pattern consistent with CBFB disruption and inv916), as seen on metaphase analysis. "	50	TRUE	"Myeloid blast immunophenotype: CD13, CD33, CD34, CD38, CD58, CD117,  CD123, dim HLA-DR and MPO+  | Monocytic blast immunophenotype: CD11b, CD13, CD14, partial CD16, CD33,  dim CD34, CD38, CD58, CD64, CD117, dim CD123, HLA-DR and MPO+ "	FALSE	TRUE	7.3	99.89	TRUE	negative	0	negative				KIT (p.D816Y; MAF 6%)|NRAS (p.Q61H; MAF 32%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.844255713	2.13241756	4.004577332	4.020819971	6.713841397	-1.257273156	7.106932866	no	no	yes	yes	yes	no	yes	5.918841258	NA	-1.014319537	NA	-0.936802129	6.444572434	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.768129584
BA3328R	BA3328D	2741	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|HiDAC|7+3 (Cytarabine, Idarubicin) plus Midostaurin"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Dead	167	Dead-Treatment	0	95	86	0	32	13	0	6	0.8	15	25	3.5	0.98	M1	25.2	8.5	"46,XX[15]"	563	93	Normal	60	FALSE	"dim CD13, CD33, CD38, partial CD56, CD58, CD64, dim CD117, CD123 and MPO+"	FALSE	TRUE	7.4	59.23	TRUE	positive	0.754385965	positive				DNMT3A (p.R326L; MAF 47%)|FLT3-ITD (MAF 43%; mutant allelic ratio 0.74)|IDH2 (p.R140Q; MAF 47%)|NPM1 (p.W288fs*12; MAF 48%)					no		Found	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.477098644	3.399225424	2.324649572	4.644857775	6.062989253	-0.824696888	3.589444817	no	no	no	yes	yes	yes	no	0.771372759	NA	-2.70825237	NA	4.938013376	-5.017844104	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.562756241
BA3240R	BA3240D	2711	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1		BCR-ABL1	79	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	79	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Vyxeos (Daunorubicin, Cytarabine - liposomal)"	1	Induction	Unknown	Standard Chemotherapy	-1	Standard Chemotherapy	"Vyxeos (Daunorubicin, Cytarabine - liposomal)"	Induction	-1	Dead	20	Dead-Disease	0	90		0	0	2.9	1.5	1.4	0.1	25	29	2.9	1.02	M1	19.9	6.2	"51~52,XX,+2,+6,add(7)(q31),+8,+9,+10,+15[cp14]/50~52,idem,del(19)(q11.2)[cp  5]/46,XX[1]"	483	108.2	"BCR/ABL/ASS: 72/100 cells had a variant abnormal fusion reflecting a single BCR/ABL fusion. The Philadelphia rearrangement was not visible in the metaphase karyotype  and is, thus, likely a cryptic rearrangement involving at least three chromosomes.    (Twenty-one cells (21%) had three signals for ASS and ABL with  no fusion signal.) | RUNX1T1: æ89/100 cells (89%) had three signals, consistent with the trisomy  8 in the metaphase karyotype. æThere was no evidence for RUNX1T1/RUNX1  fusion. æIn addition, 80% of cells had three chromosome 8 centromere  signals, also consistent with trisomy 8. | DEK/NUP21: æ96/100 cells (96%) had three signals for both probes,  consistent with trisomies 6 and 9 in the metaphase karyotype. æThere was no evidence for DEK/NUP21 fusion | PML: æ41/100 cells (41%) had three signals, consistent with the trisomy 15  in the metaphase karyotype. æFifty-two cells (52%) had four PML signals _  the chromosomal context of the fourth signal was not apparent in the  metaphase karyotype. æThere was no evidence for PML/RARA fusion. "	126	TRUE	"CD13, variable CD34, CD38, dim CD58, CD117, CD123,æHLA-DR and dim MPO+"	FALSE	FALSE	6.1	130.45	TRUE	negative	0	negative				DNMT3A (p.R882C; MAF 64%)|FLT3 (p.D835H; MAF 5%)|IDH1 (p.R132L; MAF 54%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	0.041398241	1.356321008	0.152257105	2.025886694	5.529855625	-1.733767228	-1.543587363	no	no	no	no	no	no	no	-6.96719552	NA	2.420184091	NA	-9.643931397	-3.015469969	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.237847155
BA3142R	BA3142D	2612	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			54	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	54	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Other	3	"7+3 (Cytarabine, Idarubicin)|Decitabine, MGB453|MEC (Cytarabine, Etoposide, Mitoxantrone)"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Other	"Decitabine, MGB453"	Salvage	56	Dead	214	Dead-Disease	0		65	1.8	0.9	41.7	1.7	14.8	0	71	50	3.7	1.13	M1	22.6	8.1	"43,XY,add(5)(q11.2),add(9)(q12),add(10)(p11.2),-12,idic(12)(p11.2),t(14;14)  (q31;q32),-16,-17,add(17)(q21),add(19)(p13),-20,add(21)(p11.2),+mar[19]/46,  XY[1] "	185	89.7		23	FALSE	"CD13, dim CD33, CD34, CD38, CD117, dim CD123,  HLA-DR positive "	FALSE	TRUE	7.6	8.94	FALSE	negative	0	negative			TP53 (p.V216M; 78.5%)	TP53 (p.V216M; MAF 57%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	2.196033715	3.679910928	1.493354808	3.898748141	4.911936986	-2.099328339	2.724935193	no	yes	no	yes	no	no	no	-0.842617655	NA	3.47776528	NA	-3.481538767	-3.094852295	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.48110755
BA3339R	BA3339D	2742	Waves3+4	yes	yes	yes	yes	Female	Female				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	31	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.158979115	7.362523625	3.71874267	7.263234377	8.490906744	-0.141427107	4.204838162	yes	yes	yes	yes	yes	yes	no	4.031924233	NA	-2.829459597	NA	-1.802127866	-0.253611399	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.720818286
BA3333R	BA3333D	2746	Waves3+4	yes	yes	yes	yes	Male	Male	White			5			NA	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Prostate Cancer	n	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NA	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	2	Dead-Disease	NA	93		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	positive				FLT3-TKD (I836del; VAF 8%)|GATA2 (T358A;16%)|NPM1 (W288Cfs*12; VAF 46%)|SRSF2 (P95L; VAF 41%)|TET2 (A1344E; VAF 52%)|TET2 (R1440Tfs*38; VAF 47%)		yes			yes		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	2.907121591	2.949393646	0.253940584	2.671935251	4.851961831	-0.112757807	-0.43050765	yes	no	no	no	no	yes	no	-1.575663517	NA	-1.054475574	NA	2.431790443	-4.732068391	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.404754753
BA3381R	BA3381D	2754	Waves3+4	yes	yes	yes	yes	Male	Male	Black	NON-HISPANIC		1			51	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	51	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"HiDAC + Midostaurin|Fludarabine, TBI|Azacitidine|7+3 (Cytarabine, Idarubicin) plus Midostaurin|Decitabine, Venetoclax"	5	Consolidation|Induction|Allogeneic - Child|Maintenance|Re-induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"Decitabine, Venetoclax"	Re-induction	-1	Dead	486	Dead-Treatment	4.3	14		0.9	6.1	7	25.2	52.2	0.6	19	34	3.4	1.36	M4	19.7	6.3	"46,XY[20]"	1116	106.5	Normal	17	TRUE	"CD13, CD33, CD34, CD38, CD58, dim CD71, CD117, dim CD123  and HLA-DR+ "	TRUE	TRUE	7.5	80.58	TRUE	negative	0	negative	RUNX1 (p.F259Sfs*338; 18.3%)	ASXL1 (p.G646Wfs*12; 32.0%)		"ASXL1 (p.S1236A; MAF 51% )|CBL (p.R420Q, MAF 3%)|CBL (p.Y368_C372delinsP; MAF 9%)|DNMT3A (p.E616*; MAF 50%)|FLT3 (p.D835V; MAF 37%)|FLT3-ITD (Allelic Ratio = .03)|SF3B1 (p.K666N; MAF 47%)"	yes				yes	yes	Found	FALSE	FALSE	TRUE	TRUE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	4.619298469	6.472289491	5.268871336	3.638674576	7.21378005	-0.83073183	7.539743542	yes	yes	yes	no	yes	yes	yes	5.270650646	NA	0.002582631	NA	3.185189942	4.612116361	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.733384298
BA3290R	BA3290D	2753	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			66	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	67	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine"	2	Induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	232	Dead-Disease	0.9	17	22	7.1	8	38	7.1	22.1	0.3	43	30	2.9	1.04	M2	25	8.3	"46,XY,del(12)(p11.2)[9]/46,XY[11]"	287	94.7	Normal	16	TRUE	"dim partial CD7, CD13, CD33, CD34, dim CD38, CD58,  CD117, dim CD123, HLA-DR and partial TdT+"	TRUE	TRUE	5.6	6.21	FALSE	negative	0	negative	RUNX1 (p.D198N; MAF 6%)	ASXL1 (p.G646Wfs*12; 36.6%)		RUNX1 (p.D198N; MAF 6%)|SF3B1 (p.K666N; MAF 45%)|SRSF2 (p.P95H; MAF 46%)	yes	yes			yes		Found	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	2.3905136	7.884946951	5.091442436	3.284332729	7.153278187	0.683432199	7.829887696	no	yes	yes	no	yes	yes	yes	2.766479764	NA	-0.700627468	NA	3.37599944	-1.144363794	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.560996116
BA3207R	BA3207D	2641	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			65	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Melanoma	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute myelomonocytic leukaemia	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	2	"7+3 (Cytarabine, Idarubicin)|Methotrexate"	1	Induction	Complete Response	Standard Chemotherapy	-1	Intrathecal	Methotrexate	Induction	6	Dead	21	Dead-Disease	0	90	96	0	0	3.6	92.8	0.9	0.4	15	60	2.2	6.73	M4	19.7	6.6	"46,XY[20]"	2285	90.4	Normal	18	TRUE	"CD11b, variable CD14, CD15, CD33, CD38, variable CD56,  CD58, CD64, CD123, HLA-DR, variable MPO"	FALSE	TRUE	5.9	89.55	TRUE	negative	0	negative	RUNX1 (p.F396Vfs*204; 55.4%)	ASXL1 (p.G646Wfs*12; 35.0%)		IDH1 (p.R132H; MAF 46%)|MLL (Partial tandem duplication )|NRAS (p.Q61R; MAF 45%)|RUNX1 (p.F396fs*204; MAF 46%)|SRSF2 (p.P95L; MAF 28%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	1.503978465	2.273772977	3.060581114	3.738666444	6.860253168	-1.833195787	6.134616331	no	no	yes	no	yes	no	yes	6.73301457	NA	-3.126494257	NA	0.201396499	1.393378427	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.689534804
BA3305R	BA3305D	2634	Waves3+4	yes	yes	yes	yes	Male	Male	White			5			84	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	84	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Complete Response	Standard Chemotherapy	344	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	344	Dead	394	Dead-Disease	NA	90		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,+8[12]/47,XY,+15[8]/46,XY[5]"	NA	NA	Gain of 8q22 and 15q22 sequences	NA	NA		NA	NA	NA	NA	NA	negative	0	negative				IDH2 (R140Q; VAF 51%)|NRAS (Q61K; VAF 27%)|SMC1A (E687*; VAF 64%)|SMC1A (R807H; VAF 13%)|SRSF2 (P95R; VAF 38%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	1.317843449	4.90219466	1.371851629	4.16243646	5.892800706	-1.189469267	6.276035046	no	yes	no	yes	no	no	yes	1.867463062	NA	1.926845174	NA	0.902809771	-1.932939442	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.60347693
BA3434R	BA3434D	2651	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			78	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	78	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	CPX-351 (Liposomal Cytarabine + Daunorubicin)|Lenalidomide|Azacitidine	2	Experimental|Supportive/Palliative Care			NA	Standard Chemotherapy	CPX-351 (Liposomal Cytarabine + Daunorubicin)	Experimental	0	Dead	79	Dead-Disease	NA	35	23	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"46,XX,del(9)(q22q22)[20] "	NA	NA	"With the TP53 probe set, 7/200 cells (3.5%) were missing a TP53  signal, within normal limits, but also this patient's previous abnormal  pattern. æ"	NA	NA	"CD13, CD33, CD34, CD38, CD58, CD117, HLA-DR, partial  MPO "	FALSE	TRUE	NA	NA	NA	negative	0	negative	RUNX1 (p.T196Dfs*17; 40.6%)|RUNX1 (p.X20_splice; 49.2%)			"DNMT3A (p.A644fs*7; MAF 37%)|ETV6 (p.L205fs*12; MAF 30%)|IKZF1 (p.N159S; MAF 35%)|NRAS (p.Q61H; MAF 31%)|RUNX1 (c.58+2T>C, Donor-splice-site mutation in intron 1; MAF 46%)|RUNX1 (p.T196fs*17; MAF 46%)|SF3B1 (p.K700E; MAF 51%)"	yes				yes	yes	Found	FALSE	FALSE	TRUE	TRUE	NA	FALSE	FALSE	FALSE	TRUE	FALSE	NA	TRUE	TRUE	5.330282684	6.42812419	2.09051066	6.055736452	5.753781149	-0.678720436	6.039384133	yes	yes	no	yes	no	yes	yes	2.735042614	NA	4.345036496	NA	-0.463571315	1.116065912	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.660168901
BA3189R	BA3189D	2676	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			20	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	20	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	4	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal|Targeted Therapy - Kinase Inhibitor(s)	5	"Cytarabine|MEC (Cytarabine, Etoposide, Mitoxantrone)|Sorafenib|7+3 (Cytarabine, Daunorubicin) plus Midostaurin|Busulfan, Cyclophosphamide"	4	Allogeneic - Sibling|Induction|Re-induction|Maintenance	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Sorafenib	Maintenance	317	Alive	1356	Alive	0	80	75	0.9	NA	11.3	0	11.3	0.1	16	17	2.5	0.77	M2	24.6	8.3	"46,XY,del(2)(q11.2q21)[3]"	NA	98.4	Normal	102	TRUE	"CD13, CD33, CD34, CD38, CD58, dim CD64, CD117,  variable MPO "	FALSE	TRUE	7	34.16	TRUE	positive	1	negative				"FLT3-ITD (p.E608delinsDPVDFREYEYDLKWEFPRE; p.E598delinsDLSYVDFREYE;  ratio: ~1.0; Two visible FLT3 ITD insertions, one  of ~ 10 amino acids (predominating, with a high mutant allele ratio) and  one of ~18 amino acids (smaller sub-clone).)"					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.974501064	3.408866847	2.708560547	1.669643049	6.184638057	-0.254367735	4.300493472	yes	no	no	no	yes	yes	no	-2.084205193	NA	0.340931706	NA	0.983660024	-1.79231998	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.433537247
BA3264R	BA3264D	2603	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		PML-RARA	41	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	41	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"ATRA, Arsenic Trioxide, Idarubicin|ATRA, Arsenic Trioxide"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	26	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Consolidation	200	Alive	1253	Alive	0	72	86	0	NA	14.3	4.4	2.7	0.1	87	65	4.1	0.84	M3	36.5	13.5	"46,XY,t(15;17)(q24;q21)[20]"	588	81.5	PML/RARA (92% of  cells had the dual fusion signal pattern consistent with PML/RARA fusion and t(15;17).)	55	TRUE	"partial CD11b, CD13, CD33, CD34, CD38, CD58, variable  CD64, CD117, CD123, partial HLA-DR and bright MPO"	FALSE	TRUE	7.8	39.57	TRUE	positive	1.127659574	negative				FLT3-ITD (Mutant Allele Ratio:  0.85)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.113133927	1.468121529	3.900499214	2.72869261	5.383300347	-2.67774829	4.477187156	no	no	yes	no	no	no	yes	-6.206442498	NA	-2.002046727	NA	-1.315575622	1.933665035	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.424039591
BA3329R	BA3329D	2715	Waves3+4	yes	yes	yes	yes	Male	Male		HISPANIC		5	mono		77	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	77	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	2	"Venetoclax (ABT-199), Azacitidine|Azacitidine"	2	Induction|Maintenance	Refractory	Standard Chemotherapy	36	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	36	Dead	113	Dead-Disease	NA	22		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,inv(4)(p14q21)[9]/47,sl,+8[2]/46,XY[10]æ"	NA	NA	Gain of chromosome 8 (trisomy)	NA	NA		NA	NA	NA	NA	NA	negative	0	negative				CEBPA (P189dup; VAF 30%)|ETV6 (N228S; VAF 52%)|SRSF2 (P95R; VAF 18%)|STAG2 (VAF 34%)|TET2 (Q745*; VAF 23%)		yes			yes	yes	Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.303259475	3.696205542	2.71568991	4.251887854	4.835825507	-0.579262827	1.62461307	yes	yes	no	yes	no	yes	no	0.339713576	NA	-1.677201876	NA	-6.782892636	-3.007790748	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.613331374
BA3417R	BA3417D	2600	Waves3+4	yes	yes	yes	yes	Female	Female				3		BCR-ABL1	NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	50	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.332317747	4.718245442	3.24991106	5.858934954	6.973186097	-3.752786206	4.711928061	yes	yes	yes	yes	yes	no	yes	2.649867078	NA	-2.024186928	NA	-0.948240508	2.916037829	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.816621951
BA3367R	BA3367D	2730	Waves3+4	yes	yes	yes	yes	Male	Male	White			3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	34	0	Unknown	Unknown	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.120206457	2.824860517	5.305617434	3.940941794	6.890586444	0.074223775	6.85335943	yes	no	yes	yes	yes	yes	yes	5.622308728	NA	-4.479495672	NA	5.372103455	1.678278169	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.779151399
BA3225R	BA3225D	2658	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	UNKNOWN	Standard Chemotherapy	4	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	4	Dead	16	Dead-Disease	NA	85		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M5	NA	NA		NA	NA	Normal	NA	NA	"Monocytic blast immunophenotype (75%):  CD11b, CD13, CD14, CD33, CD38, CD58, CD64, dim CD117, CD123, and dim HLA-DR+. | Myeloid blast immunophenotype (13%): dim CD13, CD33, CD38, CD58 dim CD117, dim CD123 and MPO+.           | Monoclonal plasma cell population immunophenotype (approximately10% involvement): CD138 and kappa+. "	FALSE	TRUE	NA	NA	NA	negative	0	positive				"GNA13 (p.T365S; MAF 46%)|NPM1 (p.W288fs*12; MAF 43%)|PHF6 (c.730-2A>G, Acceptor-splice-site mutation in intron 6; MAF 89%)|TET2 (c.3594+1G>T, Donor-splice-site mutation in intron 3; MAF 46%)|TET2 (p.D1242fs*11; MAF 42%)"					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	4.752010161	2.861265344	3.813035578	1.516603718	7.091190411	-2.613288524	0.645555631	yes	no	yes	no	yes	no	no	7.612582558	NA	-3.463792756	NA	1.416396167	2.852901259	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.752104841
BA3183R	BA3183D	2798	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			64	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	64	0	Post-Chemotherapy|Residual Disease	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Fludarabine, Melphalan|5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|Azacitidine|Decitabine"	4	Consolidation|Induction|Supportive/Palliative Care|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Dead	337	Dead-Treatment	0	51	65	0.9	NA	12.3	3.5	15.8	0.1	20	13	2.6	1.2		24.4	8.2	"46,XY[20]"	NA	103	Normal	46	TRUE	"CD13, CD33, CD38, CD58, CD117, CD123, partial MPO+"	FALSE	TRUE	6.5	15.38	FALSE	negative	0	positive				"ATM (p.H1136R; MAF 45%)|DNMT3A (p.R882H; MAF 46%)|IDH1 (p.R132H; MAF 27%)|IDH2 (p.D314V (Low allele frequency, subclonal), MAF 2%)|IDH2 (p.R140Q; MAF 18%)|KRAS (p.G12A; MAF 3%)|NPM1 (p.W288fs*12; MAF 49%)|U2AF1 (p.D208E; MAF 46%)"			yes		yes		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.872750258	1.397328316	-0.334928321	2.422475967	5.908410754	-0.49525152	5.319397189	no	no	no	no	no	yes	yes	-0.33993936	NA	-0.090694291	NA	3.567414397	-6.044539275	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.383597965
BA3397R	BA3397D	2674	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			79	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	79	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	54	Dead-Disease	0	60	74	0	NA	10.7	22.9	9	0.4	22	27	2.2	1.36	M2	27.9	9.2	"44,XY,-3,-5,dic(10;12)(q26;p13),add(11)(p15),-17,+mar[20] "	219	97.9	"ETV6 (12p13): 93.5% of cells were missing a signal for ETV6, consistent with 12p deletion resulting from dic(10;12).  | CEP17: 98.5% of cells were missing a signal for CEP17, consistent with monosomy 17.  | PML/RARA: 189/200 cells (94.5%) were missing a signal for RARA (17q21.2)."	92	TRUE	"CD13, CD33, CD34, variable CD38, CD117, CD123, HLA-DR, partial MPO"	FALSE	TRUE	6.3	13.72	FALSE	negative	0	negative			TP53 (p.L194R; 86.6%)	TP53 (p.L194R; MAF 80%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	2.562577463	2.964675357	3.816959788	2.224894915	5.936506688	-0.067402502	5.706431736	no	no	yes	no	no	yes	yes	-0.609467963	NA	3.672057852	NA	0.402512438	-0.049628414	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.423309082
BA3311R	BA3311D	2720	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			74	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	y	Prostate Cancer	y	y	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	74	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Induction	Unknown	Standard Chemotherapy	6	Standard Chemotherapy	Azacitidine	Induction	6	Dead	24	Dead-Disease	NA	21	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	NA	NA	"48,XY,+11,+13[17]/46,XY[3]"	NA	NA	"MLL (11q23):  161/200 cells (80.5%) had three intact signals for MLL, consistent with the trisomy 11 seen on metaphase analysis. "	NA	NA	"CD13, CD33, CD34, variable CD38, partial CD64, CD117, dim CD123, HLA-DR, partial TdT. "	FALSE	TRUE	NA	NA	NA	negative	0	negative				CBLB (p.V581M; MAF 52%)|DNMT3A (p.V877fs*4; MAF 40%)|MLL (Partial tandem duplication (exon 9/exon 3) )|NRAS (p.G12D; MAF 14%)|U2AF1 (p.S34F; MAF 43%)|WT1 (p.R353fs*15; MAF 26%)|WT1 (p.S364*; MAF 25%)			yes		yes		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	6.518633362	7.086715234	4.125761549	4.502099476	8.040607806	-0.286763973	6.330027942	yes	yes	yes	yes	yes	yes	yes	7.391280665	NA	0.21362249	NA	1.053431956	0.786188154	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.822026286
BA3175R	BA3175D	2783	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			62	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	248	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"Decitabine, anti-PD1, anti-TIM3|7+3 (Cytarabine, Idarubicin)|JNJ-40346527 (CSF1R inhibitor)|Mitoxantrone|FLAG, Midostaurin"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	Mitoxantrone	Salvage	0	Dead	373	Dead-Disease	0.9	25		0	NA	6.8	58.1	16.2	0.1	55	53	3.5	1		27.2	9.5	"46,XY,t(1;3)(p36;q21)[2]/46,sl,-1,+der(1)t(1;3)(p36;q21)[15]/46,sl,add(3)(q12)[2]/46,sl,-1,+t(1;3)(p36;q21),-3[1]"	NA	83.4	"MECOM/RPN1: æ171/200 cells (85.5%) had a 2 red/ 3 green signal pattern,  reflecting an extra RPN1 (3q21.3) signal, consistent with RPN1 disruption  due to the 1;3 translocation observed in the metaphase karyotype. æThere  was no evidence for MECOM/RPN1 fusion. "	20	FALSE	"CD7, CD13, CD33, CD34, CD117, and HLA-DR positive"	TRUE	TRUE	7.1	39.59	TRUE	positive	0.234567901	negative	RUNX1 (p.D198N; 44.9%)			"BCL2 (p.A32G; VAF 48%)|FLT3-ITD (p.N609delinsIIPCPEYDLKWEFPREN; VAF 19%, allelic ratio 0.24)|GATA2 (p.S201fs*1; VAF 13%)|NPM1 (p.H30Q; VAF 3%)|NRAS (p.G12D; VAF 72%)|RUNX1 (p.D198N; VAF 44%)|WT1 (p.R380fs*5; VAF 45%)|WT1 (p.V371fs*14; VAF 22%)|ZRSR2 (p.P350R; VAF 5%)"				yes	yes	yes	Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	FALSE	1.667792673	3.694364627	-1.132160519	4.092741897	6.813948945	-2.713314441	5.768788583	no	yes	no	yes	yes	no	yes	4.805795638	NA	0.769344925	NA	0.555995878	4.612092563	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.703729223
BA3422R	BA3422D	2636	Waves3+4	yes	yes	yes	yes	Female	Female	Black			5			72	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	-1	Alive	521	Alive	NA	97		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	positive				GATA2 (A372T; VAF 48%)|NPM1 (W288Cfs*12; VAF 39%)|TET2 ( E843*; VAF 47%)|TET2 (T1726Lfs*19; VAF 51%)					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	1.20914253	1.586439704	-0.423494402	1.998665413	3.696690741	-0.311019674	-1.500222088	no	no	no	no	no	yes	no	-6.829990819	NA	1.413107038	NA	-3.928102127	-8.176232565	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.298116815
BA3228R	BA3228D	2717	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			68	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	69	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"Azacitidine|7+3 (Cytarabine, Idarubicin) plus Midostaurin|Cytarabine, Midostaurin"	3	Induction|Re-induction|Supportive/Palliative Care	Refractory	Standard Chemotherapy	11	Standard Chemotherapy	"Cytarabine, Midostaurin"	Re-induction	-1	Alive	494	Alive	2.1			0	NA	6.2	29.4	3.4	1.1	NA	NA	NA	0.99		24.8	7.8	"46,XX,i(14)(q10)[8]/46,XX[12] "	1036	91.5	"IGH (14q32) breakapart probe set, as listed  below. æ4/200 interphase cells had three intact signals, but one abnormal  metaphase was found, which had an IGH signal on either end of the  i(14)(q10). "	482	TRUE		NA	NA	NA	105.01	TRUE	positive	NA	negative	RUNX1 (p.R320*; 49.8%)								no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	TRUE	FALSE	3.498480131	3.684855788	0.743435116	2.156453828	5.992306309	-0.202451946	4.336786719	yes	yes	no	no	no	yes	no	2.715843565	NA	3.019960901	NA	-0.839180892	1.721617124	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.621185348
BA3213R	BA3213D	2817	Waves3+4	yes	yes	yes	yes	Male	Male	White			5		CBFB-MYH11	50	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	50	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin) plus Gemtuzumab Ozogamicin"	1	Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin) plus Gemtuzumab Ozogamicin"	Induction	7	Alive	536	Alive	NA	73		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY,inv(16)(p13.1q22)[18]/47,sl,+9[2]"	NA	NA	Positive for a CBFB rearrangement	NA	NA		NA	NA	NA	NA	NA	negative	0	negative				CBL (L399V; VAF 50%)|KIT (N587_R588ins16; VAF 34%)					no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	1.333561525	1.833862971	-2.022299506	2.803035574	6.118864571	-0.467690122	6.667811052	no	no	no	no	yes	yes	yes	4.370104446	NA	0.873953121	NA	-0.227165621	3.032893115	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.695900909
BA3415R	BA3415D	2825	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			79	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	79	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	14	Dead-Disease	0	65	15	0	NA	25.2	0.9	24.3	1.7	NA	NA	NA	NA	M2	23.9	8.3	"49~50,XX,+X,-3,del(5)(q13q33),der(7)t(3;7)(q11.2;q21),+8,-9,  del(17)(p11.2),+18,+21,der(21)t(9;21)(q22;q22)X2,+22,+1~2mar[cp20]"	NA	92.6	"EGR-1/ D5S23, D5S721:  97/100 cells (97%) had a 1 red/ 2 green signal pattern, indicating a deleted 5q, consistent with the metaphase karyotype.  | CEP 8:  179/200 cells (89.5%) had three signals, consistent with the trisomy 8 in the metaphase karyotype.  | RUNX1T1/RUNX1:  92/100 cells (92%) had a 3 red/ 3 green signal pattern, reflecting the extra copies of chromosome 8 and chromosome 21 in the metaphase karyotype.  There was no evidence for RUNX1T1/RUNX1 fusion.  | BCR/ABL:  95/100 cells (95%) had a 3 red/ 2-3 green signal pattern, reflecting the extra copies of chromosome 9q and chromosome 22 in the metaphase karyotype.  There was no evidence for BCR/ABL fusion. | DEK/NUP214:  184/200 cells (92%) had a 3 red/ 2 green signal pattern, reflecting an extra copy of NUP214 (9q34),consistent with the extra chromosome 9q material in the metaphase karyotype.  There was no evidence for DEK/NUP214 fusion.  | TP53/CEP 17:  93/100 cells (93%) had a 1 red/ 2 green signal pattern, reflecting TP53 deletion and consistent with the deleted chromosome 17 short arm in the metaphase karyotype. "	31	FALSE	"partial CD7, CD13, CD33, CD34, CD38, CD56,  CD117, HLA-DR, MPO"	TRUE	TRUE	NA	11.5	FALSE	negative	0	negative			TP53 (p.R196*; 89.6%)	CBL (p.L209V; MAF 92%)|FLT3 (p.L198F; MAF 52%)|TP53 (p.R196*; MAF 80%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	3.284332729	4.443717515	2.60644037	2.242712282	5.14613707	1.316669546	5.397803331	yes	yes	no	no	no	yes	yes	-1.852248909	NA	1.879968138	NA	2.36518521	-0.893272379	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.455513403
BA3270R	BA3270D	2814	Waves3+4	yes	yes	yes	yes	Female	Female	White	DECLINED		1			47	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	7	Standard Chemotherapy	HiDAC	Consolidation	100	Alive	432	Alive	0	18	9	0	NA	13.3	16.8	46	0.6	16	23	2.7	0.7		23.4	7.4	"46,XX[20"	470	98.7	Normal	189	TRUE		NA	NA	6.1	65.11	TRUE	negative	0	positive				DNMT3A (p.R882C; MAF 46%)|NPM1 (p.W288fs*12; MAF 48%)|NRAS (p.G12D; MAF 46%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	1.156033745	6.356703151	2.608418792	3.697153947	7.410087978	0.648604039	7.190649758	no	yes	no	no	yes	yes	yes	6.466738199	NA	-2.259473929	NA	3.264906641	-1.802380288	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.6998325
BA3324R	BA3324D	2625	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			60	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	60	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"Decitabine, MGB453|7+3 (Cytarabine, Idarubicin) plus Sorafenib"	2	Induction|Re-induction	Complete Response	Standard Chemotherapy	15	Standard Chemotherapy	"Decitabine, MGB453"	Re-induction	84	Dead	200	Dead-Disease	0	85	72	0.9	NA	14.6	32.8	4.3	0.1	12	37	2.5	1.2	M1	27.5	9.1	"46,XY,del(5)(q13q34),add(7)(q11.2),+11,add(12)(p13),-16, add(17)(p11.2)[cp17]/46,idem,add(4)(q35)[4] "	1498	107.4	"EGR-1/ D5S23, D5S721:  193/200 cells (96.5%) had a 1 red/ 2 green signal pattern, indicating a deleted 5q, consistent with the metaphase karyotype.  | D7S522/ CEP 7:  191/200 cells (95.5%) had a 1 red/ 2 green signal pattern, indicating deleted 7q, consistent with the metaphase karyotype.  | MLL:  150/200 cells (75%) had three intact signals, consistent with the trisomy 11 in the metaphase karyotype. An additional 18 cells (9%) had four intact MLL signals.  There was no evidence for MLL rearrangement.  | CBFB:  195/200 cells (97.5%) had a single intact signal, consistent with the monosomy 16 in the metaphase karyotype.  There was no evidence for CBFB rearrangement. "	133	TRUE	"variable CD4, dim CD7, dim CD11b, CD13, variable CD14, variable CD15, CD33, variable CD34, CD38, dim CD56, partial CD64, CD117, HLA-DR, MPO positive."	TRUE	TRUE	7.1	62.69	TRUE	negative	0	negative			TP53 (p.L194R; 88.3%)	PTPN11 (p.S502P; MAF 34%)|TP53 (p.L194R; MAF 87%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	3.616243408	3.465532596	3.495979988	2.803035574	6.644646271	-1.054173263	6.61700352	yes	no	yes	no	yes	no	yes	2.946685794	NA	4.163809846	NA	1.117806062	1.999683686	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.59568343
BA3194R	BA3194D	2757	Waves3+4	yes	yes	yes	no	Male	Male				3	mono		NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NA	9	Unknown	Unknown	Peripheral Blood	y	y	n	y	y	n	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	16.24	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	4.118618509	4.910923314	1.582482866	2.675065913	3.500869591	-2.461297057	1.478579391	yes	yes	no	no	no	no	no	-4.850638549	NA	-0.867475336	NA	-1.07343397	1.04063004	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.399877946
BA3335R	BA3335D	2602	Waves3+4	yes	yes	yes	yes	Female	Female	White			5			56	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	FavorableOrIntermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	56	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Refractory	Standard Chemotherapy	30	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	30	Alive	514	Alive	NA	80		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XX[22]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	positive	NA	positive				DNMT3A (P38SRfs*22; VAF 22%)|FLT3-ITD|GATA2 (T354_T355 insF; VAF 15%)					no		Found	FALSE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	TRUE	2.550005513	5.277244153	1.821369594	3.163668633	5.616270358	-1.784790142	0.49238161	no	yes	no	no	no	no	no	-0.657905292	NA	0.313195887	NA	-1.86372965	-8.63582955	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.5416015
BA3199R	BA3199D	2724	Waves3+4	yes	yes	yes	yes	Male	Male	White			5	mono		69	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	7	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	7	Dead	156	Dead-Disease	NA	94		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[19]æ"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative	RUNX1 (p.X269_splice; 48.1%)	ASXL1 (p.K618_A619ins*; 43.5%)		ASXL1 (A619*; VAF 47%)|CEBPA (H24Afs*84; VAF 44%)|CEBPA (R165Afs*153; VAF 48%)|RUNX1 (VAF 45%)|SRSF2 (P95H; VAF 53%)|TET2 (S1486*; VAF 48%)		yes			yes		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	TRUE	FALSE	NA	FALSE	FALSE	2.294287283	2.634397104	1.316669546	0.117009636	3.854717163	-1.141186731	3.29390664	no	no	no	no	no	no	no	-0.574427787	NA	1.381306266	NA	-1.990434577	0.851955836	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.389294875
BA3326R	BA3326D	2797	Waves3+4	yes	yes	yes	yes	Male	Male	White			5			63	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Venetoclax (ABT-199), Azacitidine"	1	Induction	Refractory	Standard Chemotherapy	29	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Induction	29	Dead	52	Dead-Disease	NA	59		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"47,XY,+6[4]/49,sl,+6,+22[2]/49,sl,+4,+8,i(8)(q10)x2[5]/47,XY,+r[2]/46,XY[7]"	NA	NA	"Gain of 8q22, 8 centromere and 16q22 sequences"	NA	NA		NA	NA	NA	NA	NA	negative	0	negative		ASXL1 (p.G646Wfs*12; 36.6%)		ASXL1 (G64Wfs*12; VAF 39%)|NRAS (Q61K; VAF 33%)|TET2 (Q892*; VAF 49%)					no		Found	FALSE	TRUE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	4.843555783	4.666461236	2.524098871	2.554574235	5.830943608	0.399544051	6.650696125	yes	yes	no	no	no	yes	yes	2.726861629	NA	-5.891209392	NA	3.668335099	3.000540681	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.680858
BA3297R	BA3297D	2657	Waves3+4	yes	yes	yes	yes	Female	Female	Asian	NON-HISPANIC		1			46	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	46	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	HiDAC	Consolidation	102	Alive	1159	Alive	0	81	84	0	NA	12.1	16.1	8.9	0.2	45	29	2.9	0.41	M2	30	9.9	"46,XX[20] "	NA	95.2	Normal	220	TRUE	"dim CD13, CD33, CD38, CD117 and MPO+"	FALSE	TRUE	7.4	61.13	TRUE	negative	0	positive				IDH2 (p.R140Q; VAF 46%)|NPM1 (p.W288fs*12; VAF 40%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.180017992	2.018354671	-0.303521767	3.645217725	5.792001118	-4.288398574	2.244244934	no	no	no	no	no	no	no	-0.190021505	NA	0.513020068	NA	1.403391189	2.106322677	Not_Monoctyte_Like		HSC_Like		Promono_Like	cDC_Like	0.46852274
BA3227R	BA3227D	2650	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			70	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	70	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	4	"MIDAC, Midostaurin|7+3 (Cytarabine, Idarubicin) plus Midostaurin|Methotrexate|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	3	Allogeneic - Sibling|Consolidation|Induction	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Sibling	-1	Alive	1188	Alive	0	95	96	0	NA	2.7	0	0	0.2	163	68	3.1	0.78	M1	16.8	5.6	"46,XX[20]"	469	106.3	Normal	45	TRUE	"dim CD13, CD33, CD38, CD117, and MPO +"	FALSE	TRUE	7.6	159.73	TRUE	positive	0.149425287	positive				ATM (p.K1454N; VAF 49%)|BCL6 (p.A321V; VAF 49%)|FLT3-ITD (Allelic ratio: 0.32)|IDH2 (p.R140Q; VAF 49%)|NOTCH2 (p.P2377L; VAF 48%)|NPM1 (p.W288fs*12; VAF 69%)|NRAS (p.A59T; VAS 3%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	2.357223898	0.497480704	-1.170291732	2.484498674	4.014407252	-3.311376794	-1.290112818	no	no	no	no	no	no	no	-8.386007358	NA	-0.066266923	NA	-2.002693265	-6.890962134	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.146730412
BA3394R	BA3394D	2653	Waves3+4	yes	yes	yes	yes	Male	Male				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NA	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	12	FALSE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	4.57691282	4.577270164	2.003588552	3.087546497	6.789809223	-1.180086359	5.029071613	yes	yes	no	no	yes	no	yes	4.107302454	NA	1.980879024	NA	-1.42818028	1.16619165	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.604317139
BA3412R	BA3412D	2833	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			74	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Breast Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	74	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Vidaza, BI836858 (anti-CD33)"	1	Induction	Refractory	Standard Chemotherapy	90	Standard Chemotherapy	"Vidaza, BI836858 (anti-CD33)"	Induction	90	Dead	149	Dead-Disease	NA	81	85	NA	NA	NA	NA	NA	NA	13	23	2.5	1.1	M5	19.7	6.3	"46,XX,t(8;16)(p11.2;p13.3)[19] /46,XX[1] "	1017	102.6	Normal	111	TRUE	"dim CD4, dim CD11b, CD15, bright CD33, CD38, variable CD56, bright CD64, partial CD117, HLA-DR, MPO, and dim TdT+"	FALSE	TRUE	5.4	43.06	TRUE	negative	0	negative				KMT2D (p.R1918C; VAF 50%)|PTPN11 (p.S502P; VAF 41%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	-0.821921733	1.010052081	-0.670700712	1.845452255	4.990348457	-3.198742635	0.880316656	no	no	no	no	no	no	no	-6.532619059	NA	-2.944711958	NA	5.560468717	2.365473404	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.370600904
BA3293R	BA3293D	2685	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			53	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	y	Cervical Cancer	y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	55	0	Relapse|Post-Chemotherapy|Post-Transplant	Relapse	Leukapheresis	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Mismatched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Mismatched Unrelated Donor	-1	Dead	835	Dead-Disease	NA		90	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	27.2	8.8	"46,XX[20]"	NA	97.5		34	TRUE	"variable CD11b, CD13, CD33, dim CD123, partial HLA-DR, dim/partial MPO"	FALSE	TRUE	NA	43.57	TRUE	positive	11.5	positive									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.254618437	0.764705649	8.042424664	2.640801758	5.128770175	-2.455611746	0.824641148	no	no	yes	no	no	no	no	-5.670765922	NA	-0.086442026	NA	0.370516753	-4.331443938	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.403691638
BA3250R	BA3250D	2718	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		CBFB-MYH11	58	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	58	2	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	UNKNOWN	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	22	Dead-Disease	NA	82	63	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	22	7.4	"46,XY,inv(16)(p13q22)[20] "	NA	98.7	"CBFB/MYH11:  165/200 cells (82.5%) had the abnormal 1 red/ 1 green/ 2 yellow signal pattern, reflecting CBFB/MYH11 fusion and consistent with the inverted chromosome 16 observed in the metaphase karyotype. "	29	FALSE	"Myeloid blasts: CD13, CD33, CD34,  CD117, HLA-DR+ | Promonocytic/ monocytic population (56%): variable CD13, variable CD14, partial CD16, CD33, CD64, HLA-DR+"	FALSE	TRUE	NA	26.58	TRUE	negative	0	negative				CARD11 (p.N191S; VAF 45%)|KRAS (p.G12V; VAF 4%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	2.49443655	1.617109534	1.940033158	3.813860416	6.052378749	-2.719272208	6.469282832	no	no	no	yes	yes	no	yes	2.228620648	NA	0.99338306	NA	-3.542272436	7.275071942	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.716495161
BA3177R	BA3177D	2793	Waves3+4	yes	yes	yes	yes	Male	Male	Unknown	UNKNOWN		1		CBFB-MYH11	66	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	66	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	1	Dead-Disease	0		82	0.9	NA	17.4	7.8	1.7	0	76	125	2.8	2.11		15.8	5.6		3316	94.6		57	TRUE	"partial CD1a, CD13, variable CD14, CD33, CD34, CD38, dim CD117, HLA-DR and cMPO"	FALSE	TRUE	5.5	310.71	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	1.917959857	0.651829022	-1.485040412	0.750088706	5.714053005	-1.681775566	5.988353025	no	no	no	no	no	no	yes	-0.647113426	NA	-0.623810281	NA	-0.024338918	3.190517707	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.581180385
BA3315R	BA3315D	2812	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			57	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	57	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	3	"7+3 (Cytarabine, Idarubicin)|HiDAC|Decitabine"	3	Salvage|Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Decitabine	Salvage	0	Dead	127	Dead-Disease	0	83	12	0.9	NA	69.9	0.9	8.8	7.1	72	49	3.2	0.9	M1	21.5	6.9	"69~82<3n>,X,-X,+4,+8,+8,+8,+8,+8,+8,-9,+10,-12,-15,-17,+18,+20,+21,+22,+1~2mar[cp13]/47~48,X,-X,+4,+6,+8,+8,-9,-16,-17,+mar[cp3]/92,XXXX[2]/46,XX[2]"	1498	89.2	BCR/ABL: 38% of cells had three signals for BCR and another 18% of cells had three signals for BCR and for ABL/ASS.  | PML/RARA: 6% of cells had three signals for both probes. 	32	TRUE	"MPO, CD33, CD43, CD45, and CD117 positive"	FALSE	TRUE	6.1	3.65	FALSE	negative	0	negative			TP53 (p.V143M; 44.0%)	BCL6 (p.R459C; VAF 44%)|IDH2 (p.R172K; VAF 14%)|NRAS (p.Q61K; VAF 12%)|TP53 (p.V143M; VAF 32%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	2.407234345	4.069250368	1.038589712	5.152070504	7.000109985	-1.620833694	4.784670382	no	yes	no	yes	yes	no	yes	-0.807881815	NA	-3.011839127	NA	2.42550365	-2.513396466	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.568342023
BA3182R	BA3182D	2804	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		CBFB-MYH11	30	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	30	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Intrathecal	4	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA, Gemtuzumab|Methotrexate"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	5	Standard Chemotherapy	HiDAC	Consolidation	38	Alive	1076	Alive	NA	80	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M2	17.5	5.7	"46,XY,del(7)(q32q36),inv(16)(p13.1q22)[20]"	NA	100.6	CBFB/MYH11: 90% of cells had a 1r1g2f dual-fusion signal pattern consistent with CBFB/MYH11 fusion and inv(16). 	14	FALSE	"Myeloid blast immunophenotype: CD13, CD33, CD34, CD117, HLA-DR, MPO positive | Aberrant monocytoid population with variable CD14, CD15, and CD64 expression"	FALSE	TRUE	NA	41.42	TRUE	negative	0	negative				No clinically significant variants identified					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.520760213	2.453272792	-1.070651419	4.263239179	6.597851509	-2.67774829	5.212553978	no	no	no	yes	yes	no	yes	3.782514747	NA	-0.285206451	NA	-0.821333484	4.956352019	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.702339345
BA3260R	BA3260D	2806	Waves3+4	no	no	no	no	Male	Male	White			5			72	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	n		n	n	y	y	n	n	n	n	MYELODYSPLASTIC SYNDROMES	Refractory cytopenia with multilineage dysplasia	NonAML	MYELODYSPLASTIC SYNDROMES	Refractory cytopenia with multilineage dysplasia	72	0			Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	308	Dead-Disease	NA	2		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	"46,XY[20]"	NA	NA	Normal	NA	NA		NA	NA	NA	NA	NA	negative	0	negative		ASXL1 (p.G646Wfs*12; 36.2%)		ASXL1 (G646Wfs*12; VAF 41%)|BRAF (G469A; VAF 50%)|ETV6 (VAF 48%)|KRAS (Y64N; VAF 10%)|SRSF2 (P95H; VAF 45%)		yes			yes		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	4.985486885	9.222877206	7.782535318	3.471966761	7.130443928	1.479667395	9.144815023	yes	yes	yes	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.90648429
BA3369R	BA3369D	2621	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		CBFB-MYH11	73	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Melanoma	n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	10	Dead-Unknown	NA		80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M4	27.5	9	"46,XY,inv(16)(p13.1q22)[cp20]"	NA	102.6	"CBFB/MYH11: 93/100 cells (93%) had the abnormal 1 red/ 1 green/ 2 yellow signal pattern, reflecting CBFB/MYH11 fusion, consistent with the metaphase karyotype and the diagnosis of AML. "	96	TRUE	"Myeloid blasts: CD13, CD33, CD34, dimCD38, CD117, dim HLA-DR, and MPO. | Promonocytes/monocytes: dimCD4, CD11b, bright CD13, variable CD14, bright CD33, CD64, variable HLA-DR positive"	FALSE	TRUE	NA	21.23	TRUE	negative	0	negative				EP300 (p.S1033L; VAF 50%)|FLT3-TKD (p.D835V; VAF 26%)|KRAS (p.G12V; VAF 19%)|WT1 (p.T225M; VAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	3.54397006	2.152706008	1.456443638	3.629309176	5.886843413	-2.707305721	5.227135906	yes	no	no	no	no	no	yes	1.197643788	NA	-0.402676748	NA	-1.960661786	5.353645989	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.649082205
BA3078R	BA3078D	2737	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			68	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with minimal differentiation	68	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	1	Standard Chemotherapy	1	"7+3 (Cytarabine, Idarubicin)"	1	Induction	Refractory	Standard Chemotherapy	6	Standard Chemotherapy	"7+3 (Cytarabine, Idarubicin)"	Induction	6	Dead	24	Dead-Disease	NA	74		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M0	19.9	6.8	"46,XY[20]"	NA	102.1	Normal	64	TRUE	"dimCD2, partial CD7, dimCD13, CD34, CD38, CD117, HLA-DR"	TRUE	FALSE	NA	38.83	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.572423223	1.100327312	2.689687498	1.840909006	5.008643732	-2.493836153	-0.500052309	no	no	no	no	no	no	no	-2.641115526	NA	-1.462231334	NA	-3.275528073	2.654597698	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.426623653
BA3386R	BA3386D	2654	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			63	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	4	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal|Targeted Therapy - Kinase Inhibitor(s)	5	"Fludarabine, Melphalan|Gilteritinib or Placebo|MIDAC, Midostaurin|7+3 (Cytarabine, Idarubicin) plus Midostaurin|Methotrexate"	5	Consolidation|Induction|CNS|Maintenance|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Gilteritinib or Placebo	Maintenance	734	Alive	1046	Alive	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	M1	27.9	9.2	"46,XX[20]"	NA	87.2		135	TRUE	"dim CD7, partial CD11b, dim CD13, variable CD25, CD33, partial CD34, CD117, HLA-DR, and MPO positive"	TRUE	TRUE	NA	40.36	TRUE	positive	32.33333333	positive				DNMT3A (p.G543C; VAF 49%)|FLT3-ITD (VAF 76%; VAR 13.3)|NPM1 (p.W288fs*12; VAF 45%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	3.602616205	0.252190376	5.292327329	0.395932963	6.041929479	0.295993387	-1.057221694	yes	no	yes	no	no	yes	no	-3.651898074	NA	0.073717201	NA	-2.180997078	0.38507238	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.292318333
BA3445R	BA3445D	2786	Waves3+4	yes	yes	yes	yes	Male	Male				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NA	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	1.601361911	1.90509897	2.967562526	3.104347426	5.522115109	-0.695382162	9.06667487	no	no	yes	no	no	yes	yes	-3.289532114	NA	-3.282761932	NA	4.012564808	-5.34120318	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.512069321
BA3176R	BA3176D	2765	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			53	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	53	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	3	"HiDAC|Vyxeos (Daunorubicin, Cytarabine - liposomal)|MEC (Cytarabine, Etoposide, Mitoxantrone) plus Midostaurin"	3	Consolidation|Salvage|Induction	Complete Response	Standard Chemotherapy	4	Standard Chemotherapy	"MEC (Cytarabine, Etoposide, Mitoxantrone) plus Midostaurin"	Salvage	-1	Dead	326	Dead-Disease	0	34	0	0.5	NA	46.5	2.7	50.3	0	10	11	3.3	0.63	M2	23.4	8.2	"47,XX,+4[3]/46,XX[17] "	NA	104.9	Normal	40	FALSE	"dim CD7, CD13, CD33, CD38, CD117 and HLA-DR+"	TRUE	TRUE	7	1.87	FALSE	negative	0	positive				DNMT3A (p.N879D; VAF 37%)|NPM1 (p.W288fs*12; VAF 28%)|PTPN11 (p.A461T; VAF 3%)|RAD21 (p.E534*; VAF 4%)|SMC1A (p.R496H; VAF 31%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.902424558	4.69576436	0.962688765	3.854289573	5.958911233	0.028593421	7.296871226	no	yes	no	yes	no	yes	yes	0.193770117	NA	-0.665363442	NA	1.524169707	-1.935586291	Monocyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.413632945
BA3258R	BA3258D	2739	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			66	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	66	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	5	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|MiDAC|HiDAC, Mitoxantrone, CPI-613|Methotrexate"	4	Consolidation|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	1130	Alive	0.2	90		0	NA	8.1	85.9	4	0.1	30	25	2.8	1.17	M5	30.8	10.1	"46,XX[20]"	363	86.8	Normal	130	TRUE	"partial CD7 and CD9, CD11b, dim CD13, CD14, CD15, CD33, CD38, partial CD56, CD64, HLA-DR+"	TRUE	TRUE	6.1	145.55	TRUE	negative	0	positive				DNMT3A (p.N797D; VAF 46%)|IDH2 (p.R140Q; VAF 46%)|NPM1 (p.W288fs*12; VAF 46%)|NRAS (p.Q61P; VAF 47%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	0.230814198	2.736165519	2.246470288	2.726861855	6.977312527	-2.618821697	2.948830076	no	no	no	no	yes	no	no	6.153934088	NA	-4.517465652	NA	2.568344766	4.296230097	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.709772116
BA3446R	BA3446D	2739	Waves3+4	no	no	no	no	Female	Female	White	NON-HISPANIC		1			66	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	67	366	Relapse|Post-Chemotherapy	Relapse	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	5	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|MiDAC|HiDAC, Mitoxantrone, CPI-613|Methotrexate"	4	Consolidation|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	1130	Alive	0	26		0	NA	7.9	21.1	22.8	0.1	35	39	2.7	0.66	M5	33.8	10.6	"46,XX,del(14)(q21q31)[20] "	775	90.1	Normal	14	FALSE	"Myeloid blasts: CD13, CD33, CD38, CD117, HLA-DR. | Blasts with monocytic features: CD11b, dim CD13, CD15, CD33, CD38, CD64, HLA-DR  "	FALSE	TRUE	5.7	39.23	TRUE	negative	0	positive				BCOR (p.E1093K; VAF 48%)|DNMT3A (p.N797D; VAF 46%)|FAT4 (p.D1836N; VAF 41%)|IDH2 (p.R140Q; VAF 47%)|KMT2D (p.P647T; VAF 67%)|NPM1 (p.W288fs*12; VAF 43%)|NRAS (p.Q61P; VAF 46%)|RBBP6 (p.P1416A; VAF 51%)					no		Found	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	0.962688765	3.40936163	0.986902066	2.294287283	6.606345231	-0.534916744	6.172970101	no	no	no	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.641676721
BA3295R	BA3295D	2763	Waves3+4	yes	yes	yes	yes	Male	Male	White	UNKNOWN		1		CBFB-MYH11	63	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	63	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin) plus Gemtuzumab Ozogamicin|HiDAC|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|FLAG-Ida-Mylotarg"	4	Consolidation|Induction|Re-induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	953	Alive	0.8	57	70	2.5	NA	20.9	46.7	8.3	0.1	90	90	3.2	1.66	M2	21	7.1	"46,XY,inv(16)(p13.1q22)[20]"	627	105.5	CBFB/MYH11: 91% of cells had the 1r1g2f dual-fusion signal pattern consistent with CBFB/MYH11 fusion and inv(16). 	27	FALSE	"Myeloid blast population, about 25%: CD13, CD33, CD34, CD117, HLA-DR and MPO.   | Atypical monocyte population, about 20%: dim CD4, partial CD9, bright CD11b, CD13, CD14, CD33, CD64, HLA-DR and MPO"	FALSE	TRUE	6.4	50.68	TRUE	negative	0	negative				NOTCH1 (p.V1739M; VAF 48%)|NRAS (p.Q61K; VAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	4.012780259	5.350809511	0.680294621	3.395114321	6.779521012	0.316215163	7.59447759	yes	yes	no	no	yes	yes	yes	5.694934388	NA	-0.347471299	NA	1.351111281	3.568623068	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.690518988
BA3283R	BA3283D	2723	Waves3+4	yes	yes	yes	yes	Male	Male				3		CBFB-MYH11	NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	NA	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	3.464588667	3.647506484	-0.551193393	5.757193645	6.415555152	-1.921727906	5.17806224	yes	yes	no	yes	yes	no	yes	1.842659943	NA	-0.172387178	NA	-1.880586347	4.312858481	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.761566909
BA3390R	BA3390D	2744	Waves3+4	yes	yes	yes	yes	Male	Male				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NA	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	2.316535318	3.763673587	3.450030757	3.538263063	7.146870014	-4.03086008	3.573747573	no	yes	yes	no	yes	no	no	5.805249084	NA	-4.297062136	NA	3.176230289	3.540157039	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.847366757
BA3275R	BA3275D	2639	Waves3+4	yes	yes	yes	yes	Male	Male				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NA	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	0.388888889	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	1.164885487	2.738714433	-0.308098294	3.343077242	6.123859813	-4.042783597	2.768544573	no	no	no	no	yes	no	no	-3.002389323	NA	-1.410957491	NA	-1.875862943	-4.43167417	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.377670422
BA3136R	BA3136D	2649	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		KMT2A_re	47	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute monoblastic and monocytic leukaemia 	47	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	HiDAC	Consolidation	133	Alive	529	Alive	0	95	60	0	NA	18.5	0	3.4	0.2	100	142	2.2	0.92	M5	23.7	8.2	"46,XY,t(10;11)(p12;q23)[8]/45,sl,-Y[12]"	3738	100.9	"86/100 cells (86%) had the abnormal 1 red/ 1 green/1 yellow signal pattern, reflecting MLL (11q23) rearrangement and consistent with the 10;11 translocation observed in the metaphase karyotype. "	32	TRUE	"dim CD4, CD9, CD11b, CD15, CD33, CD38, partial CD56, CD64, partial CD117, and partial HLA-DR+"	FALSE	TRUE	6.7	12.35	FALSE	negative	0	negative				FLT3 (p.I836del; VAF 3% (in frame deletion in the tyrosine kinase domain))|MLL (Partial tandem duplication (exon 11/3 breakpoint) )					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	4.179789841	2.326749366	-0.926284489	4.507864603	7.181545546	-3.993048051	6.366952257	yes	no	no	yes	yes	no	yes	-2.252211131	NA	-3.183128714	NA	2.813639346	2.054948057	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.529049778
BA3190R	BA3190D	2726	Waves3+4	yes	yes	yes	yes	Male	Male				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Unknown	NA	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative		ASXL1 (p.G646Wfs*12; 26.8%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	TRUE	2.011655413	5.370849517	3.528161439	4.561451145	6.42233933	-0.180095332	6.578211307	no	yes	yes	yes	yes	yes	yes	0.182260177	NA	1.581765096	NA	2.428446976	0.089484568	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.71790386
BA3234R	BA3234D	2688	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			75	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	Azacitidine	1	Induction	UNKNOWN	Standard Chemotherapy	8	Standard Chemotherapy	Azacitidine	Induction	8	Dead	91	Dead-Disease	0	80		0	NA	4.4	77.4	11.3	0.1	52	29	2.4	2.78	M5	31.4	10.1	"46,XY[20]"	747	99.1	Normal	39	TRUE	"Monocytic population (about 80%) : dim CD4, dim CD9, CD11b, partial CD13,  partial CD14, CD15, subset CD16, CD33, CD38, CD56, CD64, and HLA-DR. | Myeloid blasts phenotype (8%): CD33, CD56, CD117, HLA-DR, and MPO"	FALSE	TRUE	5.9	84.29	TRUE	negative	0	positive				NPM1 (p.W288fs*12; VAF 24%)|SRSF2 (p.P95R; VAF 48%)|TET2 (p.R506*; VAF 95%)		yes			yes		Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	TRUE	2.261333777	4.308013345	3.732390207	1.685176012	7.065966362	-0.722823053	2.736165519	no	yes	yes	no	yes	yes	no	8.238414459	NA	-3.936318548	NA	2.381087261	5.708990831	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.768492021
BA3087R	BA3087D	2693	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			31	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	31	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Fludarabine, Melphalan|5+2 (Cytarabine, Idarubicin)|7+3 (Cytarabine, Idarubicin)|Azacitidine"	4	Induction|Re-induction|Maintenance|Allogeneic - Matched Unrelated Donor	Refractory	Standard Chemotherapy	6	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Alive	1073	Alive	0	90		0.9	NA	26.1	1.7	0.9	0.9	13	10	3.8	0.97	M1	24.8	8.6	"46,XY,del(5)(q13q33),t(10;11)(p13;q21)[15]/46,XY[5] "	165	98	"93% of cells were missing a signal for both 5q probes (EGR1, 5q31; and 5q33) but had two signals for 5p, consistent with 5q deletion. "	196	TRUE	"partial CD7, CD13, CD33, CD34, dim CD38, CD56, CD117, HLA-DR, partial MPO, and dim TDT."	TRUE	TRUE	7.1	17.92	FALSE	negative	0	negative		ASXL1 (p.D821Efs*15; 26.7%)|ASXL1 (p.D821Wfs*6; 20.1%)		ASXL1 (p.D821fs*12; VAF 28%)|CREBBP (p.N970fs*21; VAF 8%)|JAK1 (p.T114A; VAF 49%)|KMT2D (p.R598H; VAF 49%)|WT1 (p.S165fs*35; VAF 45%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	2.583142494	1.744206884	0.680294621	2.393236193	4.934705374	-2.713314441	1.317843449	no	no	no	no	no	no	no	-9.237558952	NA	2.035660234	NA	-4.042636133	2.041703643	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.24810203
BA3454R	BA3454D	2679	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			82	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	82	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	14	Dead-Disease	0	50	50	0	NA	11	5	35	0.3	22	35	3.2	0.8	M2	29.4	9.4	"46,XX[20] "	574	98	Normal	71	TRUE	"CD13, CD33, CD117, and MPO"	FALSE	TRUE	5.9	87.73	TRUE	positive	0.960784314	positive				DNMT3A (p.R882C; VAF 48%)|FLT3-ITD (VAF 44%; Allelic ratio 0.77)|NPM1 (p.W288fs*12; VAF 48%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.262913855	1.539016813	6.188149436	3.515946526	5.985890216	-0.816169203	1.13465748	no	no	yes	no	no	yes	no	-1.648445348	NA	0.000716329	NA	0.029219535	-0.580838934	Not_Monoctyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.439347493
BA3302R	BA3302D	2805	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			65	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	65	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Targeted Therapy - Other|Targeted Therapy - Kinase Inhibitor(s)	5	"7+3 (Cytarabine, Idarubicin)|SY-1425 (Tamibarotene) plus Daratumumab|Pexidartinib|Azacitidine, BI 836858 (anti-CD33)|Ruxolitinib, Venetoclax"	2	Induction|Experimental|Re-Induction	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	"Ruxolitinib, Venetoclax"	Experimental	69	Dead	541	Dead-Disease	1.7	80	80	0	NA	12.9	1.7	7.8	1.4	41	47	3.5	1.4	M1	26.9	8.5	"46,XY[20] "	1042	95.4	Normal	29	FALSE	"partial CD10, CD13, CD33, CD34, subset CD79a, CD117, HLA-DR, partial MPO, and TDT+"	TRUE	TRUE	6.3	32.75	TRUE	negative	0	negative	RUNX1 (p.D198N; 47.7%)			CBL (p.V363_Q365del; VAF 31%)|RUNX1 (p.D198N; VAF 50%)|SF3B1 (p.K666N; VAF 51%)	yes				yes	yes	Found	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	1.844439662	1.572277307	1.399473865	1.474388626	4.205974553	-3.689319128	5.239657954	no	no	no	no	no	no	yes	-2.620996737	NA	4.198371371	NA	-3.17314215	-1.115240117	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.346201051
BA3242R	BA3242D	2805	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1			65	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	66	316	Residual Disease|Post-Chemotherapy	Residual	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Targeted Therapy - Other|Targeted Therapy - Kinase Inhibitor(s)	5	"7+3 (Cytarabine, Idarubicin)|SY-1425 (Tamibarotene) plus Daratumumab|Pexidartinib|Azacitidine, BI 836858 (anti-CD33)|Ruxolitinib, Venetoclax"	2	Induction|Experimental	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	"Ruxolitinib, Venetoclax"	Experimental	69	Dead	541	Dead-Disease	0.3	46	23	0.3	NA	43.8	21.3	21.7	3.9	12	22	3.9	0.94	M1	23.8	7.8	"46,XY[20]"	530	105.3	Normal	14	FALSE	"partial CD10, CD34, CD13, CD117, and HLA-DR"	FALSE	FALSE	5.8	10.24	FALSE	negative	0	negative	RUNX1 (p.D198N; 47.3%)			ATG2B (p.L1989V; VAF 51%)|CBL (p.V363_Q365del; VAF 34%)|FLT3-ITD (Allelic Ratio: ~0.013)|MED12 (p.N1049T; VAF 97%)|RTEL1 (p.S925Y; VAF 50%)|RUNX1 (p.D198N; VAF 47%)|SF3B1 (p.K666N; VAF 47%)|SH2B3 (p.S488Y; VAF 49%)	yes				yes	yes	Found	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	4.595808654	6.361822386	2.885208585	2.029156318	6.666754375	0.041398241	7.56094852	yes	yes	yes	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.552726339
BA3117R	BA3117D	2629	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1	bi		35	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	35	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	5	"7+3 (Cytarabine, Idarubicin)|HiDAC|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|FLAG (Fludarabine, High-dose Cytarabine, G-CSF)|Fludarabine, Cyclophosphamide, TBI "	4	Haploidentical - Parent|Consolidation|Induction|Re-induction	Complete Response	Standard Chemotherapy	5	Bone Marrow Transplant	"Fludarabine, Cyclophosphamide, TBI "	Haploidentical - Parent	-1	Alive	1064	Alive	0	85	53	0	NA	40.4	0	10.5	2.9	29	15	4.4	0.9	M1	23.3	7.6	"47,XY,del(9)(q13q22),+10[3]/46,XY[17] "	199	98.7		18	FALSE	"CD7, CD33, CD34, CD38, CD117, HLA-DR, and MPO positive"	TRUE	TRUE	7.4	4.18	FALSE	negative	0	negative	RUNX1 (p.R166Q; VAF 6%)			CEBPA (p.A111fs*56; 35% (likely underestimate VAF))|CEBPA (p.D322delinsETQQKVLELTSDND; VAF 37% (likely underestimate VAF))|GATA2 (p.P304H; VAF 32%)|RUNX1 (p.R166Q; VAF 6%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	1.894709615	3.605946262	0.827628838	4.842123184	4.567640213	-2.689817862	4.718245442	no	yes	no	yes	no	no	yes	-2.802615934	NA	-0.954031715	NA	-3.603612805	0.617800505	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.413748475
BA3083R	BA3083D	2692	Waves3+4	yes	yes	yes	yes	Female	Female				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	57	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	positive	5.666666667	positive									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	TRUE	NA	FALSE	FALSE	1.36067003	3.333737476	3.184847938	1.560156281	6.924992481	-0.180095332	6.459912266	no	no	yes	no	yes	yes	yes	2.6107325	NA	-3.929088645	NA	6.053823817	0.542072887	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.520927318
BA3266R	BA3266D	2672	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			83	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	83	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	28	Dead-Disease	0.9	75	52	0	NA	9.4	14.5	27.3	0.2	19	24	2.7	0.77	M2	20.5	6.5	"46,XX[20]"	333	95.8		273	TRUE	"dim CD4, CD7, partial CD9, CD13, CD25, CD33, partial CD34, CD38, CD117, CD123, HLA-DR and MPO-positive"	TRUE	TRUE	7	44.85	TRUE	positive	0.587301587	positive				BRAF (p.S87N; VAF 52%)|DNMT3A (p.R882C; VAF 47%)|FLT3-ITD (Allelic ratio: 0.464; VAF 31.7%)|IDH1 (p.R132H; VAF 32%)|IDH2 (p.R140Q; VAF 3%)|NPM1 (p.W288fs*12; VAF 42%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.930534563	3.132660267	-0.069657965	3.39814496	5.947571694	-0.649189872	4.088367032	no	no	no	no	no	yes	no	1.650783526	NA	1.653320164	NA	-0.749674071	2.844529915	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.533318595
BA3268R	BA3268D	2773	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			73	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	2	"Azacitidine, Ivosidenib|Ivosidenib"	2	Induction|Maintenance	Complete Response	Standard Chemotherapy	324	Targeted Therapy - Other	Ivosidenib	Maintenance	-1	Alive	1028	Alive	0	92	90	0	NA	17.7	1	0	9.6	23	39	2.7	0.85	M1	25.5	8.3	"46,X,-X,add(5)(q23),del(7)(q22),add(11)(p13),add(21)(q22),+mar1[9]/47,sl,add(3)(q28),+5,-add(5)(q23),+mar2[3]/46,XX[1] "	615	97.3	"D7S486/ CEP 7:  93/100 cells (90%) had a 1 red/ 2 green signal pattern, consistent with the deleted 7q observed in the metaphase karyotype.  | RUNX1T1/RUNX1:  10/200 cells (5%) had a 2 red/ 3 green signal pattern, suggesting low level presence of an extra copy of RUNX1 (21q22).  There was no evidence for RUNX1T1/RUNX1 fusion.  | EGR-1/ D5S23, D5S721: While this probe set showed a normal numeric signal pattern in interphase cells, metaphase FISH showed an EGR-1 (5q) signal on the add(11p) and a 5q33 signal on the add(21q).  (The G-banded chromosomes were not of adequate band length/morphology to establish specific breakpoints.  Therefore, it is possible that some or all of the apparently missing 5q material is actually accounted for on other chromosomes.  This probe set will not be useful for monitoring the abnormal 5q.)"	48	TRUE	"CD7, dim CD13, CD33, CD34, CD38, CD117, partial HLA-DR, and partial MPO"	TRUE	TRUE	5.8	11.49	FALSE	negative	0	negative				DNMT3A (Splice site; VAF 46%)|IDH1 (p.R132S; VAF 44%)|STAG2 (p.F437fs*11; VAf 48%)					no		Found	TRUE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.152257105	1.706039969	3.444616701	4.23854264	3.974234977	-5.203063766	-2.837666896	no	no	yes	yes	no	no	no	-8.474281278	NA	2.85406679	NA	-8.234513737	-3.615213949	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.351967255
BA3229R	BA3229D	2619	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			56	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	56	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"HAM (Cytarabine, Mitoxantrone)|Azacitidine|Vyxeos (Daunorubicin, Cytarabine - liposomal)|MBG453 (TIM-3 inhibitor)|Decitabine, Ruxolitinib"	4	Salvage|Induction|Maintenance|Re-induction	Refractory	Standard Chemotherapy	5	Standard Chemotherapy	"Decitabine, Ruxolitinib"	Salvage	-1	Dead	164	Dead-Disease	2.5		35	2.5	NA	3.4	12.6	41.2	0.9	17	27	3.3	1.31		29.1	8.7	"49,XY,+10,+13,+21[6]/51,idem,+9,+15[14]"	363	105.8	"Chromosome 9:  With all chromosome 9 probes (ABL, ASS and NUP214) ~20% of cells had three signals, consistent with trisomy 9.  | PML (15q24): 17% of cells had three signals, consistent with trisomy 15.  | RUNX1 (21q22):  69% of cells had three signals, consistent with trisomy 21. "	112	FALSE	"partial CD11b, CD13, partial CD25, CD33, CD34, CD38, partial CD56, CD117 and HLA-DR positive"	FALSE	TRUE	7.2	85.46	TRUE	negative	0	negative	RUNX1 (p.S322*; 49.8%)	ASXL1 (p.G646Wfs*12; 37.6%)		ASXL1 (p.G646fs*12; VAF 36%)|BRAF (p.G469R; VAF 36%)|CREBBP (p.F1703fs*33; VAF 12%)|CSF3R (p.T618I; VAF 5%)|EZH2 (p.F672L; VAF 73%)|FLT3 (p.V491L; VAF 53%)|NRAS (p.G12D; VAF 10%)|RUNX1 (p.G199E; VAF 7%)|RUNX1 (p.S322*; VAF 52%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	FALSE	5.103157571	6.310689736	4.999926136	1.950096804	6.71095851	-1.192589773	6.510045959	yes	yes	yes	no	yes	no	yes	5.086524888	NA	1.296461293	NA	2.967511831	1.475409439	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.751656692
BA3138R	BA3138D	2619	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1			56	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	56	48	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"HAM (Cytarabine, Mitoxantrone)|Azacitidine|Vyxeos (Daunorubicin, Cytarabine - liposomal)|MBG453 (TIM-3 inhibitor)|Decitabine, Ruxolitinib"	4	Salvage|Induction|Maintenance|Re-induction	Refractory	Standard Chemotherapy	5	Standard Chemotherapy	"Decitabine, Ruxolitinib"	Salvage	-1	Dead	164	Dead-Disease	1.7			0.3	NA	14.3	16	67.7	NA	20	21	3.6	1.1		27.9	8.6	"49,XY,+10,+13,+21[1]/51,sl,+9,+15[1]/49,sl,+8,-10[12]/46,XY[6] "	201	106.9	"Chromosome 9:  With all chromosome 9 probes (ABL, ASS and NUP214) ~20% of cells had three signals, consistent with trisomy 9.  | PML (15q24): 17% of cells had three signals, consistent with trisomy 15.  | RUNX1 (21q22):  69% of cells had three signals, consistent with trisomy 21. "	31	FALSE		NA	NA	7.1	16.7	FALSE	negative	0	negative	RUNX1 (p.S322*; 17.2%)	ASXL1 (p.G646Wfs*12; 31.3%)							no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	TRUE	TRUE	5.066716822	7.133591612	5.680011002	2.962371469	6.858955929	-0.514774106	5.855422004	yes	yes	yes	no	yes	yes	yes	NA	NA	NA	NA	NA	NA							0.718279381
BA3388R	BA3388D	2619	Waves3+4	no	no	no	no	Male	Male	White	NON-HISPANIC		1			56	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	56	55	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	5	"HAM (Cytarabine, Mitoxantrone)|Azacitidine|Vyxeos (Daunorubicin, Cytarabine - liposomal)|MBG453 (TIM-3 inhibitor)|Decitabine, Ruxolitinib"	4	Salvage|Induction|Maintenance|Re-induction	Refractory	Standard Chemotherapy	5	Standard Chemotherapy	"Decitabine, Ruxolitinib"	Salvage	-1	Dead	164	Dead-Disease	2.6			0	NA	2.6	10.4	40.9	2.5	20	23	3.5	1.3		29.9	9	"49,XY,+10,+13,+21[1]/51,sl,+9,+15[1]/49,sl,+8,-10[12]/46,XY[6] "	254	110.3	"Chromosome 9:  With all chromosome 9 probes (ABL, ASS and NUP214) ~20% of cells had three signals, consistent with trisomy 9.  | PML (15q24): 17% of cells had three signals, consistent with trisomy 15.  | RUNX1 (21q22):  69% of cells had three signals, consistent with trisomy 21. "	43	FALSE		NA	NA	7.3	23.94	TRUE	negative	0	negative	RUNX1 (p.S322*; 17.2%)	ASXL1 (p.G646Wfs*12; 37.2%)							no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	TRUE	TRUE	TRUE	5.254196585	7.419905092	5.473591179	2.84794513	6.799899913	-1.518043713	5.753781149	yes	yes	yes	no	yes	no	yes	NA	NA	NA	NA	NA	NA							0.694368967
BA3353R	BA3353D	2696	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			71	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	71	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	2	"Venetoclax (ABT-199), Azacitidine|Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	2	Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	103	Bone Marrow Transplant	"Bu/Flu/TBI (Busulfan, Fludarabine, Total Body Irradiation)"	Allogeneic - Matched Unrelated Donor	-1	Dead	972	Dead-Other	1	98	44.8	3.8	NA	39.4	1	7.7	0.4	44	22	3.4	0.7	M1	30	9.5	"46,XX,del(5)(q13q33)[14]/46,XX[6]"	NA	107.5	"5q:  96% of cells were missing a signal for EGR1 (5q31) and 5q33, consistent with deletion, as seen on metaphase analysis. "	100	TRUE	"CD7, CD13, CD33, dim CD38, CD117, HLA-DR and variable MPO +"	TRUE	TRUE	6.4	4.92	FALSE	negative	0	negative				DNMT3A (p.R749H; VAF 42%)|ETV6 (p.R378Q; VAF 52%)|JAK2 (p.V617F; VAF 3%)|KMT2D (Partial tandem duplications (exon 9/exon3))|STAT3 (p.D661Y; VAF 38%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	0.562030007	1.723828981	1.361764058	2.134894412	3.560951078	-0.891707138	3.166990042	no	no	no	no	no	yes	no	-5.693048161	NA	3.310338134	NA	-1.74189687	-4.637371786	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.222974963
BA3312R	BA3312D	2703	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1	bi		43	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated CEBPA	43	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|HiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	HiDAC	Consolidation	132	Dead	472	Dead-Disease	0	70	68	1.7	NA	14.8	5.2	9.6	0.1	25	24	2.9	0.84	M2	16.5	5.5	"46,XY,t(2;12)(p13;q13)[20]"	1024	102.5	Normal	21	FALSE	"CD13, CD33, variable CD34, CD117, and HLA-DR positive (CD7, dim CD15, and MPO expression was noted on the prior flow cytometric analysis and was not tested in the current assay)"	TRUE	TRUE	7	79.15	TRUE	negative	0	negative				CEBPA (p.G36fs*122; VAF 45%)|CEBPA (p.Q311_Q312linsRKAKQRNVETQ; VAF 45%)|DNMT3A (p.R19P; VAF 48%)|EZH2 (p.K30fs*17 (loss of function); VAF 65%)|GATA2 (p.R362Q; VAF 47%)|NRAS (p.G13D; VAF 43%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.66937549	4.388170118	1.046216879	2.083415254	5.022017225	-0.470048586	8.184160358	no	yes	no	no	no	yes	yes	0.287250421	NA	-2.296288491	NA	2.594860271	0.955165264	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.461881012
BA3119R	BA3119D	2778	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			61	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	2	"7+3 (Cytarabine, Idarubicin)|MiDAC"	2	Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	MiDAC	Consolidation	101	Alive	784	Alive	0.8	90	65	0	NA	30.2	3.1	6.2	5.3	21	13	3.4	0.5	M1	31.3	10.8	"46,XX[20] "	NA	95.7	Normal	104	TRUE	"CD33, CD38, CD117, MPO positive"	FALSE	TRUE	7.7	4.68	FALSE	negative	0	positive				ASXL1 (p.L1395V; VAF 50%)|IDH1 (p.R132H; VAF 45%)|KMT2D (p.R3167W; VAF 48%)|NPM1 (p.W288fs*12; VAF 48%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	1.923986914	1.637454821	-1.173606791	3.678995048	3.865404352	-2.52260439	-1.030400299	no	no	no	no	no	no	no	-7.654073799	NA	-0.30587103	NA	-0.607608561	-4.739709741	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.154983267
BA3219R	BA3219D	2731	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			73	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	73	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Leukapheresis	y	y	y	y	y	y	1	Standard Chemotherapy	1	Cytarabine	1	Induction	Refractory	Standard Chemotherapy	1	Standard Chemotherapy	Cytarabine	Induction	1	Dead	4	Dead-Disease	0.4	90		0.4	NA	13.9	80	1.8	0.1	130	186	2.1	6.6	M5	17.8	6	"46,XY[15]"	1072	89.4	Normal	35	TRUE	"dim CD9, CD11b, variable CD13, partial CD14, dim CD15, dim CD16, CD33, CD38, dim CD56, CD64, CD123, and HLA-DR"	FALSE	TRUE	6.3	104.23	TRUE	negative	0	positive				CCND1 (p.R245W; VAF 48%)|DNMT3A (p.P633R; VAF 46%)|NPM1 (p.W288fs*12; VAF 46%)|NRAS (p.G13D; VAF 6%)|PTPN11 (p.T73I; VAF 33%)|TET2 (p.N926fs*28; VAF 16%)					no		Found	FALSE	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	2.398131803	3.109368232	2.3905136	4.262866018	6.373585661	-3.458680576	0.609653767	no	no	no	yes	yes	no	no	4.712468996	NA	-4.619223895	NA	0.724980762	5.204578311	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.760460879
BA3351R	BA3351D	2623	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1		PML-RARA	72	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA	72	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	1	Standard Chemotherapy	1	"ATRA, Arsenic Trioxide"	1	Induction	Complete Response	Standard Chemotherapy	-1	Standard Chemotherapy	"ATRA, Arsenic Trioxide"	Induction	-1	Alive	927	Alive	0	95		0.9	NA	52.3	0	3.8	0.4	45	44	3.4	0.67	M3	20.4	7.2	"46,XX,t(15;17)(q22;q21)[20] "	506	94	positive for PML/RARA fusion	93	FALSE	"CD7, CD11b, CD13, CD15, CD16, CD33, CD38, CD56, CD64, CD117, CD123, and MPO positive"	TRUE	TRUE	6.5	5.6	FALSE	positive	0.03092784	negative				FLT3-ITD (allelic ratio 0.03; VAF 3.09%)|NRAS (p.A146T; VAF 19%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	1.608277517	1.929655182	5.23139219	4.980903249	5.695268191	-2.488577871	6.952775244	no	no	yes	yes	no	no	yes	-4.437374663	NA	-4.84087781	NA	5.19422649	-6.398297254	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.52031528
BA3357R	BA3357D	2788	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1	mono		75	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with maturation	75	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	4	"Gilteritinib (ASP2215)|Venetoclax (ABT-199), Azacitidine|Gilteritinib, Decitabine|PIM kinase inhibitor"	3	Salvage|Induction|Re-induction	Refractory	Standard Chemotherapy	-1	Targeted Therapy - Other	PIM kinase inhibitor	Salvage	21	Dead	583	Dead-Disease	0	48		2.6	NA	15	4.4	25.7	1.3	22	13	3.4	1.15	M2	25.7	8.7	"47,XY,+21[2]/46,XY[18]"	190	86.5	"RUNX1 (21q22): 19/200 cells (9.5%) had three signals for RUNX1, consistent with trisomy 21. "	16	FALSE	"dimCD7, dimCD11b, dimCD13, CD33, varibleCD34, CD38, CD117, partial HLA-DR, and MPO positive "	TRUE	TRUE	6.1	10.15	FALSE	positive	0.162790698	negative				CEBPA (p.R300_D301delinsQY; VAF 85%)|FLT3-ITD (VAF 15%; allelic ratio 0.18)|GATA2 (p.G320S; VAF 30%)|NOTCH1 (p.A929D; VAF 52%)|RAD21 (p.E447fs*19; VAF 3%)|RAD21 (p.N462fs*1; VAF 3%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	3.814731348	4.914761726	2.250111559	4.057242878	4.525878061	-0.976484324	5.762180197	yes	yes	no	yes	no	no	yes	-1.414280142	NA	-0.807895373	NA	0.023005943	-2.494057422	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.392359305
BA3208R	BA3208D	2620	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			70	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	n	n	y	y	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	70	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"Ruxolitinib, Vyxeos (Daunorubicin, Cytarabine - liposomal)"	1	Induction	Refractory	Standard Chemotherapy	43	Standard Chemotherapy	"Ruxolitinib, Vyxeos (Daunorubicin, Cytarabine - liposomal)"	Induction	43	Dead	84	Dead-Disease	0	85	78	0.9	NA	19.3	0	0	1.2	30	34	3.5	0.81	M1	28.1	9.5	"46,XX[18]"	623	110.6	Normal	57	FALSE	"variable CD11b, CD13, CD33, CD34, variable CD38, dim variable cCD79a, CD117, HLA-DR, cMPO, and cTdT positive"	TRUE	TRUE	6.7	27.26	TRUE	negative	0	negative				"DNMT3A (p.R882H; VAF 47%)|FLT3-ITD (allelic ratio 0.03; VAF 3%)|KMT2A (PTD, exon 9/3 break)|TET2 (p.H578fs*2; VAF 36%)|TET2 (p.Y1345fs*14; VAF 27%)|WT1 (p.D367_V374delinsWS; VAF 3%)|WT1 (p.R370fs*6; VAF 5%)|WT1 (p.R380fs*5; VAF 2%)|WT1 (p.R380fs*5; VAF 47%)|WT1 (p.T377fs*73; VAF 23%)|ZRSR2 (p.R452C; VAF 48%)"				yes	yes		Found	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	-0.68144834	0.91026955	1.950937219	2.842422378	5.292721338	-2.996770219	0.843813627	no	no	no	no	no	no	no	-5.059694	NA	2.154817277	NA	-3.263537581	1.453599576	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.427384487
BA3310R	BA3310D	2716	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			82	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	82	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Dead	17	Dead-Disease	0	90	70	0	NA	1.7	0	16.7	0.2	11	38	1.9	0.7	M1	25.7	7.8	"46,XY[20]"	421	88.6	Normal	23	TRUE	"dim CD13, CD33, CD117 and MPO"	FALSE	TRUE	6.4	44.35	TRUE	negative	0	positive				CBL (p.G838V; VAF 48%)|CREBBP (p.N1615S; VAF 48%)|FLT3 (p.D839G; VAF 6%)|FLT3 (p.N676K; VAF 2%)|FLT3-ITD (Allelic ratio 0.01)|IDH2 (p.R140Q; VAF 46%)|KIT (p.D816V; VAF 4%)|KMT2D (p.F4579S; VAF 49%)|NPM1 (p.W288fs*12; VAF 46%)|SRSF2 (p.P95_R102del; VAF 45%)		yes			yes		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	2.583768981	4.769951631	0.483801055	2.236016563	4.343078332	-1.296592903	2.455968127	no	yes	no	no	no	no	no	-1.77701507	NA	0.946293611	NA	-0.262302702	-6.216933444	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.299014644
BA3200R	BA3200D	2665	Waves3+4	yes	yes	yes	yes	Female	Female	Asian	NON-HISPANIC		1			76	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	76	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	2	"SY-1425 (Tamibarotene) plus Azacitidine|Ruxolitinib, Venetoclax"	2	Salvage|Induction	Complete Response i	Targeted Therapy - Other	357	Standard Chemotherapy	"Ruxolitinib, Venetoclax"	Salvage	37	Dead	425	Dead-Disease	NA		predominant	NA	NA	NA	NA	NA	0.1	NA	NA	NA	0.56	M1	21.8	7.3	"46,XX[8]"	411	97.3	Normal	10	FALSE	"CD33, CD38, CD56, CD117, and cMPO positive"	FALSE	TRUE	NA	97.67	TRUE	negative	0	positive				NPM1 (p.W288fs*12; VAF 50%)|PHF6 (p.R274*; VAF 45%)|PRDM1 (p.P467L; VAF 48%)|TET2 (p.H1382R; VAF 50%)|TET2 (p.K1720*; VAF 48%)					no		Found	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	3.081389854	1.744206884	-0.874344283	3.848664311	4.56407532	-3.254984414	-2.077222414	yes	no	no	yes	no	no	no	-8.10511568	NA	-1.193577214	NA	0.747158765	-7.170851102	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.228363118
BA3325R	BA3325D	2782	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			56	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	57	0	Post-Chemotherapy|Residual Disease	Residual	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Targeted Therapy - Other|Targeted Therapy - Kinase Inhibitor(s)	6	"7+3 (Cytarabine, Idarubicin)|Gilteritinib (ASP2215)|Venetoclax (ABT-199), Azacitidine|CSF1R inhibitor|IMGN779 (Immunogen Trial)|Decitabine"	4	Salvage|Induction|Experimental|Re-induction	Refractory	Standard Chemotherapy	6	Targeted Therapy - Kinase Inhibitor(s)	Gilteritinib (ASP2215)	Experimental	-1	Dead	568	Dead-Disease	0			1	NA	22	2	17	27.3	20	52	2.6	0.5		19.9	6	"46,XY[20]"	1243	94.8		11	FALSE		NA	NA	5.8	26.1	TRUE	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	TRUE	1.426744801	3.297552693	1.859285774	2.349371591	5.337218856	0.18182155	4.347954656	no	no	no	no	no	yes	no	-0.08398933	NA	4.974653208	NA	-0.046300652	0.137969986	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.530873321
BA3146R	BA3146D	2776	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			42	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	42	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"HIDAC + Gemtuzumab Ozogamicin|7+3 (Cytarabine, Daunorubicin) plus Gemtuzumab Ozogamicin plus Midostaurin|Busulfan, Cyclophosphamide"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Sibling	-1	Dead	140	Dead-Treatment	0	70		1	NA	22	30	5	0	NA	NA	NA	0.95	M2	23.6	8	"46,XY[20]"	1811	98.7	Normal	18	TRUE	"CD7, CD13, CD25, CD33, partial CD34, CD117, dim CD123, HLA-DR, and MPO."	TRUE	TRUE	NA	22.79	TRUE	positive	0.176470588	positive				DNMT3A (p.R882H; VAF 45%)|FLT3-ITD (allelic ratio 0.85; VAF 45.9%)|NPM1 (p.W288fs*12; VAF 69%)					no		Found	FALSE	FALSE	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.696432296	1.01268719	1.038589712	2.717494698	6.111189099	-0.725312818	1.507099664	no	no	no	no	yes	yes	no	1.672610378	NA	-0.909907227	NA	0.463896729	3.049618026	Monocyte_Like		Not_HSC_Like		Promono_Like	cDC_Like	0.531728016
BA3211R	BA3211D	2697	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			69	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	y	y	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	69	0	Initial Acute Leukemia Diagnosis|Post-Chemotherapy	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Targeted Therapy - Other	4	"Gilteritinib (ASP2215)|Azacitidine|RVD (Bortezomib, Dexamethasone, Lenalidomide)|7+3 (Cytarabine, Daunorubicin) plus Gemtuzumab Ozogamicin plus Midostaurin"	3	Salvage|Induction|Maintenance	Refractory	Standard Chemotherapy	6	Targeted Therapy - Other	Gilteritinib (ASP2215)	Salvage	-1	Dead	76	Dead-Disease	0	90	78	0	NA	35	31	7	0	12	8	2	0.87	M0	21.6	7.4	"46,XY,del(20)(q11.2)[cp20]"	198	87.8	"CEP 3:  16/100 cells (16%) had three signals, reflecting trisomy 3. "	15	TRUE	"CD43+ and dim CD45+ with dim CD13, dim CD33, dim CD38, partial CD11b, variable HLA-DR, and partial, dim CD117"	FALSE	TRUE	4.9	5.79	FALSE	positive	0.176470588	negative	RUNX1 (p.R346Pfs*254; 37.7%)|RUNX1 (p.X269_splice; 43.5%)			FLT3-ITD (allelic ratio 0.84; VAF 45.7%)|KMT2A (PTD (exon 11/exon 3))|RUNX1 (splice site; VAF 43%)|U2AF1 (p.S34F; VAF 44%)			yes		yes	yes	Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	FALSE	4.847741882	2.761737646	5.311447479	4.883287719	6.622989664	-2.325231175	4.024941179	yes	no	yes	yes	yes	no	no	-2.485207546	NA	1.005503007	NA	-1.548279454	1.954608305	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.499890382
BA3237R	BA3237D	2760	Waves3+4	yes	yes	yes	yes	Male	Male				3			NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	76	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative		ASXL1 (p.C594Mfs*25; 38.2%)							no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	TRUE	FALSE	FALSE	FALSE	NA	TRUE	FALSE	4.016817129	5.537225968	2.636326831	5.119580014	6.214966691	-0.880516778	5.425650141	yes	yes	no	yes	yes	yes	yes	3.786960447	NA	0.297712357	NA	1.807516038	-0.340393204	Monocyte_Like		HSC_Like		Promono_Like	Not_cDC_Like	0.721633468
BA3130R	BA3130D	2610	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1			61	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	n		y	n	n	n	y	y	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with myelodysplasia-related changes	61	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|7+3 (Cytarabine, Idarubicin)|HiDAC"	3	Allogeneic - Sibling|Consolidation|Induction	Complete Response	Standard Chemotherapy	-1	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Sibling	-1	Dead	110	Dead-Treatment	0	20	20	0	NA	20.5	55.4	15.2	0.1	160	228	2.1	2.11	M2	22.3	7.6	"48,XY,+7,+mar[4]/46,XY[16] "	NA	99.1	"Chromosome 7: 44% of cells had three signals for both chromosome 7 probes, consistent with trisomy 7"	23	TRUE	"CD4, dim CD7, CD11b, CD13, variable CD14, CD16, dim CD33, dim CD 38, dim CD56, CD64."	TRUE	TRUE	4.6	69.09	TRUE	negative	0	negative				BRAF (p.V600E; VAF 36%)|TET2 (p.A1355V; VAF 48%)|TET2 (p.Q803*; VAF 44%)|ZRSR2 (Splice site; VAF 92%)				yes	yes	yes	Found	FALSE	TRUE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	3.232408718	4.236648699	4.116634861	4.756222067	6.917333013	4.0684852	7.270225477	yes	yes	yes	yes	yes	yes	yes	8.326394339	NA	-4.33845493	NA	-0.34610074	0.59637286	Monocyte_Like		Not_HSC_Like		Not_Promono_Like	cDC_Like	0.941099468
BA3376R	BA3376D	2781	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1	N/A		58	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	58	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Targeted Therapy - Other	4	"Gilteritinib or Placebo|HiDAC + Midostaurin|7+3 (Cytarabine, Daunorubicin) plus Gemtuzumab Ozogamicin plus Midostaurin|Busulfan, Cyclophosphamide"	4	Allogeneic - Sibling|Consolidation|Induction|Maintenance	Complete Response	Standard Chemotherapy	6	Targeted Therapy - Other	Gilteritinib or Placebo	Maintenance	-1	Alive	803	Alive	0.9	91		0	NA	4.3	1.7	1.7	0.2	49	90	2.8	0.69	M1	19.7	6.5	"46,XX[20]"	1122	98	Normal	26	TRUE	"CD11b, CD13, CD33, variable CD34, CD38, CD117, CD123, and MPO positive"	FALSE	TRUE	6.9	145	TRUE	positive	1.040816327	positive				CEBPA (p.G242S; VAF 47%)|FLT3-ITD (allelic ratio 1.03; VAF 51%)|NPM1 (p.W290fs*10; VAF 49%)|SYNE1 (p.A2715G; VAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.535019163	1.095167045	4.127338634	1.78469624	5.63016664	0.495809485	2.007637126	no	no	yes	no	no	yes	no	-3.41044567	NA	1.776765557	NA	-1.561509189	-0.37084537	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.407669798
BA3137R	BA3137D	2759	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1		CBFB-MYH11	39	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	39	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	7	"Ruxolitinib|7+3 (Cytarabine, Idarubicin) plus Gemtuzumab Ozogamicin|FLAG-IDA (Cytarabine, Filgrastim, Fludarabine, Idarubicin)|Venetoclax (ABT-199), Azacitidine|MEC (Cytarabine, Etoposide, Mitoxantrone)|HIDAC + Gemtuzumab Ozogamicin|Busulfan, Cyclophosphamide"	6	Consolidation|Salvage|Induction|Re-induction|Maintenance|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	Ruxolitinib	Maintenance	-1	Dead	751	Dead-Other	3.4	36	28	5.2	NA	19.8	38.8	6.9	0	NA	NA	NA	1.17	M4	22.1	7.6	"46,XY,inv(16)(p13.1q22)[20] "	415	90.2		13	FALSE	"CD13, CD33, CD34, CD38, CD117, HLA-DR, MPO  (the monocytic cells show an aberrant immunophenotype: CD11b, CD13, variable CD14, variable CD15, CD33, CD64, HLA-DR positive)"	FALSE	TRUE	NA	20.76	FALSE	negative	0	negative				CUX1 (p.V88I; VAF 50%)|NRAS (p.G13D; VAF 6%)|NRAS (p.Q61H ((different allele from p.Q61K); VAF 3%)|NRAS (p.Q61K (different allele from p.Q61H); VAF 18%)|PTPN11 (p.G60R; VAF 3%)|USH2A (p.R2557T; VAF 48%)					no		Found	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	2.738714433	2.843610145	1.163684756	4.017986879	6.559145862	-2.183717161	6.969120439	no	no	no	yes	yes	no	yes	3.612929494	NA	1.535283181	NA	-0.408637891	4.785438524	Monocyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.715295833
BA3300R	BA3300D	2595	Waves3+4	yes	yes	yes	yes	Male	Male	Declined	UNKNOWN		1			0	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	Intermediate	ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE	"Mixed phenotype acute leukaemia, T/myeloid, NOS"	0	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	3	Standard Chemotherapy|Bone Marrow Transplant|Intrathecal	5	"Cytarabine|Cytarabine, Mitoxantrone, Gemtuzumab ozogamicin|Cytarabine, Daunorubicin, and Etoposide|Clofarabine, Cytarabine|Busulfan, Cyclophosphamide"	3	Induction|Intensification|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	28	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Dead	314	Dead-Disease	0	90	92	0.9	NA	13	3.5	2.6	0.1	NA	NA	NA	0.21		NA	6	"46,XY,t(3;12)(q29;p13),ins(12;?)(p13;?)[20]"	NA	75.1	ETV6 is disrupted by the insertion of unidentified material within the locus.  Any fusion partners with the ETV6 rearrangements were not identified in this study. 	90	TRUE	"cCD3, CD7, CD11b, dim CD13, CD33, CD34, CD56, C117, MPO"	TRUE	TRUE	NA	95.48	TRUE	negative	0	negative				FAT4 (p.S2691L; VAF 50%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	6.047756593	7.911113486	1.535019163	2.095141958	3.831304671	-0.006757303	3.713833237	yes	yes	no	no	no	yes	no	-5.118823601	NA	-0.256979482	NA	-5.165824866	-5.789228818	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.391487544
BA3375R	BA3375D	2749	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			63	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	63	1	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Peripheral Blood	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"Fludarabine, Melphalan|MiDAC|7+3 (Cytarabine, Daunorubicin) plus Gemtuzumab Ozogamicin plus Midostaurin"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	7	Bone Marrow Transplant	"Fludarabine, Melphalan"	Allogeneic - Matched Unrelated Donor	-1	Dead	171	Dead-Treatment	0.8	95	85	0.8	NA	9.2	2.3	4.6	0.3	NA	NA	NA	0.64	M1	26.9	8.8		476	94.1	Normal	30	TRUE	"dim CD13, CD33, CD117 and MPO-positive"	FALSE	TRUE	NA	62.54	TRUE	positive	0.754385965	positive				CHD2 (p.P1353L; VAF 50%)|CHEK2 (p.T410fs*15; VAF 51%)|FLT3 (p.N676K; VAF 4%)|FLT3-ITD (p.F594delinsLPSDNEYFYVDF (33-nucleotide internal tandem duplication); allelic ratio 0.85; VAF 46%)|IDH1 (p.R132S; VAF 47%)|KMT2A (p.F798L; VAF 49%)|NPM1 (p.W288fs*12; VAF 48%)|PLCG2 (p.Y206F; VAF 50%)					no		Found	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.062011926	2.168790458	1.653275016	3.846960485	5.611759574	-0.991836124	1.894709615	no	no	no	yes	no	no	no	-4.216322881	NA	-1.964909461	NA	3.589852102	-8.32601949	Not_Monoctyte_Like		Not_HSC_Like		Promono_Like	Not_cDC_Like	0.358042922
BA3249R	BA3249D	2774	Waves3+4	yes	yes	yes	yes	Female	Female				3		KMT2A_re	NA	FALSE	unknown	unknown	unknown	FALSE	FALSE	n		n	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	NonInitial	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	"Acute myeloid leukaemia, NOS"	28	0	Unknown	Unknown	Peripheral Blood	y	y	y	y	y	y	0		0		0				NA	NONE	NONE	NONE	NA	Unknown	0		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA		NA	NA		NA	NA		NA	NA	NA	NA	NA	negative	0	negative									no		Found	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	FALSE	FALSE	FALSE	NA	FALSE	FALSE	1.868945705	2.709889173	-0.963685424	2.997879764	4.174100486	0.10465675	1.627545444	no	no	no	no	no	yes	no	-8.166908268	NA	-0.952153915	NA	-3.810985065	-4.484441357	Not_Monoctyte_Like		Not_HSC_Like		Not_Promono_Like	Not_cDC_Like	0.352877145
BA3385R	BA3385D	2594	Waves3+4	yes	yes	yes	yes	Female	Female	White	NON-HISPANIC		1			50	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	Favorable	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	50	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	2	Standard Chemotherapy|Bone Marrow Transplant	3	"HiDAC|7+3 (Cytarabine, Daunorubicin) plus Crenolanib|Busulfan, Cyclophosphamide"	3	Consolidation|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Bone Marrow Transplant	"Busulfan, Cyclophosphamide"	Allogeneic - Matched Unrelated Donor	-1	Dead	264	Dead-Disease	0	88		0	NA	23.5	48.7	9.5	0.1	20	14	2.9	0.65	M4	20.5	6.8	"46,XX[20]"	409	97.2	Normal	29	FALSE	"Myeloid blasts immunophenotype:  CD7, partial CD13, CD33, partial CD34, CD117, HLA-DR and MPO | Monoblasts immunophenotype: dim CD4, CD11b, partial CD13, CD14, CD15, bright CD33, CD64, HLA-DR"	TRUE	TRUE	6.9	31.8	TRUE	positive	0.492537313	positive				DNMT3A (p.S714C; VAF 43%)|FLT3-ITD (p.E596delinsQVTGSSDNEYFYVDFRE (48-nucleotide internal tandem duplication); VAR 0.79; VAF 44%)|NPM1 (p.W288fs*12; VAF 44%)|WT1 (p.S381fs*4; VAF 43%)					no		Found	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE	FALSE	FALSE	1.907788417	3.923280222	2.454556883	4.1566116	6.478138032	-1.036537236	5.731709462	no	yes	no	yes	yes	no	yes	1.997369998	NA	0.70334019	NA	2.060416168	2.909514488	Monocyte_Like		HSC_Like		Promono_Like	cDC_Like	0.58740853
BA3416R	BA3416D	2607	Waves3+4	yes	yes	yes	yes	Male	Male	White	NON-HISPANIC		1	mono		54	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	n		y	n	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	Intermediate	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML without maturation	54	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	y	y	y	y	1	Standard Chemotherapy	1	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)"	1	Induction	Refractory	Standard Chemotherapy	3	Standard Chemotherapy	"FLAG (Fludarabine, High-dose Cytarabine, G-CSF)"	Induction	3	Dead	24	Dead-Disease	0	92	85	0	NA	33.3	2.6	0	0	NA	NA	NA	1.75	M1	23.9	7.8	"46,XY[20]"	528	89.5	RUNX1:  17/200 (8.5%) interphase cells had three RUNX1 (21q22) signals. There was no evidence for RUNX1T1/RUNX1 fusion.	8	TRUE	"Partial immunophenotype: CD33, cCD79a, CD117, HLA-DR, and cMPO"	TRUE	TRUE	NA	4.67	FALSE	negative	0	negative				CBL (p.Q490E; VAF 52%)|CEBPA (p.K304_T318dup; VAF at least 70%)|CHD2 (p.R1354K; VAF 49%)|DOCK8 (p.E766K; VAF 46%)|FAT1 (p.E38K; VAF 49%)|GATA2 (p.R307L; VAF 41%)|RUNX1 (p.I366_G367dup; VAF 46%)					no		Found	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	3.152697015	4.676371669	-0.171048827	1.816067625	2.119186009	-1.70562639	0.33112955	yes	yes	no	no	no	no	no	-7.523228726	NA	0.530188265	NA	-7.417559081	-4.343997841	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	Not_cDC_Like	0.194820794
BA3123R	BA3123D	2611	Waves3+4	yes	yes	yes	no	Male	Male	White	NON-HISPANIC		1			69	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	y	Prostate Cancer	y	y	n	n	n	n	n	n	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	Adverse	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	Therapy-related myeloid neoplasms	69	0	Initial Acute Leukemia Diagnosis	Initial Diagnosis	Bone Marrow Aspirate	y	y	n	y	y	n	2	Standard Chemotherapy|Bone Marrow Transplant	4	"Busulfan, Fludarabine|Venetoclax (ABT-199), Azacitidine|7+3 (Cytarabine, Daunorubicin) plus Glasdegib/placebo|MiDAC plus Glasdegib/placebo"	4	Consolidation|Salvage|Induction|Allogeneic - Matched Unrelated Donor	Complete Response	Standard Chemotherapy	6	Standard Chemotherapy	"Venetoclax (ABT-199), Azacitidine"	Salvage	149	Dead	468	Dead-Disease	0	60		0	NA	24.3	2.9	11.4	0	31	22	4.2	0.55	M2	33.3	10.9	"46,XY[20]"	256	109.2		21	FALSE	"variable CD5, CD7, CD11b (partial), CD13, CD33 (dim), CD34, CD38 (dim), CD117, and HLA-DR"	TRUE	TRUE	7.1	9.32	FALSE	negative	0	negative		ASXL1 (p.T514Nfs*15; 34.3%)		ASXL1 (p.T514fs*15; VAF 37%)|BLM (p.N936D; VAF 50%)|CSF3R (p.R311C; VAF 50%)|KMT2A (p.D2911N; VAF 50%)|MSH2 (p.V437M; VAF 41%)|PCLO (p.D2885N; VAF 47%)|PRPF40B (p.P751S; VAF 51%)|SRSF2 (p.P95H; VAF 37%)|TCF3 (p.H344R; VAF 49%)|TET2 (p.Q1030*; VAF 43%)|TET2 (p.R1359L; VAF 40%)		yes			yes		Found	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	3.864126404	3.836991222	1.941731631	4.952979609	5.290149278	-0.991836124	1.677635095	yes	yes	no	yes	no	no	no	-1.278732459	NA	4.14550341	NA	-5.485898047	2.88388382	Not_Monoctyte_Like		HSC_Like		Not_Promono_Like	cDC_Like	0.557342261